measure_id,measure_name,location_id,location_name,sex_id,sex_name,age_id,age_name,cause_id,cause_name,metric_id,metric_name,year,val,upper,lower
1,Deaths,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.11802290823,1.69341687965,0.701603108929
1,Deaths,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.11802290823,1.69341687965,0.701603108929
1,Deaths,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000799887673547,0.000964916945602,0.000662170521539
1,Deaths,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000603851589203,0.000749062295369,0.000473080861273
1,Deaths,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.073288565528,0.111006754009,0.0459914417182
1,Deaths,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0422142992869,0.0639400198769,0.026491124111100002
1,Deaths,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,11.3306133629,18.038110747,3.80574093222
1,Deaths,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,11.3306133629,18.038110747,3.80574093222
1,Deaths,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000912926875514,0.00139474285001,0.000320854596764
1,Deaths,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000516430511299,0.000819366003829,0.0001772012611
1,Deaths,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.43770052761600003,0.696810520161,0.147015413963
1,Deaths,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.21426369351600003,0.341103531548,0.0719671638756
1,Deaths,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.1457229448,9.65141369922,4.90188285278
1,Deaths,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.1457229448,9.65141369922,4.90188285278
1,Deaths,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000576594208164,0.000748423524286,0.000434483621116
1,Deaths,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000326130886954,0.000433795100958,0.000240718389071
1,Deaths,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.276038604704,0.372833202677,0.18935927317
1,Deaths,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.13512675280300002,0.182509761882,0.0926953812275
1,Deaths,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.4661808534,21.2368653271,4.16323580843
1,Deaths,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.4661808534,21.2368653271,4.16323580843
1,Deaths,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000823957576327,0.00131152988081,0.000287282937975
1,Deaths,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000446153130083,0.000719180483832,0.000153327748222
1,Deaths,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.408649530692,0.696158282265,0.136473582349
1,Deaths,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.204797791866,0.34888496936700003,0.0683947642516
1,Deaths,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.91257072692,8.76332004704,3.80689039878
1,Deaths,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.91257072692,8.76332004704,3.80689039878
1,Deaths,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00039046363256,0.000553859052041,0.000267483421982
1,Deaths,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000211440406211,0.000305089207574,0.000141790637255
1,Deaths,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.193817920754,0.287267340868,0.124792347645
1,Deaths,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0971333115865,0.143966192706,0.0625406254502
1,Deaths,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3.72083223823,6.90603819312,2.32192619952
1,Deaths,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.01841331328,1.56560881511,0.630385622962
1,Deaths,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4.73924555151,8.20393337554,3.20310849728
1,Deaths,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00245747046192,0.00459403510042,0.00173107213661
1,Deaths,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00116639180444,0.00163216285094,0.000863440100349
1,Deaths,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00198501452826,0.00339703179204,0.00149151693955
1,Deaths,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.497251986025,0.9229228804809999,0.31030219590400004
1,Deaths,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.134563024747,0.206864005984,0.0832928979587
1,Deaths,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.31487723367500003,0.545072378814,0.21281571756999998
1,Deaths,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.7931291265,30.2950203754,15.5078092327
1,Deaths,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.7931291265,30.2950203754,15.5078092327
1,Deaths,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000839690240929,0.00115536714323,0.000610236858542
1,Deaths,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00046963490169,0.000644952282707,0.000336860097323
1,Deaths,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.314334556353,0.43696211471699997,0.223677853092
1,Deaths,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155420830882,0.21605328959399997,0.11059616919200001
1,Deaths,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.421865815873,0.591784347347,0.286588843696
1,Deaths,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.421865815873,0.591784347347,0.286588843696
1,Deaths,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0002577330167,0.000360617491745,0.000177660570108
1,Deaths,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000155680190001,0.000215786205111,0.000106303311164
1,Deaths,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0925680273514,0.129852449737,0.0628848390263
1,Deaths,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.044929481982199995,0.0630261167675,0.0305222367034
1,Deaths,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.894245372967,1.20837280882,0.590692945716
1,Deaths,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.894245372967,1.20837280882,0.590692945716
1,Deaths,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000546130101699,0.000725593989761,0.000372153555264
1,Deaths,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000329895299756,0.000432169629723,0.000222196237936
1,Deaths,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.196220046823,0.265147549313,0.129612968622
1,Deaths,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0952387699135,0.128693917115,0.062909880495
1,Deaths,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.779838425945,1.11751265816,0.500197261863
1,Deaths,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.779838425945,1.11751265816,0.500197261863
1,Deaths,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00131843429917,0.00181231192133,0.000911700646315
1,Deaths,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000941226513969,0.00129615254205,0.000636119905474
1,Deaths,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.1627301005,0.23319310914000002,0.10437694269100001
1,Deaths,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0843689734016,0.1209011926,0.0541152219198
1,Deaths,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.32793100166,4.45097799775,2.4121976917
1,Deaths,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.32793100166,4.45097799775,2.4121976917
1,Deaths,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00562918236761,0.00706126160042,0.0043339101012
1,Deaths,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00401794637334,0.00513274390549,0.0030715001998
1,Deaths,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.694444552025,0.9287925200909999,0.50335705415
1,Deaths,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.360041404501,0.48154134473199994,0.26097026784
1,Deaths,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.1792697205,12.2362548248,6.6412619508
1,Deaths,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.1792697205,12.2362548248,6.6412619508
1,Deaths,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000353457562618,0.0004482392954,0.000269464834623
1,Deaths,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000197761641224,0.000253827815508,0.000146606344007
1,Deaths,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.132397768971,0.176490384168,0.0957906557067
1,Deaths,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0654632805857,0.0872646089832,0.047363113599
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0833250012773,0.132520410222,0.0538982977276
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0833250012773,0.132520410222,0.0538982977276
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000738337052631,0.00112915984462,0.000516190768596
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000457617304789,0.000702846138655,0.000321267897182
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.29716476917699997,0.47261201933800007,0.19221932142499998
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.153889457926,0.24474640000700001,0.09954251057020001
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.120678254352,0.171712294711,0.0784099624572
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.120678254352,0.171712294711,0.0784099624572
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00107018137575,0.00142631881747,0.000733250708781
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000663301910773,0.000888443012879,0.000450723928014
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.430378938488,0.612383362023,0.279636100062
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.222875617893,0.31712825139100004,0.14481207841000002
1,Deaths,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26.4331847351,41.8816307659,15.077573816
1,Deaths,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.79748557577,4.60561236913,1.6041379723
1,Deaths,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29.2306703109,44.4652085842,17.7864587094
1,Deaths,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0188996574602,0.0251275079118,0.0126910369721
1,Deaths,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00629847158273,0.00828809748701,0.00455944614179
1,Deaths,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0158164009007,0.0208552212125,0.0109035975268
1,Deaths,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.73274641988,2.74542195711,0.9883641457479999
1,Deaths,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.249121997454,0.410139506289,0.142851873594
1,Deaths,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.1036913964600001,1.6789169606599998,0.671580953922
1,Deaths,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,28.7032846424,52.8119642717,10.5342238097
1,Deaths,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.63262371574,14.0483219177,3.24058842923
1,Deaths,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,37.3359083581,61.8432364876,19.811768559
1,Deaths,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0161607609429,0.0296092538224,0.00600130731402
1,Deaths,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00826832770074,0.0129413716589,0.00329839952374
1,Deaths,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0132344245938,0.0218486099813,0.00698104032792
1,Deaths,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7708720067500001,3.25827619783,0.6499173279229999
1,Deaths,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.515659441304,0.8391596888589999,0.19357266967
1,Deaths,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.13312520103,1.87690973272,0.601276765945
1,Deaths,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,178.814630364,271.070823904,80.9182926775
1,Deaths,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,18.2241994699,27.4981092226,11.9194343962
1,Deaths,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,197.038829834,290.092301748,100.301897324
1,Deaths,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0068772923967,0.0101361483041,0.00316709793047
1,Deaths,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00089192665252,0.00136142307419,0.000592069727632
1,Deaths,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00424173671385,0.0060466471626,0.00218532618721
1,Deaths,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.57914396683,3.9098069248100003,1.16713003819
1,Deaths,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.257080308986,0.38790304217099997,0.168141919352
1,Deaths,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.40521071899,2.06883492079,0.715317388829
1,Deaths,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,37.1739816498,54.5807211003,24.1090789811
1,Deaths,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.69595399671,3.81698627345,1.75156084324
1,Deaths,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,39.8699356465,57.2462412092,26.7178850842
1,Deaths,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0207510609021,0.0268566594804,0.0150103075302
1,Deaths,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00328039748109,0.00419102614723,0.00246225916098
1,Deaths,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0152413288821,0.0197799259263,0.0112201185898
1,Deaths,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.92020517443,2.81934241181,1.24534354825
1,Deaths,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.14143896725,0.20025215459299997,0.09189287244739999
1,Deaths,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.03773152487,1.49000062879,0.695410995281
1,Deaths,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.58034321506,3.56148636327,1.6205395215
1,Deaths,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.58034321506,3.56148636327,1.6205395215
1,Deaths,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00107192109387,0.0013961499335,0.000705705896818
1,Deaths,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000775397748235,0.0010198867826,0.000503147590005
1,Deaths,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.18599569339299998,0.256718223289,0.116811349053
1,Deaths,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.09503435261609999,0.131169973401,0.0596846665264
1,Deaths,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,11.895458085,15.1963503767,9.17271369911
1,Deaths,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,11.895458085,15.1963503767,9.17271369911
1,Deaths,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00494240202337,0.00596609975571,0.00405933782533
1,Deaths,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00357463813823,0.00431318864554,0.00291457136627
1,Deaths,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.857445614921,1.09537975757,0.661185393789
1,Deaths,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.43811115962499997,0.559683421859,0.337832154669
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0589623859415,0.0982498449696,0.0394056617099
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0589623859415,0.0982498449696,0.0394056617099
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000608118182857,0.000987070379022,0.000437639474475
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000379119549734,0.000607625989593,0.000262174787182
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.303687344185,0.506038451616,0.202959913501
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155446882321,0.2590233052,0.103888049318
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0807208228965,0.108581214417,0.0552540980434
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0807208228965,0.108581214417,0.0552540980434
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00083371902532,0.00108288415004,0.000591197210912
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000519681828548,0.000683957161199,0.000357379170463
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.415754755077,0.5592504459950001,0.284587708285
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.212810252795,0.286260655675,0.145670449714
1,Deaths,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,15.0824587955,22.9162117623,8.94865116946
1,Deaths,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.16130736285,9.26405690875,3.21955426633
1,Deaths,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,21.2437661584,30.0868202017,12.6216249503
1,Deaths,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00121622574234,0.00178017317686,0.000737096525508
1,Deaths,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000646820993487,0.000913878878212,0.000354370399289
1,Deaths,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000969102653857,0.00129652093528,0.000593981971833
1,Deaths,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.582633963503,0.885251103187,0.345685552306
1,Deaths,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.228239255653,0.343177401914,0.119265056263
1,Deaths,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.40172298316800004,0.568946535908,0.23867692713400002
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0297935528964,0.0384138415811,0.0218354715055
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0297935528964,0.0384138415811,0.0218354715055
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00030900943014,0.000382829314378,0.000251226073868
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000210876331151,0.000264788085864,0.000165485829157
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.101262874797,0.130561670305,0.0742148016008
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.051437377922199996,0.0663199616951,0.0376980685669
1,Deaths,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.947515867914,1.45404140945,0.567781340164
1,Deaths,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.947515867914,1.45404140945,0.567781340164
1,Deaths,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000676477691301,0.000889211568324,0.000569990657878
1,Deaths,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000511073041615,0.000687483865541,0.000390342333594
1,Deaths,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.062111499025100006,0.0953152286347,0.0372191657684
1,Deaths,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.035776295935300004,0.054901682946,0.021438282925
1,Deaths,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11.7724499426,21.0205665962,5.77437971865
1,Deaths,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.21756397324,4.01168913722,1.09557673723
1,Deaths,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,13.9900139159,23.426772159,7.2618193554
1,Deaths,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000775909862939,0.00130347433946,0.000397647104884
1,Deaths,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000173335306367,0.000304250190516,8.54355332751e-05
1,Deaths,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000499645115427,0.000796992614638,0.000275506654156
1,Deaths,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.385908579438,0.689067868936,0.189287929464
1,Deaths,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.0730305528375,0.13211608731000002,0.036080390807800004
1,Deaths,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.2298317337,0.38486135129399995,0.119299133103
1,Deaths,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,25.9247646262,36.3594561127,18.3680078471
1,Deaths,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.09083965909,7.99646722289,4.08558009872
1,Deaths,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,32.0156042853,42.3133308781,24.2656910473
1,Deaths,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0107709450302,0.0148735381999,0.00785690816048
1,Deaths,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00663521097564,0.00841819089978,0.00458626777081
1,Deaths,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00962603788244,0.0125117698585,0.00744101038862
1,Deaths,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.86870279293,2.62085377309,1.32399842619
1,Deaths,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.45869747221900004,0.602209138168,0.30768258051799996
1,Deaths,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.17913857703,1.55840509261,0.8937083353890001
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.301131883647,0.379008421195,0.223384068535
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.301131883647,0.379008421195,0.223384068535
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00313157038194,0.00384450740461,0.00237946792571
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00213400332442,0.00262350402754,0.00162578063059
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.02349257697,1.28818078313,0.7592418749900001
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.519892157792,0.654342886346,0.385663663378
1,Deaths,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.2243450638,3.06991223288,1.49451946639
1,Deaths,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.2243450638,3.06991223288,1.49451946639
1,Deaths,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000560585542003,0.000786552181917,0.000379065665967
1,Deaths,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000371367027515,0.000518341340131,0.000247959479781
1,Deaths,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.127218693202,0.175579872417,0.0854772115056
1,Deaths,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0636846884327,0.0878939186409,0.0427892273204
1,Deaths,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.3927463016,2.28022874811,0.742254331218
1,Deaths,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.331981744523,0.494159229787,0.185373139381
1,Deaths,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.72472804613,2.60820460486,1.05218385596
1,Deaths,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00245172588169,0.00380653934153,0.00136316185049
1,Deaths,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000830066627107,0.00121269172405,0.000480660499432
1,Deaths,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00178089669114,0.00261224435753,0.00110872822538
1,Deaths,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.68830963781,1.12691264872,0.36682977315799997
1,Deaths,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.167812468213,0.24979108462799998,0.09370371887369999
1,Deaths,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.430996682958,0.651770889733,0.26293290284299997
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.43660618653,0.531385711498,0.341957250632
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.43660618653,0.531385711498,0.341957250632
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00340550525086,0.00405291579936,0.00269597510348
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00231533223967,0.00274645696397,0.00182621352606
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8958780887050001,1.09035746691,0.701666667963
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.440851587316,0.5365527141349999,0.345282319367
1,Deaths,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,15.6733935455,22.8828371496,11.6190516966
1,Deaths,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,15.6733935455,22.8828371496,11.6190516966
1,Deaths,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00119877573055,0.0016917336309,0.000895389048487
1,Deaths,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000775493915365,0.00109565561245,0.000575820437299
1,Deaths,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.116634886018,0.170284571428,0.0864641576405
1,Deaths,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.058627035600700005,0.0855942846278,0.0434615870193
1,Deaths,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,36.6243617894,45.788067971,28.6656880629
1,Deaths,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,36.6243617894,45.788067971,28.6656880629
1,Deaths,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00280198905529,0.00349770047209,0.00222658185831
1,Deaths,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00181277415372,0.00226115968151,0.00142037282744
1,Deaths,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.272543291305,0.340735787263,0.21331814646
1,Deaths,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.136995077438,0.17127233379499998,0.10722529934
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.231495087656,0.425214019118,0.138291503125
1,Deaths,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.104295630261,0.175612349723,0.05639592712
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.335790717917,0.551243039535,0.217696151059
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00239739353686,0.00431409814997,0.00149214764536
1,Deaths,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00178498706747,0.00278161890491,0.00106537682179
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00216506769598,0.00352984845042,0.00147546046266
1,Deaths,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.1923216342,2.1900761666,0.7122740818050001
1,Deaths,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.5632912616569999,0.9484664102489999,0.304589299286
1,Deaths,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.885269810218,1.4532826399199998,0.573928402573
1,Deaths,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,11.7334961501,15.5223207911,8.57146936397
1,Deaths,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,11.7334961501,15.5223207911,8.57146936397
1,Deaths,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00136267362284,0.00165243785599,0.00110780897018
1,Deaths,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00104207276129,0.00129607612541,0.000838791071889
1,Deaths,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.518584474172,0.686038880686,0.37883260676200003
1,Deaths,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.25921824374,0.342921554049,0.189362250294
1,Deaths,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.64543480381,3.62641074908,1.84962371851
1,Deaths,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.64543480381,3.62641074908,1.84962371851
1,Deaths,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00148676311373,0.00202583057996,0.00108399561767
1,Deaths,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000936475155414,0.00128004785852,0.00068074099802
1,Deaths,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.163212207178,0.22373429941900003,0.11411400844700001
1,Deaths,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0802875562883,0.110059660787,0.0561351079976
1,Deaths,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.42785124671,2.31578505165,0.492051034698
1,Deaths,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.42785124671,2.31578505165,0.492051034698
1,Deaths,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00145095207777,0.00232404799549,0.000505434648678
1,Deaths,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000850323926382,0.00136112636221,0.00029071247437
1,Deaths,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.583873614467,0.946965443042,0.20120836592299998
1,Deaths,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.293612899764,0.47620112095899997,0.10118178028899999
1,Deaths,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.618915621747,1.10716446583,0.391554934513
1,Deaths,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.618915621747,1.10716446583,0.391554934513
1,Deaths,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00062809578677,0.0011205537995,0.000408073962729
1,Deaths,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000368553138617,0.00067330148797,0.000230480900466
1,Deaths,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.25308553811400003,0.452739121084,0.16011373411899998
1,Deaths,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12726928721,0.227669212796,0.08051649638189999
1,Deaths,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.72768270409,8.11945480493,4.21344838021
1,Deaths,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.72768270409,8.11945480493,4.21344838021
1,Deaths,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00035634184172,0.000491180226546,0.000268008624386
1,Deaths,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000214765679237,0.00029809479715,0.000159462373639
1,Deaths,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0638507038983,0.0905135517013,0.0469704169757
1,Deaths,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.031165210907800004,0.0441792142696,0.0229260268424
1,Deaths,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,25.4521136167,32.5838593939,18.5249449995
1,Deaths,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,25.4521136167,32.5838593939,18.5249449995
1,Deaths,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00158420162017,0.00202154805699,0.00119276750817
1,Deaths,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000954494425559,0.00121501804617,0.000713420619995
1,Deaths,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.283733484218,0.363236314844,0.206511226094
1,Deaths,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.138488902039,0.177293838131,0.10079710203799999
1,Deaths,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.57864345992,2.40033065448,1.08054281943
1,Deaths,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.57864345992,2.40033065448,1.08054281943
1,Deaths,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000881946735601,0.00135539763378,0.000708564942965
1,Deaths,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000603459425027,0.000910497293916,0.000459989831845
1,Deaths,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0815441124621,0.12398799209900001,0.055814949623
1,Deaths,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0410888068496,0.0624756160219,0.028124282859100003
1,Deaths,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.80330656641,5.28553131832,2.65619389547
1,Deaths,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.80330656641,5.28553131832,2.65619389547
1,Deaths,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00212718380324,0.00259603614585,0.00170442154302
1,Deaths,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00145539724342,0.00184190672404,0.00112533312314
1,Deaths,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19645807698399997,0.273021724782,0.13720449185199998
1,Deaths,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.098992161856,0.13757139021599998,0.0691352041781
1,Deaths,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,16.2004993811,21.0904313755,11.4532524107
1,Deaths,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.37871990979,3.08886767511,1.79676865257
1,Deaths,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18.5792192909,23.4332154812,13.9128653672
1,Deaths,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0274141972095,0.0326033970204,0.0213397592899
1,Deaths,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100718322703,0.0118072233081,0.00861601828946
1,Deaths,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0224509218669,0.0262155792081,0.0178722733819
1,Deaths,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.38058347054,4.400973205660001,2.38996804189
1,Deaths,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.534427330824,0.693976327386,0.403680261449
1,Deaths,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.01004413995,2.53518712066,1.5052017559700002
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,13.6749331679,23.8626600775,6.87988521569
1,Deaths,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.00136619437,1.90676641458,0.461889108915
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14.6762993622,25.2868648873,7.68784117787
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00452373368552,0.00783113599178,0.00234153237729
1,Deaths,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000469823377729,0.000869951907773,0.000217485564048
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00285033537439,0.00484803121771,0.0015060705466
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.99599141354,5.22798348034,1.50728905065
1,Deaths,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.217896242455,0.41491038874100006,0.100506589727
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.6022125543199999,2.76056868164,0.8392821205640001
1,Deaths,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.87266991213,2.97890556872,1.05677071854
1,Deaths,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.247506349381,0.417164035857,0.12592638289
1,Deaths,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2.12017626151,3.21678379069,1.22311243396
1,Deaths,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00190249410908,0.00286014034596,0.00108336157898
1,Deaths,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000356353353465,0.000594703824491,0.00017947308555
1,Deaths,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00126285959446,0.00190093122742,0.000723911443593
1,Deaths,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.765767829681,1.2181271442500001,0.432132227024
1,Deaths,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.10237857989799999,0.172555822032,0.0520882162589
1,Deaths,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.435977558298,0.661475919762,0.251511905949
1,Deaths,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.313028333681,0.400250758306,0.234676875696
1,Deaths,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.313028333681,0.400250758306,0.234676875696
1,Deaths,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000724934514158,0.000908913143048,0.000552915485242
1,Deaths,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000492437745201,0.000616223025299,0.00037178621719
1,Deaths,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.21676364312299998,0.277162809874,0.162507380512
1,Deaths,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.109874613063,0.14049014886199998,0.0823728338218
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.195689358115,0.312081855155,0.136367764545
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.195689358115,0.312081855155,0.136367764545
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00146817781126,0.00230943821302,0.00105995645525
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000906108246244,0.00140342033289,0.000645535360958
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.131766857423,0.21013940517,0.0918228357483
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0670905698288,0.10699482944399999,0.0467526242498
1,Deaths,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10.2814425176,15.1967488371,5.17157558343
1,Deaths,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.752669010906,1.05743342381,0.393901175838
1,Deaths,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,11.0341115285,15.8916813155,5.69189034777
1,Deaths,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00628161189665,0.00893302590014,0.00304564472461
1,Deaths,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000701434655381,0.000981078288695,0.000369173250154
1,Deaths,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0040725623323,0.00576152057359,0.00206609466763
1,Deaths,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.25600846613,3.33455096164,1.13477445208
1,Deaths,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.155762757966,0.218832905396,0.0815167525507
1,Deaths,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.17515308531,1.6924931636199998,0.6061967459840001
1,Deaths,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2.5546651258,3.39242266409,1.92972066342
1,Deaths,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.295338461468,0.396286419383,0.20574181327
1,Deaths,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2.85000358727,3.65026779712,2.1862440895
1,Deaths,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0059175932968,0.0077470881072,0.00455148448339
1,Deaths,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0014482841978,0.00190247306228,0.00103678226864
1,Deaths,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00448429571337,0.00567401465641,0.00352363606576
1,Deaths,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7690364099499998,2.34916081568,1.33627929553
1,Deaths,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.21022628839399998,0.28208253904299996,0.146450068021
1,Deaths,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0003664451,1.28126344688,0.7673833246
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.166481477453,0.206395148685,0.125518777729
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.166481477453,0.206395148685,0.125518777729
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00129889044794,0.0015972487534,0.000988445144523
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000882983284307,0.00108012140384,0.000671288381045
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.341605575977,0.423504973191,0.257553663135
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16810028318,0.20840206052799998,0.12673927696600001
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.363517362811,0.628787833199,0.215877979876
1,Deaths,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.15372749317,0.262679574868,0.07973229171
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.517244855981,0.812337661388,0.322519988551
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00322641105376,0.00533345377117,0.00205231130774
1,Deaths,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00221123158669,0.00343633627791,0.00125829764476
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0028409368831,0.00430217519382,0.00186356877852
1,Deaths,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2964242610899999,2.2424673081299997,0.769892938217
1,Deaths,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.588858631288,1.00620345609,0.30541737979100003
1,Deaths,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.955277879166,1.50027243261,0.595648670236
1,Deaths,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.62862357197,6.93420294819,2.31894743223
1,Deaths,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.62862357197,6.93420294819,2.31894743223
1,Deaths,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00305763121194,0.00416886795178,0.00165604575615
1,Deaths,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00193910881483,0.00273739575239,0.00101496043083
1,Deaths,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.618569211499,0.926686818089,0.309904113471
1,Deaths,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.307527468291,0.46071101789100005,0.154071728203
1,Deaths,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.13629902738,1.64249300446,0.778095292094
1,Deaths,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.13629902738,1.64249300446,0.778095292094
1,Deaths,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000750305521092,0.000994357957073,0.000587198379178
1,Deaths,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00047579437337,0.000652419694954,0.000357752007447
1,Deaths,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.151854991546,0.21950274997900002,0.103984647664
1,Deaths,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0754961291792,0.109127844919,0.0516969400398
1,Deaths,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.439929289458,0.593799855631,0.31562398453
1,Deaths,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.439929289458,0.593799855631,0.31562398453
1,Deaths,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00500719826221,0.00609682981731,0.00398141746384
1,Deaths,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00346800537218,0.00435178017939,0.00271666272969
1,Deaths,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.439467716515,0.593176841994,0.315292832468
1,Deaths,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.225691533539,0.304629864944,0.161920705889
1,Deaths,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.8605412517,3.98457147577,2.04216399273
1,Deaths,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.8605412517,3.98457147577,2.04216399273
1,Deaths,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000720358901479,0.000974744690252,0.000512838235701
1,Deaths,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00047725813224,0.00064204348955,0.000341103090503
1,Deaths,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16360515542999998,0.22789268822,0.116799069842
1,Deaths,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0818994684451,0.11408130739300001,0.058468706012499996
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,18.3702048165,48.1291269478,6.55783060893
1,Deaths,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.21172447681,21.2975639293,2.5761861385
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,24.5819292933,52.5241909337,9.99666957492
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00160668605613,0.00409566271848,0.000595775758592
1,Deaths,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000735402179213,0.0024607048503,0.00032893813981
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00123852375258,0.00261706336484,0.000526972566969
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.888839025368,2.32871907066,0.31729944359400003
1,Deaths,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.316243824275,1.08427588665,0.13115568141
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.609824533024,1.30301164837,0.247995764799
1,Deaths,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,68.1193953909,102.883702543,37.5275535545
1,Deaths,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.27488383057,8.5263051436,2.09545344306
1,Deaths,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,72.3942792215,106.903039293,41.3202475119
1,Deaths,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00533080782984,0.00773557021768,0.00305846186938
1,Deaths,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000396217041151,0.000774389296927,0.00020111336481
1,Deaths,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00306934240263,0.00439530071706,0.00176306897768
1,Deaths,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.2213713140799998,3.3550342630600003,1.22377232615
1,Deaths,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.141563975622,0.28235098340299997,0.0693915277906
1,Deaths,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.18946268189,1.7564533715600001,0.6789057498800001
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.363728043352,0.466951995931,0.260584318393
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.363728043352,0.466951995931,0.260584318393
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00273247312093,0.0033134006369,0.00204009018463
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00168506294861,0.00207204465562,0.00125230126803
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.244915215066,0.314420761884,0.17546368928300002
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.124701322168,0.160090849045,0.0893393007051
1,Deaths,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,68.6356046388,87.5011982819,51.5652994115
1,Deaths,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.39370355281,8.39691912622,4.71336343835
1,Deaths,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,75.0293081916,93.8801079601,57.9237481494
1,Deaths,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0900023405852,0.10624377363,0.0708631245217
1,Deaths,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0279629050251,0.0345180169158,0.0226798151964
1,Deaths,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0756491050398,0.0886580689776,0.0601758252617
1,Deaths,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,22.8266149829,29.100875183299998,17.1494261956
1,Deaths,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.22700485718,2.92474925135,1.6417219197200001
1,Deaths,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,12.7648378558,15.9719499604,9.85464575044
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5.61209727129,7.80713558532,3.91413367387
1,Deaths,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.715402388504,0.963601706401,0.511017747679
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,6.32749965979,8.61205461326,4.65305392431
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00482306871898,0.0065609947522,0.00343795160024
1,Deaths,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00132630682308,0.00177411543728,0.000981609156434
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00371509910337,0.00495139145272,0.0027746066655
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.59426420025,2.21782270843,1.11191287136
1,Deaths,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.203513369951,0.274119619548,0.145371256242
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.899375102318,1.2240960751399999,0.661373539987
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.54210419297,2.62490283272,0.908182675313
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.54210419297,2.62490283272,0.908182675313
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000509741586543,0.000874685920537,0.000306059318719
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000299359690513,0.000512273698241,0.000177665639501
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.337854003688,0.5750804228190001,0.19897044203199998
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.16835161487699998,0.286560812685,0.09914636163280001
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.83035521503,2.46030262304,1.22920136928
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.83035521503,2.46030262304,1.22920136928
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000604788405994,0.000794868555768,0.000411195123874
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00035526069322,0.000475220987224,0.000239481285991
1,Deaths,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.40100587261599996,0.539018761031,0.269301261122
1,Deaths,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.199819997671,0.268591397106,0.134191993297
1,Deaths,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.525196899007,0.756407218817,0.36128128025
1,Deaths,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.212951629388,0.32513771635,0.133666787132
1,Deaths,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.738148528395,1.00521627042,0.543922822782
1,Deaths,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00398588810594,0.00554682793862,0.00291157213229
1,Deaths,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00281889006432,0.00413930075583,0.00194010032794
1,Deaths,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00355878839816,0.00478325237383,0.00273710791023
1,Deaths,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.09188567192,1.57257250743,0.751104688899
1,Deaths,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.49068326318200006,0.749182507316,0.307995085444
1,Deaths,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.806728608038,1.09860914358,0.594457734214
1,Deaths,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34.1607117764,58.6067027057,24.8329295044
1,Deaths,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.11480862599,4.26946720726,2.19502363542
1,Deaths,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,37.2755204024,62.1576680923,27.8639267152
1,Deaths,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0159049685563,0.0273161580474,0.0116285755959
1,Deaths,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00331445218315,0.00446601487031,0.00236642826274
1,Deaths,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120715364677,0.0199126350301,0.00904093467571
1,Deaths,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.78319040623,4.77488917032,2.02322397753
1,Deaths,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.261982202081,0.35909892227,0.184620371482
1,Deaths,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.54264831247,2.57239659579,1.15314928033
1,Deaths,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.634426050064,0.870462625472,0.371586712455
1,Deaths,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.634426050064,0.870462625472,0.371586712455
1,Deaths,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000832463894659,0.00108876817705,0.000496791196527
1,Deaths,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000639759572699,0.000844412167264,0.000386427583423
1,Deaths,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.210995433874,0.289495740778,0.123581148044
1,Deaths,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.107935763447,0.148092985815,0.0632185508329
1,Deaths,6,China,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,321.815955439,386.452263208,240.108118591
1,Deaths,6,China,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,321.815955439,386.452263208,240.108118591
1,Deaths,6,China,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000434406450123,0.000516553651693,0.000324647706315
1,Deaths,6,China,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000307746663244,0.00036740050396,0.000230048657
1,Deaths,6,China,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0834417719976,0.10020094122,0.0622562261056
1,Deaths,6,China,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0431546422093,0.051822194853400005,0.0321978440602
1,Deaths,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,80.4394567049,97.916743763,62.7706517101
1,Deaths,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21.3899307245,26.0345169239,17.2306571389
1,Deaths,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,101.829387429,118.454625426,83.5921096257
1,Deaths,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0262851416768,0.0305395370609,0.0214783201298
1,Deaths,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00979323909582,0.0115021380683,0.00825137875348
1,Deaths,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0194109669099,0.0221640414949,0.0163680764737
1,Deaths,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.09077276835,2.54504032985,1.63152729547
1,Deaths,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.562483085667,0.684620048647,0.45310820873400004
1,Deaths,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.33108152969,1.5484013799100003,1.09268960523
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9.45629497949,12.8967075195,6.49642278258
1,Deaths,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.81258593345,3.69625480106,2.10869659876
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,12.2688809129,15.8161455206,9.00273377197
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0710184751726,0.0917882406352,0.0506640148837
1,Deaths,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0341000433633,0.0435181079,0.0262431675237
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0568567147157,0.0703718414884,0.0436036884799
1,Deaths,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.36736859025,8.683960320150002,4.37434729611
1,Deaths,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.9645413621999999,2.58176838458,1.4728871531799999
1,Deaths,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.20629010969,5.42244210771,3.0865170420899997
1,Deaths,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10.7085856294,16.4170223301,4.98430222118
1,Deaths,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7.48864852744,11.1623454264,3.98098785652
1,Deaths,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18.1972341569,25.0655733432,12.6811808775
1,Deaths,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00339325185937,0.00504076277051,0.001602138334
1,Deaths,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120588806812,0.0176158361187,0.00646780930024
1,Deaths,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00482500726368,0.00649613859756,0.00341932682229
1,Deaths,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.47245962417,0.724314159542,0.219905936756
1,Deaths,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.817157990094,1.21803015857,0.43440362082699996
1,Deaths,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.5717030552810001,0.7874858750020001,0.39840504275099997
1,Deaths,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.40737713524,10.3527852485,2.2571076396
1,Deaths,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.40737713524,10.3527852485,2.2571076396
1,Deaths,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0012016362481,0.00184596880628,0.000445414287367
1,Deaths,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00066741532206,0.00104300499596,0.000241690473372
1,Deaths,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.488883248256,0.789918116874,0.17221744424
1,Deaths,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.24496337557099998,0.39580208367700004,0.0862925179452
1,Deaths,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.85701749946,5.37148366282,2.65845340983
1,Deaths,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.85701749946,5.37148366282,2.65845340983
1,Deaths,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000724592201129,0.000973831340635,0.000549665495901
1,Deaths,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000401849297258,0.000544707813906,0.000291702189105
1,Deaths,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.29429065964400003,0.409844516033,0.20284014986199997
1,Deaths,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.147459405988,0.205359656861,0.101636552263
1,Deaths,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.37990825093,9.0610686358,4.41545602949
1,Deaths,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.37990825093,9.0610686358,4.41545602949
1,Deaths,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00358786435187,0.00499588012041,0.00249436098762
1,Deaths,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0022592696573,0.00319506150585,0.00158587419725
1,Deaths,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.393613520819,0.559029846174,0.27241507642900004
1,Deaths,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.193626863181,0.274998672083,0.134006770454
1,Deaths,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.6871064201,9.45719810519,4.06762886555
1,Deaths,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.6871064201,9.45719810519,4.06762886555
1,Deaths,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00077599475111,0.000974340621399,0.000462772452794
1,Deaths,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000593433564158,0.000756627178373,0.000362537652646
1,Deaths,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.295549555071,0.417979095383,0.17977669650900002
1,Deaths,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.147732607549,0.208929909054,0.08986269712139999
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,296.889613087,437.603599244,197.61842828
1,Deaths,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,61.1371059651,91.5089490372,34.1989212757
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,358.026719052,497.381083474,252.110789231
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00331860865559,0.00442268487685,0.00246752245664
1,Deaths,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000881317189399,0.00119295340998,0.000527028977809
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00225519254187,0.00293618636292,0.00171305945034
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.18958116811,1.7533958003599999,0.791820092013
1,Deaths,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.24503120433400002,0.36675841350300004,0.137065743215
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.717370042119,0.996591231364,0.505148688256
1,Deaths,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,21.6514550916,34.6307736262,12.7478360239
1,Deaths,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,21.6514550916,34.6307736262,12.7478360239
1,Deaths,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00400075207729,0.0061964200081,0.00271450169364
1,Deaths,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00236466043746,0.00369277037351,0.00148438133475
1,Deaths,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.7677366247480001,1.2279688891,0.45202415082299996
1,Deaths,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.38518729517100003,0.616094113135,0.226788659541
1,Deaths,6,China,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,248.470034194,266.514611905,231.634518146
1,Deaths,6,China,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,248.470034194,266.514611905,231.634518146
1,Deaths,6,China,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000335386909696,0.00035657467717,0.000315143099547
1,Deaths,6,China,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000237603121915,0.000253173506922,0.000222987914957
1,Deaths,6,China,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0644243381691,0.06910301091269999,0.060059155934299994
1,Deaths,6,China,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0333191541443,0.035738882817700005,0.0310615573434
1,Deaths,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.10801116897,1.85808634869,0.371942210127
1,Deaths,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.10801116897,1.85808634869,0.371942210127
1,Deaths,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00195280149328,0.00307833453745,0.000683357587873
1,Deaths,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00114470324339,0.0018471170429,0.000401291031746
1,Deaths,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.547590588123,0.9182855055620001,0.18381769001599998
1,Deaths,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.27688373223699997,0.464321928743,0.0929455859299
1,Deaths,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.425441899785,0.617863416897,0.291928013308
1,Deaths,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.425441899785,0.617863416897,0.291928013308
1,Deaths,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000749561962867,0.00103862972891,0.00054476048732
1,Deaths,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000439259110571,0.00061318710203,0.000311004650148
1,Deaths,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.210257790391,0.305354495798,0.144273845765
1,Deaths,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.10631475959999999,0.154399462455,0.07295063455419999
1,Deaths,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.72197424099,10.1224003141,4.17192902524
1,Deaths,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.72197424099,10.1224003141,4.17192902524
1,Deaths,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00123972663339,0.00160212526288,0.000863806079738
1,Deaths,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000733282269596,0.00100616285933,0.000489724656251
1,Deaths,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.23835376392000002,0.358929107473,0.147931984016
1,Deaths,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.119586377227,0.18008119921500002,0.07422014132900001
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,117.258243934,191.681874351,38.1373774471
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,117.258243934,191.681874351,38.1373774471
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00130976223258,0.00196424818877,0.000481109824363
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000737964152072,0.00114852672476,0.000258436413736
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.46983185884799994,0.768033430421,0.152809340618
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.23494769220800002,0.38406863778499994,0.0764150009196
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,48.2163886369,67.0122753668,33.3000889606
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,48.2163886369,67.0122753668,33.3000889606
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000538922636931,0.000682776005652,0.000423453490295
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00030352801461,0.000402274299525,0.000223055475895
1,Deaths,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19319405391199998,0.26850565764,0.133427230114
1,Deaths,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.096610087758,0.134270981031,0.06672263534839999
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.60268971466,0.805027379752,0.437307292472
1,Deaths,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0651591316862,0.0871874016951,0.046805306801
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.667848846346,0.869436576724,0.499377991571
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00625437119132,0.00790663049094,0.00486276381084
1,Deaths,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00145243575447,0.00185897520822,0.00108118022329
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00472919746763,0.00599473405489,0.00370462706681
1,Deaths,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.04843287167,2.73614184408,1.48632805759
1,Deaths,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.228628532232,0.305920707702,0.16422914667
1,Deaths,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.1530143324600002,1.5010474894299999,0.8621561371959999
1,Deaths,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.30942640332,13.0502996191,4.38260413235
1,Deaths,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.30942640332,13.0502996191,4.38260413235
1,Deaths,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000615744028946,0.000870937342353,0.000349966108911
1,Deaths,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000332602355227,0.000488061489459,0.000179431672274
1,Deaths,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.20240728822100001,0.317889060948,0.10675478363
1,Deaths,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10291291384899999,0.16162900965899998,0.0542789044173
1,Deaths,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.81025215617,14.4536371534,6.55906563063
1,Deaths,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.81025215617,14.4536371534,6.55906563063
1,Deaths,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00072718279573,0.000947277748706,0.000549364990772
1,Deaths,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000392747767556,0.000542084784497,0.000279779101434
1,Deaths,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.238965536165,0.352072617188,0.159770677676
1,Deaths,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12150076142300001,0.179009457811,0.08123455499980001
1,Deaths,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.775029917812,1.22012388129,0.453520022986
1,Deaths,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.775029917812,1.22012388129,0.453520022986
1,Deaths,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000616301994928,0.000811091951125,0.000460913265599
1,Deaths,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000508247900595,0.000683576310083,0.00036502667375
1,Deaths,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0587910824617,0.0925543673477,0.034402456546
1,Deaths,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0447133752408,0.0703919367378,0.026164681518600002
1,Deaths,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.99057166662,4.16962850605,1.94110701588
1,Deaths,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.99057166662,4.16962850605,1.94110701588
1,Deaths,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000768397620245,0.00103892621657,0.000507289816315
1,Deaths,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000409488119965,0.000567532513645,0.000271718227902
1,Deaths,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.26866521726799997,0.374588631667,0.174384029643
1,Deaths,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.135704131381,0.189206572412,0.0880822367332
1,Deaths,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,133.351507292,192.851612145,91.9703387872
1,Deaths,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,25.5231801972,38.7286113468,16.1864276546
1,Deaths,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,158.874687489,220.300440464,114.513990971
1,Deaths,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00829463807353,0.0116723712715,0.00581366754238
1,Deaths,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00241096355701,0.00372545956227,0.00159835161962
1,Deaths,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00595496418402,0.00801516126174,0.00434270798862
1,Deaths,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.48656761318,2.14985916985,1.0252612047
1,Deaths,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.271291730081,0.41165528334299994,0.17204924810799999
1,Deaths,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.864461842479,1.19868890175,0.623088405012
1,Deaths,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.63584025488,2.08414409142,1.10720865705
1,Deaths,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.63584025488,2.08414409142,1.10720865705
1,Deaths,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000681080488829,0.000853373837429,0.000457170064541
1,Deaths,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000521003148924,0.000661461366885,0.000350449316289
1,Deaths,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.251416601147,0.320317599596,0.170169817307
1,Deaths,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.125771715183,0.16023959325200002,0.0851278304515
1,Deaths,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.86527531901,3.77020435926,1.98715358258
1,Deaths,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.86527531901,3.77020435926,1.98715358258
1,Deaths,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00119278341339,0.00155693122967,0.000840390168724
1,Deaths,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000912534958568,0.00119614239419,0.000637316676649
1,Deaths,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.440371717168,0.579452646923,0.305410872607
1,Deaths,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.220296933193,0.289872478343,0.152782469845
1,Deaths,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.899893808293,1.18533008707,0.656213035493
1,Deaths,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.899893808293,1.18533008707,0.656213035493
1,Deaths,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00118046462017,0.00147927332524,0.000912848255322
1,Deaths,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000907136753356,0.00114287182386,0.000699645625087
1,Deaths,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.299283871622,0.394213377556,0.218241281428
1,Deaths,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.153100152823,0.20166181365400002,0.111642412796
1,Deaths,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.56178649644,7.26265085173,4.35171232783
1,Deaths,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.56178649644,7.26265085173,4.35171232783
1,Deaths,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00151292973823,0.00190228121112,0.00122071282541
1,Deaths,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00106610076729,0.00134012431761,0.00085203573948
1,Deaths,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.24244917066100002,0.31659318043400003,0.189699666737
1,Deaths,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11847075429500001,0.15470060296899998,0.0926951515097
1,Deaths,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.54004050087,3.43226268112,1.74408562266
1,Deaths,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.54004050087,3.43226268112,1.74408562266
1,Deaths,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0017345107125,0.00223021516734,0.00130920498116
1,Deaths,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00130227959635,0.00168132505128,0.000973988629909
1,Deaths,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.582483322752,0.7870881469700001,0.39995456304800003
1,Deaths,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.29367278555,0.396829161566,0.201646581174
1,Deaths,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.149969105039,0.217623932346,0.0925296993722
1,Deaths,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.149969105039,0.217623932346,0.0925296993722
1,Deaths,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00113477499664,0.00150637814043,0.000751337164942
1,Deaths,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00072140805424,0.000997647315449,0.00046623937844
1,Deaths,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.311786145982,0.45244070185,0.19236947735800003
1,Deaths,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.163902470441,0.23784298859,0.101126470765
1,Deaths,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.342952431143,0.471315044956,0.248845209501
1,Deaths,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.342952431143,0.471315044956,0.248845209501
1,Deaths,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00259888612176,0.00332361542549,0.00200658094092
1,Deaths,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00165038973304,0.00215595519003,0.00126675462646
1,Deaths,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.712998965577,0.979865162042,0.51734981546
1,Deaths,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.374815537464,0.515104095636,0.27196497961500005
1,Deaths,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4.55032374414,6.13398830111,3.22270701584
1,Deaths,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.536869886938,0.737241172577,0.379856864837
1,Deaths,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,5.08719363108,6.68541877149,3.76322949801
1,Deaths,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0517201864535,0.0616453049308,0.040239959313
1,Deaths,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0138284757658,0.0161402933446,0.0117847281511
1,Deaths,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0400876724153,0.0482379525951,0.031814726892
1,Deaths,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.545549553440001,6.12755253268,3.219325758
1,Deaths,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.566198994873,0.777516528767,0.400608378863
1,Deaths,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.60982062236,3.42973848535,1.9306035238300001
1,Deaths,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,19.7683466369,24.8279613581,15.5246141521
1,Deaths,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,19.7683466369,24.8279613581,15.5246141521
1,Deaths,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00200579849353,0.00245670462358,0.0016166646944
1,Deaths,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0013665761628,0.00168964107535,0.00110387187143
1,Deaths,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.45848096159599994,0.5758269928709999,0.360057426935
1,Deaths,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.229960999446,0.28881842842,0.180594556135
1,Deaths,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.14910703562,0.205902231689,0.0970991884958
1,Deaths,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.14910703562,0.205902231689,0.0970991884958
1,Deaths,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0017850372154,0.00227232155425,0.00125997996197
1,Deaths,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0011606496409,0.00151307014035,0.000802268447588
1,Deaths,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.571905739422,0.7897458867249999,0.37242765214400003
1,Deaths,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.28963524894700005,0.39995794890499997,0.188611808394
1,Deaths,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.962214603328,1.41825432042,0.616169305195
1,Deaths,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.962214603328,1.41825432042,0.616169305195
1,Deaths,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000769147828171,0.000933294851459,0.000623544363746
1,Deaths,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000633778501735,0.000798723904515,0.00050636117293
1,Deaths,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0729902637175,0.107583855522,0.0467404671736
1,Deaths,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0555125184615,0.0818225673079,0.0355483171963
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.62166142121,11.9610454092,6.33282019929
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.62166142121,11.9610454092,6.33282019929
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000583884240916,0.0007902672175,0.000436061096809
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000453648287783,0.00061743553345,0.000336169518823
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0792656289027,0.109967179221,0.05822253406860001
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0461069929171,0.0639653784832,0.0338667087246
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,12.1671993036,15.7079428893,9.6362009914
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,12.1671993036,15.7079428893,9.6362009914
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000823523021428,0.00102219342331,0.000685523235982
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000639831031943,0.000797365788584,0.000530175144799
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11186251206900001,0.144415317543,0.0885930790482
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0650678500007,0.08400306810460001,0.051532556099399995
1,Deaths,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.15736403227,7.63345332976,4.85101454966
1,Deaths,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.15736403227,7.63345332976,4.85101454966
1,Deaths,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00167532544378,0.00201421905455,0.00134367070831
1,Deaths,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00118038150048,0.00143149964704,0.000944903977568
1,Deaths,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.268411562371,0.33275718697,0.211465228876
1,Deaths,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.131157059308,0.162599009227,0.103330710944
1,Deaths,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.15202522574,2.95430819066,1.52172287614
1,Deaths,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.15202522574,2.95430819066,1.52172287614
1,Deaths,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00055299748288,0.00074206631958,0.00040205137472
1,Deaths,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000294709375772,0.000404944679318,0.000210724408928
1,Deaths,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19333237564400002,0.26540740045800004,0.13670764412800002
1,Deaths,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09765314010970001,0.134058591981,0.0690517078769
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.509338022984,0.901629120133,0.333276969076
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.509338022984,0.901629120133,0.333276969076
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000665796604166,0.00115642393386,0.000465034484137
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000373607120436,0.000645624674601,0.000259878156061
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.340958840834,0.603564638395,0.223100816992
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.171424432705,0.303455178006,0.112168761765
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.797200107049,1.10098617464,0.534559092712
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.797200107049,1.10098617464,0.534559092712
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00104321329075,0.00138205827136,0.000723529402178
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000585497430507,0.000774754784992,0.000405805051248
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.533658223315,0.737017369488,0.357842219477
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.268308215638,0.370551425355,0.179912916532
1,Deaths,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,200.172127592,354.189544678,88.3135828469
1,Deaths,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,106.557935259,152.240317108,59.2166744727
1,Deaths,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,306.73006285,471.094464126,154.50225262
1,Deaths,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00863393635499,0.0149661995612,0.00386589913671
1,Deaths,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00905743601999,0.0125505892731,0.00493236215321
1,Deaths,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00878039759377,0.013363549165,0.00442851433064
1,Deaths,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.92423707447,5.17421786139,1.29013892317
1,Deaths,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.59680655127,2.2813724302800003,0.8873818126559999
1,Deaths,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.26897075571,3.4848216452800003,1.1428977310800001
1,Deaths,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,51.0870633458,63.2558995676,39.2799826872
1,Deaths,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19.6560641035,23.8730679977,15.983197498
1,Deaths,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,70.7431274493,82.6454755626,58.5861498861
1,Deaths,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00518459610698,0.00628877074665,0.0040620504733
1,Deaths,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00426725791494,0.00504306570084,0.00354690414976
1,Deaths,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00489256755677,0.00568332935836,0.00409518484559
1,Deaths,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.18484597413,1.46707391332,0.9110081163960001
1,Deaths,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.458751568753,0.557171941301,0.373030780083
1,Deaths,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.8229398538480001,0.961397354527,0.6815203025809999
1,Deaths,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0679504499967,0.0914362863789,0.0436034253181
1,Deaths,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0679504499967,0.0914362863789,0.0436034253181
1,Deaths,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00081573662158,0.00105829626324,0.000531147781147
1,Deaths,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000529647581881,0.000692985811962,0.000345348752597
1,Deaths,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.26062655050399997,0.350707374432,0.167242605919
1,Deaths,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.131991394095,0.17761181729699999,0.084698142475
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.817714575299,1.13563219423,0.559357625729
1,Deaths,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0960428534356,0.128836245236,0.0689427687013
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.913757428735,1.22820085862,0.653640621686
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00637637424487,0.00864752332256,0.00444848010544
1,Deaths,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00159148715105,0.0020824882519,0.00114700672418
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00484484637143,0.00638553007646,0.00349703021484
1,Deaths,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.677879502,2.3302189273300002,1.1477534128
1,Deaths,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.19093247472400002,0.256125492497,0.137057708841
1,Deaths,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.922642475776,1.24014343995,0.659996386892
1,Deaths,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,29.5417467887,50.0779279389,9.66004805091
1,Deaths,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,29.5417467887,50.0779279389,9.66004805091
1,Deaths,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00125477276301,0.00189358322823,0.000464847161914
1,Deaths,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000724058391783,0.00114207866172,0.000255937074568
1,Deaths,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.490598417285,0.831641824143,0.160423969462
1,Deaths,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.244651640388,0.414723181575,0.0800002321727
1,Deaths,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,15.8595663629,23.3745152792,9.91765217089
1,Deaths,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,15.8595663629,23.3745152792,9.91765217089
1,Deaths,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000674299437357,0.000883891329195,0.000512999284592
1,Deaths,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000388760828513,0.000528028318073,0.000275492790288
1,Deaths,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.263379082223,0.388179489954,0.16470198912099998
1,Deaths,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.131341892349,0.19357736518600002,0.0821335952055
1,Deaths,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,122.686161641,185.938727957,75.9329887366
1,Deaths,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,62.1706642318,87.4084929193,40.1627113698
1,Deaths,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,184.856825872,246.423328149,132.752153018
1,Deaths,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114757286887,0.0162960631785,0.00813993378802
1,Deaths,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00989569822092,0.0127303392892,0.0072491732838
1,Deaths,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108851474077,0.0135640873072,0.00853974442322
1,Deaths,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.4366676763100001,2.1773617876599998,0.889183172941
1,Deaths,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.741427364897,1.04240560038,0.478967590679
1,Deaths,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0922180611,1.45598091069,0.784359995857
1,Deaths,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,361.567629821,444.793612261,279.314604985
1,Deaths,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,71.5613576419,85.8360514204,58.3463198117
1,Deaths,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,433.128987463,515.912813562,351.838480547
1,Deaths,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0276664318588,0.03275981723,0.0216149982593
1,Deaths,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100379659684,0.0116659398364,0.0084588039173
1,Deaths,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0214442355402,0.0249150525613,0.0175079586922
1,Deaths,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.6906361516299997,3.30996935138,2.0785432983
1,Deaths,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.538214216425,0.645574436799,0.438823686883
1,Deaths,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.62013851653,1.9297951525200001,1.3160677082999999
1,Deaths,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,23.8533272636,30.301267614,17.4691826943
1,Deaths,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5.71621025421,7.53625673066,4.31483248137
1,Deaths,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29.5695375178,36.1011801097,23.1319909242
1,Deaths,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0162872826864,0.0193374654696,0.0128201058548
1,Deaths,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.011812085247,0.0143169692078,0.00971174754195
1,Deaths,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0151737782927,0.0176932654229,0.0126481319564
1,Deaths,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.47005660676,6.948701423219999,4.00604146982
1,Deaths,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.33291273374,1.75731334473,1.00613779105
1,Deaths,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.41875196373,4.1739232586399995,2.67445980003
1,Deaths,1,Global,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,63280.7456317,73061.5127541,55598.7006302
1,Deaths,1,Global,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20893.558427,23096.4073304,19271.4103333
1,Deaths,1,Global,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,84174.3040587,94032.376836,76579.8750625
1,Deaths,1,Global,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0118898451869,0.0135145027935,0.010461986178
1,Deaths,1,Global,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00710945536572,0.00782728100729,0.0065746100162
1,Deaths,1,Global,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101895073806,0.0113002150889,0.00930600595162
1,Deaths,1,Global,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.25083790045,3.75329229063,2.85619838104
1,Deaths,1,Global,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.11576128162,1.23339818508,1.02913505936
1,Deaths,1,Global,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.20398822077,2.46210827918,2.00513855711
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.01352233398,11.2108994554,3.9052411472
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.01352233398,11.2108994554,3.9052411472
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000524090207859,0.000960219009535,0.000365844919403
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000302059350695,0.000554128318378,0.000211322230113
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.290963186516,0.542437335074,0.18895438400300002
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.149182491146,0.278118183629,0.0968805918577
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.68655608215,13.1072000615,6.82509437686
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.68655608215,13.1072000615,6.82509437686
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000845908889254,0.00108595703509,0.000635879134056
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00048762724738,0.000631584691779,0.000360685559478
1,Deaths,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.468682257669,0.634189495672,0.330230952489
1,Deaths,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.24030251934,0.325161302898,0.169315839353
1,Deaths,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.6372462322,7.93887988393,4.20768969412
1,Deaths,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.6372462322,7.93887988393,4.20768969412
1,Deaths,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0018404200887,0.00247854422715,0.00140369963381
1,Deaths,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00107386019265,0.00146225978222,0.00080861542336
1,Deaths,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.146522631971,0.206346419437,0.109365768871
1,Deaths,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0736882989029,0.10377452567199999,0.055001588204599994
1,Deaths,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,11.433864616,14.244236991,8.93427523248
1,Deaths,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,11.433864616,14.244236991,8.93427523248
1,Deaths,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0037354667255,0.00445684750867,0.00305347445152
1,Deaths,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00217910726627,0.00261806163806,0.00174783994269
1,Deaths,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.297187645905,0.370234509614,0.232218616661
1,Deaths,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.14945986014,0.18619615851500002,0.116786018686
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.07538442237,2.60729454558,1.55583395513
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.07538442237,2.60729454558,1.55583395513
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00178373708919,0.00218589361939,0.00141474363433
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00121853177858,0.00150937746632,0.000959081580381
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.589567665418,0.740670760429,0.441975656567
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.29498999250499996,0.370594377682,0.221142378162
1,Deaths,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,66.3352935152,108.166165661,33.185968143
1,Deaths,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.7215216388,9.72668915643,2.11128012815
1,Deaths,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,71.056815154,113.214392712,37.3703374602
1,Deaths,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00491830927756,0.00746549913892,0.00265647660122
1,Deaths,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000410834872704,0.000815298568307,0.000200782052155
1,Deaths,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00284607587678,0.00433870838336,0.0015187685976
1,Deaths,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.61584521266,2.63479321025,0.80836889248
1,Deaths,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.118962048645,0.245070754113,0.053195183358800004
1,Deaths,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.880044366653,1.40216935299,0.46283463296899996
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,8863.99072466,13379.1145969,5346.39128314
1,Deaths,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1704.50941575,2838.67529041,888.291494813
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,10568.5001404,15141.3859781,6989.90173153
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0445347127733,0.0521786858016,0.0361015357474
1,Deaths,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0253789841054,0.0293039319499,0.0218771190292
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0396873682334,0.0458530260981,0.0330148758984
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,25.6857725498,38.7695458094,15.4925918502
1,Deaths,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.88951456535,8.14295541611,2.54813153981
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,15.2350062519,21.8270432865,10.0762828372
1,Deaths,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34.8753847522,46.4143851409,25.6724237992
1,Deaths,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10.4029924255,27.795047907,5.65416120201
1,Deaths,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,45.2783771777,68.8158776696,33.011875692
1,Deaths,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000708047420345,0.000934919134399,0.000523801139139
1,Deaths,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000316801344377,0.000858002125899,0.000171912408289
1,Deaths,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000551574579862,0.000833752797061,0.000401722441282
1,Deaths,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.299640081479,0.39878012082799996,0.220570675094
1,Deaths,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.0903369085156,0.24136504163899997,0.049099280509399996
1,Deaths,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.195545856621,0.297198366788,0.142569939853
1,Deaths,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,52.1224005728,77.2107847763,32.5889672294
1,Deaths,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10.8205729836,15.5200371578,6.72530329332
1,Deaths,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62.9429735564,87.2379806865,43.4872375238
1,Deaths,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110082357411,0.0148998250316,0.00740721510565
1,Deaths,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00481635123542,0.00644634799072,0.00327844973255
1,Deaths,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00900643827341,0.0118197702011,0.00645487679992
1,Deaths,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.74170372023,2.5800483018600002,1.08898141371
1,Deaths,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.351923117458,0.504766232612,0.21873053344
1,Deaths,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.03741186775,1.43783668565,0.716746822624
1,Deaths,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,97.9818701311,118.391455107,79.028282548
1,Deaths,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13.2595526567,16.629498885,10.6755998832
1,Deaths,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,111.241422788,132.396692166,91.8084540408
1,Deaths,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0407855908793,0.0481029767198,0.0335852872321
1,Deaths,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0180000192653,0.0216879923462,0.0149984909876
1,Deaths,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0354318912614,0.0411104541035,0.0299365994788
1,Deaths,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,15.0590919186,18.1958948369,12.1460650778
1,Deaths,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.03995270729,2.55841144493,1.64241731584
1,Deaths,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,8.5528061201,10.1793307804,7.05870068828
1,Deaths,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.65896816521,2.46412165327,1.19906355783
1,Deaths,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.65896816521,2.46412165327,1.19906355783
1,Deaths,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00139738753845,0.00204227666745,0.00104082691532
1,Deaths,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000926179048892,0.00137450348331,0.000683138842969
1,Deaths,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.128485650848,0.19084409275,0.0928664364197
1,Deaths,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.06619329288879999,0.0983191418191,0.047842970673199994
1,Deaths,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.72535725753,4.67518197339,2.8570373666
1,Deaths,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.72535725753,4.67518197339,2.8570373666
1,Deaths,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00313823853733,0.00376458980585,0.0025548546693
1,Deaths,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00207954728829,0.00253812628827,0.0016747884357
1,Deaths,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.288525700441,0.362088803922,0.22127507522
1,Deaths,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.14864279449999998,0.18654106580399998,0.11399658846199999
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.66439284536,3.91791735101,0.766141486916
1,Deaths,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.654159007333,1.76422202109,0.315824081242
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2.31855185269,4.43423768571,1.15077515395
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00218327430047,0.00491200171723,0.00102939089618
1,Deaths,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00108805225848,0.00286316042698,0.000559564578854
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00170279909509,0.0031678367719,0.000870148068925
1,Deaths,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.11417060898,2.62271516793,0.512867097107
1,Deaths,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.44278617227499995,1.19416396779,0.21377453261
1,Deaths,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.780339220931,1.49240120598,0.38730856334299996
1,Deaths,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,211.769040563,257.850322813,168.210581144
1,Deaths,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,32.7131712468,40.2739598357,26.0431818711
1,Deaths,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,244.48221181,291.348662755,198.499598897
1,Deaths,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.106594096219,0.119875431279,0.0887488841251
1,Deaths,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0308740617182,0.0347399959068,0.0274030556218
1,Deaths,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0802263411977,0.0905832707127,0.0682254556044
1,Deaths,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,9.33181009126,11.3624269065,7.41236393385
1,Deaths,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.50986974372,1.85883639826,1.2020177451099998
1,Deaths,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.51138780789,6.56790306283,4.4747970052
1,Deaths,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,75.7536631058,110.62352696,54.678917383
1,Deaths,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13.9667967563,20.8584599743,8.99026268445
1,Deaths,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,89.7204598621,124.609631578,67.5720561137
1,Deaths,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0023756948342,0.00537015283897,0.00111427212521
1,Deaths,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00141591567362,0.00277964766825,0.000717116467438
1,Deaths,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0021454035156,0.00464471697518,0.00106910666763
1,Deaths,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5915875675200002,2.32420483666,1.14880629588
1,Deaths,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.30262118254,0.45194413103799996,0.19479369338500002
1,Deaths,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.957028142622,1.32918315895,0.720776057714
1,Deaths,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.59095139288,2.37815689035,1.11734045535
1,Deaths,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.59095139288,2.37815689035,1.11734045535
1,Deaths,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000504684782302,0.000723299667222,0.000367670989161
1,Deaths,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0004212296922,0.000605224485152,0.000306402884478
1,Deaths,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.070192303929,0.104923577166,0.049296729733600005
1,Deaths,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0499829679758,0.07471462687279999,0.0351035188427
1,Deaths,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.34030452176,3.14718955526,1.74879857727
1,Deaths,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.34030452176,3.14718955526,1.74879857727
1,Deaths,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000742038998891,0.000946872175226,0.000576704703076
1,Deaths,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000619466161379,0.000801086452211,0.000480789602619
1,Deaths,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.103253541883,0.138853070417,0.0771564749219
1,Deaths,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0735254178655,0.0988753493405,0.054942057736699995
1,Deaths,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0763864488,47.1625580318,23.3684658428
1,Deaths,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0763864488,47.1625580318,23.3684658428
1,Deaths,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00115214340377,0.00168911874737,0.000871971941083
1,Deaths,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000846343176535,0.00125811401574,0.000634834480008
1,Deaths,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.24570356346900002,0.36126290563400004,0.17900131424
1,Deaths,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.121911766275,0.179249329125,0.0888158318764
1,Deaths,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,41.0923125747,70.5266954509,20.0122098005
1,Deaths,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13.4377828947,24.510550808,4.79022700472
1,Deaths,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,54.5300954694,86.5474936579,31.0473727893
1,Deaths,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103654711908,0.0179433517929,0.00512771255438
1,Deaths,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00664050833902,0.011834404483,0.0025616899737
1,Deaths,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00911346198491,0.0146350330638,0.0051474921371
1,Deaths,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.35022451844,4.03368801773,1.1445738434900001
1,Deaths,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.7703803327750001,1.4051757225000001,0.274620947732
1,Deaths,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.56123804561,2.47792047104,0.888909861568
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.746683633401,1.65972317777,0.336382142758
1,Deaths,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.282330822215,0.666615575313,0.15176312404
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.02901445562,1.94249054481,0.523948525078
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00226298776798,0.00491675530782,0.00105167313143
1,Deaths,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00121487130052,0.0027336498021,0.000711538423246
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00183173293505,0.00332684387475,0.000976901980095
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0951011130300001,2.43418312389,0.49334476137
1,Deaths,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.41515563212699996,0.9802302433129999,0.223161308425
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.755572641206,1.42630912855,0.38471876540600003
1,Deaths,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.271053881853,0.415517673512,0.17317349543
1,Deaths,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0915806550761,0.136043684847,0.058714820431
1,Deaths,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.36263453693,0.500297524515,0.2594542209
1,Deaths,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00324852245157,0.0047269919302,0.00232436141685
1,Deaths,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00204582936931,0.00282400099666,0.00146882000397
1,Deaths,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00282652887915,0.00381053181299,0.0021779600295
1,Deaths,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0396375333999999,1.59373393298,0.664213566722
1,Deaths,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.36042590827500004,0.535415133636,0.231078741088
1,Deaths,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.704405019815,0.971810602083,0.503980831946
1,Deaths,1,Global,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3198.316311,3504.83171354,2476.35130669
1,Deaths,1,Global,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3198.316311,3504.83171354,2476.35130669
1,Deaths,1,Global,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00060100137291,0.000656768091527,0.000465014276299
1,Deaths,1,Global,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000387183092922,0.000423161364724,0.000297596416356
1,Deaths,1,Global,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.164302866182,0.180049075834,0.127214314595
1,Deaths,1,Global,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0837435076485,0.0917691913084,0.0648398483534
1,Deaths,1,Global,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5569.25253816,5884.01880741,5292.50036648
1,Deaths,1,Global,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5569.25253816,5884.01880741,5292.50036648
1,Deaths,1,Global,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00104653796455,0.00110110227506,0.0010022470027
1,Deaths,1,Global,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000674207210656,0.000710499256112,0.0006433626692
1,Deaths,1,Global,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.286101831568,0.30227190206300003,0.27188460894
1,Deaths,1,Global,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.14582320733,0.15406492857100001,0.13857683287800002
1,Deaths,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,61.6906809424,83.235342252,47.4251826376
1,Deaths,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,61.6906809424,83.235342252,47.4251826376
1,Deaths,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00221734664555,0.00286562344955,0.00175693081052
1,Deaths,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00162849519347,0.00213115302495,0.00129226682272
1,Deaths,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.472547622052,0.6375786820789999,0.363274597369
1,Deaths,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.23446593301299998,0.316350085339,0.18024747864
1,Deaths,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,72.3764556043,120.041452124,36.0840417645
1,Deaths,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.61737868973,9.87334659609,2.11473769595
1,Deaths,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,76.993834294,124.882350918,39.0040790982
1,Deaths,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00512773406048,0.00820858390818,0.00261141162727
1,Deaths,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000378860917862,0.000790743355776,0.000180353890771
1,Deaths,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00292819248074,0.00463016518818,0.00149785819997
1,Deaths,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7763294740600002,2.9461676140099997,0.885607707568
1,Deaths,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.10869200413900001,0.23241624765799998,0.0497804260482
1,Deaths,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.925114676204,1.50051619967,0.46865111130500003
1,Deaths,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,6.4816589536,8.48861484267,4.85314340797
1,Deaths,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.839721194937,1.14323943698,0.611419633129
1,Deaths,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7.32138014854,9.4297000079,5.67242552894
1,Deaths,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00796213860545,0.00953306627884,0.00641605698101
1,Deaths,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0023714354198,0.00298925528331,0.00187314802185
1,Deaths,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00626441145692,0.00751200170685,0.00509257407917
1,Deaths,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.93990792213,2.54057353204,1.45250643574
1,Deaths,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.253906206185,0.345680911659,0.184874742201
1,Deaths,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.10121939141,1.41833483485,0.853197738959
1,Deaths,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,32.1867365898,49.7269060161,19.3344147048
1,Deaths,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9.1127092388,14.2193616758,5.27070208178
1,Deaths,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,41.2994458286,59.6155449033,26.4562254087
1,Deaths,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00136785557974,0.00192709206626,0.00093728161279
1,Deaths,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000530866371083,0.000758547080872,0.000342860972249
1,Deaths,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00101365016136,0.00134944541929,0.000705285891694
1,Deaths,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.534523640103,0.825812419369,0.321085727298
1,Deaths,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.150537424417,0.234896782882,0.0870693770061
1,Deaths,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.342023687406,0.493709493807,0.21909872124399998
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.83033828362,12.6196568752,7.7974731346
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.83033828362,12.6196568752,7.7974731346
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00479407023322,0.00594296309436,0.00392219540768
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00336721438705,0.00418148576438,0.00271993094631
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.752446575347,0.965950237299,0.596844359493
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.379369866633,0.48701452661800004,0.3009180618
1,Deaths,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.82538860718,3.69575942045,1.39739707436
1,Deaths,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.82538860718,3.69575942045,1.39739707436
1,Deaths,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000844044570835,0.00103813641092,0.000396443583475
1,Deaths,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000624254943033,0.000774071392969,0.000294676297305
1,Deaths,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.261115385212,0.341552890201,0.129143960742
1,Deaths,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.13121696433,0.171638807778,0.0648980468018
1,Deaths,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.94187778981,6.40323332655,3.77346407814
1,Deaths,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.94187778981,6.40323332655,3.77346407814
1,Deaths,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00147686785324,0.00181802556465,0.0011890041825
1,Deaths,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00109202623359,0.00135699089232,0.000876173868718
1,Deaths,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.456716049422,0.591770892122,0.34873416132699997
1,Deaths,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.22951115468500002,0.297379566433,0.175247574824
1,Deaths,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.30450806835,8.8158630213,4.15544322892
1,Deaths,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.30450806835,8.8158630213,4.15544322892
1,Deaths,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000493181796475,0.00065311360382,0.000339110645061
1,Deaths,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000267112088988,0.000355427582172,0.000180565666549
1,Deaths,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.205589807309,0.287485012338,0.135508871344
1,Deaths,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.103585216341,0.144847634168,0.0682753485589
1,Deaths,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,17.3597314817,24.1534441055,11.7602799666
1,Deaths,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,17.3597314817,24.1534441055,11.7602799666
1,Deaths,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00135749158447,0.00178328561516,0.000966535383585
1,Deaths,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000735252791796,0.000987651995138,0.000515834467718
1,Deaths,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.566100290709,0.787643042988,0.383502355144
1,Deaths,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.285226304996,0.396849318918,0.19322540813
1,Deaths,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,17.4784764272,24.6013268656,12.5918463596
1,Deaths,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,17.4784764272,24.6013268656,12.5918463596
1,Deaths,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00115025737297,0.00161896020902,0.000871051751441
1,Deaths,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000768546212747,0.00107873400361,0.000570798532072
1,Deaths,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.414750664649,0.583770371019,0.298794730109
1,Deaths,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.204664730631,0.288069956044,0.14744459301399998
1,Deaths,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,24.1138062848,46.1383674152,6.38340224907
1,Deaths,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.59938462596,2.38191428666,0.759955128039
1,Deaths,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,25.7131909108,47.7643224122,7.65319603753
1,Deaths,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0121642097533,0.0215225764517,0.00362468102014
1,Deaths,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000869144825275,0.0012252194821,0.000434564000274
1,Deaths,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00672777885935,0.0120358504612,0.00207194459596
1,Deaths,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.32472199011,4.44802765896,0.615399966509
1,Deaths,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.158316202798,0.235775447091,0.07522468843050001
1,Deaths,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.25581881036,2.3327845523999997,0.373778096102
1,Deaths,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,300.737167264,403.755884876,209.690476318
1,Deaths,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,58.1383629638,80.7556171648,41.0687338776
1,Deaths,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,358.875530228,466.372928947,263.601465766
1,Deaths,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0349199614384,0.0423017146253,0.0269683543638
1,Deaths,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.022072676722,0.0269816935989,0.0179043074268
1,Deaths,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0319044809663,0.0379391613787,0.0258594034096
1,Deaths,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,13.2916586629,17.8447694168,9.26767469889
1,Deaths,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.56807088887,3.56711367472,1.81407618889
1,Deaths,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.9283346989400005,10.303184151,5.82352507121
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.04154693707,10.6193599416,4.47230702877
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.04154693707,10.6193599416,4.47230702877
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000666438794386,0.000897980664023,0.000482800740289
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00056394040547,0.000759709898609,0.000399212978583
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.134301802874,0.202540606244,0.0852992818676
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.101673356821,0.153333632823,0.0645759337277
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,14.241714572,21.9769381945,8.90764734518
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,14.241714572,21.9769381945,8.90764734518
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00134621878979,0.00185367280941,0.00100400398171
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00113931295194,0.00158222137904,0.000847293739646
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.271628941783,0.419161080307,0.169893506145
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.205637048273,0.31732644813,0.128618102678
1,Deaths,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.5905485367,15.305667552,6.62868414295
1,Deaths,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.5905485367,15.305667552,6.62868414295
1,Deaths,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000749394875883,0.00100975023496,0.000511045631502
1,Deaths,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000402609398401,0.000559744130944,0.000268115063204
1,Deaths,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.25992297295,0.375645756148,0.162687256775
1,Deaths,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.127250083986,0.18390430625100002,0.07964654625640001
1,Deaths,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,149.908047742,291.433956402,79.7122694393
1,Deaths,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,36.1214238545,80.4038534735,18.5015920711
1,Deaths,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,186.029471596,330.114309809,104.506440951
1,Deaths,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0054497935634,0.0106369370278,0.002913031593
1,Deaths,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00195065797523,0.00429270499381,0.00100592379176
1,Deaths,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0040438579655,0.00716636895625,0.00224678149215
1,Deaths,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.4766777956300001,2.87078685097,0.785210267849
1,Deaths,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.358560816433,0.7981321960589999,0.183656823303
1,Deaths,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9197672315340001,1.63215173497,0.516700924033
1,Deaths,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,8.02186397042,13.722574289,5.40602194775
1,Deaths,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.72403931057,6.56398547118,2.54865312573
1,Deaths,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,11.745903281,19.0517871433,8.62650982482
1,Deaths,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00127246973206,0.0021238923386,0.000905960097278
1,Deaths,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00174129402363,0.00308966249085,0.0012320684606
1,Deaths,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00139139672826,0.0022444568325,0.00107255473103
1,Deaths,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.52925632508,0.905370530541,0.356671631421
1,Deaths,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.21218533141100002,0.373997510881,0.145215118057
1,Deaths,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.359116933209,0.582485587304,0.26374521213700003
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,29.1762321123,33.8322444752,25.7329856076
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,29.1762321123,33.8322444752,25.7329856076
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00168260411089,0.00195345117681,0.001472316208
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00106976875207,0.00123668877626,0.000933080306968
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.19161667275699998,0.22219531615000002,0.169002942644
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.09586784389370001,0.11116666194000001,0.0845539560303
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,40.4373029728,43.8068378006,38.0411295185
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,40.4373029728,43.8068378006,38.0411295185
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00233195586276,0.00252017245045,0.00221753470413
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00148260294322,0.00160551386974,0.00140414770502
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.265574438163,0.28770406237100005,0.24983742377
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.13286969455,0.14394137911899998,0.124996300145
1,Deaths,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9.29914024493,13.3968272889,6.03110104231
1,Deaths,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.96417057407,2.82590154748,1.19906099619
1,Deaths,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,11.263310819,15.5015478753,7.90076746836
1,Deaths,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00174711220576,0.00242076637941,0.00117519102708
1,Deaths,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000459287493372,0.00063581339864,0.000291636510793
1,Deaths,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00117445914963,0.00157678851488,0.000841406840615
1,Deaths,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.709524941793,1.02217870169,0.46017336046999996
1,Deaths,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.15050746565,0.216538871777,0.0918798163856
1,Deaths,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.43061280459999995,0.592646790403,0.30205786670699997
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,92.8470395839,144.164284906,52.1391357113
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,92.8470395839,144.164284906,52.1391357113
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000465585241724,0.00057796649133,0.00030571993687
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000347514552194,0.00045551112539,0.000217476716526
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.269049011303,0.417754389294,0.151087024166
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.133843517031,0.20781981858,0.0751610964637
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12.6921121277,15.8186198251,10.0236546013
1,Deaths,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.73933164439,4.59139672631,3.05818908504
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,16.431443772,19.7523021855,13.5965800773
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00618830773301,0.00749870244501,0.0050235965771
1,Deaths,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00430744474166,0.00506158165395,0.00362738239953
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00562838080005,0.00660371074635,0.00476676820001
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.971496201741,1.21080943205,0.76724364509
1,Deaths,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.291048849387,0.357368872664,0.238032487903
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.634118018376,0.762275725373,0.524715693576
1,Deaths,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,44.6028226149,53.8789386386,33.0338757254
1,Deaths,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10.1378186482,12.1629830526,8.16284756712
1,Deaths,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,54.7406412631,64.1882561764,42.6773096785
1,Deaths,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0121383017194,0.0143181535417,0.00915557922928
1,Deaths,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00658574104604,0.00776558059608,0.00545026336532
1,Deaths,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0104990667812,0.012056521039,0.00833375599749
1,Deaths,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.94432442868,2.3486885009700003,1.4400113665799998
1,Deaths,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.422295036136,0.506654098474,0.34002679747500003
1,Deaths,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.16602193651,1.3672641211499998,0.9090627754449999
1,Deaths,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40.960829078,63.189875344,24.863756703
1,Deaths,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19.5793306144,30.0672644449,12.1300894619
1,Deaths,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,60.5401596925,83.6018230258,42.1590070565
1,Deaths,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00757530533094,0.0106108586032,0.00526628311726
1,Deaths,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00524200171311,0.00706186070298,0.00377500882338
1,Deaths,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00661983741634,0.00857236532334,0.00503807090054
1,Deaths,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.45242564669,2.24064301497,0.8816412831830001
1,Deaths,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.699048839932,1.07350382626,0.433085539727
1,Deaths,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.07703155573,1.4873069706600002,0.75002413586
1,Deaths,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.774309882,19.9545511596,6.02277498349
1,Deaths,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.774309882,19.9545511596,6.02277498349
1,Deaths,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000457764399536,0.000697090812172,0.000219202557143
1,Deaths,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000272640047955,0.000424141395973,0.000128140186639
1,Deaths,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.30750933399700003,0.48035555689200005,0.144983137335
1,Deaths,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15457301742,0.241456110937,0.07287740089610001
1,Deaths,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10.3468368338,14.4989334046,6.60606139009
1,Deaths,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10.3468368338,14.4989334046,6.60606139009
1,Deaths,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000370353922268,0.000505292887177,0.000248720709712
1,Deaths,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000220559409777,0.000307865029949,0.000142863867509
1,Deaths,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.249074034771,0.349025301257,0.15902428837
1,Deaths,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12519985853899998,0.175441484231,0.0799353430254
1,Deaths,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,28.4083744412,40.2086518654,19.3638549884
1,Deaths,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,28.4083744412,40.2086518654,19.3638549884
1,Deaths,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000975384673235,0.00128905400032,0.000752286939289
1,Deaths,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000692111151079,0.000934140144419,0.000526588942965
1,Deaths,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.134151268962,0.189875055406,0.0914408434058
1,Deaths,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.06697071628319999,0.0947890285586,0.0456489068482
1,Deaths,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,152.047513347,202.554547917,112.593396175
1,Deaths,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,152.047513347,202.554547917,112.593396175
1,Deaths,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00523187301656,0.00639124446251,0.00415479729784
1,Deaths,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00371093613563,0.00459769487107,0.00295051683524
1,Deaths,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.718005421265,0.9565119501439999,0.531693462606
1,Deaths,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.358441166672,0.47750789783900005,0.265430899829
1,Deaths,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.83849582883,2.33763290035,1.42278361449
1,Deaths,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.83849582883,2.33763290035,1.42278361449
1,Deaths,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00136135992712,0.00161583301073,0.00112645087658
1,Deaths,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000966376387665,0.00116896439365,0.000786182625737
1,Deaths,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.262683164783,0.33399956569699996,0.20328645667499998
1,Deaths,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.122309214711,0.155515198806,0.0946532180616
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0759960401869,0.116257991252,0.042208071902
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0759960401869,0.116257991252,0.042208071902
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000655904067179,0.000936158186283,0.000403574489444
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000401376222266,0.000575189424632,0.000238773595224
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.161281953131,0.24672753804,0.0895757233863
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.08108668670420001,0.12404561198599999,0.045035408348799995
1,Deaths,6,China,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9598.74588167,15714.8329319,7745.17943863
1,Deaths,6,China,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3974.79196384,5605.43817086,3244.98075283
1,Deaths,6,China,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,13573.5378455,20481.2616259,11650.6058381
1,Deaths,6,China,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129578061683,0.0213086196091,0.0104818684582
1,Deaths,6,China,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0130394604555,0.0184136983152,0.0106564796932
1,Deaths,6,China,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129816481001,0.0195832670544,0.0111860115937
1,Deaths,6,China,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.48880253382,4.0746068811,2.00820215988
1,Deaths,6,China,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.10395543437,1.55684976398,0.901258271909
1,Deaths,6,China,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.8201744175099999,2.7464813429,1.56231447809
1,Deaths,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0802639981499,0.122467917584,0.0543144466371
1,Deaths,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0802639981499,0.122467917584,0.0543144466371
1,Deaths,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00091090990284,0.00131784630402,0.000711555223299
1,Deaths,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00063146382356,0.000914327546053,0.000475369303882
1,Deaths,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0801797853214,0.122339424487,0.05425746002680001
1,Deaths,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0411768556095,0.0628282153319,0.0278642751201
1,Deaths,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,115.767708009,225.063919968,68.1784698079
1,Deaths,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21.4075364769,56.6656272793,10.0925523295
1,Deaths,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,137.175244486,247.619844892,84.2184826299
1,Deaths,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00384371286,0.00748607636834,0.0023045800086
1,Deaths,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00136411148214,0.00360767896877,0.000651316780388
1,Deaths,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00299384799109,0.00533038060467,0.00185071688187
1,Deaths,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.6388469776,3.18608126005,0.965157565125
1,Deaths,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.312927459379,0.828317204912,0.147529201341
1,Deaths,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.986515484552,1.78079370067,0.605669321101
1,Deaths,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.87386972833,12.2244601911,6.16780115878
1,Deaths,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.87386972833,12.2244601911,6.16780115878
1,Deaths,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000629075678792,0.000811430120728,0.00046172238717
1,Deaths,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00033747132535,0.00044163202819,0.000240686414232
1,Deaths,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.21779066432299998,0.30002393403600003,0.151375843111
1,Deaths,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.106623435443,0.14688224888600002,0.0741088351323
1,Deaths,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.631545444288,0.8381442653,0.429896609115
1,Deaths,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.631545444288,0.8381442653,0.429896609115
1,Deaths,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00077518838215,0.000959914925471,0.000539380551555
1,Deaths,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000539842465831,0.000668071676706,0.000367884585315
1,Deaths,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.18901642609299998,0.25084977654400004,0.128664566231
1,Deaths,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0949916649177,0.12606649279499998,0.0646613715793
1,Deaths,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.9648808852,18.4792057702,3.82251626976
1,Deaths,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.9648808852,18.4792057702,3.82251626976
1,Deaths,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00127104886663,0.0019578083881,0.000471937281423
1,Deaths,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000716524565175,0.00114764941386,0.00025743428652
1,Deaths,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.392169433526,0.660926437308,0.136715943917
1,Deaths,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.186943526311,0.315057493674,0.0651712205844
1,Deaths,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.6930312609,6.96607251901,2.49901624253
1,Deaths,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.6930312609,6.96607251901,2.49901624253
1,Deaths,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000545161194799,0.00075652949352,0.000298462742799
1,Deaths,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000306939024621,0.000440118557386,0.00016654129505
1,Deaths,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.167850743696,0.249148234468,0.0893797018383
1,Deaths,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0800128904442,0.118766649166,0.0426064736662
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,197.214066878,293.845205977,116.70310847
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,197.214066878,293.845205977,116.70310847
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00099093869546,0.0011723027926,0.000821192146914
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000738823259564,0.000906874866515,0.000561259885993
1,Deaths,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.571480253398,0.8514947003,0.33817832093
1,Deaths,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.284293655858,0.42359213612799995,0.168233198991
1,Deaths,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1504.76572918,2232.23559083,929.645833409
1,Deaths,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,331.127036116,521.731888742,185.368107271
1,Deaths,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1835.89276529,2588.30244826,1233.3336683
1,Deaths,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0303820017402,0.036895461174,0.0235854204879
1,Deaths,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0201335311996,0.0246973885151,0.0160293760045
1,Deaths,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0278440765226,0.0335690593744,0.0221336200651
1,Deaths,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,13.8696731622,20.574882498599997,8.56869851298
1,Deaths,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.06274806167,4.82574105003,1.7145558934100003
1,Deaths,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,8.475662094130001,11.9492692404,5.693861656559999
1,Deaths,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.412810272497,0.658022267906,0.253766889095
1,Deaths,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.262692280083,0.426983521403,0.164125908572
1,Deaths,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.67550255258,0.960463148332,0.476481903814
1,Deaths,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00187664223845,0.00234805338324,0.00142461878305
1,Deaths,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00221862268954,0.00354006764413,0.0016281350847
1,Deaths,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00199997798911,0.00250448734819,0.00164608641159
1,Deaths,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.318023447557,0.5069314504770001,0.19549857724599998
1,Deaths,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.21777060353900002,0.353967231652,0.13605956808
1,Deaths,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.269733885101,0.383521062216,0.190263256008
1,Deaths,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.10712061433,15.0442189147,6.33488478406
1,Deaths,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.10712061433,15.0442189147,6.33488478406
1,Deaths,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000331033388591,0.000549697145573,0.000233563407575
1,Deaths,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000197861729033,0.00032500012785,0.000139705796901
1,Deaths,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0897102123325,0.148193938608,0.062402144777400005
1,Deaths,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0450274413124,0.0743816528803,0.0313209481805
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0561882057973,0.0851973554786,0.0250857126868
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0561882057973,0.0851973554786,0.0250857126868
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000484442455591,0.000678560186651,0.000225273913534
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000296501964302,0.000428065718991,0.000138480581309
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.119244944231,0.180809366637,0.0532379414487
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0599520110358,0.09090435836829999,0.026766096238499997
1,Deaths,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,456.8915957,550.245734491,354.35260974
1,Deaths,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,223.12296333,300.073273208,67.616824984
1,Deaths,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,680.01455903,786.282341405,466.547160357
1,Deaths,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00246512094395,0.00293891287899,0.00194147905428
1,Deaths,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0019362959771,0.00259156946683,0.000597087849535
1,Deaths,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00226238098275,0.00259241264019,0.00153771165486
1,Deaths,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.642350336,0.773598235905,0.49818932996599996
1,Deaths,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.31892144487199997,0.428910590064,0.0966483019034
1,Deaths,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.48197276124500005,0.557291996433,0.33067383652599996
1,Deaths,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.675966547468,0.881994551256,0.424006784812
1,Deaths,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.675966547468,0.881994551256,0.424006784812
1,Deaths,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00156631170761,0.00201120218876,0.00100117510747
1,Deaths,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00106369414347,0.00135357168244,0.000677424122671
1,Deaths,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.468088526477,0.610757339109,0.293613214829
1,Deaths,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.237267859982,0.309584787112,0.148828640747
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.237465892422,0.397175373995,0.157785210934
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.237465892422,0.397175373995,0.157785210934
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000717759438991,0.00116376515928,0.000517569370845
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000422193250265,0.000683819735408,0.000303652652924
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.348272215254,0.582505327122,0.23141093816
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.17436366472200002,0.29163326590099997,0.11585667034899999
1,Deaths,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,415.250652454,500.328097714,322.322516683
1,Deaths,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,83.5905722554,99.5220338436,68.5224817559
1,Deaths,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,498.841224709,582.730447753,404.24224765
1,Deaths,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0399210645518,0.0473575243612,0.0312028914222
1,Deaths,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0155360523684,0.018274946542,0.0129576241479
1,Deaths,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.031607652555,0.036818538037,0.0257029276545
1,Deaths,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.82798046567,4.61226532254,2.9713241634000003
1,Deaths,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.7884434671139999,0.9387122889659999,0.6463181389139999
1,Deaths,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.32562747412,2.71672402394,1.8846014137699998
1,Deaths,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.7663769285,7.83609341243,2.71245659199
1,Deaths,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.7663769285,7.83609341243,2.71245659199
1,Deaths,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000947582330467,0.00124750687542,0.000732945963182
1,Deaths,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000562625437046,0.000801843473655,0.000377585258814
1,Deaths,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.21280853121399998,0.349864803932,0.121105382974
1,Deaths,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10593241129,0.174156656664,0.060284167957699995
1,Deaths,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.581623993783,0.751590889662,0.443857579207
1,Deaths,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.581623993783,0.751590889662,0.443857579207
1,Deaths,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000713991503606,0.000854390487037,0.000595687923611
1,Deaths,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000497312219024,0.000610205019264,0.000408717196876
1,Deaths,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.1740753411,0.22494505365,0.132842971277
1,Deaths,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.087482907248,0.113047874213,0.06676126131
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,136.809833899,191.08045222,69.6252888851
1,Deaths,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,33.188317239,47.0750791564,14.9524333531
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,169.998151138,225.729324581,104.128330355
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0092731340562,0.0125711350063,0.00489801709146
1,Deaths,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00785483114503,0.0109107874819,0.00362290009328
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00895395482817,0.0116370342907,0.00561006556217
1,Deaths,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.25779904757,1.75675098757,0.640119350713
1,Deaths,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.42427683471800004,0.601804105787,0.191150730804
1,Deaths,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.909117531703,1.20715716626,0.5568583542769999
1,Deaths,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.66523211534,4.49992729946,1.54848404772
1,Deaths,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.66523211534,4.49992729946,1.54848404772
1,Deaths,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000527672355263,0.000664829892156,0.000405819042787
1,Deaths,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000313772941926,0.000437273521104,0.000199983024738
1,Deaths,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11899691113800001,0.20091212540099998,0.06913649943070001
1,Deaths,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0592346070945,0.100010585946,0.034414955317
1,Deaths,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,28.2387601785,37.8434285954,20.7277995424
1,Deaths,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,28.2387601785,37.8434285954,20.7277995424
1,Deaths,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0010263327862,0.00137204740338,0.000754530949259
1,Deaths,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00061362372521,0.000818625462277,0.00045124958367
1,Deaths,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.278167521756,0.372778857167,0.204180374554
1,Deaths,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.139618126356,0.187105544365,0.10248242193700001
1,Deaths,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.911139011856,1.19612098307,0.696044628812
1,Deaths,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.911139011856,1.19612098307,0.696044628812
1,Deaths,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000424139500895,0.000552111557516,0.000323931983646
1,Deaths,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000295036131232,0.000386090263956,0.0002263190754
1,Deaths,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0742336217449,0.0974520808167,0.0567091442913
1,Deaths,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0377075100198,0.049501495783999996,0.0288058237806
1,Deaths,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.84065873663,2.53252795754,1.38123716435
1,Deaths,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.84065873663,2.53252795754,1.38123716435
1,Deaths,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000857070173289,0.00116557989543,0.000655136504157
1,Deaths,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000596115977353,0.000813819063874,0.000456852222799
1,Deaths,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.14996478324200002,0.206333742724,0.11253413130600001
1,Deaths,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0761757062879,0.104808730711,0.0571625334186
1,Deaths,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26.5210908179,37.6364706004,13.8850619081
1,Deaths,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.96380386506,2.9656701249,0.947407690002
1,Deaths,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,28.4848946829,39.5275048453,15.6784105373
1,Deaths,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00681480631921,0.00952435439285,0.00364627861475
1,Deaths,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000575448870331,0.000849257100339,0.000277903071876
1,Deaths,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00389926246311,0.00545746607957,0.00219602753198
1,Deaths,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.38258614776,3.38116309463,1.24739801957
1,Deaths,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.180062740809,0.271924656288,0.0868685658277
1,Deaths,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.29256821816,1.79365228747,0.7114442723909999
1,Deaths,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.677487683007,1.76477264731,0.266740761045
1,Deaths,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.291656332828,0.527723356176,0.106580749508
1,Deaths,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.969144015835,2.07280105134,0.523557131157
1,Deaths,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00824472625991,0.0213180801784,0.0033284245101
1,Deaths,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00936285744102,0.015780575451,0.00373089396411
1,Deaths,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00854996273046,0.01821607009,0.00475178896601
1,Deaths,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.55616952827,6.658509340509999,1.00641623816
1,Deaths,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.18472845601,2.14364924259,0.432938471044
1,Deaths,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.89574708787,4.05461571512,1.02413252366
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,61.4824368416,90.1477771576,39.9970527753
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,61.4824368416,90.1477771576,39.9970527753
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00113456986211,0.00169853909695,0.000723959821445
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000685582247461,0.00103012159253,0.000445118730813
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.735339266381,1.0781810827,0.478370815407
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.38326500369800004,0.561957038799,0.24933088809300002
1,Deaths,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.71108763006,15.5640206875,5.80770209187
1,Deaths,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.71108763006,15.5640206875,5.80770209187
1,Deaths,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000515142733983,0.000680628076291,0.00038936910832
1,Deaths,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000357583421709,0.000499485022926,0.000257398234708
1,Deaths,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0732463676174,0.117392410027,0.0438048855739
1,Deaths,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.037644299958200005,0.06033275423250001,0.0225131198422
1,Deaths,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.78790741247,11.6839740524,4.91072691486
1,Deaths,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.78790741247,11.6839740524,4.91072691486
1,Deaths,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000414169905335,0.000497213348312,0.000344963704691
1,Deaths,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000287214006771,0.00036122324943,0.00022174924134
1,Deaths,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0587406839516,0.0881269628362,0.0370394051189
1,Deaths,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0301892366591,0.045292045617,0.0190360631103
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.607826440468,1.11608796865,0.258748210314
1,Deaths,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0303581478871,0.0499502175178,0.0110694438672
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.638184588355,1.14188469451,0.291107120432
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00525345538238,0.009185318821,0.00233015745653
1,Deaths,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00041437034308,0.000664684681557,0.000163392722837
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00337559812851,0.00590346264056,0.00157520642941
1,Deaths,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2899545192400002,2.36860824598,0.5491261995469999
1,Deaths,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.0651434722026,0.107184753776,0.0237531621344
1,Deaths,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.680933817711,1.21837461858,0.310607129184
1,Deaths,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,16.7367893934,24.7147718114,9.86820309805
1,Deaths,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,16.7367893934,24.7147718114,9.86820309805
1,Deaths,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00106692966868,0.00128942977614,0.000641541406546
1,Deaths,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000751599080059,0.000965862762147,0.00045493854769
1,Deaths,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.404012839978,0.5965950167749999,0.23821060691
1,Deaths,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.196230909528,0.289768965679,0.115699996207
1,Deaths,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,22.1166986392,32.3304360677,14.25312556
1,Deaths,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,22.1166986392,32.3304360677,14.25312556
1,Deaths,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00141016369212,0.00175479977112,0.001161608216
1,Deaths,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000993272428641,0.00128131536659,0.000764419525183
1,Deaths,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.533879588141,0.780431120115,0.344059162167
1,Deaths,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.25930779122,0.379059013402,0.16711113024799998
1,Deaths,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,125.56428576,192.572258358,76.7825118718
1,Deaths,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,125.56428576,192.572258358,76.7825118718
1,Deaths,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000909533192884,0.00131469336116,0.000586107196888
1,Deaths,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000509768542113,0.000758775928968,0.000321401534546
1,Deaths,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.283103638155,0.434183228287,0.173117764546
1,Deaths,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.144618214129,0.221794405359,0.0884339816535
1,Deaths,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,41.0393371205,58.2014321348,27.6117367145
1,Deaths,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,41.0393371205,58.2014321348,27.6117367145
1,Deaths,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000297579773227,0.000396535269969,0.000214318544895
1,Deaths,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000166725120767,0.000229314965961,0.000115031835708
1,Deaths,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0925293810732,0.131223915172,0.0622548288498
1,Deaths,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0472669087988,0.0670332899529,0.0318017183666
1,Deaths,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,16.8495016014,21.560092091,12.9037157476
1,Deaths,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.05570261943,2.62996428729,1.62828572365
1,Deaths,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18.9052042208,23.6973963528,15.0167531715
1,Deaths,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0124731616123,0.0148928116758,0.0102826397043
1,Deaths,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00374021490918,0.00452445744502,0.00311704339343
1,Deaths,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00993841966361,0.011794122213,0.00836170195924
1,Deaths,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.40744653115,3.08049283259,1.8436750504900001
1,Deaths,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.255919004188,0.327410120069,0.20270892150999997
1,Deaths,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.25770243583,1.57651156622,0.9990162931609999
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,111.406032644,169.447918392,67.6955882449
1,Deaths,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,14.4999956888,27.1790705834,5.71500717014
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,125.906028333,187.052934361,81.100787735
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0105325217674,0.0138100412208,0.00718462473659
1,Deaths,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00769541912027,0.0133300769996,0.00332669760176
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100921668333,0.0129777636702,0.00724280641262
1,Deaths,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.12482160082,3.2318411191000003,1.29114236249
1,Deaths,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.861772058775,1.6153221087,0.339657583397
1,Deaths,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.81796537877,2.70086955461,1.17101957901
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,120.182976601,181.227091863,65.7270983966
1,Deaths,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,30.1852650927,42.2718783445,19.7808741928
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,150.368241694,213.791640028,92.3399261328
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.017414730432,0.0227853290053,0.00971092447104
1,Deaths,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108628476464,0.0142174473877,0.00804198739199
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0155218015416,0.0196197833641,0.0101831531234
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.5429210756,6.85039094872,2.4844868132699998
1,Deaths,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.1340050932199999,1.58807700364,0.743131193781
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.83321931444,4.028234931609999,1.73985716177
1,Deaths,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,19.9935189561,29.8118162817,11.4068643229
1,Deaths,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,19.9935189561,29.8118162817,11.4068643229
1,Deaths,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0018666496914,0.00237482073194,0.00113582110632
1,Deaths,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00117370782717,0.00157187815148,0.000717657985456
1,Deaths,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.23412618045800002,0.34909946037399997,0.133575564201
1,Deaths,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11813078800700001,0.176141746583,0.0673969336819
1,Deaths,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,84.6901428606,124.442538225,47.6366936268
1,Deaths,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5.74223619473,9.57689955561,2.87692779516
1,Deaths,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,90.4323790554,132.096241301,51.0515327406
1,Deaths,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00674301988442,0.0098179760425,0.00388913975496
1,Deaths,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000650620711953,0.00107058091829,0.000339662039076
1,Deaths,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00422696113218,0.00600511215418,0.00245546895477
1,Deaths,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.3629521485400002,3.4720895860599996,1.32911840449
1,Deaths,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.152806626656,0.254850839514,0.076557915175
1,Deaths,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.23172538775,1.7992039547899998,0.695342416255
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.906161356893,1.22727006275,0.681574547476
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.906161356893,1.22727006275,0.681574547476
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000779723059646,0.00105120581345,0.000588725815827
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000532397853707,0.000720227435396,0.000402833745979
1,Deaths,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.257419025564,0.348638419915,0.193619220822
1,Deaths,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.128799526968,0.174441121707,0.0968773151058
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.304843756335,0.429306471553,0.185911322367
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.304843756335,0.429306471553,0.185911322367
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000921111246295,0.00121243510439,0.000589874314063
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00054184642498,0.000716982749901,0.000344146663013
1,Deaths,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.447089934653,0.629629435815,0.272661254302
1,Deaths,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.223837090793,0.315226110603,0.136508780906
1,Deaths,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.43146562479,4.61859024754,2.58473228947
1,Deaths,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.43146562479,4.61859024754,2.58473228947
1,Deaths,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00172678517464,0.00227073457266,0.0013439456783
1,Deaths,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00112557997402,0.00148041826339,0.000865652702531
1,Deaths,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.151210892112,0.203522700791,0.113898758751
1,Deaths,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0773558847807,0.104117358034,0.0582678875547
1,Deaths,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.77049144405,5.95387858978,3.78943454466
1,Deaths,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.77049144405,5.95387858978,3.78943454466
1,Deaths,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00240117869029,0.00279611710805,0.00199412105797
1,Deaths,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00156488248458,0.00184409060429,0.00129172492518
1,Deaths,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.210216375724,0.26236348882,0.16698514301200001
1,Deaths,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.10754168243,0.134218901353,0.0854256151956
1,Deaths,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.18876775221,1.66865805371,0.703887227553
1,Deaths,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.18876775221,1.66865805371,0.703887227553
1,Deaths,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000810813414089,0.00104930448815,0.000530263609113
1,Deaths,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00060908102222,0.000807111481199,0.000398568872294
1,Deaths,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.27260879897400003,0.382657476261,0.161415761287
1,Deaths,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.137442193163,0.19292584452800002,0.08138158535579999
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,13.8356970364,22.516126922,9.0247062934
1,Deaths,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.92274784059,6.5336049703,2.52049829508
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,17.758444877,27.8823937205,12.4524007394
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00412797687795,0.00676542298031,0.0030332199846
1,Deaths,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00286036729462,0.0045139155204,0.0020326883115
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00375800005196,0.00576830292746,0.00287375711512
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.828550843826,1.34837846708,0.540444619089
1,Deaths,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.229605627927,0.38242388570299995,0.14752938940899998
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.525656098519,0.825328479042,0.368595360415
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,387.662685514,598.045169479,250.748674556
1,Deaths,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,141.78443362,253.373943849,75.08531362
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,529.447119135,793.799719985,367.267751994
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00371793764123,0.00555915377117,0.00254613154606
1,Deaths,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00238860037726,0.00405229548064,0.00131321619094
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00323418557027,0.00468900885547,0.00230478558583
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.849619423968,1.3107033805100001,0.54955236188
1,Deaths,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.310919429583,0.555624338167,0.164654766992
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.580346603662,0.870113283899,0.40257579048200004
1,Deaths,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.07189516992,6.89373856364,3.39994065235
1,Deaths,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.07189516992,6.89373856364,3.39994065235
1,Deaths,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00041585150565,0.000526277048231,0.000290534522472
1,Deaths,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000303637147728,0.000389621243278,0.000208334837075
1,Deaths,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0818321572876,0.111226569071,0.054856117666
1,Deaths,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0413080579115,0.056146064197500005,0.027690821804700002
1,Deaths,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.72629940089,9.88457763541,5.84144457262
1,Deaths,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.72629940089,9.88457763541,5.84144457262
1,Deaths,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000633864924038,0.000760438301434,0.000524838047647
1,Deaths,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000462790447651,0.000563655395758,0.00037681968268
1,Deaths,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12465946685500001,0.159482064333,0.0942484012461
1,Deaths,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.06292685720050001,0.0805049575582,0.04757565419
1,Deaths,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.57283356104,3.18978390032,2.03379705348
1,Deaths,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.57283356104,3.18978390032,2.03379705348
1,Deaths,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00157775414744,0.00190114857125,0.00128241332046
1,Deaths,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00107639843083,0.00131041501093,0.000868537335288
1,Deaths,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.309576006372,0.38381050994,0.244716478797
1,Deaths,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15528473204100002,0.19252109648,0.122750898176
1,Deaths,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.23775122805,10.1361457643,6.61667826461
1,Deaths,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.23775122805,10.1361457643,6.61667826461
1,Deaths,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00505215815861,0.00608679828625,0.00414304184722
1,Deaths,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00344657732658,0.00418078768398,0.00279978260872
1,Deaths,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.991206802215,1.21963098323,0.796151318775
1,Deaths,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.497193837737,0.611772445284,0.399353120577
1,Deaths,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,107.78979078,125.049383493,89.9657985106
1,Deaths,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,101.402811496,111.164145663,90.6167865186
1,Deaths,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,209.192602276,226.605928041,186.764326213
1,Deaths,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00422892558358,0.00490269521532,0.00354361109232
1,Deaths,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00729661227859,0.00798078132022,0.00663923328082
1,Deaths,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00531123223526,0.00573051584753,0.00473934870144
1,Deaths,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.40855522370999997,0.473974190675,0.340997015309
1,Deaths,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.39898070109800005,0.43738776193000006,0.356541879688
1,Deaths,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.403857397396,0.43747474498300004,0.36055842267
1,Deaths,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.41069718452,10.6098139025,5.61014857215
1,Deaths,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.41069718452,10.6098139025,5.61014857215
1,Deaths,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00042648123232,0.000598709443419,0.000327670723702
1,Deaths,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000309673984586,0.000436635510124,0.000238476804487
1,Deaths,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.08535990897939999,0.122208845734,0.0646203399701
1,Deaths,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0425630100944,0.0609369948584,0.03222163912
1,Deaths,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.9212632644,3.50934482744,1.12317861899
1,Deaths,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.9212632644,3.50934482744,1.12317861899
1,Deaths,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00121092227798,0.00219309688284,0.000811706288026
1,Deaths,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000785572931364,0.00141210374764,0.000502632580156
1,Deaths,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.09642197203719999,0.176122635086,0.0563686920993
1,Deaths,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.04883809550650001,0.0892067844231,0.0285509569049
1,Deaths,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.35329006873,12.783716865,5.06930907735
1,Deaths,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.35329006873,12.783716865,5.06930907735
1,Deaths,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00528244713697,0.00645791184407,0.00351158605435
1,Deaths,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00342173265031,0.0044116188303,0.0022424424218
1,Deaths,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.41922453645499996,0.641573288227,0.254412181381
1,Deaths,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.212338821925,0.324959310236,0.128860737338
1,Deaths,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5.55560838201,8.239421574,3.33301552729
1,Deaths,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.24520402725,3.2769688569,1.40157417777
1,Deaths,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7.80081240926,10.6196526958,5.35400599768
1,Deaths,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00741211350835,0.00990462180987,0.00511597435453
1,Deaths,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00511355230557,0.00667421057356,0.00381572212673
1,Deaths,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00656055772726,0.00830226023816,0.00497243390798
1,Deaths,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.5543477811249999,0.822143094552,0.33257379479599997
1,Deaths,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.21715818435,0.316951421119,0.135561534713
1,Deaths,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.383126937788,0.5215706780580001,0.2629551661
1,Deaths,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.66604963235,4.04642568283,1.74160642763
1,Deaths,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.66604963235,4.04642568283,1.74160642763
1,Deaths,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000562561337736,0.000781150326812,0.000403254139407
1,Deaths,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000380682075412,0.000539088763564,0.000268164247993
1,Deaths,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.089087772473,0.135213930824,0.0581969049937
1,Deaths,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.043941227627899995,0.0666922737863,0.0287047636121
1,Deaths,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.01298516914,12.6848565007,6.42132689259
1,Deaths,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.01298516914,12.6848565007,6.42132689259
1,Deaths,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00190318050835,0.00242073934089,0.0014996471643
1,Deaths,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00128768858822,0.00166074190568,0.000984106350063
1,Deaths,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.301174727698,0.423872682667,0.21457279048400002
1,Deaths,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.148549985011,0.209068938613,0.10583485890000001
1,Deaths,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34.1972453302,53.9216593412,19.8170759038
1,Deaths,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10.2002196732,15.2746986522,6.20780540578
1,Deaths,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,44.3974650034,65.1280348288,29.1363386215
1,Deaths,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000783529699856,0.00120250041881,0.000485745289561
1,Deaths,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00032185682181,0.000491105982423,0.000199104248168
1,Deaths,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000589700507188,0.000854890237891,0.00039412567721
1,Deaths,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.5419646866169999,0.854561088898,0.31406492622800003
1,Deaths,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.153702788341,0.230167961979,0.09354278936339999
1,Deaths,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.342938383799,0.503067078322,0.225057193601
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.04190133175,5.85138215456,2.64877669358
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.04190133175,5.85138215456,2.64877669358
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000591782251585,0.000820722566629,0.000399308794266
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000315939680658,0.000442564632171,0.000212324745238
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.256291974574,0.371028920127,0.167955660785
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.12645594784199998,0.183067822742,0.08287029789110001
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.04130687957,5.4521352524,2.87441277848
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.04130687957,5.4521352524,2.87441277848
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000591904109979,0.000758090246723,0.000439308676092
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000315942044696,0.000410177953246,0.000229503885802
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.256254281095,0.345713166847,0.182262966429
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.126437349661,0.170576883134,0.08992960553900001
1,Deaths,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,65.8780929909,87.9373552185,46.867408845
1,Deaths,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,65.8780929909,87.9373552185,46.867408845
1,Deaths,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00132961937171,0.00176188731056,0.000958183550612
1,Deaths,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000822250311332,0.00110240989109,0.000587619602281
1,Deaths,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.72390119969,0.96629932729,0.515002361922
1,Deaths,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.363020403005,0.48457769011400004,0.258262267079
1,Deaths,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,14.9125700056,21.6096795463,9.5349717619
1,Deaths,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5.25873573713,8.31718920095,2.93823008655
1,Deaths,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,20.1713057427,27.5228514306,13.4439695064
1,Deaths,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00173184254106,0.0023403179409,0.00119151716698
1,Deaths,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000788787481622,0.001205197127,0.000442036418005
1,Deaths,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00132019953425,0.00172575393852,0.000928825405904
1,Deaths,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.533362303955,0.772890820713,0.34102736853399995
1,Deaths,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.171328422506,0.270972145533,0.0957268725509
1,Deaths,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.343906611054,0.469245307309,0.229210248015
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36872146571,12.1097993578,5.62608023777
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36872146571,12.1097993578,5.62608023777
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000475918398382,0.000633508831685,0.000366101796005
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000347813634369,0.000474258116425,0.000258912545845
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.187561568803,0.271407403716,0.126092909165
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.09268888099030001,0.134123683778,0.0623123954761
1,Deaths,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,13.0207970471,16.5337811851,9.48557588591
1,Deaths,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,13.0207970471,16.5337811851,9.48557588591
1,Deaths,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000264374151909,0.000334003351965,0.000193172229966
1,Deaths,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000158603433778,0.000200811013494,0.000115590088422
1,Deaths,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.111871244313,0.14205387486499998,0.08149755913870001
1,Deaths,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0562335284781,0.0714052182642,0.0409658026142
1,Deaths,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,39.2502855601,48.3350398507,29.2766615125
1,Deaths,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,39.2502855601,48.3350398507,29.2766615125
1,Deaths,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000796986801905,0.000976798927469,0.000600562017664
1,Deaths,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000478143870355,0.00059101911919,0.000358857138442
1,Deaths,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.337228072087,0.415281878094,0.251537332229
1,Deaths,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16951205389600002,0.20874680943899998,0.126438494736
1,Deaths,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.581866057443,0.877943787498,0.387669100801
1,Deaths,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.581866057443,0.877943787498,0.387669100801
1,Deaths,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000776191715774,0.00103039178116,0.000568364744094
1,Deaths,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000488947963744,0.000665763524138,0.000348920251757
1,Deaths,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0580595563395,0.0876026813064,0.038682263230699995
1,Deaths,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0285776082151,0.0431190877575,0.0190398727303
1,Deaths,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,58.4298629312,81.5845418834,29.8007481649
1,Deaths,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.09924496672,5.95288336912,1.89914569895
1,Deaths,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62.5291078979,86.2574218845,33.4598669092
1,Deaths,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0063533199391,0.00874455641545,0.00317927490542
1,Deaths,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000682987274678,0.00100849520856,0.000327234061111
1,Deaths,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00411146595166,0.00565268709473,0.00221347831048
1,Deaths,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.24257084135,4.5275419681699995,1.6537953745299998
1,Deaths,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.22348160949300003,0.32453780324299997,0.10353714913599998
1,Deaths,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.71961553572,2.3721688623199997,0.920181158737
1,Deaths,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.89607488078,4.7792031045,1.02949111259
1,Deaths,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.89607488078,4.7792031045,1.02949111259
1,Deaths,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00146185664553,0.00224932389926,0.000569076287523
1,Deaths,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00075733171587,0.00121547754442,0.000259754273252
1,Deaths,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.279199761365,0.460745119247,0.09924939264189998
1,Deaths,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.141442784138,0.233413782754,0.0502798080867
1,Deaths,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.29817164153,2.06590535276,0.528105717166
1,Deaths,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.29817164153,2.06590535276,0.528105717166
1,Deaths,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000655432392254,0.00100132766245,0.000282120084415
1,Deaths,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000339558129229,0.00054277413984,0.00014204147142
1,Deaths,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.125151878818,0.19916621815399999,0.0509126995255
1,Deaths,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0634020247497,0.100897738108,0.0257924073204
1,Deaths,163,India,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,319.648753954,463.554915016,277.975504349
1,Deaths,163,India,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,319.648753954,463.554915016,277.975504349
1,Deaths,163,India,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000270091971368,0.000395547935725,0.000237327588165
1,Deaths,163,India,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000169192247104,0.000245086143872,0.000148074703867
1,Deaths,163,India,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0862777766591,0.125120110535,0.075029569752
1,Deaths,163,India,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.044901418942,0.0651160787718,0.039047530835000004
1,Deaths,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.96907674969,5.65311613845,2.06713400868
1,Deaths,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.96907674969,5.65311613845,2.06713400868
1,Deaths,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00132290234914,0.00157480314607,0.000722923890116
1,Deaths,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00101508253057,0.00124554724879,0.000527901932765
1,Deaths,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.40910767916,0.582687957245,0.21306728242800002
1,Deaths,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.20380190204,0.290273001538,0.10614202478500001
1,Deaths,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.58620319365,10.3854665282,5.10944693845
1,Deaths,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.58620319365,10.3854665282,5.10944693845
1,Deaths,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00253527329069,0.00319361561753,0.00189221972728
1,Deaths,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00194425921236,0.00247761887697,0.00144465139925
1,Deaths,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.7819385156599999,1.07046912325,0.5266499265719999
1,Deaths,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.389532059376,0.53326704559,0.262356983777
1,Deaths,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.31774579598,0.459681598739,0.166957495133
1,Deaths,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.31774579598,0.459681598739,0.166957495133
1,Deaths,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00385856103863,0.00511355429904,0.00220609369505
1,Deaths,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00279881730546,0.00377392115001,0.00158854946081
1,Deaths,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.19885887492,1.73438443956,0.629932723915
1,Deaths,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.621544019845,0.89918529952,0.326586327754
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,13.5978367763,19.9275791346,9.51509118725
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,13.5978367763,19.9275791346,9.51509118725
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00077448456601,0.00107164127588,0.000617422658411
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000565715171526,0.000794180816753,0.000436402026361
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.304757615429,0.446621149986,0.213254251285
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.150604638934,0.220710537255,0.105385650398
1,Deaths,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,867.568433002,1059.57693251,709.208143985
1,Deaths,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,227.745133509,246.055656508,192.318430699
1,Deaths,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1095.31356651,1287.10468705,928.38745508
1,Deaths,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00515737840925,0.00628676400085,0.00422544445705
1,Deaths,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00361520284757,0.00387524952318,0.00307869099968
1,Deaths,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00473717824161,0.00554781678617,0.00402040598723
1,Deaths,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5289220652700002,1.8673000196199998,1.24984259334
1,Deaths,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.399297679493,0.43140088728000003,0.337185264591
1,Deaths,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.962657233641,1.13122002258,0.815947986566
1,Deaths,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.56576225024,2.07661413372,1.16011134662
1,Deaths,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.56576225024,2.07661413372,1.16011134662
1,Deaths,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00134492538778,0.00166947571873,0.00105799896445
1,Deaths,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00083101515885,0.0010554037895,0.000640691863638
1,Deaths,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15269276548900002,0.20251092072399998,0.113133785007
1,Deaths,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.07476616055669999,0.0991596685336,0.0553960674374
1,Deaths,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.47783602797,11.3708224492,4.77797923591
1,Deaths,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.47783602797,11.3708224492,4.77797923591
1,Deaths,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00032310951501,0.00048094866001,0.000210897627123
1,Deaths,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000214020310038,0.000321738521053,0.000139572508709
1,Deaths,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10924080996100001,0.166111940625,0.069799647887
1,Deaths,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.055315710190899994,0.0841132537381,0.035344090686500004
1,Deaths,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,13.6898549885,20.9015727416,8.42625298971
1,Deaths,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,13.6898549885,20.9015727416,8.42625298971
1,Deaths,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000590570449255,0.00086885156807,0.00037191987464
1,Deaths,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000391323432041,0.00057448730238,0.000243924596782
1,Deaths,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.199989788705,0.305342979869,0.123095865982
1,Deaths,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.10126780639099998,0.154614962936,0.062331424041699994
1,Deaths,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.17453069709,10.6904891803,6.41918003776
1,Deaths,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.17453069709,10.6904891803,6.41918003776
1,Deaths,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00134577456113,0.00171806891095,0.0010789845335
1,Deaths,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000874842003305,0.00112762996921,0.00070303640765
1,Deaths,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.139297933368,0.182171075588,0.10938591416599999
1,Deaths,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0700906357139,0.0916631437945,0.055039784702100004
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,157.281896822,561.593176454,31.4847467891
1,Deaths,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,46.0927041818,187.037287451,12.8376556801
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,203.374601004,603.488410438,49.208540175
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00290300926993,0.0105141486694,0.000572055996881
1,Deaths,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00129817899052,0.00521535003159,0.000373031507607
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00226632429307,0.00679760671346,0.000548881686521
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.88111533253,6.7167395372,0.376562345206
1,Deaths,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.600114002235,2.43517270535,0.167142654488
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2677826581,3.76198471856,0.306752827328
1,Deaths,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,38.2117750633,55.5476740513,25.866449274
1,Deaths,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,38.2117750633,55.5476740513,25.866449274
1,Deaths,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00128841564531,0.00165547445751,0.00100316795022
1,Deaths,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000994993036909,0.00130367944231,0.000756018767684
1,Deaths,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.459577354115,0.668078178138,0.311098720173
1,Deaths,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.229909832038,0.33421520958100004,0.155631372742
1,Deaths,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,51.4064782108,79.964200573,33.734273978
1,Deaths,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,51.4064782108,79.964200573,33.734273978
1,Deaths,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00173768458789,0.00249531654243,0.00126939957496
1,Deaths,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0013412523919,0.00197058694963,0.00096293435292
1,Deaths,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.618271545914,0.9617385128639999,0.40572594055399996
1,Deaths,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.30929876331399997,0.48112279244699996,0.202969928808
1,Deaths,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.577340390799,0.807865543094,0.409016287703
1,Deaths,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.577340390799,0.807865543094,0.409016287703
1,Deaths,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000771073393327,0.000918877636058,0.000625865960092
1,Deaths,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000485502561131,0.000609342930081,0.000370994743241
1,Deaths,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.05760797784629999,0.0806101583243,0.0408123208012
1,Deaths,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.028355335878299998,0.039677284292,0.020088312549
1,Deaths,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,516.821923883,614.181664473,431.527519626
1,Deaths,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,138.171580883,149.615874449,118.098874326
1,Deaths,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,654.993504765,757.974379005,563.72950327
1,Deaths,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00638095521777,0.00754482033482,0.00531409419779
1,Deaths,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00413270206752,0.00442053617459,0.00354477503009
1,Deaths,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00572405507709,0.00658359133327,0.00493052906269
1,Deaths,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.4835437367700002,1.76301607858,1.23870509241
1,Deaths,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.39551980512699997,0.42827939817899996,0.338061151654
1,Deaths,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9387739796469999,1.08637203128,0.807969217067
1,Deaths,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,78.7971604521,109.928543122,53.9274491601
1,Deaths,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,28.5009713411,47.0333532793,15.9538538905
1,Deaths,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,107.298131793,144.969711274,76.7339992243
1,Deaths,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0046700677457,0.00644411951679,0.00322839563856
1,Deaths,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00213662758835,0.00353258334906,0.00122712815367
1,Deaths,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00355192071031,0.00471851145952,0.00255755056265
1,Deaths,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.11613791515,1.55710452295,0.763865986153
1,Deaths,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.35505287428000004,0.585921338224,0.198746267693
1,Deaths,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.711193488546,0.960888255663,0.508608301807
1,Deaths,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,22.5043326348,28.9842603572,17.0996072865
1,Deaths,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,22.5043326348,28.9842603572,17.0996072865
1,Deaths,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00045411678188,0.000586871083337,0.000349058347144
1,Deaths,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000280804322878,0.000365275018016,0.000212481127231
1,Deaths,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.24728878224899997,0.318493445881,0.187898976229
1,Deaths,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.124009841991,0.15971740222,0.0942271709235
1,Deaths,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.36513442261,5.42015929505,3.50808632105
1,Deaths,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.36513442261,5.42015929505,3.50808632105
1,Deaths,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00374983159386,0.00443635058249,0.00322274355783
1,Deaths,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00231632097898,0.00275632522415,0.00193245385721
1,Deaths,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.425686879738,0.528572656559,0.342107750938
1,Deaths,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.208437993087,0.258816113388,0.167513391695
1,Deaths,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,25.8811043275,36.3403396854,15.6683190367
1,Deaths,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.48739666492,5.02926938799,2.01472452935
1,Deaths,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29.3685009924,39.6569434915,18.2095781526
1,Deaths,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00629685021418,0.00814804551067,0.00399857992228
1,Deaths,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00231468801247,0.00311257158212,0.0014583210251
1,Deaths,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0052260361153,0.00668172317641,0.00336881154622
1,Deaths,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.08304014759,4.32897780595,1.86646041158
1,Deaths,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.41824034111900005,0.603155748118,0.241624098255
1,Deaths,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7551320266900001,2.36999401572,1.0882480456299999
1,Deaths,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,58.0724268417,112.215693205,30.4695989822
1,Deaths,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.63012325132,16.3419494153,5.05221411776
1,Deaths,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,66.702550093,121.822679606,37.9817447793
1,Deaths,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00382021945049,0.00715695259333,0.00205999018657
1,Deaths,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00114626901459,0.00221886948861,0.000683711240079
1,Deaths,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00293281627672,0.00527571704823,0.00169901514041
1,Deaths,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.37801356604,2.6627912069199997,0.723019908633
1,Deaths,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.199501675772,0.377775171779,0.116791516587
1,Deaths,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.781055460068,1.4264862278000001,0.44474835072100005
1,Deaths,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1051.36784808,1878.52622787,373.207056804
1,Deaths,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,65.8626129232,107.289311408,30.9207903344
1,Deaths,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1117.230461,1945.96981567,432.788306904
1,Deaths,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00763440769244,0.0131488235619,0.00279296269831
1,Deaths,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00060567687823,0.000928930941388,0.000286378252625
1,Deaths,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00454291158402,0.0079110274172,0.0017801716531
1,Deaths,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.37046753404,4.23542097388,0.8414516510539999
1,Deaths,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.15507336294000001,0.252612424394,0.0728029261076
1,Deaths,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2867661617500001,2.24126373027,0.498462374564
1,Deaths,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,189.320466858,231.56645958,145.752399787
1,Deaths,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,47.7710420718,59.1750022446,37.3870785065
1,Deaths,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,237.09150893,281.049017315,192.890724557
1,Deaths,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.159543373725,0.183316295894,0.130518109558
1,Deaths,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0791561111271,0.0910802468169,0.0680716156285
1,Deaths,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.132422399715,0.149200105085,0.112036262796
1,Deaths,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,14.6627065626,17.9346221933,11.288397416
1,Deaths,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.93152016313,4.8700573483,3.07692791728
1,Deaths,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,9.46001738983,11.213934245,7.69639375481
1,Deaths,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12.7153627741,21.1904664841,8.20312928546
1,Deaths,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.01823506554,5.41396254117,1.62859461474
1,Deaths,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,15.7335978396,24.1451345626,10.4546762945
1,Deaths,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00093968082935,0.00151654579329,0.000612338117718
1,Deaths,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000263026930508,0.000463364835682,0.000143626915012
1,Deaths,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000629176658216,0.000942745703561,0.000432953827109
1,Deaths,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.520219571238,0.8669587792789999,0.33561200537700003
1,Deaths,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.122185858544,0.219171021095,0.0659296664776
1,Deaths,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.320151022675,0.49131098948999996,0.21273426088199998
1,Deaths,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1031293127,20.0106037058,11.5851460969
1,Deaths,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1031293127,20.0106037058,11.5851460969
1,Deaths,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000869348685304,0.00116343564217,0.000677960520415
1,Deaths,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000631239414662,0.000843259779413,0.000490940627518
1,Deaths,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.173964974055,0.23049158107800002,0.133443182433
1,Deaths,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0867441523227,0.11493001350899999,0.06653877199290001
1,Deaths,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,531.350421719,780.60137495,357.651313198
1,Deaths,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,208.620148469,306.189503842,138.440589818
1,Deaths,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,739.970570188,990.363831447,548.996586593
1,Deaths,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0036226315944,0.00481907554631,0.00260889494354
1,Deaths,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00206670975157,0.00296221625758,0.00145626618321
1,Deaths,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00298693803097,0.00374484901484,0.00233746342728
1,Deaths,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.04269504954,1.5318124462799998,0.701836751208
1,Deaths,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.42879909117,0.629343723208,0.284551609855
1,Deaths,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.74285641142,0.994226191512,0.551137640643
1,Deaths,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.250211586136,0.431564677756,0.138263802098
1,Deaths,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.250211586136,0.431564677756,0.138263802098
1,Deaths,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000509999882688,0.000831690663131,0.000303575785202
1,Deaths,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000342016898632,0.000562679054039,0.000197512201223
1,Deaths,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0995649135708,0.171729457075,0.0550183295605
1,Deaths,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.054141008104800006,0.0933823532194,0.0299176458836
1,Deaths,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.17149022378,1.92451211752,0.616861236985
1,Deaths,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.311587604821,0.486357671787,0.17047874441
1,Deaths,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.4830778286,2.25585814303,0.87003130655
1,Deaths,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0568907391627,0.0795480762176,0.0341213593856
1,Deaths,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0333875301992,0.0453348044218,0.021164016208
1,Deaths,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0494850098894,0.0671572625301,0.0311576137614
1,Deaths,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.32450643215,10.389834263200001,3.3302393668
1,Deaths,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7190376361800002,2.683249043,0.940536058803
1,Deaths,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.04673730468,6.155351476100001,2.37397395912
1,Deaths,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,33.2413882157,50.1001551869,17.6401548457
1,Deaths,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,33.2413882157,50.1001551869,17.6401548457
1,Deaths,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000671277386403,0.000838086729323,0.00042068598869
1,Deaths,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00050292038601,0.000659450630418,0.000301791103041
1,Deaths,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.306391341237,0.461781368584,0.162592207875
1,Deaths,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15346363327,0.231294547402,0.0814383032535
1,Deaths,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,73.6871262482,106.55555543,46.5646975641
1,Deaths,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,73.6871262482,106.55555543,46.5646975641
1,Deaths,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00148888088249,0.00181674186098,0.00122489210729
1,Deaths,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00111510499668,0.00142031659712,0.000857856586369
1,Deaths,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.679186359383,0.9821400758800001,0.42919447432100005
1,Deaths,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.340187180087,0.49192899452199995,0.214972600541
1,Deaths,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,162.813865389,226.427345444,142.032880161
1,Deaths,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,162.813865389,226.427345444,142.032880161
1,Deaths,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00087842718435,0.00121290499147,0.000779849210187
1,Deaths,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000541647098272,0.000748238070707,0.000479134595
1,Deaths,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.228902308825,0.318337397304,0.199686028706
1,Deaths,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.115397306173,0.16048452412599998,0.100668402654
1,Deaths,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,200.874862404,345.905728285,123.636685141
1,Deaths,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,54.9226389666,107.181990245,37.4976304063
1,Deaths,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,255.79750137,436.64582087,169.851161111
1,Deaths,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00381567359339,0.00646841039723,0.00242761758493
1,Deaths,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00224693067038,0.0043136259072,0.00152615025262
1,Deaths,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00331763639414,0.00552734628018,0.00227613471846
1,Deaths,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.3829028177,2.38135324937,0.851164342846
1,Deaths,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.36793324389,0.718024809069,0.25120105394
1,Deaths,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.868495851908,1.48252067415,0.5766867466519999
1,Deaths,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,25.9546052613,37.1407382281,14.9641140058
1,Deaths,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,25.9546052613,37.1407382281,14.9641140058
1,Deaths,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000548488326041,0.00073506531684,0.000327180034661
1,Deaths,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000362642983004,0.000493802823989,0.000215490899496
1,Deaths,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10798117301099999,0.154519802555,0.0622564884789
1,Deaths,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0547421219,0.0783353396852,0.0315615415756
1,Deaths,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11.2366021216,17.7126366511,8.31965999558
1,Deaths,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1.84920002567,3.54330478238,1.35209711324
1,Deaths,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,13.0858021472,20.1136559507,10.0630558074
1,Deaths,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0428954569072,0.0673637815624,0.0321515883823
1,Deaths,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0157279255543,0.0304610907251,0.0116095136914
1,Deaths,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0344713727297,0.05349727447,0.0266918717432
1,Deaths,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.86028158172,7.6614265369300005,3.59858699322
1,Deaths,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.738862650849,1.41575574731,0.54024120886
1,Deaths,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.71789107141,4.17756017604,2.09007359444
1,Deaths,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,80.6642479558,122.150897764,50.1768942996
1,Deaths,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,26.5338856804,43.1695864368,15.515336484
1,Deaths,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,107.198133636,158.145107581,70.6088786298
1,Deaths,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00380688456738,0.0051170571872,0.00276097497721
1,Deaths,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00148774923721,0.00208900671511,0.000918006683023
1,Deaths,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00274664736504,0.00358800408885,0.00201317148779
1,Deaths,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.42403321981,2.15643163674,0.885814548084
1,Deaths,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.46037088408599997,0.749005287537,0.269195746906
1,Deaths,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9380239206270001,1.38382907248,0.617854200598
1,Deaths,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.5406343982,14.1628676699,7.02887473121
1,Deaths,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.5406343982,14.1628676699,7.02887473121
1,Deaths,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000839272613666,0.00110747187935,0.000567104790684
1,Deaths,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000492742899359,0.000651961102892,0.000336863491366
1,Deaths,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.29409579269499997,0.39516025666800003,0.19611366904
1,Deaths,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.143567681474,0.192903956023,0.0957361018716
1,Deaths,163,India,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,825.399115744,915.880047947,734.716059625
1,Deaths,163,India,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,825.399115744,915.880047947,734.716059625
1,Deaths,163,India,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000697343421838,0.000765961045538,0.000628140018832
1,Deaths,163,India,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000436855855869,0.000483910794129,0.000391453389169
1,Deaths,163,India,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.22278704259600002,0.247209142053,0.198310386999
1,Deaths,163,India,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11594473944299999,0.12865469746,0.103206388852
1,Deaths,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.65508213788,3.42779593788,1.22802083307
1,Deaths,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.65508213788,3.42779593788,1.22802083307
1,Deaths,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00196453437455,0.00236342243163,0.000963609449631
1,Deaths,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00139465781695,0.00170593924817,0.000672688345763
1,Deaths,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.379356519498,0.489761396829,0.17545886903500002
1,Deaths,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.176634075631,0.22804023962199998,0.08169627659
1,Deaths,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.45444101769,6.11245996807,3.16996615768
1,Deaths,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.45444101769,6.11245996807,3.16996615768
1,Deaths,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00199277137729,0.00259645654766,0.00154498583552
1,Deaths,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00140737533453,0.00184381430708,0.00106888181841
1,Deaths,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.423427562243,0.581034525613,0.301328727265
1,Deaths,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.21337167826700001,0.292792257557,0.151844192442
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,11.6875738809,16.8483328866,7.95154073496
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,11.6875738809,16.8483328866,7.95154073496
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00100321472077,0.00124448818352,0.000806158456235
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000736486386175,0.000934879251347,0.000567541867863
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.234581285928,0.338162875765,0.159595367672
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11324814094999999,0.163253930795,0.0770474022323
1,Deaths,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.825002568804,1.28884021211,0.558590119611
1,Deaths,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.825002568804,1.28884021211,0.558590119611
1,Deaths,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000200879402808,0.000312144239604,0.000144661263209
1,Deaths,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000146856097181,0.000224494070838,0.000105020375472
1,Deaths,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0982769517601,0.15353077934700002,0.0665410464337
1,Deaths,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0493041313544,0.0770241809124,0.0333826846994
1,Deaths,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.579490496821,0.757201787666,0.429344500427
1,Deaths,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.579490496821,0.757201787666,0.429344500427
1,Deaths,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000141163367877,0.00017350129457,0.000110296755768
1,Deaths,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000103135924649,0.000127108899293,8.03353721284e-05
1,Deaths,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.069030766394,0.0902003052754,0.051144893788799994
1,Deaths,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0346317413476,0.0452521941296,0.0256586566464
1,Deaths,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,195.685742549,282.325964221,79.7774559057
1,Deaths,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,49.9171049171,68.4118958794,30.2321998557
1,Deaths,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,245.602847466,335.509266539,126.138787612
1,Deaths,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016061015017,0.0217014773549,0.00665192522936
1,Deaths,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0111123001883,0.0143667615302,0.00675085652054
1,Deaths,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0147228422543,0.0189765275809,0.00769184895928
1,Deaths,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.15727867528,4.55516960356,1.2871640877700001
1,Deaths,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.8209647810580001,1.12514051477,0.49721576154400005
1,Deaths,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.00031276406,2.73255573069,1.0273375472100001
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,94.834510999,118.132909788,72.9953752469
1,Deaths,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,17.936331668,22.9110858811,14.1570328481
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,112.770842667,135.812599257,89.98094099
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0214093129195,0.0252524795337,0.0173804636346
1,Deaths,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00964787355456,0.0117415472709,0.00795516660711
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0179292312017,0.0208280463575,0.0150921145673
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.06901636388,7.560017498490001,4.67140202647
1,Deaths,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.15216964274,1.4717311278099998,0.9094001929059999
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.61520904764,4.35388196102,2.88461010212
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1566.56577255,1709.63039914,1384.62869121
1,Deaths,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,421.174249677,444.122854247,391.091115329
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1987.74002222,2130.70865812,1798.95943069
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0903407877573,0.0982726028589,0.0803694867923
1,Deaths,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0423988719854,0.0442132026003,0.0395547465142
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0728795254476,0.0780131432427,0.0661619533825
1,Deaths,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,10.2885156601,11.2281012664,9.09363285135
1,Deaths,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.76952563653,2.92042932717,2.57170724695
1,Deaths,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.5313557082500004,7.00112489624,5.91105668506
1,Deaths,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,63.3282536591,79.6419795468,47.6493219037
1,Deaths,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10.9972168351,14.4030617203,8.42136615612
1,Deaths,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,74.3254704942,90.9672960403,58.6116016514
1,Deaths,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0189077532132,0.0222019835869,0.0155953177503
1,Deaths,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00936141895205,0.0113470364766,0.00773237610172
1,Deaths,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0164263856954,0.0189758132701,0.0137745131009
1,Deaths,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.852639635829999,7.360313592099999,4.40363177382
1,Deaths,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.02665180487,1.3446065065800001,0.7861817124539999
1,Deaths,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.4518305148799997,4.2247117474,2.72204553515
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.57585551866,5.56414755485,2.40801289528
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.57585551866,5.56414755485,2.40801289528
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000717276094743,0.00105909225855,0.00052070910783
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000465874525536,0.000695520491999,0.000333467383202
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.156718986597,0.243859843197,0.105535958791
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.07893970000719999,0.12283274211800001,0.053158695751200004
1,Deaths,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.152804979036,0.221583058636,0.102953266225
1,Deaths,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.152804979036,0.221583058636,0.102953266225
1,Deaths,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00257106422777,0.00329091120448,0.00187811364223
1,Deaths,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00149082758046,0.00199590004419,0.00105621856377
1,Deaths,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.765753967639,1.11042262747,0.515931304009
1,Deaths,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.379635926689,0.550511444945,0.255781970427
1,Deaths,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0576118263997,0.0749490534718,0.04230066804
1,Deaths,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0576118263997,0.0749490534718,0.04230066804
1,Deaths,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000701522662424,0.000855231310506,0.000563658758221
1,Deaths,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000508677270237,0.000635213329498,0.000400698260803
1,Deaths,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.217370143849,0.28278371911800004,0.159600951252
1,Deaths,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11269475984899999,0.146608189842,0.08274453222799999
1,Deaths,102,United States,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,128.155404605,153.646589998,115.133463732
1,Deaths,102,United States,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,128.155404605,153.646589998,115.133463732
1,Deaths,102,United States,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000915534517931,0.0010816494171,0.000814320274903
1,Deaths,102,United States,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000594199485544,0.000707288714985,0.000528302529545
1,Deaths,102,United States,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.170099567712,0.203933799122,0.15281565744599998
1,Deaths,102,United States,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0857648591483,0.10282420932900001,0.07705024482310001
1,Deaths,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0317702813915,0.04550089395,0.0220728968446
1,Deaths,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0317702813915,0.04550089395,0.0220728968446
1,Deaths,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000674721302791,0.000846951073923,0.000547042066703
1,Deaths,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00047142331546,0.00060744558717,0.000371235216933
1,Deaths,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.240573140489,0.344545042511,0.167141928904
1,Deaths,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12812183359600002,0.183494061362,0.0890146354594
1,Deaths,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,22.1422767528,29.2126784927,16.1882983918
1,Deaths,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,22.1422767528,29.2126784927,16.1882983918
1,Deaths,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000468304861622,0.000591716922446,0.000365872087758
1,Deaths,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000309465714353,0.000390337057106,0.00023565810791
1,Deaths,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0921204153495,0.121536014849,0.0673495679016
1,Deaths,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.046701354189,0.0616138828147,0.0341435284797
1,Deaths,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.47161279033,3.44496881928,1.75028332756
1,Deaths,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.47161279033,3.44496881928,1.75028332756
1,Deaths,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00117286496171,0.00164135069503,0.000855666291715
1,Deaths,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000775795454798,0.00108307493156,0.000561320100055
1,Deaths,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.121628124383,0.16952699779199998,0.0861314843102
1,Deaths,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0614096966246,0.0855937025821,0.0434875432646
1,Deaths,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.34050019379,9.25033131296,4.89848063928
1,Deaths,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.34050019379,9.25033131296,4.89848063928
1,Deaths,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00348306088489,0.0043522089694,0.00239830492129
1,Deaths,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00230399460272,0.0028664721646,0.00156559969112
1,Deaths,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.361226189677,0.455209024619,0.24105434913399998
1,Deaths,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.18238208336599998,0.229833751399,0.121707660341
1,Deaths,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,25.1142104151,38.5286907496,15.1248199574
1,Deaths,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.14625406426,7.01997925164,1.97299486317
1,Deaths,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29.2604644793,43.0318943333,19.057521486
1,Deaths,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000855862816463,0.00120097884127,0.000561753921818
1,Deaths,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000213242360637,0.000350989299132,0.00011318596034
1,Deaths,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000601159403002,0.000831074082173,0.000400880069197
1,Deaths,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.643828479158,0.987722407327,0.38774023430500004
1,Deaths,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.10710267497400001,0.18133441522399998,0.050964804442900004
1,Deaths,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.376483223912,0.5536749534869999,0.24520585221400001
1,Deaths,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10.0988656547,15.2520666324,7.14710099549
1,Deaths,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10.0988656547,15.2520666324,7.14710099549
1,Deaths,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000803729691632,0.00118690078067,0.000594534230225
1,Deaths,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000471885883107,0.000705383385332,0.000342906368994
1,Deaths,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.281769937922,0.42555015733100005,0.199412317451
1,Deaths,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.137550613444,0.207739284126,0.0973463911589
1,Deaths,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,152.791202892,249.663734072,101.488861954
1,Deaths,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,52.2308589922,78.6526249083,33.9410915246
1,Deaths,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,205.022061885,317.259748191,147.89488207
1,Deaths,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00525137194423,0.00820889589365,0.00397823125393
1,Deaths,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00440497740537,0.0064038393143,0.00314204710317
1,Deaths,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0050055175765,0.00744586788912,0.00393731076687
1,Deaths,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.721517304579,1.17897301055,0.479255145165
1,Deaths,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.245876454138,0.370256758059,0.159777483937
1,Deaths,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.483324886001,0.74791722519,0.348651634656
1,Deaths,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,45.8474098795,128.724751452,22.9539441162
1,Deaths,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,23.407231296,71.8071933384,11.1033958632
1,Deaths,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,69.2546411755,179.797886599,39.3459368805
1,Deaths,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00242802131262,0.00629614919698,0.00145703423168
1,Deaths,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00285346590884,0.00845822090827,0.00175350720108
1,Deaths,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00255922556911,0.00644321872044,0.00169690123048
1,Deaths,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.345806398445,0.9709129219629999,0.173131279734
1,Deaths,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.186677626288,0.572677572725,0.0885519332575
1,Deaths,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.268460401679,0.696972968716,0.152521561589
1,Deaths,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26.440143276,38.4295479548,15.9214930505
1,Deaths,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.88328412088,7.36982407428,2.64866081593
1,Deaths,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,31.3234273969,43.8013353725,20.1649971021
1,Deaths,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000946869844814,0.00133870648308,0.000600430005163
1,Deaths,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000257920919168,0.000399085340064,0.00013288147434
1,Deaths,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000668431334772,0.000931916738624,0.000432525857856
1,Deaths,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.636479850941,0.92509456922,0.383269841534
1,Deaths,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.118810796549,0.17930856510100002,0.0644421855334
1,Deaths,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.37902295571399996,0.5300094203210001,0.24400257056
1,Deaths,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.202390491871,0.309574061804,0.126120007853
1,Deaths,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.202390491871,0.309574061804,0.126120007853
1,Deaths,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000923985595433,0.00116905207673,0.000709902162887
1,Deaths,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000596741554408,0.000783845627783,0.000432757201688
1,Deaths,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155918896078,0.238491667888,0.09716114732520001
1,Deaths,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0808162359581,0.12361554238099999,0.050360786317100004
1,Deaths,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.576383914224,0.887743899132,0.374514223026
1,Deaths,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.576383914224,0.887743899132,0.374514223026
1,Deaths,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00262425700329,0.00322975011397,0.00213028819939
1,Deaths,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00169609727324,0.0022010619076,0.00125163708634
1,Deaths,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.444038367576,0.683905886455,0.288520689288
1,Deaths,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.23015497409900001,0.354483650687,0.149546698257
1,Deaths,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.22839734049,3.21463305631,1.49757112536
1,Deaths,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.22839734049,3.21463305631,1.49757112536
1,Deaths,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000266337182306,0.000372996479078,0.000180856530141
1,Deaths,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000153490908039,0.000219961561412,0.000102177912541
1,Deaths,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.376897855737,0.543703891533,0.253290261888
1,Deaths,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19307089700100002,0.27851948861799997,0.129751276957
1,Deaths,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,24.4949582565,34.0403105448,17.0088761568
1,Deaths,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.34079764807,8.84784646804,4.47353420654
1,Deaths,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,30.8357559046,40.3734692061,22.989806672
1,Deaths,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00818197790885,0.00988588380394,0.00664178827768
1,Deaths,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.007060503527,0.00863005032411,0.00574520109491
1,Deaths,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00791516219013,0.00927642744676,0.00671734236103
1,Deaths,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.52478754013,3.5086629267,1.7531688824599998
1,Deaths,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.648782446662,0.9053005312310001,0.45772639797600007
1,Deaths,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.58333690692,2.0730740006,1.1804675552500001
1,Deaths,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,33.2226083824,46.7947747237,20.9528369524
1,Deaths,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.58088596015,18.7118116346,2.32979478684
1,Deaths,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,41.8034943425,60.241842538,25.9880295387
1,Deaths,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00771751242344,0.0108447371244,0.00511593163393
1,Deaths,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00316046573788,0.00693639891712,0.00087796652502
1,Deaths,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00595127303497,0.00872445782663,0.003665758977
1,Deaths,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.20032822771,7.3247767033799995,3.27974336632
1,Deaths,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2852930548500001,2.80275972077,0.348969683627
1,Deaths,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.1997115618899996,4.61101453622,1.98916860644
1,Deaths,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,19.6572947394,34.2515248932,6.01510555983
1,Deaths,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,19.6572947394,34.2515248932,6.01510555983
1,Deaths,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000668374556941,0.00108469242927,0.000218874130957
1,Deaths,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000403201013134,0.000681068451073,0.000127390989647
1,Deaths,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.503934862664,0.8780728844910001,0.154203385277
1,Deaths,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.252922905653,0.440701292517,0.0773940664864
1,Deaths,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,13.0296742822,19.3602125936,8.22774357923
1,Deaths,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,13.0296742822,19.3602125936,8.22774357923
1,Deaths,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000443985262111,0.000621925429073,0.000311252538611
1,Deaths,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000267745588513,0.000391543063994,0.000177483433736
1,Deaths,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.334029031311,0.496318857904,0.21092662472700002
1,Deaths,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16764784385999998,0.249100463119,0.10586323502900001
1,Deaths,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.06429414767,4.13706729871,2.20935585708
1,Deaths,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.06429414767,4.13706729871,2.20935585708
1,Deaths,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00137044984651,0.0016930359822,0.00109853135965
1,Deaths,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000967702705879,0.00121526117209,0.000770191848358
1,Deaths,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.2912838212,0.393258843067,0.21001561384999998
1,Deaths,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.146782409374,0.198169195443,0.105830106458
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.04744279864,1.34509158771,0.765837159335
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.04744279864,1.34509158771,0.765837159335
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0028496353218,0.00353346688255,0.00215481784176
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0018733053122,0.00236662228732,0.00138712876449
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.9960658230930001,1.27911496569,0.728272915197
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.495802770125,0.636693608588,0.36250589106700004
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.072912616351,0.0955411766944,0.0558795810001
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.072912616351,0.0955411766944,0.0558795810001
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000198456650707,0.000251394981807,0.00015996824412
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000130452533129,0.000167151214247,0.000103063941466
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0693362590432,0.09085489052660001,0.053138692552100006
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0345128891151,0.045224025720099995,0.0264503714085
1,Deaths,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.78037529784,3.48891317711,2.15167931816
1,Deaths,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.78037529784,3.48891317711,2.15167931816
1,Deaths,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00189901554545,0.00236950100802,0.00146420540671
1,Deaths,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00135765240273,0.00168960037472,0.00104869656418
1,Deaths,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.230423261129,0.289143250801,0.178320159072
1,Deaths,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.117972901779,0.148036566099,0.0912969745697
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3.0788998767,6.07404103281,0.943416490075
1,Deaths,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.436754464263,0.908433179467,0.179229830825
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3.51565434096,6.6208089988,1.19334150289
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00619718132332,0.0119897707452,0.00207830192252
1,Deaths,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00127902721943,0.00250524919792,0.000615547342493
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00419421791982,0.0080295738927,0.00153363892827
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.11499801373,2.19966350258,0.341650444858
1,Deaths,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.164046012892,0.341209657288,0.0673191496457
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.648197420257,1.22070911893,0.22002188174399998
1,Deaths,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.67216626397,4.59536851335,0.99788103338
1,Deaths,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.67216626397,4.59536851335,0.99788103338
1,Deaths,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000572497075547,0.000893027807647,0.000262546192488
1,Deaths,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000356484320209,0.000571105008734,0.000166584875477
1,Deaths,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.411921903538,0.708388909401,0.15382615233
1,Deaths,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.207578170475,0.356975612453,0.07751700261069999
1,Deaths,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.615058751807,0.850070816263,0.419034883443
1,Deaths,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.182535725365,0.265400445612,0.115602626015
1,Deaths,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.797594477171,1.03602563946,0.592707612571
1,Deaths,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00443003388886,0.00565217563022,0.00330675440878
1,Deaths,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00314294686975,0.00404141787534,0.00235548441165
1,Deaths,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0040501587759,0.0049106794353,0.00319800059992
1,Deaths,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.40376234407,1.9401356344499998,0.956372685538
1,Deaths,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.436981157385,0.635355044402,0.276746753064
1,Deaths,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9319106686530001,1.21049402177,0.692520526854
1,Deaths,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.82110291067,11.991930415,7.45349690479
1,Deaths,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.82110291067,11.991930415,7.45349690479
1,Deaths,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000996236028295,0.00119299273925,0.000762176298979
1,Deaths,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000678716941249,0.000815832069254,0.000519702728671
1,Deaths,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.227777708937,0.278125019206,0.172866577612
1,Deaths,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.114246814996,0.139499592666,0.08670495459619999
1,Deaths,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,138.380670013,172.895971186,83.0695621859
1,Deaths,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,138.380670013,172.895971186,83.0695621859
1,Deaths,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000746570204573,0.000915960206643,0.000450310673875
1,Deaths,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000460366233262,0.000567811903273,0.000278653405611
1,Deaths,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.194551334967,0.243076883509,0.116788668655
1,Deaths,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0980798318849,0.12254318313299999,0.058877072160500005
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,18.3168293877,46.2412006944,8.69922397679
1,Deaths,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.62405184992,9.00114645971,2.0726279782
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,22.9408812376,51.8564946789,11.716066907
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0015351700289,0.00370644726312,0.000759642519396
1,Deaths,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000512474906058,0.000960533488444,0.000244553578707
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00109672346261,0.00242202788399,0.000575947407754
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.4776021744899999,3.73023612607,0.701758584547
1,Deaths,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.367976516002,0.716300470187,0.16493725571
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.919014499112,2.07737749869,0.469347068606
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,51.9522163908,67.3513970638,32.5293270857
1,Deaths,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20.4325731175,25.7805588004,14.6018041421
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,72.3847895083,88.6579909687,50.9146104705
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108330460008,0.0137704543533,0.00676582537436
1,Deaths,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00936881205537,0.0117482649675,0.00688982975702
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103754096622,0.0125285084391,0.00736843783035
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.45546446124,4.47970029264,2.16360227727
1,Deaths,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.34486402873,1.69686636978,0.961085078827
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.3946398336,2.9329912842600003,1.6843615236500002
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3.36755477261,6.74513600224,1.41824117902
1,Deaths,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.961776299107,1.74249748015,0.388014962575
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4.32933107172,7.91177050113,2.0940444652
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00356020963666,0.00630601397856,0.0016388930296
1,Deaths,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00123413829281,0.00205560929236,0.000591440691085
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00251322719922,0.00415272705488,0.00131060517088
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.60105122939,3.2068693809,0.674280579399
1,Deaths,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.48271517823099996,0.8745588578939999,0.19474457001099998
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.05702494811,1.9316930640999999,0.511270033522
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.33927865741,12.3752612067,4.46923463958
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.33927865741,12.3752612067,4.46923463958
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00121079907779,0.00157892057482,0.000683896658247
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000859905566562,0.00114350530072,0.000483705228399
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.315225049667,0.46778534316799997,0.168937238952
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.157127629442,0.23317310010000003,0.0842087515224
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,16.9838799386,25.6274297644,11.1744331857
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,16.9838799386,25.6274297644,11.1744331857
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00246259632056,0.00322491863193,0.0017558960581
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00175030606422,0.00235482459343,0.00124778895198
1,Deaths,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.641991306098,0.968717817475,0.42239399841
1,Deaths,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.320008108989,0.48286877714599996,0.210547251023
1,Deaths,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,245.030232238,528.389516678,150.065559911
1,Deaths,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,32.532830974,73.4818265732,17.409118509
1,Deaths,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,277.563063212,585.549460715,178.336836733
1,Deaths,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0140969418155,0.0309272844861,0.0087196671731
1,Deaths,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00496710752134,0.0114491903644,0.00270181411674
1,Deaths,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115981557716,0.0245200581678,0.00751760696825
1,Deaths,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.8223739008999997,6.08623992132,1.7285259694200001
1,Deaths,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.372680582843,0.841772730371,0.199430551799
1,Deaths,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5941711241399998,3.3630773173699997,1.02426970001
1,Deaths,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.71781649593,6.13957160689,3.52425845225
1,Deaths,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.71781649593,6.13957160689,3.52425845225
1,Deaths,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00161822102448,0.00200802912996,0.00126623223231
1,Deaths,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00104976362793,0.00130912637898,0.000799279310618
1,Deaths,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.1833114282,0.23855392442,0.136935561353
1,Deaths,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09274430151930001,0.120693604934,0.0692809669069
1,Deaths,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,813.016226618,1217.89295644,453.623911443
1,Deaths,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,105.761804892,169.755067934,62.5363294004
1,Deaths,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,918.778031509,1329.65445419,533.96478345
1,Deaths,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0190332217011,0.0287145646236,0.0110280714766
1,Deaths,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00531399882406,0.00717605978011,0.00351278172173
1,Deaths,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0146666401169,0.0210811411888,0.00886136748256
1,Deaths,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,8.629787232670001,12.927364475800001,4.81500579108
1,Deaths,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.16175714245,1.86470118245,0.686940123781
1,Deaths,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.95975837728,7.177756315329999,2.88245497505
1,Deaths,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,24.5546796705,41.8507468282,12.9168610699
1,Deaths,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.52124070968,8.58669670069,2.64723837381
1,Deaths,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29.0759203802,46.9919566763,16.724317389
1,Deaths,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0043539329211,0.00714487071909,0.00236713255896
1,Deaths,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00133192603516,0.00250716555551,0.000790478862343
1,Deaths,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00322024006101,0.00517440612328,0.00190296018261
1,Deaths,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.33943188749,2.28291411532,0.704601152831
1,Deaths,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.244879031226,0.465071891659,0.14337948586
1,Deaths,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.790207027938,1.277117764,0.45452295113900004
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,36.2319850468,55.8646250777,20.7666870787
1,Deaths,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.6484977939,6.60397196151,1.49893151564
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,39.8804828407,59.6150409168,23.1866768122
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00530509407476,0.00795210118913,0.0031107873322
1,Deaths,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000612409935889,0.00113925417303,0.000257272093248
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00311747963024,0.00466542830887,0.0018528681717
1,Deaths,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.29742545109,3.5423069231100004,1.31678999558
1,Deaths,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.225323989438,0.407848213857,0.0925710382949
1,Deaths,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.24771087765,1.8651312553200001,0.7254242379839999
1,Deaths,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,66.3655355005,100.534788192,39.2706445648
1,Deaths,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.0270025984,12.6919501251,4.14538654778
1,Deaths,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,74.3925380989,109.334639773,47.6726757597
1,Deaths,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00112792376508,0.0016296036519,0.000699750305368
1,Deaths,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000196226396292,0.000302837407076,0.000101546449385
1,Deaths,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000745984422345,0.00107486963968,0.000481711901392
1,Deaths,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.534059771137,0.809028143423,0.316020526174
1,Deaths,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.0631671180077,0.0998771211885,0.0326214073113
1,Deaths,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.295981595376,0.435003858411,0.189672714331
1,Deaths,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.75140998791,7.74525771367,3.70033212333
1,Deaths,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.75140998791,7.74525771367,3.70033212333
1,Deaths,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00102023277857,0.0013547427743,0.000672211793006
1,Deaths,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000637166168368,0.000852334194155,0.000425060659894
1,Deaths,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.313733351002,0.422495642285,0.201849215986
1,Deaths,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.156308193638,0.21049572974800002,0.100565292907
1,Deaths,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,7.7093098788,9.35366418569,6.12362758065
1,Deaths,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.28352716268,3.94682300115,2.67583972209
1,Deaths,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,10.9928370415,12.7243972912,9.32444781058
1,Deaths,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00472771844417,0.00565805587614,0.0038809939211
1,Deaths,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00432524733505,0.00504439452956,0.00367475561633
1,Deaths,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00459999160965,0.00527099442163,0.00395606188934
1,Deaths,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9276221362729999,1.12547894563,0.736825031994
1,Deaths,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.397634085583,0.47795899874299996,0.324043331559
1,Deaths,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.6634785009849999,0.767987736817,0.562781985445
1,Deaths,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.955341240242,1.56140783885,0.495782955807
1,Deaths,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.955341240242,1.56140783885,0.495782955807
1,Deaths,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000271595735839,0.000416966735132,0.000149503108481
1,Deaths,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000167560904419,0.000261489039374,9.14199235477e-05
1,Deaths,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.278668124862,0.455454633661,0.144617337568
1,Deaths,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.140193034267,0.22913121870599998,0.0727544399684
1,Deaths,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.669160122296,1.02427072903,0.342542350713
1,Deaths,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.669160122296,1.02427072903,0.342542350713
1,Deaths,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000190973206159,0.000282088016551,0.000101028026394
1,Deaths,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000117723780984,0.000175894306331,6.04126515582e-05
1,Deaths,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.195190565065,0.298774502123,0.09991784143500002
1,Deaths,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09819694157820001,0.150308199171,0.0502669093394
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.5380664804,10.1558296654,5.19493884869
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.5380664804,10.1558296654,5.19493884869
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00151264379237,0.0019843199755,0.00114432200552
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000982360415308,0.00130305252888,0.000731967977385
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.33037076961,0.445099452399,0.22767853666200003
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.166408487002,0.22419757815299998,0.114682182245
1,Deaths,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.90798634616,11.2756508709,4.4620009995
1,Deaths,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.90798634616,11.2756508709,4.4620009995
1,Deaths,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000520311971656,0.00073090504871,0.000299921106073
1,Deaths,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000347689534137,0.000488127251017,0.000200067862674
1,Deaths,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.187650371402,0.267562433862,0.105879816694
1,Deaths,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0925987972753,0.132032563467,0.052247931130500004
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.51440569768,10.0388007385,3.60755227226
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.51440569768,10.0388007385,3.60755227226
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000558758978866,0.000747952326881,0.000336013880399
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000410279556632,0.000563704993154,0.00024445652952
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.13075063149900001,0.201488761518,0.0724071787441
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0631221108995,0.0972721569581,0.0349558079698
1,Deaths,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.16062134248,2.51309402075,0.653485055726
1,Deaths,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.282261460128,0.456813673736,0.162332881118
1,Deaths,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.44288280261,2.92732876381,0.884148100051
1,Deaths,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0136544144374,0.0285852832766,0.00878222046039
1,Deaths,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00575663386656,0.00835489365542,0.00382254899381
1,Deaths,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.010743383325,0.0205931574027,0.00744999870236
1,Deaths,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.09890694806,2.3794638091299998,0.618736914363
1,Deaths,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.26159542180600004,0.423367630896,0.150447526522
1,Deaths,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.675772746664,1.37101155792,0.41408989624599996
1,Deaths,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40.4836601235,81.7961257962,17.0431809766
1,Deaths,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.7086263241,8.41817994044,1.9223184336
1,Deaths,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,45.1922864476,86.7633162547,21.5314836633
1,Deaths,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00805669616684,0.0136740082315,0.00411431105717
1,Deaths,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00137707111738,0.0020268917868,0.000665217499642
1,Deaths,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00533873748408,0.00889421051054,0.00294864986617
1,Deaths,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.8075088014,3.65202199717,0.760941563214
1,Deaths,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.20837377336000001,0.372534959939,0.0850695549058
1,Deaths,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.00439557066,1.92830895253,0.478535797171
1,Deaths,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.66832885871,8.15616873304,3.60329057845
1,Deaths,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.66832885871,8.15616873304,3.60329057845
1,Deaths,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000615881356667,0.000875413916438,0.000406718559961
1,Deaths,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000372538723342,0.000531427841755,0.000242626519486
1,Deaths,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.314564453079,0.452627365257,0.199964955871
1,Deaths,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155884942145,0.224303127565,0.0990942405345
1,Deaths,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.97596115025,14.1495184997,4.48177575577
1,Deaths,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.97596115025,14.1495184997,4.48177575577
1,Deaths,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000757257160126,0.00150507176083,0.000494319325399
1,Deaths,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00045819452673,0.00092417738653,0.000295130563305
1,Deaths,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.387131632378,0.785228884759,0.248716574951
1,Deaths,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19184619090000002,0.389126482897,0.123253497073
1,Deaths,80,France,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,437.011293154,534.410002346,322.283703708
1,Deaths,80,France,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,143.402930741,174.056106315,117.347355139
1,Deaths,80,France,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,580.414223895,684.713843101,461.931526115
1,Deaths,80,France,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0243549114475,0.0293354704412,0.0175895521622
1,Deaths,80,France,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165944397755,0.0197469409495,0.0139319913896
1,Deaths,80,France,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0218314895637,0.0254215259186,0.0172894603044
1,Deaths,80,France,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.1190027349199996,3.8141491650200003,2.3001779794600004
1,Deaths,80,France,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0190256061799998,1.23684800812,0.833873890066
1,Deaths,80,France,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.0667221751,2.43810924143,1.64483241295
1,Deaths,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.76414641313,11.8146826592,4.90671798424
1,Deaths,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.76414641313,11.8146826592,4.90671798424
1,Deaths,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00109935138484,0.00143131106965,0.000899255488232
1,Deaths,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000771937131612,0.00103663955136,0.000574535901749
1,Deaths,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.163638195698,0.24900784325999997,0.103414649211
1,Deaths,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.08301857712249999,0.126329166315,0.0524653611251
1,Deaths,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,76.0723490302,109.043832086,49.8632190668
1,Deaths,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,76.0723490302,109.043832086,49.8632190668
1,Deaths,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0107846550523,0.0128018974251,0.0090806549146
1,Deaths,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00757071075585,0.00937417484027,0.00588347378513
1,Deaths,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.60331107573,2.29822249414,1.05092392204
1,Deaths,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.813407918759,1.16595737665,0.533165305934
1,Deaths,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.86658302279,6.32664182706,3.83643061068
1,Deaths,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.86658302279,6.32664182706,3.83643061068
1,Deaths,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00144673385444,0.00179697988209,0.0012048823427
1,Deaths,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00102506065507,0.00130012184481,0.000849003463028
1,Deaths,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.197401275818,0.256625061661,0.155615612348
1,Deaths,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0999942271407,0.12999421913300002,0.0788275700008
1,Deaths,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10.8559934909,13.6415452538,8.61485809628
1,Deaths,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10.8559934909,13.6415452538,8.61485809628
1,Deaths,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0032278053515,0.00391205574361,0.00261044776672
1,Deaths,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00228707872395,0.00277238685814,0.00183221699937
1,Deaths,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.44034735569699995,0.553336586391,0.349441070096
1,Deaths,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.22305931572100002,0.280294360184,0.177010455433
1,Deaths,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.352550612583,0.491841753783,0.24295869741
1,Deaths,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0549331355792,0.0769698856682,0.0387117581602
1,Deaths,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.407483748162,0.54688503805,0.295280177729
1,Deaths,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0136954650995,0.0176828172199,0.0102071292299
1,Deaths,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00517596777854,0.00664730611332,0.00404693814559
1,Deaths,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112050478829,0.0141305211327,0.00874019665764
1,Deaths,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.9170298762699998,2.67443964851,1.32111267152
1,Deaths,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.298198942001,0.417823199608,0.21014284374400002
1,Deaths,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.10692883091,1.4856121711299999,0.802128044119
1,Deaths,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,120.049126924,189.260795245,72.2126225905
1,Deaths,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,40.6085479979,54.7086045483,29.1052687532
1,Deaths,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,160.657674922,232.973355615,108.165308167
1,Deaths,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00405811541027,0.00601399340666,0.002623012789
1,Deaths,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00467955352719,0.00551293697326,0.00377207000987
1,Deaths,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00419886430275,0.0057575258773,0.0030085071748
1,Deaths,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.44384447004,2.27626105755,0.8685094049909999
1,Deaths,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.488918902754,0.658680800611,0.350421691115
1,Deaths,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.966633426367,1.40173716008,0.650801167752
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,223.018289981,279.823595768,168.245218476
1,Deaths,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,49.2646736876,64.2545659642,36.8415706609
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,272.282963668,331.617868168,217.839218173
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00851658652651,0.0100990089072,0.00709265625854
1,Deaths,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0038300482186,0.00468002778881,0.00309749643031
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00697013459171,0.00812650804415,0.00595715524236
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.72121100618,3.4143345312999998,2.05288427372
1,Deaths,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.58981745296,0.769282765951,0.44108282352699996
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.64540497299,2.00396558809,1.3164016142
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,114.820021304,161.546212587,78.1410706167
1,Deaths,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,15.8094795461,20.8749751085,11.8723101005
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,130.62950085,178.262648392,92.4661693695
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0546982386707,0.0747020375891,0.0392242258417
1,Deaths,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0211619421297,0.0267592280427,0.0166697313071
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0458842293054,0.0607821407297,0.0343644941302
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,12.7976231272,18.0056363239,8.709456427100001
1,Deaths,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.71712076551,2.26730128172,1.28949154516
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.185755981200001,9.805992395059999,5.086441617559999
1,Deaths,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,6.51388042139,14.8389672029,3.32756870993
1,Deaths,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.724444853212,1.19699333331,0.386836088199
1,Deaths,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7.2383252746,15.4789055606,4.00128144937
1,Deaths,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.005206279615,0.0110161421479,0.00328972979077
1,Deaths,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00276464871458,0.00395329506554,0.0019937222859
1,Deaths,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00478048908213,0.00975884564067,0.00320361896219
1,Deaths,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.494120384514,1.12563260388,0.252417825333
1,Deaths,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.174543566526,0.28839667309,0.0932020569903
1,Deaths,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.41759672327400005,0.893015994275,0.230843732323
1,Deaths,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36134376886,12.2777400112,3.75775841239
1,Deaths,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36134376886,12.2777400112,3.75775841239
1,Deaths,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000261614029073,0.000616755825021,8.58147711778e-05
1,Deaths,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000199666052658,0.000455595579535,6.67177055047e-05
1,Deaths,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.175672175373,0.257955820985,0.07895065830100001
1,Deaths,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.08918858986270001,0.13096391543900002,0.040083171211599995
1,Deaths,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.23288715308,4.17554130788,2.51321217711
1,Deaths,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.23288715308,4.17554130788,2.51321217711
1,Deaths,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000101048322754,0.000229997026207,5.05900444807e-05
1,Deaths,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.71295902668e-05,0.000169156429744,3.94594151353e-05
1,Deaths,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0679230916246,0.0877282940629,0.052802690874999995
1,Deaths,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0344844865059,0.0445395682151,0.0268078739851
1,Deaths,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0884906432,44.4288119415,18.7503126358
1,Deaths,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0884906432,44.4288119415,18.7503126358
1,Deaths,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00060891173125,0.000806052520817,0.000361961303412
1,Deaths,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000415698749058,0.000551595717108,0.000246941081563
1,Deaths,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.2209099914,0.305865694122,0.129084644372
1,Deaths,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10894837075500001,0.15084681699299998,0.0636619539243
1,Deaths,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,48.7468164889,66.329079541,36.0383874414
1,Deaths,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,48.7468164889,66.329079541,36.0383874414
1,Deaths,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000925074944699,0.00120814111856,0.000707572547455
1,Deaths,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000631587832063,0.000828536138976,0.000481257923906
1,Deaths,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.3355925628,0.45663588711299996,0.24810265924599997
1,Deaths,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.165507511557,0.225203647939,0.122359248369
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,52.6020048892,123.207827533,28.1540259427
1,Deaths,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12.3490956266,19.7627651655,6.67036092636
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,64.9511005158,135.467223204,39.1237196649
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00450557369388,0.0101204861072,0.00273988340419
1,Deaths,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00295129563574,0.00443596294289,0.0017863502521
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00409254024543,0.00827019182427,0.00271773539415
1,Deaths,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0557747976699998,2.47290420694,0.5650794319670001
1,Deaths,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.231342686116,0.37022720664799996,0.124959694274
1,Deaths,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.629351434354,1.31262581472,0.37909394748999997
1,Deaths,102,United States,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,278.111582593,304.163338046,254.172604018
1,Deaths,102,United States,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,278.111582593,304.163338046,254.172604018
1,Deaths,102,United States,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00198687323338,0.00216185053093,0.0018187227724
1,Deaths,102,United States,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00128951096226,0.00140622839916,0.00118134627443
1,Deaths,102,United States,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.369135114674,0.40371338591,0.337361114041
1,Deaths,102,United States,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.186119350816,0.203553848751,0.17009877695099998
1,Deaths,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,550.0556821,645.273068356,455.976714275
1,Deaths,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,210.243880645,245.753557728,176.098402675
1,Deaths,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,760.299562745,858.895823008,662.184195936
1,Deaths,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.090595478374,0.103788148571,0.0761285570859
1,Deaths,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0643212684182,0.0732226719214,0.0562021245426
1,Deaths,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.081391276732,0.0906419253934,0.0715738005865
1,Deaths,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,9.37321328812,10.995763330199999,7.7700624434900005
1,Deaths,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.62838460576,4.24120988888,3.03910264309
1,Deaths,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.5190139545,7.36440493986,5.6777462796
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,66.1051591446,88.1524679363,41.8093124899
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,66.1051591446,88.1524679363,41.8093124899
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000849454127412,0.00112107018585,0.000538231590581
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00048239052261,0.000630775911286,0.000309439941101
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.370805051378,0.49447548156900006,0.234521850738
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.18494023894199998,0.246621272748,0.11696854439099999
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.77865948349,2.44894414957,1.32516876783
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.77865948349,2.44894414957,1.32516876783
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000401592316819,0.000539680518149,0.000319074496661
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000282722390958,0.000377413811988,0.000222757866559
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.113826848447,0.156722294041,0.0848053187824
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.057020287383799995,0.0785082813724,0.042482276498
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.31988888598,6.94747126705,4.00382635771
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.31988888598,6.94747126705,4.00382635771
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00120099472887,0.00152556751454,0.000944640305759
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000845564105563,0.00108891727922,0.000662229908801
1,Deaths,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.340450879779,0.444609418693,0.256228322655
1,Deaths,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.17054506269699998,0.222722118491,0.128354714138
1,Deaths,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.919003439715,1.38921254682,0.583391132192
1,Deaths,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.381790539715,0.544955086292,0.255804912256
1,Deaths,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.30079397943,1.81150342944,0.922271154571
1,Deaths,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00310325157673,0.00420684643961,0.00223230376776
1,Deaths,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00236976664459,0.00320752752326,0.00170361877487
1,Deaths,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00284643118128,0.00360941032485,0.00222034672907
1,Deaths,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.930014626895,1.40585761987,0.590381126656
1,Deaths,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.37531994873499996,0.535719180476,0.251469527311
1,Deaths,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.64864551709,0.903312590067,0.459893772122
1,Deaths,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.255029644762,0.337161125089,0.178751435265
1,Deaths,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.255029644762,0.337161125089,0.178751435265
1,Deaths,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00490966976579,0.00597979097414,0.00373086955469
1,Deaths,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00337724367325,0.00418154767887,0.00249303349635
1,Deaths,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.3262099596799999,1.7533116298099998,0.929546578699
1,Deaths,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.662542695943,0.875912449286,0.46437918201600004
1,Deaths,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0130237400282,0.0173330540378,0.00996971359721
1,Deaths,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0130237400282,0.0173330540378,0.00996971359721
1,Deaths,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000250756839953,0.00029796269784,0.000208185790632
1,Deaths,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000172469698945,0.000212528484578,0.000138613530201
1,Deaths,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0677262980692,0.09013567390590001,0.051844692330200004
1,Deaths,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.033834434571699996,0.045029621406900006,0.0259003651542
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,36.3440117343,56.8211751245,22.9759411308
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,36.3440117343,56.8211751245,22.9759411308
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000348508873743,0.000524572276759,0.000232785658589
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000221845241848,0.000332783412123,0.000146602504958
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0796532126207,0.124531908493,0.050355132433699996
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.039838017832499996,0.0622837953174,0.0251847803478
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.04752764367,3.99333427522,2.43403121672
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.04752764367,3.99333427522,2.43403121672
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00148607520932,0.0019014548157,0.0012436022476
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00104366555254,0.00134863137306,0.000869297940746
1,Deaths,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.233267836019,0.30566300089700005,0.186308792278
1,Deaths,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.117609396786,0.154109721121,0.0939335017194
1,Deaths,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.87621129295,4.00819277887,1.59154434219
1,Deaths,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.87621129295,4.00819277887,1.59154434219
1,Deaths,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000510502113835,0.000692258636452,0.000287822092822
1,Deaths,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000318779832546,0.000436102666827,0.00017941107422
1,Deaths,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.156894293578,0.21864269016100002,0.086817065866
1,Deaths,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.078167856694,0.108932135656,0.0432539884559
1,Deaths,102,United States,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,15207.9462939,16247.153927,14121.7461812
1,Deaths,102,United States,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7420.25059822,7808.96507636,7004.97436859
1,Deaths,102,United States,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,22628.1968921,23663.0808881,21270.6559185
1,Deaths,102,United States,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.108644615023,0.115734130928,0.100870096945
1,Deaths,102,United States,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0980325613111,0.102472831862,0.0931973375063
1,Deaths,102,United States,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.104920628265,0.109311292654,0.0990473776666
1,Deaths,102,United States,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,20.185376483899997,21.5647078487,18.743672404399998
1,Deaths,102,United States,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,10.0158517262,10.540538396199999,9.455312013150001
1,Deaths,102,United States,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,15.143365394700002,15.835936109299999,14.2348644169
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.21553908252,3.87924116699,2.14121021205
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.21553908252,3.87924116699,2.14121021205
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00067056909729,0.000785898297643,0.000446941766384
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00046081199451,0.000544027273101,0.000303011703028
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.21387308945199998,0.25801748068499997,0.14241694206299998
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.106376740553,0.12833339000799998,0.0708357004383
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,14.9349371562,18.2888413294,11.3987238368
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,14.9349371562,18.2888413294,11.3987238368
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00311543183691,0.00377927638582,0.00241088557712
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00214062371651,0.00259752894664,0.00165621201224
1,Deaths,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.993357899995,1.21643397802,0.758156010617
1,Deaths,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.494078875817,0.605033022205,0.377093562573
1,Deaths,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.520265486695,0.786429395265,0.329279523233
1,Deaths,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.520265486695,0.786429395265,0.329279523233
1,Deaths,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00106000082216,0.00155023790723,0.000728185817568
1,Deaths,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00071137830271,0.00105935984829,0.000471649439483
1,Deaths,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.20702553793200001,0.312938245499,0.131027854376
1,Deaths,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.112575514055,0.170168300039,0.0712497994654
1,Deaths,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.0103533949,10.1638395507,3.67250986957
1,Deaths,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.0103533949,10.1638395507,3.67250986957
1,Deaths,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000137948826242,0.000233648753255,8.71716992705e-05
1,Deaths,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.99076733081e-05,0.000136540335837,4.93591888858e-05
1,Deaths,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0952532656554,0.16107853318999998,0.058202660516599995
1,Deaths,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.046425643427,0.0785083271859,0.0283674889785
1,Deaths,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.85313023208,8.18629451813,3.96500868227
1,Deaths,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.85313023208,8.18629451813,3.96500868227
1,Deaths,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000134178118119,0.00018339868185,9.32704820871e-05
1,Deaths,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.77203102666e-05,0.000107120403322,5.21374908065e-05
1,Deaths,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0927615619715,0.129738009604,0.0628382393718
1,Deaths,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0452112079327,0.0632332186339,0.0306268312648
1,Deaths,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.311999894699,0.446078639923,0.208153379977
1,Deaths,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0847647653932,0.143053135387,0.0552017450091
1,Deaths,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.396764660092,0.537557961045,0.284822959303
1,Deaths,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00526822207711,0.0075001983027,0.00384276981241
1,Deaths,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00197207261625,0.00319471988501,0.00145308230308
1,Deaths,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00388046784785,0.00531017811899,0.00301766494234
1,Deaths,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.56352992406,2.235440825,1.04312226997
1,Deaths,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.417651769122,0.704849412322,0.271989267648
1,Deaths,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9857409121209999,1.33553445691,0.707627649173
1,Deaths,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,39.553047572,58.0883503261,25.1376707363
1,Deaths,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19.5637288531,29.2514552942,12.6411530086
1,Deaths,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,59.1167764251,79.6807452257,42.9996317257
1,Deaths,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00560963859796,0.00673375881198,0.00436169167618
1,Deaths,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0065865194235,0.00765272082869,0.00559023000283
1,Deaths,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00590242302712,0.00677700090993,0.0049589634974
1,Deaths,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.833625358749,1.22427789645,0.529804934689
1,Deaths,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.424597220864,0.6348527275879999,0.274354570966
1,Deaths,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.632109494301,0.8519909003139999,0.45977600791
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.185414047214,0.246931888729,0.134932322969
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.185414047214,0.246931888729,0.134932322969
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00419799885111,0.00528291578008,0.00339468932055
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00256221720203,0.00328703885557,0.00197512195215
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.790847201104,1.05323947133,0.575527321481
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.376704687554,0.5016901437,0.274141249428
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0317265761881,0.0410832177217,0.0246984662599
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0317265761881,0.0410832177217,0.0246984662599
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000718929181194,0.000839240921964,0.000613673954679
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000438592298769,0.000529964642526,0.000360640514538
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.135323479294,0.175232396012,0.10534645679099999
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0644587082245,0.0834685447413,0.0501797364077
1,Deaths,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,134.713167195,163.373745016,109.366910281
1,Deaths,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,49.586271038,59.288863889,40.990672417
1,Deaths,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,184.299438233,214.016843126,156.518242779
1,Deaths,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00670367016813,0.00783758885134,0.00545567069341
1,Deaths,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00484377208613,0.00554810169547,0.00413116399944
1,Deaths,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0060754427196,0.00689945649939,0.00522792440735
1,Deaths,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.22425937332,1.4847237494,0.993915203919
1,Deaths,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.454499152056,0.543431433737,0.375713387309
1,Deaths,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.8410224078580001,0.976633257563,0.714247154946
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.17630449465,7.09759639601,2.56913799914
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.17630449465,7.09759639601,2.56913799914
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00139160776922,0.00173521730401,0.000691970627306
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000973871781645,0.00122640356638,0.000497569208105
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.306181744166,0.41982739735700003,0.151966167059
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.158881407557,0.217853510518,0.0788570807483
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,18.5203335169,24.3743964742,13.9538183757
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,18.5203335169,24.3743964742,13.9538183757
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00497930229236,0.00595211489861,0.00414808034637
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00348431862002,0.00433026991444,0.00283483763685
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.09548965378,1.4417612474600001,0.825377342555
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.568462821425,0.748147336421,0.428298278554
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.416750365021,0.719779806708,0.115949822437
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.416750365021,0.719779806708,0.115949822437
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000837694093525,0.00127328407022,0.000257831560494
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000496346573843,0.000793561371687,0.000145057241818
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15092268272,0.260662277742,0.0419902649929
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0768381886553,0.132709125702,0.0213782040251
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.487472455019,0.963824846615,0.169307475307
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.487472455019,0.963824846615,0.169307475307
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000978790618187,0.00173237338008,0.000354088345191
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000579187303406,0.00105967272079,0.000202355880097
1,Deaths,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.17653410012,0.349041161646,0.0613132957341
1,Deaths,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.08987754686449999,0.177704836302,0.0312160008011
1,Deaths,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.92365206072,8.12663139163,3.30575578994
1,Deaths,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.92365206072,8.12663139163,3.30575578994
1,Deaths,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0015077771469,0.00198719738007,0.000852154891314
1,Deaths,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00103780305308,0.00138250702553,0.000590639054776
1,Deaths,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.323818046269,0.44424450879399996,0.18071003670799998
1,Deaths,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.16493729640100002,0.226276728755,0.0920449778221
1,Deaths,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,13.8639832263,18.08728057,10.4231243129
1,Deaths,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,13.8639832263,18.08728057,10.4231243129
1,Deaths,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00352355249255,0.00432207200351,0.0027777825746
1,Deaths,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00242640668775,0.00301900527911,0.00189426584501
1,Deaths,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.757878402683,0.9887460972469999,0.569782917099
1,Deaths,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.386026709073,0.5036195789160001,0.290219939762
1,Deaths,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,389.789973564,529.906434987,228.151432953
1,Deaths,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,62.8083176886,89.4088829239,39.9387748526
1,Deaths,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,452.598291252,589.163407131,296.506510674
1,Deaths,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00672720824262,0.00874463111401,0.00402441416401
1,Deaths,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00292263107396,0.00401993784228,0.00194516684698
1,Deaths,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00569803278248,0.00728129770001,0.00380944352871
1,Deaths,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.22275531203,3.0217615206399997,1.30102066225
1,Deaths,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.356738434827,0.5078242202259999,0.22684409572100003
1,Deaths,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.2878904473500001,1.67649312566,0.8437236950610001
1,Deaths,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0984197520213,0.121134132863,0.0781791714302
1,Deaths,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0984197520213,0.121134132863,0.0781791714302
1,Deaths,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00143375601844,0.00171656231612,0.00113129433983
1,Deaths,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000942730940984,0.00113624482291,0.000738786253849
1,Deaths,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12366213743,0.15220223052600002,0.0982303170143
1,Deaths,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0626303994173,0.0770849241992,0.0497501023141
1,Deaths,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,238.82125548,281.866860499,210.810025969
1,Deaths,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,238.82125548,281.866860499,210.810025969
1,Deaths,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00141965094134,0.00166079794572,0.00126176387044
1,Deaths,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.001032840767,0.00121332523003,0.000918003791062
1,Deaths,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.420876409593,0.496735987722,0.371512019136
1,Deaths,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.20989697942600002,0.247729216983,0.185278264259
1,Deaths,163,India,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4559.30913592,5483.66920094,3586.7411542
1,Deaths,163,India,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1619.07279099,1944.31150265,1188.82779034
1,Deaths,163,India,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,6178.38192692,7324.01943423,5229.62925383
1,Deaths,163,India,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0038522141783,0.00463663067063,0.00303738269803
1,Deaths,163,India,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00229402015866,0.0027474530647,0.0016935048549
1,Deaths,163,India,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00327022583641,0.00383865464601,0.00278015756538
1,Deaths,163,India,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.23062283361,1.48012085372,0.968112806349
1,Deaths,163,India,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.474242106651,0.569507676328,0.348219177589
1,Deaths,163,India,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.867884238099,1.02881322354,0.734611886119
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.65130121924,7.48967605086,4.16159022635
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.65130121924,7.48967605086,4.16159022635
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00409981229954,0.00504834475159,0.00324444510325
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00280631371708,0.00350874365088,0.00218147749413
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.6016253279770001,0.7973347439340001,0.44303391160800004
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.308960488561,0.409465693309,0.227516973462
1,Deaths,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,111.775031496,145.802592158,80.3678069618
1,Deaths,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,27.6560404959,37.21973567,19.9806435127
1,Deaths,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,139.431071991,173.985920347,106.347892521
1,Deaths,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0910504992472,0.1111749405,0.0718140446466
1,Deaths,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0429359015136,0.0553825677987,0.0334047261972
1,Deaths,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0744748390069,0.0882612182173,0.0607126916663
1,Deaths,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,10.3078758056,13.4458920923,7.41150650416
1,Deaths,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.48670541542,3.3466294014500004,1.7965686170400001
1,Deaths,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.34781359527,7.92097611237,4.8416510633400005
1,Deaths,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,43.4888170372,77.1589124327,18.9222820086
1,Deaths,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,11.7569287059,24.9826389707,2.33116137164
1,Deaths,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,55.2457457431,96.5028086806,23.159204155
1,Deaths,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0093657978371,0.0154576725837,0.00459815733225
1,Deaths,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00407758739892,0.00817981840232,0.00112306326411
1,Deaths,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00738173724209,0.0117043457135,0.00385369428118
1,Deaths,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.70392278283,11.894262161999999,2.91692269652
1,Deaths,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.84105028443,3.91210117314,0.365043066406
1,Deaths,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.29157832822,7.49649329149,1.79904420356
1,Deaths,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,842.208206057,1034.06430726,641.242086198
1,Deaths,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,173.07530921,209.020585067,141.057354543
1,Deaths,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1015.28351527,1213.87962063,815.728241936
1,Deaths,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0423181271717,0.0502002298231,0.0331690936246
1,Deaths,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0169543379654,0.0195592651443,0.0145672429172
1,Deaths,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0337136030894,0.0389692052123,0.0276970057802
1,Deaths,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.66960559711,5.73334769508,3.55535319328
1,Deaths,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9951529723499999,1.2018320664,0.81105529313
1,Deaths,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.8657828263400003,3.4263487171099998,2.30250954689
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2.00365476552,2.86638748424,1.34662335899
1,Deaths,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.402543447238,0.543580776343,0.293424842872
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2.40619821275,3.27064453879,1.75576866865
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00545540403746,0.00746818786458,0.00383497223517
1,Deaths,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00210022509922,0.00272800064,0.0016050253878
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00430555848336,0.00563152179829,0.003187492405
1,Deaths,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.9053756785500002,2.72579143462,1.28057160373
1,Deaths,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.379385741572,0.512309409959,0.276544562761
1,Deaths,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.13896409513,1.54814623245,0.83108592731
1,Deaths,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0214175560766,0.0286101729968,0.0151807222719
1,Deaths,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0214175560766,0.0286101729968,0.0151807222719
1,Deaths,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000361189612413,0.000439985746025,0.000278610525717
1,Deaths,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000209271260365,0.000261824182287,0.000157033415678
1,Deaths,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.10733013182100001,0.143374604842,0.076075389589
1,Deaths,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0532107906421,0.0710804687577,0.0377157053641
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,11.4251305492,15.2525085654,7.61310944739
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,11.4251305492,15.2525085654,7.61310944739
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000718811898338,0.000958300291752,0.000482879437566
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000391979842754,0.000522428651142,0.000263476861931
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.264477716282,0.353076808669,0.176234117569
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.13234108825,0.176674881165,0.08818517958210001
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,14.3116086394,29.2608114647,9.50752605351
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,14.3116086394,29.2608114647,9.50752605351
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000900740916491,0.00181818551046,0.000598998707962
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000491085084988,0.000993181613486,0.00032639893187
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.331296132938,0.6773517868700001,0.22008753136700002
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.165776124289,0.338937714158,0.110128837396
1,Deaths,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0117071704905,0.0181723324521,0.00740237747578
1,Deaths,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0117071704905,0.0181723324521,0.00740237747578
1,Deaths,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00024820061567,0.000356912554277,0.000180582288239
1,Deaths,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000173488903672,0.000250161546361,0.00012169092568
1,Deaths,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.08864985287419999,0.13760580317600002,0.0560527989818
1,Deaths,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0472121770334,0.07328460600589999,0.029851991661
1,Deaths,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.30495131476,0.41687221203,0.208651914486
1,Deaths,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.103941150649,0.140263061682,0.0728145080639
1,Deaths,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.408892465409,0.519507596231,0.306732521843
1,Deaths,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00225721660052,0.00302306998512,0.0016203600235
1,Deaths,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00109016709987,0.00140949791631,0.00080288677601
1,Deaths,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00177497098516,0.00224902053929,0.00134982967559
1,Deaths,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.474691649853,0.648909345617,0.324790603412
1,Deaths,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.153920852104,0.20770801398699998,0.10782708346700001
1,Deaths,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.31030549331199997,0.394250504877,0.232777061348
1,Deaths,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.39143981187,9.56685709259,3.71184751892
1,Deaths,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.39143981187,9.56685709259,3.71184751892
1,Deaths,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000179093023904,0.000318082850591,0.00012525897117
1,Deaths,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000117700372993,0.000210309981332,8.31187814501e-05
1,Deaths,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0763230523654,0.135431676941,0.0525461736465
1,Deaths,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0387733142256,0.0688014276606,0.0266942848721
1,Deaths,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,23.2330991462,32.1144328487,16.3714771629
1,Deaths,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,23.2330991462,32.1144328487,16.3714771629
1,Deaths,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000771925024886,0.00106023953202,0.000556965876088
1,Deaths,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000507319383259,0.000685895121334,0.000366954682465
1,Deaths,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.328895639128,0.45462281422499995,0.231760188819
1,Deaths,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.167084171402,0.230955559085,0.11773783080700001
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.173595291,31.7438946383,5.42948575724
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.173595291,31.7438946383,5.42948575724
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000188053964269,0.00059735403195,9.78801690682e-05
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000113635345028,0.000357442216404,5.93417999349e-05
1,Deaths,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.121677742165,0.379661792774,0.06493747285639999
1,Deaths,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.06341946151,0.197882916178,0.0338459564345
1,Deaths,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.453474454439,0.62975539319,0.315861483736
1,Deaths,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.453474454439,0.62975539319,0.315861483736
1,Deaths,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00153864165166,0.00193923072383,0.0011751147818
1,Deaths,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000992732557433,0.00126538201847,0.000737106422108
1,Deaths,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.458907831381,0.6373009084860001,0.319646028788
1,Deaths,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.226126640066,0.314029753455,0.15750544566400002
1,Deaths,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.129770357382,0.182377702226,0.086562672298
1,Deaths,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.129770357382,0.182377702226,0.086562672298
1,Deaths,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00043789265723,0.000547078777929,0.00035164529076
1,Deaths,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000283226866163,0.000366589812033,0.000211288169164
1,Deaths,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.131325221742,0.18456288993,0.0875998368463
1,Deaths,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0647104475404,0.0909432860518,0.043164782602999996
1,Deaths,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.8040359377,6.45701995428,2.84898166949
1,Deaths,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.8040359377,6.45701995428,2.84898166949
1,Deaths,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000761493157076,0.000969508097418,0.000458690953792
1,Deaths,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000568124278165,0.00072814636404,0.000342732789701
1,Deaths,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.316954565088,0.426013039434,0.18796648437
1,Deaths,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.146877648462,0.19741565618,0.0871042043714
1,Deaths,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.18750062583,1.87704999727,0.864204070178
1,Deaths,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.18750062583,1.87704999727,0.864204070178
1,Deaths,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000811582391931,0.00127755556921,0.000597940971465
1,Deaths,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000580112645442,0.000917068292852,0.000429005624166
1,Deaths,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0984139684338,0.155560287853,0.071620806114
1,Deaths,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0503863254729,0.0796442966297,0.0366686691424
1,Deaths,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0703687601385,0.0998401594731,0.0487745166343
1,Deaths,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0703687601385,0.0998401594731,0.0487745166343
1,Deaths,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00273325886499,0.0035428804115,0.00211306905923
1,Deaths,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00193502890919,0.00253860883052,0.00143959662833
1,Deaths,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.38263730291900006,0.542891039556,0.26521640369099997
1,Deaths,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.191156603776,0.271215604307,0.13249588215400002
1,Deaths,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.75394179081,5.45565284229,1.45370138729
1,Deaths,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.75394179081,5.45565284229,1.45370138729
1,Deaths,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00344535804022,0.00474454705852,0.00139013709852
1,Deaths,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00235923117373,0.00331478904236,0.00093850752883
1,Deaths,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.525931573309,0.7643432537499999,0.203665240524
1,Deaths,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.260340564083,0.37835635647800003,0.100816011613
1,Deaths,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,64.9864405776,83.9548155202,43.3287416949
1,Deaths,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,64.9864405776,83.9548155202,43.3287416949
1,Deaths,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000771253149541,0.000908033081894,0.000517164693007
1,Deaths,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000518052453738,0.00062621850855,0.00034772670977
1,Deaths,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.23778343315699998,0.30718814704999997,0.158538563784
1,Deaths,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.120740071419,0.15598192995000001,0.0805016449621
1,Deaths,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,43.7286714259,58.0620689342,32.604995545
1,Deaths,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,43.7286714259,58.0620689342,32.604995545
1,Deaths,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000519134497545,0.00062776071523,0.000426975155337
1,Deaths,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00034876596544,0.000433870237362,0.000278718568265
1,Deaths,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.160001894651,0.212447365399,0.11930069888200001
1,Deaths,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0812446852617,0.10787509344299999,0.060577705990899997
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,16.2170480936,24.9332435854,2.07871111577
1,Deaths,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.85386236716,5.74240388263,0.660300151575
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,20.0709104608,29.5852664883,3.33697162067
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117416713726,0.016962490676,0.00153619026263
1,Deaths,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00610639193235,0.00864250986556,0.00110069627223
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00996467296398,0.0138267796039,0.00166046281641
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7264319312699998,2.65433928712,0.221295097939
1,Deaths,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.433118016373,0.6453625848319999,0.0742081228166
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.09729035159,1.6174466788800002,0.18243451237799999
1,Deaths,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.74854294494,6.58092742468,3.37388579199
1,Deaths,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.74854294494,6.58092742468,3.37388579199
1,Deaths,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00436515930598,0.00588793474938,0.00325528601135
1,Deaths,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00298701700487,0.00403818498105,0.00217790157484
1,Deaths,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.665276341811,0.92199552022,0.472685289658
1,Deaths,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.329317399616,0.45639555789700004,0.23398320463800001
1,Deaths,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.6419366771,5.08929128931,2.73959490586
1,Deaths,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.6419366771,5.08929128931,2.73959490586
1,Deaths,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000577190264371,0.000782421600946,0.000456599382021
1,Deaths,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000430735578934,0.000586372860928,0.000337433583475
1,Deaths,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.240283060022,0.33577477939899997,0.18074950378500002
1,Deaths,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.111347854578,0.155598989392,0.08375983500709999
1,Deaths,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.101753437346,0.137650467392,0.0748486738907
1,Deaths,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.101753437346,0.137650467392,0.0748486738907
1,Deaths,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00148087360889,0.00195826449274,0.00112010864744
1,Deaths,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000973928407586,0.00128923417751,0.000737183822702
1,Deaths,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.12785083577800002,0.172954622078,0.09404562404399999
1,Deaths,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0647518236146,0.0875952598507,0.0476307066961
1,Deaths,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,65.2548316961,98.7601141743,37.8529642805
1,Deaths,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,65.2548316961,98.7601141743,37.8529642805
1,Deaths,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000444664603538,0.000602663001406,0.000273740937971
1,Deaths,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000262798741653,0.000366913263643,0.000161652174626
1,Deaths,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.12805276365,0.193801826313,0.07428073236089999
1,Deaths,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0655093216603,0.09914527274830001,0.0380005885908
1,Deaths,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2.94906721082,4.57947687742,1.73272982285
1,Deaths,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.825449428271,1.47492779506,0.452278848727
1,Deaths,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3.77451663909,5.54204925078,2.37449145727
1,Deaths,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00600475954549,0.0086341973973,0.00390005600231
1,Deaths,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00344008562033,0.00601789453683,0.0020096259041
1,Deaths,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00516393887059,0.00706889203345,0.00350670517288
1,Deaths,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.17350130141,1.82227860245,0.689492831719
1,Deaths,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.391499528071,0.699538355626,0.214509756466
1,Deaths,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.8167333060159999,1.1991936026499999,0.513794597677
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.3296817798,12.6794857318,7.28066113154
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.3296817798,12.6794857318,7.28066113154
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00035607119962,0.000475229241727,0.000305416551161
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000238684840523,0.000316228762823,0.000198158732758
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11383834368700001,0.154711777805,0.0888367281674
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.056379233537300004,0.0766220868059,0.043997009108
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,24.9932625452,32.303741583,18.7084292251
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,24.9932625452,32.303741583,18.7084292251
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00095466373649,0.00118959603441,0.000767935023335
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000639639703869,0.000810023478816,0.000512398983491
1,Deaths,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.304961270773,0.394161829256,0.228275373827
1,Deaths,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.15103419593,0.19521139453800002,0.11305497071500001
1,Deaths,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,17.5388083438,26.3529124622,10.1140992563
1,Deaths,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.12681038623,9.31611716856,1.380410094
1,Deaths,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,21.6656187301,32.2760387698,12.4343302708
1,Deaths,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00500552845745,0.0074165099877,0.00299488725775
1,Deaths,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00185783680672,0.00381351796467,0.00070275582006
1,Deaths,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0038022732917,0.00542414520169,0.00233657037108
1,Deaths,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.1159801624800005,7.6870089881500006,2.95023071934
1,Deaths,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.21870350987,2.7511767270900003,0.407653967392
1,Deaths,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.17935487457,4.73639744487,1.82469511031
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12.0142137488,20.7551468141,7.58567398598
1,Deaths,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.609300020431,0.908202018238,0.40044532284
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,12.6235137692,21.3982585743,8.27132564601
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0265561230593,0.0442403441755,0.0183843980656
1,Deaths,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00413456108797,0.00604179020462,0.00275314884993
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0210091456174,0.0339890121317,0.0147744577113
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.97010352112,13.768746932900001,5.032256642839999
1,Deaths,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.415651881997,0.61955664772,0.27317552354200003
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.2456236908700005,7.196803933309999,2.78186697933
1,Deaths,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.17612459454,1.56905467269,0.771036632607
1,Deaths,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.17612459454,1.56905467269,0.771036632607
1,Deaths,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000273295928623,0.000366595122425,0.000193735117787
1,Deaths,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000167537665107,0.00022627142217,0.000113298453033
1,Deaths,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.184098546927,0.24560381326199998,0.12069020947999999
1,Deaths,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0900226051092,0.120098151038,0.0590164737851
1,Deaths,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.1932944561,15.418292008,9.2185845397
1,Deaths,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.1932944561,15.418292008,9.2185845397
1,Deaths,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00278594404627,0.00342104120821,0.00217866724657
1,Deaths,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00180055472153,0.00223627254011,0.00139693116448
1,Deaths,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.43047225319900007,0.544327615896,0.325453049003
1,Deaths,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.22015613060400002,0.278385101028,0.166446230691
1,Deaths,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.43198928184,8.11193215311,4.97341611918
1,Deaths,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.43198928184,8.11193215311,4.97341611918
1,Deaths,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00146992886181,0.00177074564192,0.00116933579238
1,Deaths,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000950104118297,0.00116219677042,0.000754860031422
1,Deaths,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.22707504757500002,0.28638377629100004,0.175581558424
1,Deaths,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.116132836575,0.146465059217,0.0897975565693
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,32.3489542366,45.5021998507,21.3542336386
1,Deaths,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6.06807929534,8.53376272895,4.04259560711
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,38.4170335319,52.0931898712,27.5438740227
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0086995661081,0.0113026862949,0.00624220163536
1,Deaths,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00382132127399,0.00499285975093,0.00283061416551
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00723217987839,0.00913693730638,0.00547778040303
1,Deaths,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.91346147437,2.69148442254,1.2631166708900001
1,Deaths,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.38715071327899997,0.544464264006,0.25792243255499997
1,Deaths,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.17917181418,1.5989475386200003,0.8454312297179999
1,Deaths,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.4944362034,27.7235104773,17.3824083205
1,Deaths,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.4944362034,27.7235104773,17.3824083205
1,Deaths,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000843277749059,0.00109060699438,0.000688544205189
1,Deaths,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000545726460976,0.000706764174719,0.000444006299995
1,Deaths,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.081470277733,0.10508031366500001,0.0658844744814
1,Deaths,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0414961474219,0.0535217051951,0.0335576598236
1,Deaths,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,55.0577407009,62.7111605253,48.2992667565
1,Deaths,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,55.0577407009,62.7111605253,48.2992667565
1,Deaths,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0021598658478,0.00244010868893,0.00191993856304
1,Deaths,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0013977880022,0.00158591784318,0.00123913192891
1,Deaths,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.208685139903,0.237693867222,0.183068522464
1,Deaths,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.106291884245,0.121067216536,0.0932442923707
1,Deaths,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.6408032441,2.57863290398,0.799644061573
1,Deaths,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.6408032441,2.57863290398,0.799644061573
1,Deaths,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000380879265356,0.000575158526247,0.000194686306597
1,Deaths,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000233594852063,0.000356239275834,0.000118776629421
1,Deaths,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.256834602757,0.403632891347,0.125168124599
1,Deaths,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.125589910449,0.19737301023499998,0.0612061357418
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,64.9731651771,78.2980972252,53.1955893984
1,Deaths,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20.4025477262,24.4341033894,16.943057004
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,85.3757129033,98.8431348271,72.772258762
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0193436057293,0.0228314368524,0.0159957154457
1,Deaths,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0140726191617,0.0165358518947,0.0120529054229
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0177545230811,0.020392219242,0.0152154030922
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.5501450657299998,3.07313805247,2.08788458209
1,Deaths,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.842055813975,1.00844654768,0.699275396786
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7175560733100002,1.98848853795,1.46400458345
1,Deaths,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,220.730812541,267.717450781,194.135273946
1,Deaths,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,220.730812541,267.717450781,194.135273946
1,Deaths,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00131226464499,0.00163510185687,0.00116748105631
1,Deaths,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000954677559804,0.001193556675,0.000847792016077
1,Deaths,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.38899549238899994,0.471800381601,0.342125984178
1,Deaths,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.19399751804100002,0.235293479827,0.170623035707
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,56.773598582,73.7570900066,43.0860365446
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,56.773598582,73.7570900066,43.0860365446
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000544415784634,0.000667421426067,0.000447751322952
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000346595914948,0.000426399686128,0.000278215515465
1,Deaths,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.124427637547,0.16164944078100002,0.09442934519610001
1,Deaths,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0622316449064,0.0808478791069,0.0472282010236
1,Deaths,80,France,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,48.2310305577,60.1508748225,35.666630385
1,Deaths,80,France,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,48.2310305577,60.1508748225,35.666630385
1,Deaths,80,France,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00268778022434,0.00329420884474,0.00198368383502
1,Deaths,80,France,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00181391390506,0.00224880322952,0.00134461977888
1,Deaths,80,France,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.344230729444,0.429304107281,0.254557077721
1,Deaths,80,France,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.171739658124,0.21418349469999998,0.127000705519
1,Deaths,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.72681944536,4.36830462379,1.38463755013
1,Deaths,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.72681944536,4.36830462379,1.38463755013
1,Deaths,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000565292553182,0.000801724692007,0.000312627704518
1,Deaths,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000273209121277,0.000419598538676,0.000142177136255
1,Deaths,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.24512719638999997,0.392688363444,0.124471871894
1,Deaths,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.123144108852,0.197274146994,0.06253071045229999
1,Deaths,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.04489219941,4.6521185317,1.81330883462
1,Deaths,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.04489219941,4.6521185317,1.81330883462
1,Deaths,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000630339049132,0.000829587730311,0.000456921876334
1,Deaths,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000304829127873,0.000438941122611,0.000199250313313
1,Deaths,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.273720318894,0.418201789961,0.163007239653
1,Deaths,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.137508384387,0.210091281193,0.0818896538573
1,Deaths,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.690587032609,0.994965159296,0.447018157496
1,Deaths,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.179192256348,0.259541252194,0.119463146974
1,Deaths,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.869779288957,1.18150249532,0.622432800457
1,Deaths,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00756473780643,0.00993695580572,0.00547589662535
1,Deaths,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00415542450554,0.00540915861381,0.00316846552505
1,Deaths,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0064708541674,0.00817896727522,0.00494691334053
1,Deaths,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.33141104537,3.3589868512,1.50912632392
1,Deaths,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.635748702186,0.9208155397379999,0.42383829634000003
1,Deaths,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5046259769499999,2.04387408261,1.07674276953
1,Deaths,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.65458247213,2.18973933466,0.96171236145
1,Deaths,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.65458247213,2.18973933466,0.96171236145
1,Deaths,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00192864544649,0.00250206364037,0.00110181746557
1,Deaths,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00130821717643,0.00170021081541,0.000746830985767
1,Deaths,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.306743277559,0.405956083682,0.178291990148
1,Deaths,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15636381204900002,0.206938001296,0.09088517101089999
1,Deaths,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.44817466585,6.75271106679,4.27543408889
1,Deaths,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.44817466585,6.75271106679,4.27543408889
1,Deaths,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00634789715134,0.00771894502728,0.00514068016792
1,Deaths,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00430567260309,0.00524542358459,0.00346873923965
1,Deaths,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.01003786869,1.25188605581,0.792623327944
1,Deaths,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.514871500099,0.638154738042,0.404043427007
1,Deaths,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.64180652926,3.27379453891,0.825975847591
1,Deaths,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.64180652926,3.27379453891,0.825975847591
1,Deaths,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000195679113604,0.000379816697865,0.000104418960389
1,Deaths,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000112776053844,0.000225830726894,5.86808041254e-05
1,Deaths,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.27768537915999997,0.553710112384,0.139700636054
1,Deaths,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.142247997494,0.283645307208,0.0715634931428
1,Deaths,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0377906322447,0.0619958825861,0.0214519336338
1,Deaths,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0377906322447,0.0619958825861,0.0214519336338
1,Deaths,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00182658936692,0.00247943294957,0.0012734789965
1,Deaths,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00125422638103,0.00179839460027,0.000830882872237
1,Deaths,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.20401971083899997,0.33469622727000004,0.11581222744799999
1,Deaths,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10311580304300001,0.169162430966,0.058533907269899994
1,Deaths,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0469394079205,0.0704367092216,0.0293448160746
1,Deaths,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0469394079205,0.0704367092216,0.0293448160746
1,Deaths,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00228050335154,0.00290277304968,0.00169089625395
1,Deaths,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0015641736518,0.00203823974467,0.00109570556637
1,Deaths,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.253411066767,0.38026558949399997,0.158423411691
1,Deaths,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.128079221082,0.19219413393499998,0.08007048559289999
1,Deaths,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,18.1134517635,26.1006204422,11.3712729021
1,Deaths,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,18.1134517635,26.1006204422,11.3712729021
1,Deaths,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00027575677624,0.000368222538445,0.000190777402172
1,Deaths,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000195386180325,0.000259174458388,0.000132789542439
1,Deaths,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0688981944939,0.0992790135815,0.0432529471622
1,Deaths,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0346891528089,0.049985415411,0.0217771757963
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.04253118195,2.81096892767,1.17276257539
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.04253118195,2.81096892767,1.17276257539
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00147942655591,0.00186421221771,0.000879215301145
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0010131028981,0.00131551518032,0.000586597478202
1,Deaths,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.21744346028899997,0.299249683823,0.124849772058
1,Deaths,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11166657153699999,0.153677586724,0.06411572913920001
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,15.2772389357,22.0149709616,9.28563947506
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,15.2772389357,22.0149709616,9.28563947506
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000527018418213,0.000736795858475,0.00032606162227
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000300998975801,0.000429828610931,0.000186606691685
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.38681529006000004,0.557412724512,0.235109717277
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.18973312333800002,0.273411263536,0.115321452208
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,12.1440593406,16.501988874,8.53288717709
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,12.1440593406,16.501988874,8.53288717709
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000419430828028,0.000560109225199,0.00029847210683
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000239450527221,0.000321972257183,0.00016563004116
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.30748408505700003,0.417825605773,0.216050245882
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.150821121434,0.204943701118,0.10597277047400001
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.124499939472,0.18518358318,0.0789989666984
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.124499939472,0.18518358318,0.0789989666984
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00129969472523,0.00171860742297,0.000936807188138
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000845277076923,0.00114742194066,0.000589752868805
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.302906073702,0.450548267997,0.192203039861
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.146263270576,0.217554776714,0.0928084566978
1,Deaths,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0553757809505,0.0860250229905,0.0348295050468
1,Deaths,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0553757809505,0.0860250229905,0.0348295050468
1,Deaths,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000650147492625,0.000897702908667,0.000497958141392
1,Deaths,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000411484566707,0.000582883844556,0.000291213979742
1,Deaths,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.052431252307200006,0.08145076435450001,0.0329774954953
1,Deaths,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.025935192743199997,0.0402897352182,0.0163123645578
1,Deaths,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0641524163838,0.0917629683079,0.0420888279146
1,Deaths,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0641524163838,0.0917629683079,0.0420888279146
1,Deaths,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00075398011747,0.000926380746958,0.000604726743133
1,Deaths,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000477374644125,0.000621297845894,0.000350122209655
1,Deaths,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0607412025943,0.0868836025646,0.0398508141615
1,Deaths,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.030045721347799998,0.0429770962847,0.0197122613093
1,Deaths,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,20.9387958911,25.2337355807,17.4869670664
1,Deaths,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,20.9387958911,25.2337355807,17.4869670664
1,Deaths,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00226972278443,0.00272034540572,0.0018966141206
1,Deaths,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00143356306527,0.00170982909117,0.00119734713213
1,Deaths,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.245495821674,0.295851618331,0.20502503443200001
1,Deaths,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.123154923628,0.148416307913,0.102852432621
1,Deaths,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.19440631344,1.86847691315,0.530017416233
1,Deaths,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.19440631344,1.86847691315,0.530017416233
1,Deaths,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000256928441048,0.000372420632117,0.000141889386524
1,Deaths,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000159907363978,0.000231353818523,8.68266376656e-05
1,Deaths,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.184121073925,0.28803094222,0.0817036671506
1,Deaths,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09278340224960001,0.145146289898,0.0411726048131
1,Deaths,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,128.760719353,164.288211362,86.4588386589
1,Deaths,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,31.9506801845,39.6660251027,25.4543098229
1,Deaths,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,160.711399537,196.014791817,119.66687649
1,Deaths,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.06109467384,0.0764367307218,0.0413155241513
1,Deaths,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0296499778846,0.0364271014521,0.0240766193486
1,Deaths,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0504537796101,0.0609633963535,0.0373749238687
1,Deaths,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.336318071499999,8.084626800939999,4.254641513259999
1,Deaths,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.60339757805,1.9905807392300001,1.27738685015
1,Deaths,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.9930357733700004,4.87018393274,2.97324346678
1,Deaths,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.291497443717,0.386159437012,0.199902123931
1,Deaths,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.291497443717,0.386159437012,0.199902123931
1,Deaths,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00320213259146,0.00385992558032,0.00241761100584
1,Deaths,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00216929254182,0.00267243979128,0.00160908979864
1,Deaths,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.984090821129,1.30366823328,0.6748664508900001
1,Deaths,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.5042596801279999,0.668014894754,0.345809485617
1,Deaths,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0464425255552,0.0634802592894,0.0324456292238
1,Deaths,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0464425255552,0.0634802592894,0.0324456292238
1,Deaths,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00050896096508,0.000618027923062,0.000408229808085
1,Deaths,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000345200302859,0.000427309829809,0.000263460700268
1,Deaths,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.156789241532,0.214308364742,0.109535937941
1,Deaths,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.080340646498,0.10981411993,0.056127499457
1,Deaths,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,44.9469359939,67.9715683309,16.2220302154
1,Deaths,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,44.9469359939,67.9715683309,16.2220302154
1,Deaths,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000775633438868,0.00111556134588,0.000290677927522
1,Deaths,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000565810625354,0.000822796947121,0.000209834804503
1,Deaths,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.256307364263,0.387604029918,0.0925052112132
1,Deaths,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.12789869211399998,0.19341640310299998,0.0461605758458
1,Deaths,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,22.0944633051,28.3234709807,16.8571403656
1,Deaths,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,22.0944633051,28.3234709807,16.8571403656
1,Deaths,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000381317556126,0.00047238525342,0.000306705942626
1,Deaths,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000278070822027,0.000345203041954,0.000220319723231
1,Deaths,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12599242927899998,0.161512993785,0.0961268909786
1,Deaths,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0628708697755,0.0805958140293,0.0479678126632
1,Deaths,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.304126060248,0.43581994658,0.199837964731
1,Deaths,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0696633305952,0.0966963627866,0.0472394241745
1,Deaths,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.373789390843,0.50177841053,0.264159417783
1,Deaths,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00585139497134,0.00784063134895,0.00414327740645
1,Deaths,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00296242562236,0.00387052428781,0.00213026531529
1,Deaths,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00495162653618,0.00638509496727,0.00371534000559
1,Deaths,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.58152206374,2.2663590906,1.03920114618
1,Deaths,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.361650714832,0.501990192324,0.245239085972
1,Deaths,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9710691906260001,1.30357245798,0.686260975583
1,Deaths,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.51036303454,8.37971205099,4.84237307046
1,Deaths,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.51036303454,8.37971205099,4.84237307046
1,Deaths,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00427715190015,0.00516329399529,0.00345688938966
1,Deaths,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00301667669848,0.00368557555307,0.00238650856096
1,Deaths,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.683616796351,0.879906677439,0.508470502736
1,Deaths,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.346703827119,0.44625441359,0.257876445132
1,Deaths,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,167.872303602,224.111517049,114.619824951
1,Deaths,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,47.1449994176,66.7441908939,30.0550402606
1,Deaths,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,215.017303019,276.628067058,158.66004349
1,Deaths,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0116366277204,0.0153444431085,0.0082371856814
1,Deaths,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00482828514306,0.00670459833714,0.00314448055948
1,Deaths,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0088844646795,0.0110718834778,0.00661358582114
1,Deaths,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.54050450442,2.0565917908899998,1.05182542233
1,Deaths,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.437630642125,0.619563123976,0.278990491692
1,Deaths,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.9922343514129999,1.2765478259,0.732164077667
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,21.8201104309,30.7521102019,14.2508972556
1,Deaths,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.09878982349,4.27617298231,1.87981636312
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,24.9189002544,33.9929959202,16.9038378669
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00137284883647,0.00193151648495,0.000901916821368
1,Deaths,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000233828245476,0.000315946627527,0.000140583669655
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000854957092612,0.00115955567066,0.000585053050907
1,Deaths,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.505108711969,0.7118735179429999,0.329890739094
1,Deaths,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.07184416765,0.0991413119766,0.043582769286
1,Deaths,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.288643912072,0.393752181086,0.195802777856
1,Deaths,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,16.3347320235,27.4223760233,10.0150387339
1,Deaths,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,16.3347320235,27.4223760233,10.0150387339
1,Deaths,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00138045367188,0.00218841480712,0.000970129801525
1,Deaths,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000734741337842,0.00121054854551,0.000484314743084
1,Deaths,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.579559843334,0.9729518628770001,0.35533575152999997
1,Deaths,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.285721392233,0.47966256467600005,0.17517953806699998
1,Deaths,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.15944352628,14.0357133339,5.69804254939
1,Deaths,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.15944352628,14.0357133339,5.69804254939
1,Deaths,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000772474175845,0.00103632329987,0.000577547184999
1,Deaths,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000411581439241,0.000582256286998,0.000285439452546
1,Deaths,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.324979047558,0.497990160423,0.202167788396
1,Deaths,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16021376736600002,0.24550776523099999,0.0996681578779
1,Deaths,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.0419576662,15.0702929534,6.15802026727
1,Deaths,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.0419576662,15.0702929534,6.15802026727
1,Deaths,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000234502140918,0.000334165799034,0.000147071728354
1,Deaths,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000159992567304,0.00023216600735,0.000100439973329
1,Deaths,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10659068690399999,0.159964115677,0.0653645068095
1,Deaths,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.054208613997299995,0.0813526326927,0.0332422974436
1,Deaths,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,67.1314708793,95.3448149709,42.985691446
1,Deaths,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,67.1314708793,95.3448149709,42.985691446
1,Deaths,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00157029779069,0.00224337828495,0.00106054258497
1,Deaths,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00107122449316,0.00148946572632,0.000714252846514
1,Deaths,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.7125691853830001,1.01204064568,0.45627302270599995
1,Deaths,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.36238989576799996,0.514691501717,0.23204586520499998
1,Deaths,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.764194946096,1.14437172875,0.475927557946
1,Deaths,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.764194946096,1.14437172875,0.475927557946
1,Deaths,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0012467639763,0.00159222226623,0.000851923024474
1,Deaths,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000919480431991,0.0012228604211,0.000611187975556
1,Deaths,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.126780100286,0.189851507494,0.0789564807167
1,Deaths,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0836309065603,0.125236165989,0.052083899967399996
1,Deaths,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.543587503143,0.781526364611,0.371892558479
1,Deaths,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.543587503143,0.781526364611,0.371892558479
1,Deaths,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000888489735616,0.00107288632057,0.000720463220135
1,Deaths,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000654870414596,0.000808042749289,0.000509906082378
1,Deaths,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0901812796783,0.129655386218,0.0616970526964
1,Deaths,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0594883752044,0.08552759830090001,0.040698661994
1,Deaths,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.301519232057,0.389688155213,0.216089703155
1,Deaths,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.301519232057,0.389688155213,0.216089703155
1,Deaths,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00115178119807,0.00148154969781,0.000840331647631
1,Deaths,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000794385611572,0.00102708797897,0.000574510549675
1,Deaths,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.130419174253,0.16855577361399998,0.0934674728961
1,Deaths,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0626248524504,0.0809373354242,0.0448813353755
1,Deaths,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.868314107608,1.09349360989,0.682722067793
1,Deaths,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.868314107608,1.09349360989,0.682722067793
1,Deaths,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00331724771529,0.00417718769424,0.00266923139862
1,Deaths,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00228802832131,0.00285473219187,0.00182668097849
1,Deaths,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.375580715478,0.47297989146499997,0.295304706497
1,Deaths,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.180346847193,0.227116112985,0.14179980649499999
1,Deaths,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,424.436398321,479.279023762,376.080059851
1,Deaths,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,424.436398321,479.279023762,376.080059851
1,Deaths,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00524028874019,0.0058812089197,0.0046299768144
1,Deaths,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00370912885332,0.00416284680747,0.00329057703007
1,Deaths,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.21834994084,1.37577637676,1.07954247205
1,Deaths,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.608326409132,0.686929982091,0.539019351923
1,Deaths,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.73557684179,2.21253336839,1.29148240571
1,Deaths,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.73557684179,2.21253336839,1.29148240571
1,Deaths,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00188748866865,0.0022917266675,0.00143125396245
1,Deaths,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00124681335244,0.00153230836842,0.000938234450836
1,Deaths,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.85828713935,1.0941543409299999,0.638671082045
1,Deaths,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.437210451725,0.557360924711,0.325338292376
1,Deaths,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,485.518582867,680.799715832,342.334191879
1,Deaths,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,485.518582867,680.799715832,342.334191879
1,Deaths,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00331479053658,0.00424582961588,0.00257933768924
1,Deaths,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00195830424059,0.00259076701892,0.00146845301112
1,Deaths,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.952756979426,1.33596674513,0.6717792111750001
1,Deaths,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.48741207647600004,0.683454794251,0.34366927487599996
1,Deaths,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1782.41007946,2471.16044421,922.984566996
1,Deaths,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,317.304019491,439.38371051,191.090775754
1,Deaths,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2099.71409895,2848.81667793,1179.65391962
1,Deaths,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0404017271053,0.0509926954158,0.0223374283157
1,Deaths,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0170619806787,0.0213982480602,0.0107753268618
1,Deaths,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0334345329797,0.0414077723218,0.0199303174369
1,Deaths,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.56070323379,10.4822739599,3.9151553735199998
1,Deaths,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.34682435373,1.86500216069,0.8111013247509999
1,Deaths,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.45476830298,6.04406963985,2.50276211045
1,Deaths,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.64243262614,10.3741740934,5.37311817265
1,Deaths,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.64243262614,10.3741740934,5.37311817265
1,Deaths,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000529898017939,0.000698952517037,0.00038076857358
1,Deaths,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000315804409018,0.00042261395397,0.000224178008643
1,Deaths,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0701318897321,0.09520011090370001,0.049307197019099996
1,Deaths,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0352673206925,0.0478734118533,0.0247951785751
1,Deaths,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,16.0134248063,21.5450079411,11.6781963458
1,Deaths,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,16.0134248063,21.5450079411,11.6781963458
1,Deaths,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00111042028126,0.00145065714574,0.000814155918466
1,Deaths,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000661704540781,0.000874495234192,0.000486726675968
1,Deaths,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.146949511718,0.19771088541,0.107166659944
1,Deaths,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0738967048393,0.09942314725569999,0.053891046972099996
1,Deaths,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,41.178049687,71.2205508194,14.2398346211
1,Deaths,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,11.4112349003,18.2186269638,4.02420241986
1,Deaths,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,52.5892845873,84.2361566944,24.154750649
1,Deaths,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000869863091371,0.00142019431794,0.000306481357004
1,Deaths,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000471449413756,0.000740309945162,0.000171858827929
1,Deaths,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000735035695472,0.00114749720886,0.000348900637242
1,Deaths,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.171316576105,0.29630497334,0.0592432067602
1,Deaths,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.048815481706700005,0.07793644237809999,0.0172149098083
1,Deaths,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.11091862112800001,0.177666580236,0.0509459608874
1,Deaths,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,98.9681001928,131.924606564,71.7041275999
1,Deaths,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,27.2777123637,36.6187406842,19.6262834106
1,Deaths,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,126.245812557,159.205959993,96.3978626396
1,Deaths,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0339303995704,0.0439380886913,0.025166441139
1,Deaths,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0173052422014,0.0227195660471,0.0131442886517
1,Deaths,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0280989067218,0.0350067421264,0.0218533840294
1,Deaths,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.8454195512499996,5.12594927441,2.78607403437
1,Deaths,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0853581887200001,1.45703017659,0.780913997838
1,Deaths,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.4817793815,3.1297201936500003,1.8950191145000002
1,Deaths,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,30.9504128076,38.5858611766,24.2391719467
1,Deaths,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,15.3194274503,18.8896865359,12.0955602072
1,Deaths,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,46.2698402579,55.1911428679,38.5971242047
1,Deaths,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0265912423787,0.0312348805798,0.0221512551316
1,Deaths,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0212962258696,0.0248059310939,0.0180032830259
1,Deaths,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.02456701661,0.0278263959927,0.0216239537899
1,Deaths,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.01827695991,3.76288408467,2.36379833344
1,Deaths,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.43335742471,1.7674075963,1.13171729722
1,Deaths,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.2094148106600002,2.63541278271,1.84303765458
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.95815170379,5.27413813098,2.79003713718
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.95815170379,5.27413813098,2.79003713718
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00117803185803,0.00155170110811,0.000834272408152
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000822760854192,0.00108786716139,0.000580359098488
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155354306802,0.20700572758099997,0.109506738962
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0796285883509,0.106103102045,0.056128904424599994
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,17.2351365755,20.9119256339,13.7935800442
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,17.2351365755,20.9119256339,13.7935800442
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00513261150709,0.00613475994786,0.00418392196412
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00358410810583,0.00427497227677,0.00291662133067
1,Deaths,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.676465404993,0.820776451707,0.541387047908
1,Deaths,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.34672991291,0.42069815473,0.277493989473
1,Deaths,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,179.894506208,271.520984524,104.699719066
1,Deaths,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,70.0743785363,107.920373179,42.3883305959
1,Deaths,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,249.968884744,346.751094993,171.720501367
1,Deaths,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114774241248,0.0153650173306,0.00808762719158
1,Deaths,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0107471522127,0.0140458783745,0.00813304764543
1,Deaths,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112648641206,0.0143800659772,0.0086847146048
1,Deaths,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.3425108986600005,6.5543015146300005,2.52736829332
1,Deaths,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5975038417199998,2.4602888296,0.9663378025680001
1,Deaths,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.93076649613,4.06549196209,2.0133413509399998
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,18.0462815481,26.1417866493,12.039685356
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,18.0462815481,26.1417866493,12.039685356
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000570314390171,0.000832707629938,0.000389573527545
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00034241165099,0.00050074305724,0.00023166825848
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.322981680481,0.467870245749,0.21547917216999998
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.163266317893,0.23650707421400002,0.10892410668800001
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,16.1148301112,21.607009106,11.8550821745
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,16.1148301112,21.607009106,11.8550821745
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000509278325364,0.0006577716458,0.00039254249704
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000305723510215,0.000397664752735,0.000232506739523
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.28841370429200003,0.386709477662,0.212175253542
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.145792304565,0.195480537528,0.107253985248
1,Deaths,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,503.317082856,1526.6135825,289.490497164
1,Deaths,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,313.882120247,624.148775595,221.232669552
1,Deaths,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,817.199203103,2051.91469227,532.409912133
1,Deaths,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00431221202603,0.0132238896649,0.00242329560666
1,Deaths,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00340378006853,0.00665074098919,0.00226744518963
1,Deaths,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00391031539507,0.00998350285348,0.00245583775607
1,Deaths,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.3750729464700004,10.2369507762,1.94122468423
1,Deaths,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.11033319468,4.19635842438,1.48742032817
1,Deaths,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.74353519361,6.88877344859,1.78742872707
1,Deaths,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.85307817803,3.28577050982,1.05108559717
1,Deaths,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.953179941667,1.97957946387,0.520195803322
1,Deaths,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2.8062581197,4.61225247445,1.80111385668
1,Deaths,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00197189835832,0.00320946710451,0.00147425645663
1,Deaths,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00161683561508,0.0030580711573,0.00111209630216
1,Deaths,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00183421896933,0.00285973131857,0.00144010592571
1,Deaths,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.783655297066,1.38953202056,0.4444975963
1,Deaths,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.424823070601,0.8822793992819999,0.23184623261600001
1,Deaths,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.608948065782,1.0008424398,0.390835323229
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.18436562734,4.39151735131,2.23046422141
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.18436562734,4.39151735131,2.23046422141
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000948803286812,0.00121994725003,0.000723821438634
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000672575786564,0.000876711120362,0.000508699178567
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.190695764777,0.26298605683000004,0.133571370341
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0942583218023,0.129990429537,0.06602251090290001
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.52396895434,10.0015830989,5.3853254635
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.52396895434,10.0015830989,5.3853254635
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0022420234128,0.00279686023788,0.00181623798145
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00158921777916,0.00200535287409,0.00124194523201
1,Deaths,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.450572949786,0.598944895538,0.322500264737
1,Deaths,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.222712078299,0.296050312242,0.159407492717
1,Deaths,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,195.072613071,246.781031636,147.785752612
1,Deaths,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,48.0276651206,58.5061793232,38.7021835238
1,Deaths,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,243.100278192,295.367739365,196.452327701
1,Deaths,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106561251222,0.0128176357967,0.00836735692579
1,Deaths,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00820601010817,0.00954561670946,0.00698434837998
1,Deaths,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100604461016,0.0116989702063,0.00834084391794
1,Deaths,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.0610597085699998,2.60739031039,1.5614455325799999
1,Deaths,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.522020828198,0.635913574152,0.42066058896399994
1,Deaths,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.30243847402,1.58246757508,1.05251656564
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,20.4276672744,49.2773945446,11.8781616631
1,Deaths,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.74033105049,6.94831042668,2.37454224474
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,24.1679983249,53.2706169479,15.2207985726
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00323326600811,0.00778711033268,0.00202143155116
1,Deaths,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00118693962936,0.002103674066,0.000775058032048
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0025537679526,0.00558445263789,0.0016605060733
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.747879114188,1.80409900389,0.43487241609199995
1,Deaths,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.13522747201,0.251208366602,0.0858489103245
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.439628532799,0.969020390321,0.276874288658
1,Deaths,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.11405462089,6.6155053844,3.60047389467
1,Deaths,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.11405462089,6.6155053844,3.60047389467
1,Deaths,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00125355726991,0.0016149471137,0.000893945263366
1,Deaths,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000854157174129,0.00109372768718,0.000609721202954
1,Deaths,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.24589922208800002,0.318093518418,0.173121680443
1,Deaths,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.124633181605,0.161224614343,0.0877461329695
1,Deaths,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,66.0712045521,93.651184045,38.4702967926
1,Deaths,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4.39592992251,7.37421677671,2.20585420306
1,Deaths,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,70.4671344746,98.7456650306,41.4149657645
1,Deaths,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00653904012846,0.0089889599563,0.00375542699177
1,Deaths,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000635155816328,0.00105567947049,0.000318357364458
1,Deaths,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00413560324207,0.00565798710531,0.00242737236609
1,Deaths,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.4601770724,3.48712419204,1.43245068376
1,Deaths,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.163400460405,0.274105920176,0.0819934800416
1,Deaths,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.31079501756,1.8368183507499998,0.770380847485
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0532145428145,0.075915245598,0.033401178045
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0532145428145,0.075915245598,0.033401178045
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000556214055217,0.000695830999717,0.000405233495531
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000361712146732,0.000465135415334,0.00025446916148
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.129470008548,0.184700402873,0.0812644547578
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0625167619134,0.0891856827784,0.0392399029481
1,Deaths,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,78.8509981174,106.722927407,71.659611269
1,Deaths,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,78.8509981174,106.722927407,71.659611269
1,Deaths,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000973528206052,0.00133403369929,0.000889532329445
1,Deaths,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000689079407317,0.000940668244868,0.000628941221704
1,Deaths,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.22634276718799998,0.306349485593,0.205699802127
1,Deaths,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11301373947,0.15296137527,0.10270663443499999
1,Deaths,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,30.512739185,38.4947962733,22.3182846111
1,Deaths,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.05993354629,9.86071545422,6.52125906626
1,Deaths,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,38.5726727313,46.3149319343,30.3911771992
1,Deaths,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00644763908055,0.00766385808887,0.00489595530429
1,Deaths,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00369809771218,0.00430473923881,0.00313504141386
1,Deaths,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0055777155886,0.00639223594976,0.00450704572803
1,Deaths,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.28587861618,1.62226128116,0.9405450214479999
1,Deaths,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.351166522995,0.42962552239699997,0.284127388731
1,Deaths,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.826303792911,0.9921584690890001,0.651039796118
1,Deaths,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.173841529939,0.248466366534,0.112734458675
1,Deaths,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.173841529939,0.248466366534,0.112734458675
1,Deaths,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00124822083896,0.00160082172677,0.000889613163878
1,Deaths,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000880020361964,0.00115973727082,0.000607373460746
1,Deaths,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.396762411472,0.567080344901,0.257296376162
1,Deaths,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.203116722899,0.290308501879,0.13171912265
1,Deaths,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12.5083734885,17.6478830983,8.86726250195
1,Deaths,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.08036461617,3.44809138997,1.42517741234
1,Deaths,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14.5887381047,19.7260371692,10.8760125746
1,Deaths,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114986088767,0.0159023838916,0.00851964483156
1,Deaths,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00414988132944,0.00679405101066,0.00295016288176
1,Deaths,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00917886945788,0.0121617516453,0.00705363535414
1,Deaths,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7524375482999999,2.47248877066,1.24231370076
1,Deaths,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.285699605235,0.473531582528,0.19572175998900002
1,Deaths,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.01174725637,1.3680253797,0.754265091585
1,Deaths,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.780212545492,1.36042068694,0.285385570709
1,Deaths,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.780212545492,1.36042068694,0.285385570709
1,Deaths,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000825636279549,0.00119737027621,0.000370648020253
1,Deaths,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00050832821301,0.000792204310133,0.000207131876172
1,Deaths,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.329947058555,0.575313492006,0.12068779226
1,Deaths,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.169303357072,0.29520646734100003,0.0619276573546
1,Deaths,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.0578309821,3.1108680427,1.24777131233
1,Deaths,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.0578309821,3.1108680427,1.24777131233
1,Deaths,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00219175371224,0.00267330923275,0.00177476090255
1,Deaths,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00134424344804,0.00177148340439,0.000958994750041
1,Deaths,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.870243991166,1.3155668492800001,0.527674768408
1,Deaths,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.44654202956699995,0.675047339447,0.270761952312
1,Deaths,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.1122005472,19.2597129252,5.95523941745
1,Deaths,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.1122005472,19.2597129252,5.95523941745
1,Deaths,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000571693064102,0.000786896610982,0.000314527729381
1,Deaths,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000310225798631,0.000431658100645,0.000169539558173
1,Deaths,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.213826774331,0.340007769297,0.105132806383
1,Deaths,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10598630274,0.168529719832,0.0521105810068
1,Deaths,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,15.7091438641,23.8623840758,8.99615754004
1,Deaths,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,15.7091438641,23.8623840758,8.99615754004
1,Deaths,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000741910533349,0.00102274259213,0.000495633801836
1,Deaths,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000402741623299,0.000564552323291,0.000268116235987
1,Deaths,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.277326613515,0.421262560415,0.158816669247
1,Deaths,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.137460907362,0.208804820635,0.0787197563992
1,Deaths,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,703.099107675,918.829658586,532.114461761
1,Deaths,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,298.474113878,376.698251846,227.020535364
1,Deaths,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1001.57322155,1232.29549141,811.839725719
1,Deaths,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0761907708707,0.0983574809135,0.0583629821788
1,Deaths,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.055484996049,0.069258860337,0.0424891319468
1,Deaths,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0685670027948,0.0837249555891,0.0560241845372
1,Deaths,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,8.24344886185,10.772770468100001,6.23874828782
1,Deaths,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.5227286219900003,4.44596583735,2.67940065996
1,Deaths,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.89091532532,7.2479457711699995,4.774967000939999
1,Deaths,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.3753469512,10.5301736012,4.29914312591
1,Deaths,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.3753469512,10.5301736012,4.29914312591
1,Deaths,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000377755037495,0.000617100901982,0.000259677764592
1,Deaths,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000210973035273,0.000348296683341,0.000143389675577
1,Deaths,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.09030485887600001,0.14915672014099998,0.0608960604411
1,Deaths,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.042257075339,0.0697960977821,0.0284955809237
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.42087220838,4.31353356726,2.56105974999
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.42087220838,4.31353356726,2.56105974999
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0016303479296,0.00198816473115,0.00125909924474
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00120203508026,0.00145844863896,0.000910297008902
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.381283967655,0.48077831995899994,0.285450891877
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.188177653381,0.237281773484,0.140880507825
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.22069148035,4.71169071967,2.3273772116
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.22069148035,4.71169071967,2.3273772116
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0015352534042,0.00217010286907,0.00115127574708
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00113184069071,0.00162284479502,0.000837726133318
1,Deaths,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.35897220107,0.5251561656,0.259405076663
1,Deaths,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.177165976429,0.259183871561,0.128025940618
1,Deaths,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,63.3862263486,87.8782583844,40.276986566
1,Deaths,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,18.0808140358,27.5209338219,10.0888929866
1,Deaths,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,81.4670403844,108.656760679,55.7780939881
1,Deaths,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00127910073629,0.0017708667773,0.000829258672857
1,Deaths,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000591697227405,0.000898041417354,0.000333592352769
1,Deaths,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00101677270329,0.00134992512605,0.000693131000239
1,Deaths,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.696519331607,0.96564994193,0.442583529232
1,Deaths,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.19985891188399998,0.304206651137,0.111519048336
1,Deaths,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.448923101585,0.598751713355,0.307364485508
1,Deaths,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,15.1114044787,22.2293398294,11.5895363307
1,Deaths,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,15.1114044787,22.2293398294,11.5895363307
1,Deaths,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00163777042914,0.00237286097912,0.00125934426089
1,Deaths,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00103451124075,0.00149235691257,0.000790234886306
1,Deaths,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.17717287462200002,0.260626736852,0.135880914983
1,Deaths,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0888801760222,0.13074546708600002,0.06816573737659999
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,287.263303267,405.713857611,178.908223503
1,Deaths,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,63.7623000703,92.0836013133,38.3551411725
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,351.025603337,470.491896782,231.122238252
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0036921427842,0.00505032197651,0.00236221706489
1,Deaths,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00107693435921,0.00153936035321,0.000672921162506
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00256243034491,0.00339353417809,0.00170470170433
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.6113520533799999,2.27577922454,1.00355363887
1,Deaths,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.35588402857900003,0.513957039902,0.214076062849
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.982052835149,1.3162797720600001,0.646603117219
1,Deaths,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.00982830397909,0.0128207501843,0.00725800827217
1,Deaths,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.00982830397909,0.0128207501843,0.00725800827217
1,Deaths,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000382248907349,0.000466501927516,0.000311424410425
1,Deaths,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00027050166916,0.000337903269972,0.000213357230118
1,Deaths,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0534424042633,0.0697141353957,0.0394661594771
1,Deaths,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0266985691636,0.0348275436182,0.0197163657389
1,Deaths,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,788.569588424,1286.79822885,245.106280639
1,Deaths,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,114.487789734,170.496702906,77.7707181401
1,Deaths,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,903.057378158,1395.42209239,364.15525873
1,Deaths,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119706361178,0.0178343611832,0.00390826838808
1,Deaths,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00427202362379,0.00579724300422,0.00311552773176
1,Deaths,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00973659959486,0.0140769206637,0.00405373594536
1,Deaths,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.99948466944,4.89459854494,0.932311544792
1,Deaths,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.44158933762900004,0.6576205749049999,0.299968407027
1,Deaths,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7294492399999999,2.67237911513,0.697395371197
1,Deaths,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,44.6124861855,93.1043334424,22.9515164584
1,Deaths,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7.79563392464,20.8067839314,3.63473407595
1,Deaths,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,52.4081201102,99.9399331093,29.4177001455
1,Deaths,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00376837425694,0.00711650624501,0.00219504631915
1,Deaths,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000750754029713,0.00191318335817,0.000386847328197
1,Deaths,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00235484568685,0.00424658904391,0.00142475262109
1,Deaths,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5828607085300002,3.3033619912399996,0.81432479356
1,Deaths,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.26895018086800004,0.717836208796,0.125398703503
1,Deaths,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.916704419799,1.74811418923,0.51456407303
1,Deaths,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,315.786083276,437.577823312,218.832940651
1,Deaths,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,60.1279132225,83.0496414959,41.7386244878
1,Deaths,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,375.913996499,504.590929111,277.388436414
1,Deaths,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00374983900041,0.00490294318573,0.00277972338372
1,Deaths,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00146566115281,0.00193219269839,0.00108175247782
1,Deaths,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00299993066243,0.00384964184054,0.00232930593072
1,Deaths,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.15545178898,1.6010841057899998,0.800703153663
1,Deaths,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.22695492708700002,0.31347379811000003,0.157543908804
1,Deaths,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.698420814883,0.937493179756,0.515367503215
1,Deaths,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,11.3385899856,17.7797882196,4.27550050471
1,Deaths,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,11.3385899856,17.7797882196,4.27550050471
1,Deaths,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000838569838012,0.00127027334166,0.00032045103817
1,Deaths,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000453783800572,0.000682557677617,0.000172838202725
1,Deaths,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.463892106388,0.7274187900619999,0.17492218499099998
1,Deaths,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.230720348682,0.36178739532299997,0.0869989097843
1,Deaths,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.3534046059,13.7969525953,5.63780229501
1,Deaths,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.3534046059,13.7969525953,5.63780229501
1,Deaths,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000616701358725,0.0010026638552,0.000434012780472
1,Deaths,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000333795013187,0.00054411415813,0.000234462165424
1,Deaths,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.341760171509,0.564470309741,0.23065760252
1,Deaths,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.169977080555,0.280743700724,0.114719353373
1,Deaths,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,136.51653281,168.662678188,106.774732168
1,Deaths,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,48.9706794843,61.0142088111,39.4575454831
1,Deaths,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,185.487212294,220.684450684,154.466839319
1,Deaths,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117843222051,0.0138503974566,0.00984689349418
1,Deaths,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108735526251,0.0128374491423,0.0092599375706
1,Deaths,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115296928571,0.0130149100943,0.0101254874788
1,Deaths,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.95224054635,3.6474175468300003,2.30905874288
1,Deaths,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0935319508499999,1.36246806239,0.881100428714
1,Deaths,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.03778827142,2.42447001995,1.69699414636
1,Deaths,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.550020222046,0.699720857974,0.416208649562
1,Deaths,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.550020222046,0.699720857974,0.416208649562
1,Deaths,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000598656192733,0.000739040358058,0.000458481866451
1,Deaths,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000395360322595,0.000492149651958,0.000301686758384
1,Deaths,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.271999067743,0.346029861123,0.205825822633
1,Deaths,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.13855600279299998,0.176267201215,0.104847430148
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.721234697236,1.06825698082,0.422795710368
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.721234697236,1.06825698082,0.422795710368
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00159643727222,0.0021331348511,0.00100028787657
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00120120563468,0.00163824749768,0.000743440005278
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.478459541356,0.708670488331,0.280478244384
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.242570426369,0.35928325731,0.142197451293
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.207557488117,0.284972090794,0.140413569448
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.207557488117,0.284972090794,0.140413569448
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000459625868746,0.000595264659029,0.000324519813495
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000345820716863,0.000454590953707,0.000244039802343
1,Deaths,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.137691462918,0.189047499216,0.093148890778
1,Deaths,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0698071079794,0.095843699467,0.047224820907
1,Deaths,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,23.7532213231,28.2199377316,19.8381436547
1,Deaths,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,23.7532213231,28.2199377316,19.8381436547
1,Deaths,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000203222482373,0.000245147106494,0.000165401764975
1,Deaths,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000113510165379,0.000138259053625,9.11462270694e-05
1,Deaths,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.159281012725,0.189233291762,0.133027835211
1,Deaths,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0797453037327,0.0947411500579,0.0666014419567
1,Deaths,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.737374747851,1.07262262044,0.497365996811
1,Deaths,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.213610777542,0.336432631306,0.128228039748
1,Deaths,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.950985525393,1.29002407732,0.677078180331
1,Deaths,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0156481690046,0.0203070541221,0.0121913454004
1,Deaths,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106184042069,0.0155945017983,0.00720336088216
1,Deaths,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0141305847614,0.0177431835139,0.0113789964401
1,Deaths,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.5836004919799995,8.122187813790001,3.76618948856
1,Deaths,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.84292590743,2.90257083222,1.1062867671299998
1,Deaths,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.8350938015000002,5.20235399028,2.7304919614300003
1,Deaths,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,13.8699490277,18.169898002,9.8910911535
1,Deaths,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,13.8699490277,18.169898002,9.8910911535
1,Deaths,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000821757899397,0.00105254488592,0.000590581020542
1,Deaths,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000458982343619,0.000593448851763,0.000330764521918
1,Deaths,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19646362765099998,0.257371102691,0.140104310806
1,Deaths,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09193279761829999,0.120433719867,0.065560131434
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.08073216778,7.16065928673,1.35870880553
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.08073216778,7.16065928673,1.35870880553
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000256578510321,0.000587676650946,0.000120955997912
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00014690527777,0.000338385404769,6.62969316851e-05
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.248519896855,0.577643952942,0.109605818947
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.123414506215,0.286856883986,0.0544300403905
1,Deaths,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,125.97963741,192.698321153,78.1506012487
1,Deaths,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,38.9278084038,58.2709480406,25.0583822441
1,Deaths,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,164.907445814,230.79162719,113.886862781
1,Deaths,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0797324390734,0.0965960467146,0.054550547126
1,Deaths,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0455722814423,0.0537312229056,0.0391046011629
1,Deaths,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0676684629553,0.0798821806704,0.0510691435099
1,Deaths,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.322509413840001,9.6709037632,3.9221252120499996
1,Deaths,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.00515516164,3.00151221012,1.29074680952
1,Deaths,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.19191150824,5.86667311016,2.89497935265
1,Deaths,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.77160745559,2.53558342766,1.24595924104
1,Deaths,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.77160745559,2.53558342766,1.24595924104
1,Deaths,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00138914728622,0.0019496661722,0.00104590739972
1,Deaths,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000897291120545,0.00126392739283,0.000649717018508
1,Deaths,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.135559481805,0.194017232453,0.0953380437253
1,Deaths,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0686712294953,0.0982845443084,0.0482959996095
1,Deaths,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.82868859573,4.99822198773,2.72694753275
1,Deaths,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.82868859573,4.99822198773,2.72694753275
1,Deaths,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00300472712384,0.00371173565762,0.00218738239471
1,Deaths,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00194064807343,0.00244078015131,0.00141001533166
1,Deaths,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.292962778177,0.38245288506999997,0.208659990272
1,Deaths,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.148408019166,0.19374159219399997,0.10570221933400001
1,Deaths,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,69.3747413569,103.015798031,37.570516934
1,Deaths,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.62574813441,7.60878187223,1.66426912058
1,Deaths,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,73.0004894913,106.556223377,40.590256214
1,Deaths,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00498298365186,0.00729668146003,0.00278331160767
1,Deaths,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000305691469246,0.000640891089465,0.0001402023986
1,Deaths,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00283115061048,0.00414701429412,0.00158658548709
1,Deaths,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.14552783295,3.18593277014,1.16192995035
1,Deaths,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.113058903447,0.237258767887,0.0518956184591
1,Deaths,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.13347528672,1.65449364362,0.630243065779
1,Deaths,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,28.156035953,35.1146285119,21.9646442504
1,Deaths,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,28.156035953,35.1146285119,21.9646442504
1,Deaths,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00689837061335,0.00843187068464,0.00561491454811
1,Deaths,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00470094188279,0.0057834256429,0.00375313651055
1,Deaths,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.3538274131099999,1.6884176011199998,1.05612656395
1,Deaths,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.686182804515,0.855768699544,0.535294144996
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.757689811059,1.10499707435,0.403230789161
1,Deaths,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0989991101499,0.15204181141,0.049712866316
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.856688921209,1.22284874087,0.470031653427
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0118445594992,0.0164178192895,0.00694212109392
1,Deaths,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00373389004832,0.00527909671816,0.00206208104559
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00946565979253,0.0130026222002,0.00552004767608
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.66087488723,5.33893419299,1.9482609482800002
1,Deaths,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.435352287379,0.668609548855,0.218614187845
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.97225800611,2.81522634382,1.08210071199
1,Deaths,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,30.7009351294,59.4240443602,17.1203573324
1,Deaths,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9.33890054942,16.5053575741,4.46299233753
1,Deaths,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,40.0398356788,69.1143690499,25.0761389088
1,Deaths,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00366679361515,0.00687152875082,0.00209180917668
1,Deaths,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00150462273541,0.00264223644414,0.000760237872364
1,Deaths,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0027542273723,0.00475776124689,0.00172724959806
1,Deaths,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.1925733392,10.0506289842,2.89563528496
1,Deaths,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.65895420598,2.93199742561,0.7928020938270001
1,Deaths,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.4690972071300004,5.98814806752,2.17262538618
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,40.8081376722,58.2268905985,23.4086079743
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,40.8081376722,58.2268905985,23.4086079743
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000524816631468,0.000737910471697,0.000297757919044
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000297900826014,0.00041690988248,0.000170258188625
1,Deaths,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.228905939899,0.326613314896,0.131306394159
1,Deaths,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11416759039,0.162899465026,0.0654894959499
1,Deaths,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,51.2012773577,65.5439870678,38.7124956615
1,Deaths,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.29639031501,10.5511072911,6.27117468716
1,Deaths,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,59.4976676727,73.4715845643,47.0664542448
1,Deaths,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0336429740789,0.0397312730385,0.0270944665094
1,Deaths,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0130938284063,0.0152342644387,0.0111705520555
1,Deaths,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0275811236301,0.0322299981222,0.0229102456244
1,Deaths,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.3763596608399995,6.88240735911,4.06498257047
1,Deaths,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.8964737977180001,1.14010923597,0.677637330754
1,Deaths,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.1684975134799997,3.9126665314699998,2.50648385183
1,Deaths,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,16.4374192201,23.4221517899,10.3220271851
1,Deaths,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,16.4374192201,23.4221517899,10.3220271851
1,Deaths,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000520665404525,0.000727513974023,0.000337199410746
1,Deaths,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0002896989887,0.000414512418903,0.000181047426808
1,Deaths,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.28432405819900003,0.40514153465900005,0.17854388324700002
1,Deaths,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.142590424852,0.203181200768,0.0895409566399
1,Deaths,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,14.2039323476,20.7859812615,7.17960133901
1,Deaths,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,14.2039323476,20.7859812615,7.17960133901
1,Deaths,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000450131784831,0.00062152361994,0.000236996721187
1,Deaths,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000250365847941,0.000357150826337,0.000129745518216
1,Deaths,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.245690618058,0.35954272789299996,0.12418819290500001
1,Deaths,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.123215495139,0.18031309291,0.0622812128527
1,Deaths,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0757075101514,0.10804879829,0.0407399561435
1,Deaths,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0757075101514,0.10804879829,0.0407399561435
1,Deaths,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000427106028913,0.000570037285794,0.00024174799899
1,Deaths,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000283476144335,0.00038813415137,0.000157463205069
1,Deaths,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.262727521852,0.374961387015,0.141379734937
1,Deaths,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.129485399022,0.18479991922,0.0696790776346
1,Deaths,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.65824714443,0.890969897044,0.472355338543
1,Deaths,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.65824714443,0.890969897044,0.472355338543
1,Deaths,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00371491568979,0.00470733072001,0.00277122112843
1,Deaths,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00246472290902,0.00319727709131,0.00181179569603
1,Deaths,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.28431288622,3.0919298842000003,1.63921316764
1,Deaths,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.12582482215,1.52385928958,0.80788708239
1,Deaths,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.70517814511,6.6361116462,3.39921794515
1,Deaths,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.70517814511,6.6361116462,3.39921794515
1,Deaths,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000994011317591,0.00140070363762,0.000765750444105
1,Deaths,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00067993590845,0.000979017771853,0.000520971819144
1,Deaths,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.19828727684599998,0.279661357463,0.143251041504
1,Deaths,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.100794325939,0.14215878328200002,0.0728180466148
1,Deaths,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,24.5431830421,31.2059587777,18.2665513304
1,Deaths,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,24.5431830421,31.2059587777,18.2665513304
1,Deaths,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00518664638798,0.00628652667829,0.00409582659651
1,Deaths,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00354760488046,0.00434766673615,0.00274053833592
1,Deaths,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.0343074758200002,1.31509252074,0.769795448538
1,Deaths,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.525764065639,0.6684940470440001,0.39130606149200003
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,172.700355792,263.402942433,89.3883451379
1,Deaths,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12.2111869249,19.6808926995,5.1727699466
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,184.911542717,276.975880494,97.6932690321
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00545865999454,0.0082635277914,0.00281102684549
1,Deaths,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.000580269245574,0.000941424982022,0.000253986454553
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00350924671021,0.00524595354872,0.00189017409135
1,Deaths,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.0908888894700004,4.71423017333,1.59981976625
1,Deaths,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.223407602027,0.360068277622,0.0946374940224
1,Deaths,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.67291121081,2.50582548172,0.8838397137540001
1,Deaths,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,32.5126384172,44.7880631845,22.814315525
1,Deaths,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,32.5126384172,44.7880631845,22.814315525
1,Deaths,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00304248367645,0.00366151518749,0.00249144321197
1,Deaths,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00191126672156,0.00242590876772,0.00149713442354
1,Deaths,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.380726367676,0.524472864758,0.267158000818
1,Deaths,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.192099430062,0.264628213217,0.134797334912
1,Deaths,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0956765004273,0.128623456901,0.0667134134953
1,Deaths,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0956765004273,0.128623456901,0.0667134134953
1,Deaths,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000688649553977,0.000855008029905,0.000543933317689
1,Deaths,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000485131424849,0.00061236152523,0.000372104243438
1,Deaths,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.21836461658,0.293560192146,0.15226151556099998
1,Deaths,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.11178857682599999,0.150283853707,0.07794805951889999
1,Deaths,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,49.7585013457,74.5035780483,39.1183917067
1,Deaths,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,49.7585013457,74.5035780483,39.1183917067
1,Deaths,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000425453678007,0.00063894804642,0.00033270802931
1,Deaths,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000237634546962,0.000358319684707,0.000185591472985
1,Deaths,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.333663564121,0.499595621231,0.262314612509
1,Deaths,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.167051312709,0.250126514624,0.131329893565
1,Deaths,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10.831951776,15.6171039861,7.02831275261
1,Deaths,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.94707392801,5.56922608885,2.68242234152
1,Deaths,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14.7790257041,19.781487706,10.6872181076
1,Deaths,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00484832875789,0.00668850468196,0.00336532892459
1,Deaths,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00425503874819,0.0057157605021,0.00318259048808
1,Deaths,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00467630634428,0.00608142375037,0.00356653489179
1,Deaths,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.0296571257,1.4845212326000001,0.668093106115
1,Deaths,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.381121188485,0.537752802364,0.259009081021
1,Deaths,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.7079284482820001,0.9475508180889999,0.511927232744
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.255096639232,0.367820405055,0.155568956009
1,Deaths,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.129623446891,0.195017354545,0.0816016535539
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.384720086124,0.516654448214,0.266413303576
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00266666519845,0.00357663886322,0.00193559628854
1,Deaths,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00253651904994,0.00339855201051,0.00179016284022
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00262103281307,0.00328900472736,0.00202346373864
1,Deaths,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.620645453578,0.8949003123579999,0.3784964222
1,Deaths,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.294474193736,0.443033877138,0.185379896262
1,Deaths,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.451971449071,0.606968723628,0.312983936145
1,Deaths,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,144.318246176,185.046377955,100.575094644
1,Deaths,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,25.953317793,34.9437604448,18.8595886089
1,Deaths,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,170.271563969,210.555939513,127.094807555
1,Deaths,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0985994182697,0.124956816495,0.0697290530146
1,Deaths,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0444896938333,0.059201637516,0.033248403977
1,Deaths,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0831778630074,0.101883490126,0.0629819985423
1,Deaths,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,11.9603569166,15.3356958327,8.33514860892
1,Deaths,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.25650965616,3.0381831523500002,1.6397457984600001
1,Deaths,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.22471909008,8.93400800623,5.3927048122
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,170.263768172,251.107410783,112.838713985
1,Deaths,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,55.3229228857,94.1209848033,30.1201019578
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,225.586691057,310.651900937,163.61174792
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00587937760227,0.00846580720963,0.00398621977701
1,Deaths,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00253398280332,0.0040558502411,0.00139753661987
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0044442901092,0.00603004943852,0.00318919243495
1,Deaths,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.31102957473,6.35796732295,2.85704374094
1,Deaths,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.34852718704,2.29425164575,0.734194331173
1,Deaths,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.80163632041,3.85808952022,2.03194884091
1,Deaths,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,7.62574457197,11.2904849822,5.49260837072
1,Deaths,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.16355406035,2.98283838821,1.53098429887
1,Deaths,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,9.78929863232,13.5128968379,7.53247353455
1,Deaths,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0288980841194,0.043070968266,0.0211701342386
1,Deaths,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.017046721386,0.0229076055444,0.0120946793497
1,Deaths,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0250365250924,0.0345983696161,0.0196493471368
1,Deaths,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.0570606697,7.487356415700001,3.64245792702
1,Deaths,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.4685684387,2.02467892758,1.03919530493
1,Deaths,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.28369895384,4.53273384301,2.52667493293
1,Deaths,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,51.2763009766,79.5948646655,31.3260495291
1,Deaths,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,14.2452861785,22.0757828027,8.48307129995
1,Deaths,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,65.5215871551,95.331212168,44.8452721589
1,Deaths,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0139690800176,0.0206267544686,0.0101493249286
1,Deaths,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00798211786174,0.0106262199786,0.00557248003628
1,Deaths,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120085196129,0.0165275169167,0.00926261105173
1,Deaths,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.42128258143,3.7584938015300002,1.47922561935
1,Deaths,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.7165045830479999,1.11036025211,0.426678649244
1,Deaths,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5957922635700001,2.32181205402,1.0922161912800001
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,0.349172107988,0.496365223798,0.239396812921
1,Deaths,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.0936311397522,0.13030226172,0.0662165142517
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,0.44280324774,0.590153042644,0.326559323565
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00789820645233,0.0103020560198,0.00594063384306
1,Deaths,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00332413349317,0.00421373914118,0.00249988594005
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00611923915478,0.00767745259037,0.0047802182412
1,Deaths,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.48932504551,2.11714837071,1.02110008544
1,Deaths,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.363263252865,0.5055371917220001,0.256901992479
1,Deaths,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.899640893417,1.1990106514499999,0.663468759782
1,Deaths,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.355505702972,0.461770967104,0.254763817931
1,Deaths,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.355505702972,0.461770967104,0.254763817931
1,Deaths,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00134710276894,0.00173227929935,0.00098135476984
1,Deaths,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00090941581264,0.0011827933798,0.000654087706576
1,Deaths,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.235755851955,0.30622633293199997,0.16894823470200002
1,Deaths,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11924998396499999,0.154895350376,0.0854573666446
1,Deaths,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.02527503489,1.35505706731,0.736160991286
1,Deaths,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.02527503489,1.35505706731,0.736160991286
1,Deaths,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00388285734678,0.00500697910915,0.00287578826211
1,Deaths,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00262142069063,0.00344004772475,0.00194252895972
1,Deaths,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.679917614029,0.8986146514080001,0.488189810249
1,Deaths,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.343915809081,0.454537106429,0.246936084774
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.541981587662,1.02037939536,0.246130843299
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.541981587662,1.02037939536,0.246130843299
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000572518122602,0.000982520174769,0.000265732726844
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000314766541504,0.000539424947141,0.000145084933034
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.257676666253,0.48512341912699997,0.117019058594
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.13232715403,0.24913005255700002,0.0600939123289
1,Deaths,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,7.40792646177,10.4227078146,2.84783561864
1,Deaths,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.933397190356,1.21867225314,0.593735843873
1,Deaths,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,8.34132365213,11.4664784182,3.67156147038
1,Deaths,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00863579025094,0.0117833895543,0.00330739209622
1,Deaths,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00229515658774,0.00291622894392,0.00147092493332
1,Deaths,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00659677385562,0.00881106989701,0.00284341243131
1,Deaths,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.37335653017,1.9322672698199999,0.527960646464
1,Deaths,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.179928863377,0.23492069142900002,0.114453114534
1,Deaths,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.788284165796,1.08362218654,0.346975359254
1,Deaths,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,118.510422165,150.292636007,83.6727632887
1,Deaths,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,27.5752730135,35.5630210405,21.4198138583
1,Deaths,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,146.085695179,179.480429995,110.95260592
1,Deaths,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0929750428617,0.110130569296,0.068958595009
1,Deaths,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0395337163245,0.0473541951329,0.0336379097781
1,Deaths,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0740486614231,0.0857276513103,0.0573222358584
1,Deaths,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,9.068155231839999,11.5000598987,6.40245467291
1,Deaths,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.16624311869,2.79374023137,1.68268594662
1,Deaths,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.66258866656,6.95703879506,4.3007562652799995
1,Deaths,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.576093899349,0.738319754233,0.422666244752
1,Deaths,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.576093899349,0.738319754233,0.422666244752
1,Deaths,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00426360541425,0.00512560987221,0.00321310785112
1,Deaths,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00249963211812,0.00312504755507,0.00189607521642
1,Deaths,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8967561388199999,1.14927926293,0.6579284211850001
1,Deaths,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.437193435327,0.560305446886,0.320758313443
1,Deaths,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,19.2169173282,33.0648409494,10.0733537582
1,Deaths,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7.98932326702,15.8148589916,3.32563269586
1,Deaths,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,27.2062405952,42.3336850842,15.3671990006
1,Deaths,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00398125035101,0.00616357069996,0.00237126014618
1,Deaths,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00153866859596,0.00270228777576,0.00071171639711
1,Deaths,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00272453113582,0.0039968587865,0.00165821250368
1,Deaths,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.7275031084099999,2.97236099544,0.9055432581709999
1,Deaths,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.725035261072,1.43520671708,0.301802904863
1,Deaths,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.22864323085,1.91180385374,0.6939880195220001
1,Deaths,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.85040996563,2.84261797136,1.13702739647
1,Deaths,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.85040996563,2.84261797136,1.13702739647
1,Deaths,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000503229394255,0.00067362441249,0.000354346664278
1,Deaths,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000338232802043,0.000461002835298,0.000226634802704
1,Deaths,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0873769233146,0.134229288163,0.0536907806772
1,Deaths,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0450671303277,0.06923256843980001,0.0276925453356
1,Deaths,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.83764044115,9.97106697579,4.45187608717
1,Deaths,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.83764044115,9.97106697579,4.45187608717
1,Deaths,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00186430903103,0.00243254023016,0.00139154574081
1,Deaths,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00125175461048,0.00167322904112,0.00088209485198
1,Deaths,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.322875468451,0.470836825726,0.21021894753
1,Deaths,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.16653219482099998,0.242847467994,0.108426393907
1,Deaths,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,96.2763300653,133.854822967,66.4779891879
1,Deaths,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,30.0520602844,37.4251885922,23.8960128685
1,Deaths,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,126.32839035,165.376367175,94.3675559726
1,Deaths,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00345859974782,0.00465760264459,0.00245135068019
1,Deaths,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00299312232836,0.0035462232412,0.00245505017032
1,Deaths,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00333543363076,0.00424904319479,0.00257376539717
1,Deaths,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.737472015825,1.02532144769,0.509218170875
1,Deaths,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.226701307443,0.282321381791,0.180262428223
1,Deaths,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.480132549307,0.628541031411,0.358659958348
1,Deaths,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,78.0385352809,110.843830483,52.0831127752
1,Deaths,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,78.0385352809,110.843830483,52.0831127752
1,Deaths,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00118506301871,0.00147219319367,0.000936816731591
1,Deaths,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000840459014469,0.00107401824878,0.000631534698773
1,Deaths,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.296835426621,0.421617033065,0.198108702896
1,Deaths,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.149451949341,0.212277517492,0.0997446031498
1,Deaths,80,France,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.7709203609,29.863273103,16.1340766967
1,Deaths,80,France,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.7709203609,29.863273103,16.1340766967
1,Deaths,80,France,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00121351786798,0.00162417221244,0.000911004423018
1,Deaths,80,France,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000818932863185,0.00109065173826,0.000619437319357
1,Deaths,80,France,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15538170571600002,0.21313781117599997,0.115150867108
1,Deaths,80,France,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0775212633149,0.10633627881999999,0.057449753488500004
1,Deaths,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36357884795,11.3982056886,5.42372622837
1,Deaths,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.36357884795,11.3982056886,5.42372622837
1,Deaths,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000828382399983,0.00110168264724,0.000556029201406
1,Deaths,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00049101940529,0.000658026713665,0.000327799756144
1,Deaths,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.311419854753,0.424414909518,0.201953740733
1,Deaths,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.155575185008,0.212023822696,0.10088949082099999
1,Deaths,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.94687820431,9.15855461001,5.02474235229
1,Deaths,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.94687820431,9.15855461001,5.02474235229
1,Deaths,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000687207379594,0.000871973687919,0.000522150853501
1,Deaths,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000407409519059,0.000518267723423,0.00030574237878
1,Deaths,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.25866866812699996,0.34102096701,0.187097480871
1,Deaths,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.129222415608,0.170362933591,0.0934677887641
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.365707654174,0.637160211029,0.205487185459
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.365707654174,0.637160211029,0.205487185459
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000386447919828,0.00057622531252,0.000245748646094
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00021244042563,0.000320511487938,0.000132668752028
1,Deaths,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.173869982479,0.302927853611,0.0976956673661
1,Deaths,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.08928910905,0.15556542750900001,0.0501705870834
1,Deaths,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,20.1543124491,26.0780177517,14.9591744503
1,Deaths,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,20.1543124491,26.0780177517,14.9591744503
1,Deaths,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00110090910591,0.00137641602553,0.000844451538892
1,Deaths,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000833734041583,0.00104255363458,0.000643272894131
1,Deaths,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.212942456087,0.275529972256,0.158052692521
1,Deaths,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10797911111500001,0.139716062435,0.0801455452399
1,Deaths,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,73.4056272156,91.0836910603,58.7988262305
1,Deaths,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,73.4056272156,91.0836910603,58.7988262305
1,Deaths,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0040093468084,0.00481168343135,0.00334469180254
1,Deaths,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00303639386501,0.00367581121708,0.00252852702151
1,Deaths,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.775574686033,0.962354083418,0.621245031514
1,Deaths,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.39327932409599997,0.48799164062999995,0.31502166134599996
1,Deaths,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,8.9764629643,12.6210818063,5.76959171536
1,Deaths,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.16105097662,4.46793444739,1.77010533358
1,Deaths,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,12.1375139409,15.7952393725,8.91552395286
1,Deaths,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00228337128518,0.00307288878474,0.00146267022228
1,Deaths,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00178179930901,0.0023732048007,0.000966405829503
1,Deaths,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00212643993086,0.00265970706538,0.00153374974397
1,Deaths,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.490700782171,0.689934859514,0.315396295712
1,Deaths,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.179386847179,0.253551328292,0.100451912138
1,Deaths,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.337955152316,0.439800321054,0.248242537157
1,Deaths,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.03537893674,7.03972132671,2.88964447439
1,Deaths,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.03537893674,7.03972132671,2.88964447439
1,Deaths,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00138351982795,0.00242935597352,0.00103724547002
1,Deaths,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000897844352523,0.00158419260111,0.000659337678395
1,Deaths,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.156795220175,0.273529369285,0.11227754535400002
1,Deaths,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0793287320896,0.13838902761500002,0.056805528287899996
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.199932874311,0.285708359853,0.1213896198
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.199932874311,0.285708359853,0.1213896198
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00312655540708,0.00412526672157,0.00218209305873
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00220785694949,0.00298256646437,0.00150948149108
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.966001163026,1.38043635323,0.5865094187759999
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.460282842794,0.6577540413799999,0.279461591696
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0110929236549,0.0158048219045,0.00579496639947
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.0110929236549,0.0158048219045,0.00579496639947
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000173416480239,0.000232296121958,0.000102243787445
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000122493005073,0.000165602580871,7.14522400716e-05
1,Deaths,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0535968743953,0.07636301130449999,0.0279991187086
1,Deaths,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0255379834474,0.0363856538406,0.013341095692400001
1,Deaths,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1.37646532387,2.23696937596,0.269537479715
1,Deaths,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.343427876259,0.520863752191,0.185044101869
1,Deaths,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1.71989320013,2.60117949364,0.608765622891
1,Deaths,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0077802616801,0.0121769460133,0.00154280069952
1,Deaths,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00383025432089,0.00548833457477,0.00211856954886
1,Deaths,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00644451502406,0.00950035981286,0.00228072950059
1,Deaths,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.7767430567,7.762947420020001,0.935375023564
1,Deaths,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.15819425482,1.7565883466,0.6240524735730001
1,Deaths,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.94159795835,4.44889501698,1.04119471679
1,Deaths,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.049003523257,0.0614103818107,0.038409488355
1,Deaths,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.049003523257,0.0614103818107,0.038409488355
1,Deaths,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000362593277234,0.000436694650429,0.000302250208952
1,Deaths,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000212626323819,0.000262109823137,0.000170597252069
1,Deaths,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0762795967015,0.0955922930936,0.059788767959799996
1,Deaths,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.037188414423600005,0.046603888392,0.0291486790297
1,Deaths,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,11.7459550572,14.965995237,7.92327027249
1,Deaths,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,11.7459550572,14.965995237,7.92327027249
1,Deaths,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00101391333053,0.0012297248097,0.00070938255202
1,Deaths,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000729515248685,0.000890536249168,0.000503764470512
1,Deaths,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.254012346063,0.323647378422,0.17134481279799998
1,Deaths,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.129042693327,0.164418501885,0.0870461474563
1,Deaths,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,31.3142400028,38.954630495,24.8067119608
1,Deaths,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,31.3142400028,38.954630495,24.8067119608
1,Deaths,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00270402501353,0.00321325805917,0.00226775634315
1,Deaths,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00194556548108,0.00233325610018,0.00160754460389
1,Deaths,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.677186616975,0.842414008387,0.536457961281
1,Deaths,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.34402258903599997,0.427960979944,0.272529982316
1,Deaths,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.76516287968,2.33693382259,1.21354744671
1,Deaths,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.76516287968,2.33693382259,1.21354744671
1,Deaths,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00115913088507,0.00146492342523,0.000842095123637
1,Deaths,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000817806292783,0.00105124643751,0.000587043233151
1,Deaths,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.185349877793,0.245388345413,0.127427827502
1,Deaths,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0940022426747,0.12445141626,0.0646264335694
1,Deaths,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,26.3132789886,32.2670348892,20.5061469803
1,Deaths,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,26.3132789886,32.2670348892,20.5061469803
1,Deaths,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00130910890986,0.00155471213625,0.00100947852265
1,Deaths,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000867028160103,0.00103358463819,0.000686936646689
1,Deaths,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.23913236631100002,0.29323948605,0.18635774938799998
1,Deaths,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.12007663976499999,0.147245697747,0.0935766775779
1,Deaths,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,161.826600655,196.516617928,129.931053781
1,Deaths,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,161.826600655,196.516617928,129.931053781
1,Deaths,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00805159808815,0.00961035447533,0.00671880992064
1,Deaths,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00533289344855,0.00639044700057,0.00439799566925
1,Deaths,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.47066346097,1.78592276109,1.18080001969
1,Deaths,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.738471037372,0.896773646076,0.592920568582
1,Deaths,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,54.0057892937,72.1217438756,27.1395919872
1,Deaths,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8.54632928533,10.472539629,6.51568408786
1,Deaths,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62.552118579,80.8951398242,35.2203169684
1,Deaths,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0132329082572,0.0171577611752,0.00677233981186
1,Deaths,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00448328059165,0.00532968337278,0.00352747899626
1,Deaths,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0104439470692,0.0132485617247,0.0059456862133
1,Deaths,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.59676177906,3.4678316970200003,1.3049537113199998
1,Deaths,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.42234358187400006,0.517533288333,0.32199290059499996
1,Deaths,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5244400251,1.97147261812,0.8583444030830001
1,Deaths,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9.67606209583,15.030350841,6.17321260458
1,Deaths,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.723502302909,1.08465426538,0.46556449473
1,Deaths,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,10.3995643987,15.7830183222,6.88410858156
1,Deaths,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0158115032273,0.0217180275056,0.011528999467
1,Deaths,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00335267732071,0.00444436529372,0.00266982967557
1,Deaths,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0125335655343,0.0167200526123,0.00923311269659
1,Deaths,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.6052607114900002,2.49353832643,1.02413725332
1,Deaths,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.23263816690699998,0.34876458445499997,0.149699690237
1,Deaths,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.13809310431,1.72724006785,0.753373526581
1,Deaths,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,187.09012862,283.624528126,86.6136308651
1,Deaths,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19.6528032083,34.2161186831,7.20335339738
1,Deaths,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,206.742931828,308.272896879,109.45820754
1,Deaths,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00592094992036,0.00833959350685,0.00291143211576
1,Deaths,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00078030856956,0.00136260514083,0.000295068569833
1,Deaths,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00364054774124,0.00518584593227,0.0019293983897
1,Deaths,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.2361664508200003,4.90595730155,1.4981876834299999
1,Deaths,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.341996708047,0.595426506221,0.125352252434
1,Deaths,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.79344227276,2.67418885822,0.9495220695919999
1,Deaths,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,12.7890000198,15.7994573166,10.2388264321
1,Deaths,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,12.7890000198,15.7994573166,10.2388264321
1,Deaths,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00210560267187,0.00252026713662,0.00173230137738
1,Deaths,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00136870186226,0.00166669287964,0.00111519663012
1,Deaths,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.21793070925000002,0.26923034900799997,0.1744745252
1,Deaths,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.109656342945,0.135468817513,0.08779046530989999
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.57630492326,12.4659603192,4.96127287011
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.57630492326,12.4659603192,4.96127287011
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00071678920333,0.000955403346545,0.000422639464639
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00040965513705,0.000565554502363,0.000239730103365
1,Deaths,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.691842814904,1.005617822,0.40022142620600004
1,Deaths,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.343567820767,0.49938789012,0.19874919600799998
1,Deaths,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4.64089437738,5.59213410002,3.57848740209
1,Deaths,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2.34443236167,2.79915684454,1.94275933854
1,Deaths,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,6.98532673906,8.14233100437,5.85539000759
1,Deaths,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0675867254982,0.0789387156581,0.0546521964884
1,Deaths,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0655926379633,0.0734209255424,0.0581129846925
1,Deaths,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.066902905804,0.0747028822084,0.0582427958144
1,Deaths,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,5.831176227389999,7.026386892870001,4.496286485370001
1,Deaths,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,3.0228850562300003,3.6092017555,2.5049723200900003
1,Deaths,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.44518295101,5.181454256069999,3.72613634345
1,Deaths,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11.2069088148,14.1854362795,8.50914913336
1,Deaths,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3.43816350603,4.2389269462,2.78776334481
1,Deaths,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14.6450723208,17.6365479781,11.9825673943
1,Deaths,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00256082298743,0.00309240962849,0.0019949794187
1,Deaths,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00143703376015,0.00171279673879,0.00120625212536
1,Deaths,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00216316339388,0.0025243425861,0.0018137053602
1,Deaths,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.395648879497,0.500802858477,0.30040713061200003
1,Deaths,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.127059998294,0.15665283213200001,0.10302395602
1,Deaths,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.26442422646299996,0.318436840353,0.21635134636900002
1,Deaths,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,36.5199975934,48.3823438036,26.3325962662
1,Deaths,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,36.5199975934,48.3823438036,26.3325962662
1,Deaths,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00183489632556,0.00234014727089,0.00135792448549
1,Deaths,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0012123952431,0.00158374770972,0.000875570066432
1,Deaths,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.20248435474999998,0.268254882583,0.146000523418
1,Deaths,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.10308291265200001,0.136566080199,0.0743275164207
1,Deaths,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,78.8515713549,100.850570248,57.7810246076
1,Deaths,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,78.8515713549,100.850570248,57.7810246076
1,Deaths,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00396110526223,0.00484621533949,0.00300381575877
1,Deaths,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00261753705938,0.00323497318138,0.0019814430335
1,Deaths,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.437190870727,0.559163855108,0.320365669645
1,Deaths,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.22256982963,0.284665148107,0.163095200029
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,101.919471984,141.111509148,67.8430522577
1,Deaths,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20.0343418814,36.0265800312,12.3672542185
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,121.953813865,162.903596456,88.1727387926
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0204868458432,0.0270385297995,0.0142114284328
1,Deaths,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00744498586378,0.0126967848436,0.00497920152171
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0159160500695,0.020845473128,0.0119325020825
1,Deaths,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.46682375182,6.18449280052,2.97335682105
1,Deaths,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.891144741262,1.6024932353899999,0.550106094121
1,Deaths,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.69222216362,3.59621941302,1.94647952435
1,Deaths,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,43.9556844228,67.5388093795,19.0077327915
1,Deaths,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,43.9556844228,67.5388093795,19.0077327915
1,Deaths,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000995153897869,0.00136528472585,0.000450992881721
1,Deaths,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000698633480996,0.000980535548388,0.000310563053142
1,Deaths,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.18645310032100001,0.286489007421,0.0806278131163
1,Deaths,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0932566913753,0.143290816304,0.0403269405074
1,Deaths,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,44.4419523742,59.2635068431,32.5080778638
1,Deaths,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,44.4419523742,59.2635068431,32.5080778638
1,Deaths,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00100698554204,0.00120337850084,0.000836715486857
1,Deaths,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000706875811518,0.00086425541574,0.000577658271437
1,Deaths,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.188515772494,0.251386475535,0.137894153686
1,Deaths,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09428836090489999,0.12573387583600001,0.0689693682252
1,Deaths,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,70.5507367143,116.268809857,24.1583041585
1,Deaths,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,70.5507367143,116.268809857,24.1583041585
1,Deaths,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0011981584558,0.00187542742502,0.000425640370134
1,Deaths,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000707253487138,0.00113857275167,0.000241727547592
1,Deaths,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.567739113669,0.935643681836,0.19440780960499998
1,Deaths,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.280696426568,0.462592468458,0.0961173471041
1,Deaths,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1776328227,20.3191163683,11.052668757
1,Deaths,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1776328227,20.3191163683,11.052668757
1,Deaths,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000258042773659,0.000326217822012,0.000198151316602
1,Deaths,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000152154421067,0.000194076555128,0.000114614643919
1,Deaths,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.122138140687,0.163512922114,0.0889435412866
1,Deaths,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.060386432452900006,0.0808425768634,0.0439746594948
1,Deaths,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,17.3083557788,23.8830067346,13.2046590592
1,Deaths,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,17.3083557788,23.8830067346,13.2046590592
1,Deaths,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0016639802012,0.00233227656896,0.00129510062028
1,Deaths,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00109661012686,0.00155502026526,0.000849613003526
1,Deaths,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.159556757882,0.220165056216,0.121726905511
1,Deaths,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0806925846081,0.11134399860100001,0.061560906303000006
1,Deaths,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,21.0027209879,26.7238392339,15.9665629012
1,Deaths,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,21.0027209879,26.7238392339,15.9665629012
1,Deaths,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00201935143052,0.00255645372536,0.0015613463861
1,Deaths,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00133087139508,0.00169430612677,0.00102399254481
1,Deaths,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.19361319528999998,0.246353218112,0.147187465037
1,Deaths,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.09791593505370001,0.124588128763,0.0744370663667
1,Deaths,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,188.056899495,243.77338019,139.242763874
1,Deaths,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,25.9990179668,34.5834262762,19.5467029263
1,Deaths,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,214.055917462,273.009866624,165.913884168
1,Deaths,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0559573104116,0.0707626266752,0.0418979838451
1,Deaths,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0188113414657,0.0239741266129,0.0144557522793
1,Deaths,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0451249186454,0.0561065379301,0.035131188365
1,Deaths,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,7.62807738259,9.88808287756,5.648048971610001
1,Deaths,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.08259821271,1.4400526790600001,0.813924036649
1,Deaths,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,4.3982309417600005,5.60956434669,3.4090511847
1,Deaths,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.28020263964,9.90359413742,4.8852183995
1,Deaths,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.28020263964,9.90359413742,4.8852183995
1,Deaths,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000522734510997,0.000713444193406,0.000355651859427
1,Deaths,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000282203620678,0.00038624156636,0.000189858465678
1,Deaths,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.22515222525399997,0.306284916564,0.151083403573
1,Deaths,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.11303937592600001,0.15377265663200002,0.0758525643413
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,453.964201043,608.333068992,329.848488934
1,Deaths,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,96.7906687952,128.237205502,70.249206727
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,550.754869838,703.822091156,419.030270904
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0258332905075,0.0303817303217,0.0214090344122
1,Deaths,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0150261295813,0.0174644225133,0.0126451327049
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.022925254389,0.0265205970755,0.0196155927073
1,Deaths,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,10.1743424102,13.6340903736,7.39263462227
1,Deaths,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.1193596818900002,2.80792318559,1.5381992734899999
1,Deaths,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,6.0999583741,7.79527462024,4.64102516379
1,Deaths,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.20335632051,13.1450920784,5.65562441463
1,Deaths,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.20335632051,13.1450920784,5.65562441463
1,Deaths,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000588924872445,0.000926640993174,0.000413933832794
1,Deaths,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000317872206398,0.000498904056903,0.000219175501438
1,Deaths,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.253702269227,0.40653356494599996,0.174909475077
1,Deaths,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.12737314122500001,0.204103248026,0.08781462356820001
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,13.1525637068,19.1477722239,7.3319716064
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,13.1525637068,19.1477722239,7.3319716064
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00208246555067,0.00281474935938,0.00120735567566
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00138847885339,0.00192427903186,0.00079304442168
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.481529660838,0.7010207644900001,0.268431454095
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.239252014471,0.348307993735,0.133372399175
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.68959876117,2.32432013729,1.17607603831
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.68959876117,2.32432013729,1.17607603831
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000267536817651,0.000337253284546,0.000200288332361
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000178345730266,0.000232470981862,0.000129559614564
1,Deaths,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.0618580481002,0.0850958879453,0.043057422755800004
1,Deaths,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.030734685363899998,0.0422805992443,0.021393438390399998
1,Deaths,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.01894962372,2.7158038672,1.48129827629
1,Deaths,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.01894962372,2.7158038672,1.48129827629
1,Deaths,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00164453234826,0.00207724880938,0.001286964279
1,Deaths,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00107799176367,0.00137599084576,0.000829421412842
1,Deaths,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.186187216417,0.25045100503199996,0.13660509381
1,Deaths,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0919157809414,0.123641140128,0.06743837799249999
1,Deaths,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.30991131773,4.30555637826,2.57539200443
1,Deaths,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.30991131773,4.30555637826,2.57539200443
1,Deaths,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00269913331774,0.00329205188414,0.00222940166614
1,Deaths,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00176877613616,0.0021776865991,0.00143350786273
1,Deaths,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.305239500577,0.39705773129599997,0.237502245154
1,Deaths,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.150688793837,0.196017063649,0.11724867452700001
1,Deaths,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5.32969606878,7.47204066238,3.5739558944
1,Deaths,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,0.842934496818,1.17192176981,0.576184263149
1,Deaths,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,6.17263056559,8.288656061,4.3796451073
1,Deaths,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00579807895514,0.0078352277874,0.00399937838183
1,Deaths,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00178294616712,0.0023999557818,0.00130346690933
1,Deaths,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00443465568294,0.00586145851395,0.00326651991148
1,Deaths,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2.63567102436,3.6951152209399996,1.7674126013300002
1,Deaths,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,0.432824587219,0.601750857494,0.295855391849
1,Deaths,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1.5549519519500001,2.08800150668,1.10327965299
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,523.046773616,699.158640318,394.258126495
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,523.046773616,699.158640318,394.258126495
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000103180199373,0.000137535108701,7.77554523555e-05
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.767350459e-05,0.000103614086094,5.85549532589e-05
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.97595064151,13.3348917118,7.5195944384299995
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.5523065774099996,10.0951973404,5.69271887739
5,Prevalence,78,Denmark,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,39514.9034911,44132.8209815,35570.5522718
5,Prevalence,78,Denmark,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,63533.8370353,71259.9063082,56174.4140773
5,Prevalence,78,Denmark,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,103048.740526,114946.33417,92826.9602805
5,Prevalence,78,Denmark,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0319999806552,0.0357309390825,0.0287039270758
5,Prevalence,78,Denmark,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0507502113172,0.0568740995616,0.0448345330492
5,Prevalence,78,Denmark,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0414393401865,0.0462389013046,0.0372575339977
5,Prevalence,78,Denmark,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3023.59296577,3376.94579235,2721.7799396
5,Prevalence,78,Denmark,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4991.05619786,5597.99649502,4412.91870009
5,Prevalence,78,Denmark,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3994.3858260399998,4455.56156843,3598.1681340699997
5,Prevalence,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,718.329448659,795.404653224,655.599372202
5,Prevalence,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,718.329448659,795.404653224,655.599372202
5,Prevalence,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.87057532259e-05,5.38330901662e-05,4.4384487613e-05
5,Prevalence,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.42760524618e-05,2.68591964474e-05,2.21392957079e-05
5,Prevalence,196,South Africa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.81687264629,5.33371271914,4.39622611711
5,Prevalence,196,South Africa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.41160553696,2.67036562321,2.20100551214
5,Prevalence,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.92695456829,9.26180533628,1.97188780975
5,Prevalence,176,Comoros,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.92695456829,9.26180533628,1.97188780975
5,Prevalence,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.96191155813e-05,4.62473715275e-05,9.85938904286e-06
5,Prevalence,176,Comoros,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.49211328652e-05,2.32864094687e-05,4.96978532788e-06
5,Prevalence,176,Comoros,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.9291622943199997,4.57728006109,0.9745273655140001
5,Prevalence,176,Comoros,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,176,Comoros,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.48110176831,2.3144561179400003,0.492760065609
5,Prevalence,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.80813769667,2.7071431485,1.33493321457
5,Prevalence,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.80813769667,2.7071431485,1.33493321457
5,Prevalence,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.03607542903e-06,1.35285143243e-05,6.6798305388e-06
5,Prevalence,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.55205564277e-06,6.81039838272e-06,3.36154160059e-06
5,Prevalence,176,Comoros,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.893600364742,1.3378981641499998,0.659737811806
5,Prevalence,176,Comoros,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.45184013290999997,0.6764948943210001,0.33358986000199997
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,275.389446974,382.334352667,179.406289664
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,275.389446974,382.334352667,179.406289664
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.07342248079e-05,1.48612751566e-05,6.98063170052e-06
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.35952166585e-06,7.4254103684e-06,3.48803293818e-06
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.0474997215800002,1.4542864019300001,0.682408278668
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.527399566508,0.7322102356260001,0.343581790941
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1099.12615289,1341.58704214,876.118169675
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1099.12615289,1341.58704214,876.118169675
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.2841263214e-05,5.22016392685e-05,3.41957997229e-05
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.13905978428e-05,2.60574920456e-05,1.7069702888e-05
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.18074966845,5.10299892958,3.33249348838
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.10494143091,2.56927936867,1.6778578408599998
5,Prevalence,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,104581.713102,117830.119156,92657.4424853
5,Prevalence,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,59178.5422057,67556.277822,52505.4975311
5,Prevalence,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,163760.255308,183389.2952,147201.185532
5,Prevalence,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0231317067639,0.0260200317214,0.0204769773413
5,Prevalence,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0130067429172,0.0148421829825,0.0115430458307
5,Prevalence,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0180531543592,0.0202374824576,0.0162474007347
5,Prevalence,98,Chile,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2204.17827335,2483.40346401,1952.8607395400002
5,Prevalence,98,Chile,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1284.3688820300001,1466.1932819899998,1139.54187871
5,Prevalence,98,Chile,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1751.0158440399998,1960.9004695200001,1573.9570486300001
5,Prevalence,98,Chile,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,183216.664751,205877.416381,164628.412336
5,Prevalence,98,Chile,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,297976.651993,333248.074436,267471.404445
5,Prevalence,98,Chile,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,481193.316744,537050.395962,435701.828749
5,Prevalence,98,Chile,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0405246253516,0.0456021827347,0.0363313642862
5,Prevalence,98,Chile,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0654918352398,0.0732873416937,0.0587734499764
5,Prevalence,98,Chile,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0530475121766,0.0590526622135,0.0480542995301
5,Prevalence,98,Chile,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3861.49910709,4339.10016102,3469.7305951900003
5,Prevalence,98,Chile,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6467.07277884,7232.57858083,5805.00863823
5,Prevalence,98,Chile,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5145.18690804,5742.44190455,4658.76658524
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,81.3433889626,104.19321358,54.1278703288
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,81.3433889626,104.19321358,54.1278703288
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.69285078981e-05,7.30056405161e-05,3.79476967902e-05
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.78363781077e-05,3.56485269208e-05,1.85298985108e-05
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.41034067927,6.93013641458,3.60017233677
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.69100899144,3.4469288551400004,1.79066286271
5,Prevalence,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,375.111045697,521.178868843,282.987545604
5,Prevalence,98,Chile,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,375.111045697,521.178868843,282.987545604
5,Prevalence,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.29710099272e-05,0.000114931445057,6.2707525551e-05
5,Prevalence,98,Chile,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.13536627898e-05,5.73846394541e-05,3.12341103623e-05
5,Prevalence,98,Chile,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.905890929649999,10.9844360468,5.9642836319
5,Prevalence,98,Chile,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,98,Chile,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.01089619125,5.57273469811,3.02586042681
5,Prevalence,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,34.3363627295,50.6377909868,25.7134459681
5,Prevalence,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,34.3363627295,50.6377909868,25.7134459681
5,Prevalence,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.74286427407e-06,1.43314033371e-05,7.30455847089e-06
5,Prevalence,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.72705679466e-06,6.95924912426e-06,3.54030303566e-06
5,Prevalence,216,Senegal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.95802391334,1.41285246391,0.717434642857
5,Prevalence,216,Senegal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.46767507544,0.689707087103,0.350227479762
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,475755.829592,549730.847763,408426.744802
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,228544.323627,264423.745159,195558.493554
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,704300.153219,807612.473595,610952.944713
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0185438806083,0.0214760353437,0.0159290362449
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00888315606554,0.0102629705775,0.00759330830131
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0137067194429,0.0156889729757,0.0118944105758
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1809.6339729600002,2091.01298653,1553.53411748
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,881.515284067,1019.90532571,754.2860757230001
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1348.80838602,1546.6622746799999,1170.03872784
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,959.756222437,1072.8358873,860.19832505
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1234.13507246,1395.06825499,1086.69356349
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2193.89129489,2440.6841729,1971.01264345
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.033477842874,0.0374869716022,0.0299707459829
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0436572938099,0.0493779530441,0.0384309550256
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0385317374945,0.0428936979445,0.0346284655176
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3262.0370764799995,3646.3743183199995,2923.6578662800002
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4330.29849984,4894.97633329,3812.95987189
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3787.66560833,4213.74364538,3402.8745273600002
5,Prevalence,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,191.38848865,295.554605129,130.855784664
5,Prevalence,79,Finland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,191.38848865,295.554605129,130.855784664
5,Prevalence,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000170099490388,0.000262940759863,0.000116071274422
5,Prevalence,79,Finland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.49544979475e-05,0.000131401523969,5.79586140494e-05
5,Prevalence,79,Finland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.861297477199999,24.494051579300002,10.8446570731
5,Prevalence,79,Finland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,79,Finland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.12072218838,12.540549625899999,5.55228520529
5,Prevalence,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,52.4995611823,76.3352344223,31.0355759957
5,Prevalence,59,Latvia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,52.4995611823,76.3352344223,31.0355759957
5,Prevalence,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000126882194136,0.000185091470672,7.54051951487e-05
5,Prevalence,59,Latvia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.28304436137e-05,9.15858305249e-05,3.72740947766e-05
5,Prevalence,59,Latvia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.0392248982,17.5052330757,7.11709337836
5,Prevalence,59,Latvia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,59,Latvia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.069860841700001,8.82567853574,3.5882514671300005
5,Prevalence,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,156.127683935,211.779712897,113.240579218
5,Prevalence,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,156.127683935,211.779712897,113.240579218
5,Prevalence,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000377326079932,0.000511943046207,0.000274417968725
5,Prevalence,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000186848380986,0.000253714533322,0.000135725202561
5,Prevalence,59,Latvia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,35.803276396899996,48.5654267393,25.968384689500002
5,Prevalence,59,Latvia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,18.0510711648,24.4854120193,13.0925771951
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,50.1978267026,78.2630043146,17.4830488555
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,50.1978267026,78.2630043146,17.4830488555
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.66222652689e-05,2.59389987133e-05,5.79765704239e-06
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.30212353836e-06,1.29510717197e-05,2.89452278444e-06
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.6455174656199998,2.56551227355,0.573105732532
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8246634784210001,1.28572580945,0.287216256751
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,102510.552246,120888.145594,88440.3216028
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20034.6819855,24077.2464375,16765.1225793
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,122545.234231,143053.526622,106111.153517
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.020221669296,0.0237860874974,0.0174837350756
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120352279584,0.014478679607,0.0100697555773
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0181979395045,0.0212285064837,0.0157634219889
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1955.16015206,2305.67175714,1686.8018837599998
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1190.71270862,1430.97271733,996.3943790640001
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1769.4386528999999,2065.55922821,1532.1458865
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,185283.436281,212108.079509,162787.842977
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,75614.7249249,85678.1904381,66622.9888461
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,260898.161205,296044.287623,230382.027318
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0365499913958,0.0416559510902,0.03210172711
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0454234143736,0.0514379760863,0.0399887782483
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0387434707879,0.043826995804,0.0342747616874
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3533.86830444,4045.48854631,3104.81503471
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4493.97769287,5092.07534613,3959.57567794
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3767.1256153299996,4274.60283363,3326.50116203
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,577.213993044,720.678206792,438.802298534
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,577.213993044,720.678206792,438.802298534
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000403959948266,0.000505297522127,0.000307586036357
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000197525869046,0.000246902725765,0.000150262325848
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,38.391864256400005,47.9340075278,29.1857759579
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,19.0954429742,23.8415384353,14.516495389200001
5,Prevalence,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,607.535138718,800.729520766,477.846868618
5,Prevalence,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,607.535138718,800.729520766,477.846868618
5,Prevalence,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000539976986305,0.000710485160449,0.000424451513315
5,Prevalence,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000269681939813,0.000355024349243,0.000212288146848
5,Prevalence,79,Finland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,50.34939996130001,66.36036063190001,39.6015005142
5,Prevalence,79,Finland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,25.7780607183,33.9754079884,20.2753138185
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,26.0487215977,35.656577975,19.0706965161
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,26.0487215977,35.656577975,19.0706965161
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.62554607475e-06,1.18178175182e-05,6.30682266677e-06
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.30811969604e-06,5.90059701543e-06,3.15168025023e-06
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.853894065971,1.168845858,0.625149857278
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.42793544605800005,0.585775910093,0.31329856206900003
5,Prevalence,1,Global,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,115484.179476,125756.589138,99176.4331989
5,Prevalence,1,Global,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,1,Global,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,115484.179476,125756.589138,99176.4331989
5,Prevalence,1,Global,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.14838209949e-05,6.69028767798e-05,5.28625457878e-05
5,Prevalence,1,Global,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,1,Global,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.09610950303e-05,3.36952656494e-05,2.66124888452e-05
5,Prevalence,1,Global,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.93261573949,6.46032663046,5.09485949724
5,Prevalence,1,Global,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,1,Global,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.02379418631,3.2927630854,2.59679831027
5,Prevalence,1,Global,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,285708.905737,299064.249893,275404.190033
5,Prevalence,1,Global,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,285708.905737,299064.249893,275404.190033
5,Prevalence,1,Global,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00015211143762,0.000159269892959,0.000146674211023
5,Prevalence,1,Global,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.65980495527e-05,8.02252782569e-05,7.38718165847e-05
5,Prevalence,1,Global,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,14.677345059599999,15.3634314595,14.1479745531
5,Prevalence,1,Global,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.4808941975100005,7.8305854903,7.21107940922
5,Prevalence,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,137.824905103,186.167846602,94.598070663
5,Prevalence,139,Algeria,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,137.824905103,186.167846602,94.598070663
5,Prevalence,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.3129215696e-05,1.77561281418e-05,9.01867705815e-06
5,Prevalence,139,Algeria,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.52026388746e-06,8.80970179522e-06,4.47478357475e-06
5,Prevalence,139,Algeria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.26477020079,1.7083962042299998,0.868092894653
5,Prevalence,139,Algeria,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,139,Algeria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.636016745646,0.859103569497,0.436539078349
5,Prevalence,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,36.6718890253,47.9261036007,24.314070316
5,Prevalence,216,Senegal,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,36.6718890253,47.9261036007,24.314070316
5,Prevalence,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.04054544323e-05,1.35798259699e-05,6.8968069417e-06
5,Prevalence,216,Senegal,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.04852937806e-06,6.59214532294e-06,3.34528583566e-06
5,Prevalence,216,Senegal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.02318777648,1.33719327479,0.678390456695
5,Prevalence,216,Senegal,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,216,Senegal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.499485883276,0.652772813869,0.331167420348
5,Prevalence,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1952.34114869,2213.14251355,1728.53995401
5,Prevalence,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1105.84138322,1283.56167655,960.855710012
5,Prevalence,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3058.18253191,3458.75725692,2693.34986441
5,Prevalence,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0139934605672,0.0158485931696,0.0123927913591
5,Prevalence,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00795630487932,0.00922868906977,0.00691346814458
5,Prevalence,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0109806057297,0.0124078475183,0.00967362708179
5,Prevalence,118,Suriname,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1351.94336894,1532.54125065,1196.96710297
5,Prevalence,118,Suriname,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,787.154264944,913.6582003059999,683.951316717
5,Prevalence,118,Suriname,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1073.43836392,1214.04222683,945.3801536569999
5,Prevalence,118,Suriname,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,6298.5181264,7041.69404431,5698.41992109
5,Prevalence,118,Suriname,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,9362.11659864,10391.4030414,8438.65143554
5,Prevalence,118,Suriname,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,15660.634725,17365.1487725,14302.7773982
5,Prevalence,118,Suriname,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0451454020717,0.0505333816414,0.0407976232675
5,Prevalence,118,Suriname,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.067358651277,0.0746934507869,0.0606710224457
5,Prevalence,118,Suriname,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0562309114478,0.0623002325586,0.0514325615131
5,Prevalence,118,Suriname,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4361.55321564,4876.18241088,3946.00146132
5,Prevalence,118,Suriname,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6664.09317047,7396.754495629999,6006.75699848
5,Prevalence,118,Suriname,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5496.96623464,6095.25974762,5020.35107771
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,189.030042953,288.351535134,117.404173294
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,189.030042953,288.351535134,117.404173294
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000306099335212,0.000466087512528,0.000189917844162
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000150334141087,0.000229032632027,9.32581119723e-05
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,29.052525619199997,44.317507582299996,18.0441568924
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,14.5335907051,22.1699319609,9.026629709589999
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,227.394875112,306.849440395,155.922372319
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,227.394875112,306.849440395,155.922372319
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000368238799543,0.000497059224872,0.000252230840839
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000180849650691,0.000243956973842,0.000123943646823
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.9489178104,47.1604994056,23.9641204417
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,17.483274043,23.5921449581,11.9881046719
5,Prevalence,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,117797.66197,139298.536018,100456.432604
5,Prevalence,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,74994.0617803,91404.9203391,62758.3587872
5,Prevalence,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,192791.72375,227085.860125,163944.021119
5,Prevalence,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0168690192807,0.0199313454193,0.014409889702
5,Prevalence,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110037152403,0.0134032738671,0.00919688620901
5,Prevalence,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0139720123441,0.0164671416181,0.0119037366183
5,Prevalence,157,Yemen,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1667.58369504,1971.9573676,1422.09536481
5,Prevalence,157,Yemen,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1096.2354891599998,1336.12335671,917.378503183
5,Prevalence,157,Yemen,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1386.48938798,1633.12059822,1179.02698872
5,Prevalence,157,Yemen,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,294457.696275,332781.485714,263005.472936
5,Prevalence,157,Yemen,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,403143.338195,457697.113962,358392.771827
5,Prevalence,157,Yemen,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,697601.03447,790658.089524,624692.991045
5,Prevalence,157,Yemen,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0421670368403,0.0476096649401,0.0376194783329
5,Prevalence,157,Yemen,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0591521702736,0.0671972472589,0.0526175437644
5,Prevalence,157,Yemen,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.050556314761,0.0572826515269,0.0452779325987
5,Prevalence,157,Yemen,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4168.44311656,4710.96769075,3723.1947649900003
5,Prevalence,157,Yemen,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5893.0003797,6690.447319410001,5238.85313327
5,Prevalence,157,Yemen,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5016.89809354,5686.13127845,4492.56942144
5,Prevalence,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,18.0612158082,23.0089158678,11.5279814261
5,Prevalence,118,Suriname,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,18.0612158082,23.0089158678,11.5279814261
5,Prevalence,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000129453678955,0.000164645368258,8.23475158436e-05
5,Prevalence,118,Suriname,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.48496997662e-05,8.24829476277e-05,4.12910546966e-05
5,Prevalence,118,Suriname,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.5069027835,15.933051072900001,7.982814917710001
5,Prevalence,118,Suriname,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,118,Suriname,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.339582986089999,8.076252070319999,4.04638290627
5,Prevalence,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8.64989686102,11.0268914463,6.35646685348
5,Prevalence,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8.64989686102,11.0268914463,6.35646685348
5,Prevalence,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.1999203455e-05,7.90430789134e-05,4.55967139576e-05
5,Prevalence,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.10581677375e-05,3.95867883743e-05,2.28231012621e-05
5,Prevalence,118,Suriname,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.98981930544,7.63582367807,4.40168113968
5,Prevalence,118,Suriname,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.03615988834,3.87049765337,2.23115373538
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,85.5136835851,110.751415867,63.3013389043
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,85.5136835851,110.751415867,63.3013389043
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000110461015099,0.000142895702311,8.18844900676e-05
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.39519333788e-05,6.9793835551e-05,3.99929528211e-05
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.2894276005,13.3261558553,7.6167288831899995
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.16122365725,6.68446035396,3.8205858313100003
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,361.980941998,444.37655609,289.22744146
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,361.980941998,444.37655609,289.22744146
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000467572284322,0.000573456034991,0.000373458775493
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000228375651439,0.000280076809144,0.00018242500856
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,43.5553298525,53.4695759737,34.8012703256
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.847551444300002,26.820582366,17.4564753921
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,619553.826237,700507.179237,549153.687363
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,993579.952729,1120829.76023,881984.940274
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1613133.77897,1812596.35667,1437067.78599
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0241487898726,0.0272931698765,0.0213861843585
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0386186962969,0.0435958210146,0.0343278625113
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0313938422389,0.0352306629517,0.0279505090661
5,Prevalence,20,Vietnam,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2356.59887342,2664.5214015300003,2088.81763967
5,Prevalence,20,Vietnam,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3832.3240777700003,4323.13762513,3401.8924330799996
5,Prevalence,20,Vietnam,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3089.31974371,3471.31142194,2752.13496997
5,Prevalence,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1912.46130923,2242.8023966,1615.53549631
5,Prevalence,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1359.94184888,1598.20223753,1137.03901289
5,Prevalence,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3272.40315812,3802.00991484,2770.89687042
5,Prevalence,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00955721722602,0.011197574701,0.00808551433887
5,Prevalence,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00689931386592,0.00810626247953,0.00576980944078
5,Prevalence,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00823827527987,0.0095815944165,0.00697082252278
5,Prevalence,176,Comoros,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,945.158173868,1108.4161584199999,798.4143638050001
5,Prevalence,176,Comoros,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,687.432975013,807.87051279,574.758481017
5,Prevalence,176,Comoros,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,817.7491573909999,950.093938316,692.4264742199999
5,Prevalence,176,Comoros,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,6134.10108594,6956.33566436,5433.74858525
5,Prevalence,176,Comoros,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,8433.81657676,9552.16119944,7463.31584844
5,Prevalence,176,Comoros,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,14567.9176627,16383.4799214,12907.5898602
5,Prevalence,176,Comoros,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0306542915709,0.0347612864925,0.027192006312
5,Prevalence,176,Comoros,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0427867818413,0.0484112032813,0.0378728992626
5,Prevalence,176,Comoros,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0366748458202,0.0412232326281,0.0325894561041
5,Prevalence,176,Comoros,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3031.53624741,3437.89308657,2685.4147926
5,Prevalence,176,Comoros,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4263.18494783,4828.49365694,3772.60941074
5,Prevalence,176,Comoros,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3640.4140376400005,4094.10951326,3225.51049554
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,113097.917688,126901.85397,99950.663527
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,74212.3864444,85198.1364265,64628.0316327
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,187310.304132,209577.937746,167496.486377
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143714710963,0.0161352198489,0.0127031868507
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00899341778179,0.0103222162428,0.00783527837762
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0116186780042,0.01300926526,0.0103814103684
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1379.99129315,1548.4233232899999,1219.5719269800002
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,888.5019928940001,1020.02802541,773.75405446
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1131.91549614,1266.47872621,1012.1806665
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,233653.886286,262067.489342,210075.300517
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,300511.961551,339730.42407,266323.604357
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,534165.847837,599960.748109,479168.118253
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0296902255313,0.0333597126528,0.0266895521241
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0364176348699,0.0411814574329,0.0322604240851
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0331336571307,0.0372091008439,0.029685316252
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2850.98377829,3197.6791518699997,2563.28402456
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3597.855958,4067.39593342,3188.5385252100004
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3227.96230285,3625.5606492399997,2895.61122021
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.34851335522,7.17748513514,3.01515553692
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.34851335522,7.17748513514,3.01515553692
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.57057344788e-05,2.10734014837e-05,8.84159248672e-06
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.88128540339e-06,1.05731044559e-05,4.43987964571e-06
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.56013382937,2.0936354881100003,0.8795053581350001
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.784875900361,1.0532712052200002,0.442463682821
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,46.1004649034,59.8135697486,35.6485041059
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,46.1004649034,59.8135697486,35.6485041059
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000135847939498,0.000176487370195,0.000105135690476
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.70966128616e-05,8.70815012009e-05,5.18613937239e-05
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,13.0960525553,16.9916215507,10.1268975111
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.5526057003,8.50175239906,5.066989925180001
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,21263.2147157,23871.5169889,18792.2463381
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13946.7258456,15899.6107148,12226.246934
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,35209.9405614,39438.3686984,31389.2634213
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148807923843,0.0167037205774,0.0131887859968
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00933935083267,0.0106335573701,0.00817628041015
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120489676825,0.013493925778,0.0107370131226
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1414.26656814,1587.75090499,1249.91663262
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,917.968079714,1046.50620351,804.7268258019999
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1164.81828268,1304.70350607,1038.42231285
5,Prevalence,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5816.94394048,7004.74977881,4862.28914703
5,Prevalence,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5816.94394048,7004.74977881,4862.28914703
5,Prevalence,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00128662803234,0.00154605235355,0.00106895370303
5,Prevalence,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000641272456088,0.000770836872934,0.000533900922526
5,Prevalence,98,Chile,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,122.59869408,147.633049936,102.478261053
5,Prevalence,98,Chile,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,62.198003933,74.8986854179,51.9903032562
5,Prevalence,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.8978120916,59.3647663091,23.3341101474
5,Prevalence,157,Yemen,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.8978120916,59.3647663091,23.3341101474
5,Prevalence,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.71106800154e-06,8.51474025661e-06,3.34050487685e-06
5,Prevalence,157,Yemen,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.38416052497e-06,4.30740011225e-06,1.6903328413e-06
5,Prevalence,157,Yemen,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.465712596744,0.840387786152,0.330325585154
5,Prevalence,157,Yemen,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,157,Yemen,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.236589343491,0.426930248385,0.167810606534
5,Prevalence,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,282.338246687,378.885192676,207.214617349
5,Prevalence,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,282.338246687,378.885192676,207.214617349
5,Prevalence,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.68961325637e-05,3.59784301868e-05,1.97549707634e-05
5,Prevalence,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.33571332658e-05,1.78696307141e-05,9.80662632204e-06
5,Prevalence,139,Algeria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.59091780752,3.47689483882,1.9015349438700002
5,Prevalence,139,Algeria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.30289843258,1.7484309315400002,0.956227515465
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,119143.801185,134766.691644,104191.280845
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,153174.120997,172780.38596,133556.247259
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,272317.922183,307377.354446,239517.041423
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0307683503027,0.0348077838573,0.0268742591575
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0375106517969,0.0423423339361,0.0327101897442
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0342289748434,0.0386525483216,0.0301157625813
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3016.68673301,3412.2538200800004,2638.0932242599997
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3733.7048684700003,4211.61854258,3255.50822397
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3382.00705862,3817.42183572,2974.64198559
5,Prevalence,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,74.56604967,126.06419659,52.8909644349
5,Prevalence,522,Sudan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,74.56604967,126.06419659,52.8909644349
5,Prevalence,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.39591013249e-06,1.25068710939e-05,5.24549273737e-06
5,Prevalence,522,Sudan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.70521649833e-06,6.26319622422e-06,2.62777076128e-06
5,Prevalence,522,Sudan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.734517135764,1.24180257653,0.521005469332
5,Prevalence,522,Sudan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,522,Sudan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.36866959026900004,0.6232868163199999,0.26150359679
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,48256.4422299,54845.1482801,42871.2122465
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,61707.9591032,70749.4528395,54735.7974875
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,109964.401333,124492.873693,98142.1682618
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0375039897713,0.0426421976621,0.0332882199384
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0476090373102,0.0545504638489,0.0422219110252
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0425749115136,0.0481542075766,0.0379667725379
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3681.96935012,4184.688005139999,3271.07598903
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4728.46333086,5421.2811166,4194.211169300001
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4204.0994894899995,4759.54418334,3752.11827178
5,Prevalence,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9017.57952597,10197.4221035,8026.23343155
5,Prevalence,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5353.60917412,5799.77168386,4947.3347243
5,Prevalence,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14371.1887001,15777.0168342,13128.8292635
5,Prevalence,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0217923940097,0.0246263056998,0.0193482556203
5,Prevalence,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0126917488629,0.0137463897692,0.0117435841933
5,Prevalence,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0171983583713,0.0188606219543,0.0157283683866
5,Prevalence,59,Latvia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2067.9157216900003,2338.47779527,1840.57975327
5,Prevalence,59,Latvia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1248.36098084,1352.3976877,1153.62541943
5,Prevalence,59,Latvia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1661.55894592,1824.09708813,1517.9206235099998
5,Prevalence,59,Latvia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,14883.3744776,16689.5682493,13355.6814221
5,Prevalence,59,Latvia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,18919.9534233,21289.5354375,16903.3586432
5,Prevalence,59,Latvia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,33803.3279009,37454.8254714,30425.4439811
5,Prevalence,59,Latvia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0359677887064,0.0403627085749,0.032287641443
5,Prevalence,59,Latvia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0448532844639,0.0503876057817,0.0400805313405
5,Prevalence,59,Latvia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.040453122908,0.0447896144816,0.0364348942281
5,Prevalence,59,Latvia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3413.0626722300003,3827.25990622,3062.73135792
5,Prevalence,59,Latvia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4411.77733464,4964.31929862,3941.5453554899996
5,Prevalence,59,Latvia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3908.25164485,4330.42816629,3517.70961229
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,14502.0810534,16766.4974466,12523.93461
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9236.9908554,11062.4844491,7763.95233314
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,23739.0719088,27444.4533111,20510.1065003
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00928023220961,0.0107204002034,0.00801589007602
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00571873927417,0.00685074686943,0.00480792915738
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00747004940636,0.00862238319151,0.00645480283993
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,919.559059843,1063.14290839,794.127235472
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,570.458239942,683.197104666,479.486301577
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,742.706610756,858.6341109330001,641.684381919
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.89508187754,10.5414868713,2.37118661254
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.89508187754,10.5414868713,2.37118661254
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.8802305893e-05,4.40397986677e-05,9.87463331801e-06
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.43827083305e-05,2.19600362411e-05,4.93613417702e-06
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.81952086197,4.31060032031,0.9696201206070001
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.41785426797,2.16767435351,0.48759349322699996
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,68.3834895416,82.7160210417,53.7003458316
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,68.3834895416,82.7160210417,53.7003458316
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000201516390028,0.000243708705413,0.000158360077295
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.95300389632e-05,0.000120412196656,7.81914836066e-05
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.4261332251,23.4976666938,15.254999113799999
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.719859535380001,11.757050002,7.63283391917
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5754.49343397,6590.43387837,4982.45317039
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2677.07896159,3220.27960151,2262.41119265
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,8431.57239555,9669.60307909,7346.13366276
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0168978856563,0.0193563467802,0.0146387477932
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00791822914808,0.00952819120961,0.00669018459672
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0124242915743,0.0142515352849,0.0108262251336
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1678.5561297099998,1922.3956567,1453.35595672
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,790.578006098,950.992579214,668.120946494
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1237.30418827,1418.980924,1078.0197953699999
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,15362.246852,17414.7682241,13556.4322287
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,17139.2632126,19418.6244526,15207.4456859
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,32501.5100646,36750.7197405,28988.1980192
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.045110753464,0.0511815535312,0.0397805924443
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0506944077794,0.0574310859539,0.0449725475848
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0478924521983,0.0541614753615,0.0426795506038
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4481.08837302,5079.7982977,3954.3415377100005
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5061.458676040001,5734.58520321,4490.966557469999
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4769.48458026,5393.04145461,4253.918146800001
5,Prevalence,80,France,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2064.04006952,3021.90247978,1443.43072036
5,Prevalence,80,France,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,80,France,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2064.04006952,3021.90247978,1443.43072036
5,Prevalence,80,France,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000157295544626,0.000230571391699,0.000110359729918
5,Prevalence,80,France,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,80,France,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.66615723764e-05,0.000112317339928,5.37389675477e-05
5,Prevalence,80,France,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,14.7313049403,21.5676854278,10.3019405563
5,Prevalence,80,France,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,80,France,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.34957415989,10.760302916199999,5.13972634575
5,Prevalence,80,France,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8442.58965684,10681.9634446,6548.58339711
5,Prevalence,80,France,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8442.58965684,10681.9634446,6548.58339711
5,Prevalence,80,France,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000643394630659,0.000813941048476,0.000499161911881
5,Prevalence,80,France,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00031357072824,0.000396798401098,0.000243231983103
5,Prevalence,80,France,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,60.2557889053,76.23847191109999,46.7380359397
5,Prevalence,80,France,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,30.0621289775,38.0360263682,23.3180062879
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2334.77129171,2749.81616588,1968.61879922
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1679.6364452,1983.84254771,1422.34333603
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4014.40773691,4667.34507914,3430.13901543
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0097526147647,0.0114887896479,0.00824091667973
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00699824168981,0.00826505425376,0.00593220129595
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0083736728364,0.00972111995146,0.00714224120167
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,954.729252216,1124.44843788,805.003025673
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,694.7651825300001,820.597060579,588.3384051930001
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,825.493481332,959.75874661,705.348729595
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,8633.53443314,9751.81032596,7708.97598348
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,11180.4245183,12638.2174733,9865.01324449
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,19813.9589515,22285.1926902,17612.721261
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.036063064707,0.0407061826183,0.0322065263018
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.046583412788,0.0526609132337,0.0411284333727
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0413299792481,0.0464453912061,0.0367281962342
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3530.40484205,3987.68762205,3152.3365488500003
5,Prevalence,177,Djibouti,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4624.67321629,5227.67500953,4080.5662124399996
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4074.3977756500003,4582.56422906,3621.75133726
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.0866419525,3.94283027585,2.24875697569
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.0866419525,3.94283027585,2.24875697569
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000109407630935,0.000139578230867,7.97169762836e-05
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.35139627941e-05,6.82775305841e-05,3.89725782146e-05
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.711563349599999,13.6827908537,7.80385388833
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.2791996996899995,6.743570757,3.84613354366
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,40999.5992114,46063.1525995,36605.9642736
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,53256.631775,60419.4754533,47451.1921945
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,94256.2309864,105695.477005,84844.0907797
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0286929781504,0.0322348626719,0.0256622802984
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0356628610442,0.0404934442679,0.0317588708601
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0322546960183,0.0361336649484,0.0290110384601
5,Prevalence,40,Turkmenistan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2726.98005672,3063.76893688,2434.74903294
5,Prevalence,40,Turkmenistan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3505.3308241400005,3976.7864137499996,3123.21904518
5,Prevalence,40,Turkmenistan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3118.19274213,3496.626863,2806.81951011
5,Prevalence,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,22.4790362738,33.8397358854,10.1037639728
5,Prevalence,22,Fiji,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,22.4790362738,33.8397358854,10.1037639728
5,Prevalence,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.68198188888e-05,0.000145793615853,4.35528967902e-05
5,Prevalence,22,Fiji,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.93591908217e-05,7.43312914929e-05,2.21954164991e-05
5,Prevalence,22,Fiji,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.50624536934,14.310614949900001,4.272819275230001
5,Prevalence,22,Fiji,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,22,Fiji,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.8778711991999995,7.343102749300001,2.1924809714299998
5,Prevalence,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,70.5806896218,87.5604193669,55.467608259
5,Prevalence,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,70.5806896218,87.5604193669,55.467608259
5,Prevalence,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000303985190373,0.000376461782416,0.000239095553629
5,Prevalence,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000154975858962,0.000191944465209,0.000121999649076
5,Prevalence,22,Fiji,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,29.8481369801,37.028759641,23.456908371799997
5,Prevalence,22,Fiji,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,15.3157594895,19.0003006631,12.0362743989
5,Prevalence,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34032.9635927,39607.8090483,29294.531716
5,Prevalence,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21568.5768741,25864.4594959,17968.8809902
5,Prevalence,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,55601.5404668,64382.1345644,48171.4124243
5,Prevalence,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0096566652994,0.0112615612867,0.00829672307229
5,Prevalence,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00576766261793,0.006920752012,0.00480792070292
5,Prevalence,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00765452430352,0.00885543302359,0.00663828731696
5,Prevalence,216,Senegal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,949.5587293409999,1105.10331342,817.3510437059999
5,Prevalence,216,Senegal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,573.961321362,688.279038307,478.16982718599996
5,Prevalence,216,Senegal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,757.31535216,876.9105765959999,656.114018745
5,Prevalence,216,Senegal,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,113270.207832,127579.252682,101236.180915
5,Prevalence,216,Senegal,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,163468.313517,183934.066662,145217.54735
5,Prevalence,216,Senegal,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,276738.521349,309797.95068,247272.761932
5,Prevalence,216,Senegal,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0321397178253,0.0362079680995,0.0287004538677
5,Prevalence,216,Senegal,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0437130769683,0.0492142198638,0.0388357764562
5,Prevalence,216,Senegal,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0380978615104,0.0426570511315,0.0340199816323
5,Prevalence,216,Senegal,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3160.36875038,3559.60751808,2824.60559308
5,Prevalence,216,Senegal,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4350.05470108,4894.66878418,3864.3836284599997
5,Prevalence,216,Senegal,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3769.29000513,4219.572733919999,3367.95450647
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.42720326924,4.31132528674,1.66210574915
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.42720326924,4.31132528674,1.66210574915
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.01387613211e-05,1.79728418866e-05,6.94319417089e-06
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.06294907202e-06,8.9808409275e-06,3.46816904554e-06
5,Prevalence,177,Djibouti,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.992526321721,1.76297711972,0.679664421359
5,Prevalence,177,Djibouti,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.499112349303,0.886549437264,0.34178328439100003
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,28587.5694762,33700.6867288,24159.7595424
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20942.4321323,24789.4568884,17520.196264
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,49530.0016085,57839.9718857,41983.590957
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00946613684125,0.0111757127157,0.00799814776344
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00691968293684,0.00818626183186,0.00578693843627
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00819153473922,0.00955511793072,0.00694416575831
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,937.119153609,1104.73046859,791.9726590490001
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,689.6925702430001,816.385801243,576.988819453
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,813.69226709,950.21070712,689.717791175
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,108683.168355,122116.556479,96603.1628694
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,145639.93837,165253.723357,128958.409913
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,254323.106725,285273.372545,227515.599679
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0359879345005,0.0404804577053,0.0319947771228
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0481215774809,0.0546007648665,0.0426091181975
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.04206128584,0.0472031061698,0.0375924806552
5,Prevalence,435,South Sudan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3562.705071,4003.06028622,3166.7146204799997
5,Prevalence,435,South Sudan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4796.32846794,5442.26499025,4246.95931329
5,Prevalence,435,South Sudan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4178.08880605,4686.54814674,3737.68782735
5,Prevalence,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,29674.7896268,32329.7822712,27010.22945
5,Prevalence,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13824.7270508,15527.0329676,12369.9954633
5,Prevalence,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,43499.5166776,47534.7324536,39807.7309787
5,Prevalence,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.026374577789,0.0286928983209,0.0240382079256
5,Prevalence,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0122595975759,0.0137881878368,0.0109911880629
5,Prevalence,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0193091191773,0.0210785970671,0.0176625463711
5,Prevalence,79,Finland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2459.29454359,2679.32673272,2238.4694463799997
5,Prevalence,79,Finland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1201.9900628,1349.99694845,1075.50851233
5,Prevalence,79,Finland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1845.70917906,2016.92567446,1689.06461672
5,Prevalence,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,345088.14813,378692.458116,314679.188961
5,Prevalence,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,170922.478192,189337.691588,153797.460952
5,Prevalence,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,516010.626323,563629.747352,474073.491752
5,Prevalence,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0204248292702,0.0224025609643,0.0186699036433
5,Prevalence,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100115430331,0.0110863212874,0.00902250277499
5,Prevalence,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0151910255852,0.0166015727127,0.0139559605289
5,Prevalence,81,Germany,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1913.33394333,2099.65232977,1744.7321119599999
5,Prevalence,81,Germany,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,982.7745678489999,1088.6588469600001,884.3086925829999
5,Prevalence,81,Germany,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1456.51374112,1590.92551596,1338.14018514
5,Prevalence,80,France,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,332714.229877,368674.361652,293023.901912
5,Prevalence,80,France,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,184782.015397,205835.660742,163925.788672
5,Prevalence,80,France,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,517496.245273,571724.012044,462656.898196
5,Prevalence,80,France,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0253547239796,0.0280634362899,0.0223776597043
5,Prevalence,80,France,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.01338792658,0.0149192888,0.011866269409
5,Prevalence,80,France,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0192202417691,0.0212271855226,0.0172334429103
5,Prevalence,80,France,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2374.62191296,2631.27374579,2091.34721638
5,Prevalence,80,France,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1313.0666456899999,1462.67449261,1164.86166151
5,Prevalence,80,France,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1842.68565726,2035.77832018,1647.41529687
5,Prevalence,80,France,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,539829.806088,603223.509493,480841.060061
5,Prevalence,80,France,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,955080.043119,1071162.85922,860243.570765
5,Prevalence,80,France,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1494909.84921,1669740.74329,1352014.5362
5,Prevalence,80,France,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0411384969695,0.0458908988948,0.0367088034442
5,Prevalence,80,France,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0691981351388,0.0775809969169,0.0623327422792
5,Prevalence,80,France,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0555225641083,0.0618091002447,0.0501565158265
5,Prevalence,80,France,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3852.83096331,4305.27953248,3431.82111055
5,Prevalence,80,France,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6786.82795991,7611.71599693,6112.91709052
5,Prevalence,80,France,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5323.0317382700005,5945.56452747,4814.214242159999
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11875.644391,12986.4136384,10778.0245885
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5008.34898075,5662.18439056,4396.71307255
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,16883.9933717,18460.4295678,15371.4930727
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0192302636934,0.0210558648744,0.0174859024119
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00782726509543,0.00884807486234,0.00687438264432
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0134275805287,0.014664637946,0.0122430904679
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1825.1990928199998,1995.9161466500002,1656.50301185
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,770.523359793,871.114484464,676.424534657
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1298.12724633,1419.33167547,1181.8385339899999
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,26735.5034286,29833.0269644,23984.2466328
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,33642.7886956,37596.3015157,30293.5521607
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,60378.2921242,66983.9128658,54592.0727204
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0432931657445,0.0481716753291,0.0388155999586
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0525784044705,0.0587989681618,0.0473013059174
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0480180629316,0.0532605422429,0.043395307895
5,Prevalence,60,Lithuania,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4109.05000162,4585.11655948,3686.2020918599997
5,Prevalence,60,Lithuania,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5175.868270790001,5784.1074316,4660.59567347
5,Prevalence,60,Lithuania,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4642.19005348,5150.06375817,4197.31608937
5,Prevalence,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,96.1323106942,137.964802404,69.6387592079
5,Prevalence,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,96.1323106942,137.964802404,69.6387592079
5,Prevalence,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000143691342356,0.000205917938731,0.000104107410836
5,Prevalence,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.9622894747e-05,9.98086155761e-05,5.0471837609e-05
5,Prevalence,43,Albania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,13.468247571900001,19.3290278947,9.756470460780001
5,Prevalence,43,Albania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.66689612875,9.56803181376,4.82953515651
5,Prevalence,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,360683.91192,397494.73108,326907.128765
5,Prevalence,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,214307.832445,239395.734058,191463.378761
5,Prevalence,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,574991.744365,629168.091736,523361.562581
5,Prevalence,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0466077720077,0.0512943551909,0.042317281653
5,Prevalence,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0259122336374,0.028974847133,0.0231376754137
5,Prevalence,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0359162198588,0.0392412848435,0.0327478355904
5,Prevalence,101,Canada,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4228.81973644,4660.4062681099995,3832.80560185
5,Prevalence,101,Canada,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2529.3594994299997,2825.45844057,2259.73876147
5,Prevalence,101,Canada,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3381.90718953,3700.55416225,3078.23590263
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,89.235009054,118.43792324,58.2624652407
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,89.235009054,118.43792324,58.2624652407
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.30449929385e-05,3.06054030849e-05,1.50485068379e-05
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.12164814435e-05,1.48986653457e-05,7.32028731305e-06
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.25940472987,2.9988141067300003,1.47518884051
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.10823932585,1.4709200525500001,0.7235809788690001
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,55.6581602004,70.8451996311,41.1895150603
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,55.6581602004,70.8451996311,41.1895150603
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.43733994385e-05,1.82525147681e-05,1.06384908358e-05
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.9959080525e-06,8.89566373708e-06,5.18004562434e-06
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.40924858692,1.7937800514899997,1.04290665889
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.691237246373,0.8798501519890001,0.511546318944
5,Prevalence,81,Germany,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,647036.770128,717490.024856,584152.931518
5,Prevalence,81,Germany,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1097472.15806,1230483.39778,979746.072018
5,Prevalence,81,Germany,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1744508.92818,1943010.84113,1575874.76718
5,Prevalence,81,Germany,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0382964979645,0.0424778581838,0.0345391538668
5,Prevalence,81,Germany,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0642833793404,0.0720459878873,0.0574367305596
5,Prevalence,81,Germany,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0513575638369,0.0570584431145,0.0465569667154
5,Prevalence,81,Germany,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3587.48169585,3978.10827755,3238.82358182
5,Prevalence,81,Germany,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6310.27432592,7075.065856069999,5633.369775069999
5,Prevalence,81,Germany,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4924.12577532,5484.425794549999,4448.13175466
5,Prevalence,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,408304.938208,490996.667149,343311.990621
5,Prevalence,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,268618.021691,331697.108216,220325.864085
5,Prevalence,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,676922.959898,807152.247128,569447.152366
5,Prevalence,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0174758032403,0.0210489937563,0.0146794728489
5,Prevalence,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115885444885,0.0143130839002,0.00950464730766
5,Prevalence,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0145438096729,0.0173542081078,0.0122423331799
5,Prevalence,141,Egypt,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1698.7060958999998,2042.73559662,1428.31035505
5,Prevalence,141,Egypt,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1149.1059678,1418.94845384,942.51965556
5,Prevalence,141,Egypt,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1427.73117967,1702.4041112999998,1201.0487201199999
5,Prevalence,141,Egypt,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,737998.237191,832638.33253,657956.69321
5,Prevalence,141,Egypt,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1127435.13698,1272765.87914,999859.668896
5,Prevalence,141,Egypt,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1865433.37417,2089899.01073,1674509.29763
5,Prevalence,141,Egypt,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0315870476159,0.0356316312394,0.0281049769562
5,Prevalence,141,Egypt,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0486391791103,0.05494449936,0.0431546138069
5,Prevalence,141,Egypt,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0400792440192,0.0449371307096,0.0359700050839
5,Prevalence,141,Egypt,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3070.35743868,3464.0967541400005,2737.35373003
5,Prevalence,141,Egypt,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4822.99153295,5444.69376301,4277.24359393
5,Prevalence,141,Egypt,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3934.47637277,4407.90777791,3531.78910527
5,Prevalence,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,132.88331708,179.232586832,97.9972585623
5,Prevalence,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,132.88331708,179.232586832,97.9972585623
5,Prevalence,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.9029358398e-05,2.56410603721e-05,1.40215780099e-05
5,Prevalence,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.63031566866e-06,1.29840911667e-05,7.09722180922e-06
5,Prevalence,157,Yemen,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.88114135034,2.53727734849,1.38728246218
5,Prevalence,157,Yemen,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.955649471807,1.28897690621,0.7047613684049999
5,Prevalence,101,Canada,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,317936.136819,355843.240115,288062.692983
5,Prevalence,101,Canada,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,531021.459241,590133.71589,481085.26505
5,Prevalence,101,Canada,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,848957.59606,940163.43875,775673.995353
5,Prevalence,101,Canada,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0410840995972,0.0458450279945,0.0371788479108
5,Prevalence,101,Canada,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0642065749557,0.0714370083699,0.0582060399889
5,Prevalence,101,Canada,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0530292996445,0.0588927356776,0.0483885873185
5,Prevalence,101,Canada,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3727.6256740900003,4172.06553202,3377.37603802
5,Prevalence,101,Canada,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6267.35923279,6965.02924412,5677.98932643
5,Prevalence,101,Canada,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4993.28177467,5529.723729089999,4562.25239288
5,Prevalence,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,228126.029322,257023.583513,203349.374084
5,Prevalence,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,124576.20898,140013.732761,110725.798822
5,Prevalence,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,352702.238302,394950.123922,314909.734755
5,Prevalence,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0154678605028,0.0174228840875,0.0137805074412
5,Prevalence,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0083936680506,0.00943404489,0.00746045801772
5,Prevalence,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119196047006,0.0133496439565,0.0106468230811
5,Prevalence,196,South Africa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1529.73546135,1723.51261832,1363.59164934
5,Prevalence,196,South Africa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,837.567010418,941.358583041,744.446127034
5,Prevalence,196,South Africa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1184.10664129,1325.9430021300002,1057.22807466
5,Prevalence,196,South Africa,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,624839.161754,701034.80899,563395.564927
5,Prevalence,196,South Africa,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,749892.970044,836146.514102,676368.948488
5,Prevalence,196,South Africa,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1374732.1318,1535591.60988,1243169.9887
5,Prevalence,196,South Africa,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0423666391554,0.047532738313,0.0382217838208
5,Prevalence,196,South Africa,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0505261269604,0.0563082465441,0.045570243823
5,Prevalence,196,South Africa,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.046459217947,0.051858197156,0.0420231396746
5,Prevalence,196,South Africa,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4189.958621639999,4700.90068258,3777.93878673
5,Prevalence,196,South Africa,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5041.77818698,5621.6892601,4547.45189922
5,Prevalence,196,South Africa,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4615.30795803,5155.35209621,4173.62205286
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,476.581303164,718.236085268,169.424498677
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,476.581303164,718.236085268,169.424498677
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.9471277782e-05,2.94153174768e-05,6.92920279874e-06
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.67721010049e-06,1.46144677244e-05,3.44112199572e-06
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.90957217203,2.87783770003,0.6788522877140001
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.954915181832,1.43911340501,0.339472037378
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,183.543515001,231.95056097,146.094754753
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,183.543515001,231.95056097,146.094754753
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.49902109526e-06,9.45412015626e-06,5.97749680199e-06
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.72695665813e-06,4.70191078633e-06,2.9707091324e-06
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.735424546192,0.9293825283849999,0.585374365936
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.367761991161,0.464754094705,0.29272675695399997
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,124049.388482,141328.791196,110613.056604
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,199916.37223,224100.136231,180247.004542
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0275183671193,0.0310085045797,0.0246208382686
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0446176787999,0.0508083907944,0.0397727632986
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0361040528258,0.040399235341,0.0325485708142
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2690.15924268,3027.25471685,2405.87909147
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4428.98599654,5045.91957099,3949.26315016
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3556.58528971,3986.8232854,3206.6600534799995
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,169.903866051,234.89949389,134.948557679
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,169.903866051,234.89949389,134.948557679
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.1589782393e-05,2.99689910765e-05,1.71081229261e-05
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.05389549214e-05,1.46138225222e-05,8.35551680279e-06
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.07312265882,2.86618235739,1.6466071031900003
5,Prevalence,41,Uzbekistan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.02672845324,1.41949679918,0.8154936501039999
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10852.2861396,12717.4678447,9263.8890031
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3552.7647854,4320.09602602,2931.88937639
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14405.050925,16848.7630582,12327.1641803
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0184222499221,0.0215937513156,0.0157247997857
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114865929665,0.0139611580908,0.00947769887644
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0160344132319,0.0187264806375,0.0136945868317
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1800.3965246500002,2109.83055694,1536.88110979
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1142.3718816199998,1389.10300122,942.7328252530001
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1576.43998309,1843.87156206,1349.04309559
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,176829.654613,209584.155296,150249.576075
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,131159.338528,161935.778728,107712.160766
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,307988.993141,362900.314345,263682.938451
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0213096018656,0.0253021525224,0.0180988967136
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0171150158962,0.0211247866991,0.0140569883975
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0192956659557,0.0227307661783,0.016501893255
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2114.90947947,2506.6582737599997,1797.00771018
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1707.6575777399999,2108.3581448,1402.38193949
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1919.9206905099998,2262.22312362,1643.72864142
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,378223.155711,427341.218683,337275.854545
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,442314.637918,504291.425875,394889.474658
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,820537.793629,925887.343845,737983.470483
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0455791270082,0.0515858792311,0.0407110624978
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0577178333476,0.0657931213316,0.0515242736484
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0514070605603,0.0580338766043,0.0462637248814
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4523.606287189999,5111.06576745,4033.87035696
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5758.81177553,6565.732066420001,5141.34953209
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5115.01229725,5771.7331077300005,4600.39081197
5,Prevalence,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,19239.1031204,21393.9987922,17315.7407169
5,Prevalence,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10694.2666818,12322.5005133,9234.49346909
5,Prevalence,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29933.3698022,33184.5715284,26867.5536883
5,Prevalence,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0185680369269,0.0206438359495,0.0167101592129
5,Prevalence,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101205461148,0.011667533387,0.00874106873552
5,Prevalence,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143028090952,0.015863201326,0.0128511173992
5,Prevalence,61,Moldova,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1778.03004148,1977.1801378500002,1600.27767368
5,Prevalence,61,Moldova,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,998.3697107380001,1150.3744613,862.091702769
5,Prevalence,61,Moldova,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1390.1683851999999,1541.16100259,1247.78546392
5,Prevalence,61,Moldova,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,34614.2713184,38929.7242579,30767.5625754
5,Prevalence,61,Moldova,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,46189.2341111,51859.7686575,40711.9028409
5,Prevalence,61,Moldova,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,80803.5054294,90283.4385853,72139.6399931
5,Prevalence,61,Moldova,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.033406731049,0.0375080982448,0.0297804981474
5,Prevalence,61,Moldova,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0437112759582,0.049046610261,0.0385069492974
5,Prevalence,61,Moldova,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0386095337668,0.0431418028271,0.034487806573
5,Prevalence,61,Moldova,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3198.9648313000002,3597.7882546700002,2843.46158029
5,Prevalence,61,Moldova,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4312.02378535,4841.39995516,3800.6842238299996
5,Prevalence,61,Moldova,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3752.68402468,4192.95197494,3350.3159684700004
5,Prevalence,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3909.04100916,5203.31480197,2708.61760311
5,Prevalence,81,Germany,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3909.04100916,5203.31480197,2708.61760311
5,Prevalence,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000231372058564,0.000308105722401,0.000159651008376
5,Prevalence,81,Germany,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000115082577292,0.000153216537376,7.9459629454e-05
5,Prevalence,81,Germany,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.6735952517,28.8496689394,15.0178730496
5,Prevalence,81,Germany,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,81,Germany,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.0338269292,14.6870996872,7.645460300879999
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,50786.6066349,57597.2462224,45028.4397107
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,81888.2922182,92343.9974472,72276.5958562
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,132674.898853,148961.538874,118109.420094
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0324995833342,0.0368479755317,0.0288270351764
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0506980907521,0.0571599418565,0.0447602738498
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0417492651719,0.0468944361092,0.0371882233836
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3220.31604139,3652.17029134,2855.19778397
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5057.25855768,5702.98218084,4463.65924862
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4150.90045804,4660.4483989499995,3695.20120388
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,58158.3927588,66733.7843341,50544.1075238
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,31594.5571087,37852.2729899,26422.465517
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,89752.9498675,102778.508713,78602.8634237
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0150191335493,0.0171964578819,0.0130327662796
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00773713228742,0.00926471003557,0.006478080047
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112814569919,0.012906910448,0.00987942513446
5,Prevalence,198,Zimbabwe,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1472.5537552399999,1689.68020024,1279.76224597
5,Prevalence,198,Zimbabwe,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,770.135000128,922.670324627,644.062374868
5,Prevalence,198,Zimbabwe,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1114.6718054799999,1276.4405631299999,976.195164812
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,17599.9542076,19948.2727414,15599.3966942
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9847.52986997,11209.9712611,8569.6231856
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,27447.4840776,30939.4164721,24335.9232258
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0227336237004,0.0257743156178,0.0200979639982
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0121446209806,0.0138229847139,0.0105584763616
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0173165865396,0.0194728505164,0.0153421896804
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2117.71317758,2400.27443004,1876.99624397
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1192.53270678,1357.52392198,1037.77861743
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1656.6074365399998,1867.3648653900002,1468.8075335800002
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,28857.1030623,32072.8070176,25888.7639068
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,46497.8299878,52266.4742385,41831.1098626
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,75354.9330501,83341.4992651,68264.0225405
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0372745275027,0.0413362990166,0.033416642133
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0573443009325,0.064421956407,0.0515272456022
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0475414780431,0.0526543880193,0.0431444417384
5,Prevalence,99,Uruguay,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3472.2287740600004,3859.15811268,3115.06358652
5,Prevalence,99,Uruguay,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5630.87228847,6329.45325584,5065.73397905
5,Prevalence,99,Uruguay,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4548.0868890599995,5030.12032231,4120.1112302
5,Prevalence,102,United States,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,29314.6063385,35408.9830783,25724.7179308
5,Prevalence,102,United States,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,102,United States,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,29314.6063385,35408.9830783,25724.7179308
5,Prevalence,102,United States,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000432050752266,0.000522339888927,0.000378019809725
5,Prevalence,102,United States,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,102,United States,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00020865441883,0.000252187254272,0.000182841774378
5,Prevalence,102,United States,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,38.9090251887,46.9980390864,34.1441971414
5,Prevalence,102,United States,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,102,United States,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.6180808087,23.6965928644,17.215636100399998
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,116.056354094,147.195038739,84.356500501
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,116.056354094,147.195038739,84.356500501
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.20960678479e-05,5.33877690846e-05,3.06001256295e-05
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.09593849128e-05,2.6577395409e-05,1.5237119998e-05
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.11522981693,5.21937309725,2.99118810704
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.06468493373,2.61865350826,1.50073295862
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11946.6948289,13584.4017349,10498.9588559
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6612.54302926,7496.49448204,5826.5092888
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18559.2378582,20843.5976442,16504.0592277
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133257333223,0.0151598690075,0.0116947328425
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00756589135563,0.0085839562991,0.00665995331484
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0104824383923,0.0117535226751,0.0093278364996
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1271.8193414,1446.1660831899999,1117.69649503
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,743.153555357,842.4968279809999,654.814807879
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1014.64618033,1139.53368644,902.288164157
5,Prevalence,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,392.495300127,536.607774422,289.410746411
5,Prevalence,82,Greece,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,392.495300127,536.607774422,289.410746411
5,Prevalence,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000168795566753,0.000230527521485,0.000124606764338
5,Prevalence,82,Greece,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.36795051277e-05,0.000114360605572,6.1811537555e-05
5,Prevalence,82,Greece,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.920631094700001,21.7662081975,11.7392532521
5,Prevalence,82,Greece,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,82,Greece,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.06464494878,11.0257401199,5.94655506299
5,Prevalence,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1551.27224979,1981.64104611,1179.29461339
5,Prevalence,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1551.27224979,1981.64104611,1179.29461339
5,Prevalence,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000667133456312,0.000855898375316,0.000507189459052
5,Prevalence,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000330728699635,0.000423600973082,0.000251746026245
5,Prevalence,82,Greece,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,62.923640635699996,80.3805193258,47.835259392000005
5,Prevalence,82,Greece,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,31.8741648866,40.7170008089,24.2310986754
5,Prevalence,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,58.006318616,108.17138538,21.142863444
5,Prevalence,43,Albania,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,58.006318616,108.17138538,21.142863444
5,Prevalence,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.67058994821e-05,0.000162628286136,3.15453918316e-05
5,Prevalence,43,Albania,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.20108312861e-05,7.87401069886e-05,1.53140823571e-05
5,Prevalence,43,Albania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.126752121280001,15.1549358169,2.96213954691
5,Prevalence,43,Albania,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,43,Albania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.0228108346900004,7.501821034190001,1.46628405608
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,321.742999604,383.354025525,275.572183105
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,168.253648902,196.164782975,143.739070815
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,489.996648506,570.898249265,422.93144096
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0168178501547,0.0200224497352,0.0144375804361
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00913565402261,0.0106484165953,0.00781145356538
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0130497756808,0.0151853685758,0.0112706653275
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1657.14591599,1974.47515116,1419.34189199
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,908.7227329799999,1059.4682425199999,776.321714977
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1291.8142667,1505.10111749,1115.00531878
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,610.713089146,685.864886287,542.8540408
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,701.017196425,785.409682112,624.205162487
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1311.73028557,1467.25978616,1176.10593596
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0319228512794,0.0358310367897,0.0283600804971
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0380631826857,0.0426185338326,0.033873470742
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0349346264571,0.0390922467873,0.0313334234002
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3145.49408306,3532.56542218,2795.98424145
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3786.13044506,4241.92662385,3371.27560024
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3458.21119824,3868.24507983,3100.65473276
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,27194.9162901,30772.1199872,24023.8548365
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,18320.4620843,20978.8803769,16276.3692086
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,45515.3783743,51164.7093217,40733.4555692
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0461638664163,0.0522301688106,0.0408017969772
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0592325770003,0.0677917807623,0.0526130377688
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0506631373439,0.0569329247968,0.045301106479
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4511.6422611,5105.101097459999,3985.5625072899998
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5890.84333117,6745.643040849999,5233.57656414
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4981.04884798,5599.29249248,4457.73141263
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,28.7726219242,43.1276152532,10.6704186009
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,28.7726219242,43.1276152532,10.6704186009
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.23627352239e-05,3.35863117184e-05,8.27719588758e-06
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.11402451257e-05,1.6707864357e-05,4.12428458822e-06
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.19535272706,3.29063955336,0.814153560143
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.1000193124,1.6488316498,0.40794567013199995
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1588654021,19.7144230261,11.5697241729
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,15.1588654021,19.7144230261,11.5697241729
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.17814014169e-05,1.52648499156e-05,9.0149554451e-06
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.86911410991e-06,7.61504678978e-06,4.4881913589e-06
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.15662231225,1.5042116240499999,0.8827706276230001
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.579545539515,0.753711153565,0.442327434146
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,869.406363822,985.1328173,770.105463713
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,948.682612713,1068.07362461,842.370898067
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1818.08897653,2032.47443529,1618.71787558
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0315416702342,0.0356546788612,0.0279382304089
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0365344258047,0.041125241644,0.0324612800769
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0339634696995,0.0379430215688,0.0302771741117
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3100.5933089200003,3513.31247254,2746.45315161
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3633.9624964199998,4091.2940147199997,3226.73169154
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3357.75244849,3753.69198079,2989.54230529
5,Prevalence,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,18246.7705234,21370.7457548,15659.8401423
5,Prevalence,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9958.20709631,11980.6041693,8340.911558
5,Prevalence,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,28204.9776197,32758.0887682,24403.6077353
5,Prevalence,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0102603931866,0.0120214507575,0.00881518524374
5,Prevalence,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0054471992151,0.0065489024926,0.00456141186556
5,Prevalence,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00782058535733,0.00907792210258,0.00676873362167
5,Prevalence,218,Togo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1012.60627836,1185.97158313,869.0443290139999
5,Prevalence,218,Togo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,542.899038145,653.155574795,454.727725412
5,Prevalence,218,Togo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,775.666234978,900.881529581,671.124607404
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,295.401029542,353.680575733,227.750889873
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,295.401029542,353.680575733,227.750889873
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.98859648779e-05,8.40108753568e-05,5.35999829405e-05
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.48080514819e-05,4.17876218705e-05,2.67334205777e-05
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.851141907250001,8.20280084312,5.28215378409
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.4363377594899998,4.1142914060599995,2.64937797894
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,427.798607725,529.153450503,342.2342877
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,427.798607725,529.153450503,342.2342877
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000101207253093,0.000125355716602,8.07768682639e-05
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.04084319427e-05,6.2316922788e-05,4.02635202723e-05
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.92179673101,12.272487288599999,7.9373307337300005
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.97649081135,6.155530281469999,3.9811391559300002
5,Prevalence,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,48.3324404098,66.1418309447,22.3488151674
5,Prevalence,61,Moldova,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,48.3324404098,66.1418309447,22.3488151674
5,Prevalence,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.66478899417e-05,6.38597216595e-05,2.15383893126e-05
5,Prevalence,61,Moldova,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.30947525833e-05,3.16097590316e-05,1.0677255143e-05
5,Prevalence,61,Moldova,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.46676388649,6.112663448079999,2.06542189157
5,Prevalence,61,Moldova,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,61,Moldova,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.24465975871,3.07176515462,1.03792578309
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,245.509559482,375.201774111,180.642545016
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,245.509559482,375.201774111,180.642545016
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.90528344311e-05,0.000136130549939,6.53361309208e-05
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.43385724777e-05,6.7823953696e-05,3.2570941183e-05
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.70549714753,13.3042394812,6.405384636260001
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.36770474572,6.67497661942,3.2136968630100005
5,Prevalence,102,United States,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,61640.347153,66373.162261,56993.6668998
5,Prevalence,102,United States,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,61640.347153,66373.162261,56993.6668998
5,Prevalence,102,United States,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000908476587413,0.000979394270051,0.000839978034792
5,Prevalence,102,United States,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000438740593002,0.000472541384435,0.000405769805452
5,Prevalence,102,United States,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,81.81470330270001,88.096528142,75.6472045163
5,Prevalence,102,United States,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,41.251289461700004,44.4186098128,38.1416127481
5,Prevalence,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,348.992751509,425.177931909,284.179142417
5,Prevalence,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,348.992751509,425.177931909,284.179142417
5,Prevalence,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.78914667087e-05,4.62026693154e-05,3.08639082564e-05
5,Prevalence,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.9121188716e-05,2.32942051441e-05,1.55718210771e-05
5,Prevalence,143,Iraq,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.7043949341599998,4.51306501429,3.01642876824
5,Prevalence,143,Iraq,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.8839367764,2.2952005133999998,1.53405918939
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,937775.984718,1035807.66143,848296.414384
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,420062.65639,471337.400114,376318.167868
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1357838.64111,1485523.38946,1236230.896
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0283542262844,0.0313115579566,0.0256940859564
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0122323745851,0.0136914882333,0.010961459275
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0201418402001,0.0220457704595,0.0183278254864
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2717.4555337799998,3001.5284112,2458.16466098
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1204.98159635,1352.06708849,1079.49721251
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1957.3903497699998,2141.4541160100002,1782.0868788500002
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1279103.91305,1425341.19089,1143325.39545
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1709585.21624,1919679.65981,1520750.69266
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2988689.12929,3330805.47552,2700113.4606
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0386742825307,0.043114829952,0.0345770556985
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0497836388164,0.0558609233244,0.0442578463728
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0443332460233,0.0494114274172,0.040042342618
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3706.5440611,4130.30549921,3313.0896647000004
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4904.07488412,5506.74673353,4362.388728
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4308.34053695,4801.5178662200005,3892.34469475
5,Prevalence,1,Global,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34321573.6142,37609751.569,31425977.0838
5,Prevalence,1,Global,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,18769707.5376,20773002.3306,17068304.3589
5,Prevalence,1,Global,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,53091281.1518,58224361.7829,48558186.286
5,Prevalence,1,Global,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0182727083832,0.0200325902728,0.0167332348819
5,Prevalence,1,Global,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101365065281,0.0112154763119,0.00921805874613
5,Prevalence,1,Global,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0142336193817,0.0156021752233,0.0130231082551
5,Prevalence,1,Global,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1763.15672633,1932.07593568,1614.4050823500002
5,Prevalence,1,Global,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1002.3430432399999,1109.32332491,911.4844277520001
5,Prevalence,1,Global,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1390.1220757600001,1524.52472244,1271.42923001
5,Prevalence,1,Global,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,62624496.909,69218584.2755,56937806.3013
5,Prevalence,1,Global,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,90574053.7264,100094540.887,82297108.4769
5,Prevalence,1,Global,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,153198550.635,168995555.422,139252105.417
5,Prevalence,1,Global,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.033341115868,0.0368816332619,0.0302936830111
5,Prevalence,1,Global,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0489141739395,0.0540406916247,0.0444589985159
5,Prevalence,1,Global,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0410720996609,0.0453114039264,0.0373132416778
5,Prevalence,1,Global,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3217.1253043200004,3555.87461765,2924.99048241
5,Prevalence,1,Global,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4836.85067914,5345.265317689999,4394.84387251
5,Prevalence,1,Global,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4011.29305214,4424.91586568,3646.12459215
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5070.06605207,5679.3641544,4469.24774676
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2925.46430846,3341.25267171,2562.79703371
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7995.53036054,8946.45716505,7112.71914962
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.014940445133,0.0167070326318,0.0131846065261
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00841326126974,0.00961204694837,0.00737405095861
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.011637090147,0.0130346253747,0.0103611210507
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1440.2859410600001,1613.3731319800002,1269.60766007
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,832.218496408,950.499469957,729.049090712
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1136.46484753,1271.6272241499998,1010.98425237
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,13175.8738597,14878.5487962,11776.8100319
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,18587.0438309,21095.1534208,16534.4508811
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,31762.9176906,35390.6880708,28642.0089384
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0388268617806,0.0437528305447,0.0346788664071
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0534539343858,0.06063863942,0.0475920847262
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0462294904404,0.0515180205518,0.0416870440039
5,Prevalence,119,Trinidad and Tobago,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3742.95436912,4226.6440781,3345.51340069
5,Prevalence,119,Trinidad and Tobago,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5287.5304699200005,6001.02240542,4703.62116926
5,Prevalence,119,Trinidad and Tobago,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4514.70231274,5030.3445936299995,4071.10408607
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34643.8463643,40621.9918014,29212.3660507
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,24832.0444577,29213.0075857,20751.0368155
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,59475.890822,69116.4260867,50214.0477774
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00806818952423,0.00945959139387,0.00680263424059
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00576675363754,0.00678562481866,0.00481760233075
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00691583764021,0.00803879523806,0.00583954861996
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,801.9624222379999,940.349134407,676.230335136
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,575.720738329,677.291566737,481.104254498
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,688.929030797,800.598558138,581.646021431
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,148482.369912,167114.820592,131563.53527
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,209270.201937,234893.153069,186413.616855
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,357752.571849,399183.335339,319257.929056
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0345800066371,0.0389084037512,0.0306317175536
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0485989023285,0.0545381367026,0.043282072228
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0415993719224,0.046409440846,0.0371088766392
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3437.18419088,3868.50250128,3045.5339835600003
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4851.84356748,5445.9011518,4321.92304236
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4143.96706267,4623.87338003,3698.0708081700004
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,241926.943912,285204.114451,203908.977503
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,171207.112508,203780.44736,144777.292268
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,413134.056421,482849.169319,350829.233387
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0098844800641,0.0116452060757,0.00833609034048
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00691137819101,0.00823148755413,0.00584220873508
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00838897759506,0.00980764198403,0.00713450583606
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,969.3560294800001,1142.75955999,817.025146562
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,686.1804186859999,816.7309794610001,580.252429757
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,827.7873680499999,967.473963534,702.948602825
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,952649.339494,1074498.63496,850172.40349
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1134973.83166,1277165.9416,1006040.45599
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2087623.17115,2347112.11535,1871288.16422
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0389227022028,0.0438740395862,0.0347852500307
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0458170261151,0.0515524798286,0.0406107397268
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0423905407028,0.0476382991941,0.038018338412
5,Prevalence,179,Ethiopia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3817.0877798300003,4305.31512375,3406.48185809
5,Prevalence,179,Ethiopia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4548.85785756,5118.7491436499995,4032.10620861
5,Prevalence,179,Ethiopia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4182.92334769,4702.85547824,3749.4577855499997
5,Prevalence,79,Finland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,55866.4413348,61970.5004406,50716.4765405
5,Prevalence,79,Finland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,92754.9839625,102411.26061,84468.8048802
5,Prevalence,79,Finland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,148621.425297,162621.197091,136835.211166
5,Prevalence,79,Finland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0496534962601,0.0549956739188,0.0450643544562
5,Prevalence,79,Finland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0822539787586,0.090820038298,0.0748026797064
5,Prevalence,79,Finland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0659721593697,0.0722241457427,0.060684106445
5,Prevalence,79,Finland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4629.9244602,5135.79760846,4203.121760749999
5,Prevalence,79,Finland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,8064.57650763,8904.14090057,7344.1351651800005
5,Prevalence,79,Finland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6306.09141957,6900.1096818,5805.99566519
5,Prevalence,218,Togo,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,61356.2346127,69377.5821026,54746.0162405
5,Prevalence,218,Togo,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,89249.9436251,101167.477026,79004.1233611
5,Prevalence,218,Togo,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,150606.178238,168992.98293,134537.552295
5,Prevalence,218,Togo,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0345015806101,0.0390418858601,0.0307684679342
5,Prevalence,218,Togo,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0488202449486,0.0553616337581,0.0432244335244
5,Prevalence,218,Togo,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0417596741755,0.0468451371856,0.0372962438967
5,Prevalence,218,Togo,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3404.97011818,3850.11556563,3038.13541631
5,Prevalence,218,Togo,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4865.7060533,5515.42315177,4307.12699258
5,Prevalence,218,Togo,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4141.82662412,4647.48288669,3699.92268949
5,Prevalence,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,25279.2013236,29383.6656169,21630.8826259
5,Prevalence,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,15286.1852201,18224.685979,12841.6935871
5,Prevalence,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,40565.3865437,46699.3220827,34790.474285
5,Prevalence,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00949827697427,0.011027969998,0.00812559081085
5,Prevalence,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00569698709369,0.00678822924378,0.00478761168855
5,Prevalence,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00758989416949,0.00872456045771,0.00650380214824
5,Prevalence,200,Benin,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,941.2770953200001,1094.107803,805.4310777710001
5,Prevalence,200,Benin,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,568.2005279480001,677.4271046619999,477.336691326
5,Prevalence,200,Benin,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,754.577392188,868.677847704,647.155311356
5,Prevalence,200,Benin,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,91023.2570611,102802.349933,80728.9695737
5,Prevalence,200,Benin,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,130134.093099,147435.01361,115252.666448
5,Prevalence,200,Benin,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,221157.35016,248500.656504,196797.116968
5,Prevalence,200,Benin,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0342005248381,0.0386036369014,0.0303413834116
5,Prevalence,200,Benin,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0484995399448,0.0549560341422,0.0429341360585
5,Prevalence,200,Benin,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0413791198967,0.046477173734,0.0368350869599
5,Prevalence,200,Benin,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3389.27270352,3827.8700382399998,3005.9624517300003
5,Prevalence,200,Benin,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4837.19511039,5480.28506557,4284.03980328
5,Prevalence,200,Benin,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4113.86038112,4622.48713295,3660.72329058
5,Prevalence,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,22.8359097,32.4806732443,14.8935073429
5,Prevalence,218,Togo,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,22.8359097,32.4806732443,14.8935073429
5,Prevalence,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.28409736761e-05,1.82203768649e-05,8.3967361289e-06
5,Prevalence,218,Togo,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.33188164005e-06,8.99305195046e-06,4.13552100995e-06
5,Prevalence,218,Togo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.26728099664,1.80251807356,0.826516616893
5,Prevalence,218,Togo,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,218,Togo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.628011280069,0.893252313992,0.40958695029000003
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,351.667994964,525.018162143,225.037855595
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,351.667994964,525.018162143,225.037855595
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.8389827216e-06,1.17410402813e-05,5.02705488544e-06
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.89776434334e-06,5.83358392478e-06,2.49649789236e-06
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.770731799768,1.15065402258,0.49320334503799995
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.38547631882000005,0.575491859807,0.246672331325
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,379.247052729,462.544743666,310.981161972
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,379.247052729,462.544743666,310.981161972
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.45376292648e-06,1.03084509386e-05,6.94712359114e-06
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.20342203651e-06,5.1318559243e-06,3.45716407346e-06
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.8311753349529999,1.0137343968299999,0.68156065975
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.41570674585899997,0.507012431132,0.340877973702
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,58208.3370134,66313.7483501,51451.1680333
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,31291.708771,36694.4884295,26750.6104625
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,89500.0457843,102772.880756,78767.3250374
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.021113264785,0.0241128102257,0.0186445784408
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112548539731,0.013190335346,0.00962450416526
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0161632838552,0.0185591328257,0.0142389015743
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2064.00318139,2351.4120929700002,1824.40145099
5,Prevalence,121,Bolivia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1117.22066227,1310.1183116900002,955.0879741279999
5,Prevalence,121,Bolivia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1592.2385081,1828.3670907100002,1401.29948544
5,Prevalence,121,Bolivia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,75866.9837476,85373.6391361,67849.8086786
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.984428026555,1.56169305797,0.693083570759
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.984428026555,1.56169305797,0.693083570759
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.57142456478e-05,5.66093835928e-05,2.5117258093e-05
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.83899596625e-05,2.91288448921e-05,1.29318793335e-05
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.51079895348,5.56951875168,2.47176737075
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8180989265,2.88422555599,1.2800270430999998
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.36782584189,1.8451498953,0.900000261071
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.36782584189,1.8451498953,0.900000261071
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.9622651369e-05,6.69833936095e-05,3.26579693856e-05
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.55518795381e-05,3.44844814375e-05,1.68171429339e-05
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.87812354454,6.58042045399,3.2097013590300003
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.52618030745,3.4077301269299998,1.6621728195099998
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,56039.8980801,65965.059295,47439.9160377
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,41198.2832914,48719.7264048,34833.1638532
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,97238.1813715,113714.593792,82604.9383774
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00937752947753,0.0110366288674,0.00794918914625
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00682317331961,0.00806487295499,0.00577046872778
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00809375897702,0.00946646756369,0.0068784425252
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,930.651985461,1095.47867693,787.8324829850001
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,680.575149999,804.8256494409999,575.426542574
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,805.2834773459999,941.733815075,684.097451066
5,Prevalence,82,Greece,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,89469.9644112,101171.241,79829.3167092
5,Prevalence,82,Greece,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,165550.58952,184894.392065,146442.278958
5,Prevalence,82,Greece,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,255020.553931,282703.190084,228447.358706
5,Prevalence,82,Greece,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0384759308318,0.0434594786384,0.0342310889458
5,Prevalence,82,Greece,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0699941794768,0.0781705659973,0.0619570915049
5,Prevalence,82,Greece,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0543689012627,0.0602582799788,0.0486204197582
5,Prevalence,82,Greece,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3629.13465966,4103.76889819,3238.08489288
5,Prevalence,82,Greece,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6893.52084594,7698.99611767,6097.85145222
5,Prevalence,82,Greece,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5239.93592135,5808.7341509,4693.93349895
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.46887316295,7.33786425617,3.35211218393
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.46887316295,7.33786425617,3.35211218393
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.83006243681e-05,3.01736704678e-05,1.36959896424e-05
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.86184255193e-06,1.62189538406e-05,7.38023499111e-06
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.77826685446,2.91990403699,1.33388211564
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.966978795311,1.5877736690800002,0.725333050003
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3565.6975387,5103.70881126,2246.93540819
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3565.6975387,5103.70881126,2246.93540819
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000107811428263,0.000154440589861,6.8141381427e-05
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.28929590241e-05,7.57396063639e-05,3.33892272355e-05
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.332557739,14.7893547904,6.51109343652
5,Prevalence,62,Russian Federation,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.1401261837300005,7.3572441325,3.23906652189
5,Prevalence,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,31.6189456886,41.6876979597,20.9750514667
5,Prevalence,200,Benin,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,31.6189456886,41.6876979597,20.9750514667
5,Prevalence,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.18804878147e-05,1.56690247937e-05,7.87347500538e-06
5,Prevalence,200,Benin,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.91603868389e-06,7.80683124376e-06,3.9220353461e-06
5,Prevalence,200,Benin,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.17733899002,1.5522513842,0.781011048014
5,Prevalence,200,Benin,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,200,Benin,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.588160094462,0.775454077797,0.39016760310299997
5,Prevalence,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,25.9891187367,32.8862666677,19.7094545799
5,Prevalence,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,25.9891187367,32.8862666677,19.7094545799
5,Prevalence,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.76497541152e-06,1.23491305731e-05,7.40570552886e-06
5,Prevalence,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.86262528913e-06,6.15077495227e-06,3.68843040953e-06
5,Prevalence,200,Benin,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.9677110396490001,1.2245279891799998,0.733886245845
5,Prevalence,200,Benin,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.483436819231,0.611734176726,0.366625591558
5,Prevalence,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1692.59823589,2518.02955704,733.949638661
5,Prevalence,142,Iran,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1692.59823589,2518.02955704,733.949638661
5,Prevalence,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.44701243485e-05,0.000110920084411,3.21567764085e-05
5,Prevalence,142,Iran,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.68054474264e-05,5.4772034853e-05,1.59203451127e-05
5,Prevalence,142,Iran,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.17973551823,10.6810853653,3.11329893743
5,Prevalence,142,Iran,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,142,Iran,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.5910284046100003,5.34226934147,1.55715275138
5,Prevalence,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2125.42257513,2617.02029331,1712.08972422
5,Prevalence,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2125.42257513,2617.02029331,1712.08972422
5,Prevalence,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.35127552101e-05,0.000114897998644,7.52828394252e-05
5,Prevalence,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.62173551349e-05,5.68092460423e-05,3.72095141579e-05
5,Prevalence,142,Iran,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.01570829413,11.1009885001,7.262415346289999
5,Prevalence,142,Iran,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.50931158811,5.552288788609999,3.63238168431
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,39.5703133307,68.5677637391,28.8504815954
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,39.5703133307,68.5677637391,28.8504815954
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.92939912014e-05,3.34679501979e-05,1.40797177975e-05
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.86545208093e-06,1.71086778616e-05,7.19693669451e-06
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.9146024274499998,3.3176388016500002,1.39592531487
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.98165394427,1.70101801221,0.715718089355
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,58.6922558697,76.025043895,43.1119783087
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,58.6922558697,76.025043895,43.1119783087
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.86176173841e-05,3.70642056205e-05,2.09895871938e-05
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.46328743185e-05,1.895972526e-05,1.07396095813e-05
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.83981414606,3.6784579483099997,2.0859652445
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.45602800744,1.8860170143,1.06951499722
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,220482.182907,248407.423086,197685.126517
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,280483.109058,315014.137837,248784.487761
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,500965.291965,561617.532848,449983.986539
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.036894585674,0.04152123577,0.0331135782983
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0464530620181,0.0521790157907,0.0412097878399
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0416984918254,0.0467462946453,0.0374546087501
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3661.5373744700005,4125.29054153,3282.9477174599997
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4633.4414633,5203.87688471,4109.7960048
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4148.77228938,4651.06723934,3726.56773625
5,Prevalence,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,25.4842660748,49.7870349268,15.6974338024
5,Prevalence,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,25.4842660748,49.7870349268,15.6974338024
5,Prevalence,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.43300380493e-05,2.80789909105e-05,8.82337168885e-06
5,Prevalence,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.06618136794e-06,1.38317441266e-05,4.3512579515e-06
5,Prevalence,218,Togo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.41425178739,2.7629362732000002,0.871130592786
5,Prevalence,218,Togo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.700843836287,1.36919526947,0.431695764502
5,Prevalence,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,84.3077327815,144.478605205,41.8828162406
5,Prevalence,46,Croatia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,84.3077327815,144.478605205,41.8828162406
5,Prevalence,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.35299057172e-05,0.000160609378213,4.63598864796e-05
5,Prevalence,46,Croatia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.67152722598e-05,8.01204933666e-05,2.3152381232e-05
5,Prevalence,46,Croatia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.85268331212,15.170889965399999,4.39788019633
5,Prevalence,46,Croatia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,46,Croatia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.48973635664,7.694084814589999,2.2304336339
5,Prevalence,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1601.2429622,2721.82821693,913.291954028
5,Prevalence,101,Canada,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1601.2429622,2721.82821693,913.291954028
5,Prevalence,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000206938680036,0.000352937885926,0.000117908061439
5,Prevalence,101,Canada,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000100027311536,0.000170368068737,5.70182814612e-05
5,Prevalence,101,Canada,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,18.7736896978,31.9119331429,10.7078439395
5,Prevalence,101,Canada,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,101,Canada,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.41797015197,16.0088740503,5.37167473401
5,Prevalence,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4871.09333912,5909.26050773,3958.67201927
5,Prevalence,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4871.09333912,5909.26050773,3958.67201927
5,Prevalence,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00062946524806,0.000763757599513,0.000510535148983
5,Prevalence,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000304273694835,0.00036925059477,0.000246738173022
5,Prevalence,101,Canada,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,57.1108801078,69.2828169956,46.4132438734
5,Prevalence,101,Canada,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,28.6501254077,34.756273967,23.2835714498
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,81.5181735141,108.70834448,54.7995069715
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,81.5181735141,108.70834448,54.7995069715
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.42717770105e-05,1.9036832718e-05,9.58726088541e-06
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.12406028997e-06,9.5046472116e-06,4.78476867322e-06
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.41004969212,1.88036803398,0.947887134884
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.707149391207,0.9430171985470001,0.47537176463599995
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,562.856657091,727.460273486,438.534380419
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,562.856657091,727.460273486,438.534380419
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.15210663853e-05,9.22571969594e-05,5.58846549754e-05
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.4913053191e-05,4.50736452231e-05,2.72607983261e-05
5,Prevalence,41,Uzbekistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.86783012418,8.87628051913,5.35088213027
5,Prevalence,41,Uzbekistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.4013407602799997,4.39603982386,2.6500616882
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,17.882724344,24.3610592817,11.8505901472
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,17.882724344,24.3610592817,11.8505901472
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.14436791624e-05,1.55822599834e-05,7.57763730391e-06
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.62723174554e-06,7.66323914284e-06,3.72726288263e-06
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.13392147821,1.5447047004799999,0.751431294189
5,Prevalence,217,Sierra Leone,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.5594834389350001,0.762166265095,0.370760562061
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,16.947254537,21.0736911392,13.2755375833
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,16.947254537,21.0736911392,13.2755375833
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.0844948859e-05,1.34868445496e-05,8.49405623759e-06
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.33284796202e-06,6.63122055275e-06,4.17669697868e-06
5,Prevalence,217,Sierra Leone,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.07460449239,1.33625674412,0.841785452311
5,Prevalence,217,Sierra Leone,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.5302160938380001,0.65931683354,0.415341828118
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9996.06159809,12058.6410678,8266.83599869
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9996.06159809,12058.6410678,8266.83599869
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000302238341523,0.000363534850658,0.000249774419087
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000148279435867,0.00017865665441,0.000122677231289
5,Prevalence,62,Russian Federation,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,28.9662492412,34.9431222739,23.9553577801
5,Prevalence,62,Russian Federation,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,14.409808290500001,17.3831167731,11.9170456025
5,Prevalence,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1445.46389246,1592.46835431,1295.19092381
5,Prevalence,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,834.888851556,938.946151188,741.822874938
5,Prevalence,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2280.35274402,2515.16041686,2052.58890439
5,Prevalence,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0192158323179,0.021224550967,0.0172405270785
5,Prevalence,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0109300777989,0.0122947868087,0.00972038949734
5,Prevalence,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0150411697516,0.0165877515218,0.0135537767819
5,Prevalence,83,Iceland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1816.19188067,2000.8995799999998,1627.37737831
5,Prevalence,83,Iceland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1076.49641518,1210.66674195,956.4981782709999
5,Prevalence,83,Iceland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1451.12541169,1600.5476367400001,1306.18560077
5,Prevalence,83,Iceland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2412.01313404,2693.43306554,2152.3436318
5,Prevalence,83,Iceland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,4146.51807647,4648.10871415,3683.25157842
5,Prevalence,83,Iceland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,6558.53121051,7311.14119884,5871.41272517
5,Prevalence,83,Iceland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0320649847025,0.0358308707652,0.0286875492738
5,Prevalence,83,Iceland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0542850135565,0.0608539142386,0.0481859542853
5,Prevalence,83,Iceland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0432600848135,0.0482871991249,0.0388228629933
5,Prevalence,83,Iceland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3030.63860188,3384.2362236,2704.3698904400003
5,Prevalence,83,Iceland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5346.47436781,5993.21976673,4749.14368902
5,Prevalence,83,Iceland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4173.58732235,4652.51826057,3736.3325609900003
5,Prevalence,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,645.56453586,818.570727375,506.487643978
5,Prevalence,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,645.56453586,818.570727375,506.487643978
5,Prevalence,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000716206339848,0.000907099270955,0.000562198773003
5,Prevalence,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000357721233459,0.000452744410071,0.000280720286183
5,Prevalence,46,Croatia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,67.78711993499999,85.9535321251,53.1834336628
5,Prevalence,46,Croatia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.3789883986,43.5922854752,26.972567217
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,672.560109899,912.447143789,395.677716628
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,672.560109899,912.447143789,395.677716628
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.51430951259e-05,8.82370272638e-05,3.8253280908e-05
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.2066396691e-05,4.34839180577e-05,1.88649051626e-05
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.19909712546,8.41017536269,3.64702657749
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.1049701470900004,4.2124430226700005,1.82670289231
5,Prevalence,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,56.5867243789,79.4421201251,28.727960345
5,Prevalence,182,Malawi,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,56.5867243789,79.4421201251,28.727960345
5,Prevalence,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.3800154758e-05,1.93730665729e-05,7.01902770608e-06
5,Prevalence,182,Malawi,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.91044918597e-06,9.70749821984e-06,3.5115633518e-06
5,Prevalence,182,Malawi,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.36218285665,1.91236894021,0.6915532842359999
5,Prevalence,182,Malawi,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,182,Malawi,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.684716498502,0.961273707263,0.347617018522
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,594953.636333,694436.847736,507370.004405
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,285521.603669,352273.860168,235516.293888
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,880475.240002,1032970.58218,750996.682818
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0132621066795,0.0154925802754,0.0112683944769
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00629430811479,0.00775762124819,0.00518836433563
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00975885672691,0.0114421439929,0.00832759453719
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1303.92783386,1521.9598290000001,1111.975506
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,626.121019632,772.502205382,516.464254103
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,965.121532777,1132.27732739,823.195288978
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1557967.36836,1761927.4891,1386475.59594
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2659939.48901,2988688.42429,2376684.16408
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,4217906.85737,4730198.81679,3776028.36377
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0347283314362,0.0394143317694,0.0308820057441
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0586381962237,0.0658423386707,0.0523753483246
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467494826798,0.0525714276339,0.0417988742592
5,Prevalence,161,Bangladesh,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3414.51315159,3861.52156064,3038.66387245
5,Prevalence,161,Bangladesh,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5832.98777962,6553.90211996,5211.83648816
5,Prevalence,161,Bangladesh,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4623.4039827,5184.94618019,4139.04459396
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,8.2236744191,10.2639379871,6.56848038053
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,8.2236744191,10.2639379871,6.56848038053
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000364224158119,0.000455372003409,0.000292382318753
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000171209087168,0.000213748630147,0.000137194284528
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,35.0764680177,43.778811537500005,28.016562943900002
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,16.7079935374,20.853185670600002,13.345145023399999
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,334.471456687,380.889675938,295.161769012
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,209.229574035,240.11178255,183.295927122
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,543.701030722,615.349195187,480.490695974
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148135863539,0.0168456675024,0.0130681956277
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00821979336767,0.00943935790556,0.00720851380832
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113193048724,0.0128142274385,0.0100214762833
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1426.62230475,1624.6101019300002,1258.95455281
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,811.7536095419999,931.5681450750001,711.1381416439999
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1104.63435742,1250.20153431,976.210272194
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,591.989004843,665.765232875,526.729928688
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1102.5513318,1246.06334161,977.167067962
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1694.54033664,1888.79261205,1516.58677387
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0262189112425,0.0295535709905,0.0233131965258
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0433147211277,0.0489383764593,0.03838927562
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0352785506823,0.0393838152709,0.0315313859443
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2525.01282723,2839.6908374699997,2246.66305547
5,Prevalence,105,Antigua and Barbuda,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4277.5980758099995,4834.38548273,3791.14137284
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3442.7881687199997,3837.44943529,3081.24090588
5,Prevalence,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,99642.3927237,112880.739044,87295.7279819
5,Prevalence,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,60274.8335273,70613.5369979,51842.1859915
5,Prevalence,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,159917.226251,180461.661757,141425.304237
5,Prevalence,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119533812289,0.0135148184965,0.010469700332
5,Prevalence,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00724086703014,0.00846626154714,0.0062295034554
5,Prevalence,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00959876043844,0.0108177390323,0.00848782218099
5,Prevalence,123,Peru,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1166.82275248,1321.84516081,1022.2420279099999
5,Prevalence,123,Peru,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,718.818297084,842.114352633,618.253252159
5,Prevalence,123,Peru,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,944.8635827620001,1066.24943589,835.604911286
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,60.1437716415,79.8458132142,31.6020994202
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,60.1437716415,79.8458132142,31.6020994202
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.05295661888e-05,1.39726659425e-05,5.53094500932e-06
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.25606869481e-06,6.9709225239e-06,2.76027595163e-06
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.0403288374900002,1.38112226374,0.546633083603
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.521731899376,0.692642091583,0.274140162893
5,Prevalence,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26258.3599454,28426.1345257,24272.312912
5,Prevalence,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12034.3098281,13314.694644,10836.7014854
5,Prevalence,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,38292.6697735,41348.5248812,35378.1017153
5,Prevalence,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0258111337272,0.0279095356771,0.023838015756
5,Prevalence,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110134480368,0.0121938517357,0.00991217712311
5,Prevalence,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0181479834284,0.0196422918506,0.0167686663456
5,Prevalence,84,Ireland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2421.5418198,2621.45365029,2238.38887509
5,Prevalence,84,Ireland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1082.07042237,1197.1968033800001,974.386925451
5,Prevalence,84,Ireland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1743.3325751300001,1882.4550700000002,1610.6423900799998
5,Prevalence,84,Ireland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,46083.9257135,51629.2842345,41315.4098233
5,Prevalence,84,Ireland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,73368.173721,81743.9379845,65769.0630403
5,Prevalence,84,Ireland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,119452.099434,132594.336646,107960.793574
5,Prevalence,84,Ireland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0452983374866,0.0507294118619,0.0406338309233
5,Prevalence,84,Ireland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0671447590515,0.0748107203892,0.0601398612761
5,Prevalence,84,Ireland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.056611615114,0.0629438696719,0.0512419755709
5,Prevalence,84,Ireland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4249.85237341,4761.244463110001,3810.10058882
5,Prevalence,84,Ireland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6596.93259195,7350.043231760001,5913.65511103
5,Prevalence,84,Ireland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5438.24019958,6036.5607235,4915.0808597800005
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12602.1124456,14874.9048771,10703.9536526
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,9151.45501552,10834.4988766,7692.42014585
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,21753.5674612,25476.5408579,18513.5409834
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00979413145319,0.0115847190928,0.00833628984091
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00706053031662,0.00835828084847,0.00593366278515
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00842232799649,0.00985352290027,0.0071754775057
5,Prevalence,178,Eritrea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,961.541912903,1134.95610767,816.7122865450001
5,Prevalence,178,Eritrea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,701.243730855,830.209447707,589.443033182
5,Prevalence,178,Eritrea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,831.670620213,974.0053245989999,707.799681108
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2361.18125616,2930.20986075,1959.27045676
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2361.18125616,2930.20986075,1959.27045676
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000228685928337,0.000283865812859,0.000189434342841
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000112572873673,0.000139667650017,9.33014749883e-05
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.7633958992,27.008226116,18.0589179729
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.9007317032,13.5277338166,9.04525289083
5,Prevalence,123,Peru,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,183270.93115,206510.74879,162786.682333
5,Prevalence,123,Peru,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,275100.816119,310242.146651,243325.876741
5,Prevalence,123,Peru,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,458371.747269,512978.089248,408345.140374
5,Prevalence,123,Peru,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0219856734248,0.0248089928713,0.0195174923825
5,Prevalence,123,Peru,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.033048061324,0.0372504232164,0.0292135378474
5,Prevalence,123,Peru,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0275130057476,0.0307951034155,0.0245427661351
5,Prevalence,123,Peru,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2146.1216103700003,2418.26228508,1906.24893235
5,Prevalence,123,Peru,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3280.7639373999996,3699.84815368,2901.82622034
5,Prevalence,123,Peru,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2708.26840557,3030.90746787,2412.68849756
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.4004921093,14.2907280875,6.34860746842
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.4004921093,14.2907280875,6.34860746842
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.05407005184e-05,4.19678571307e-05,1.86444926356e-05
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.53255863371e-05,2.10569990581e-05,9.35488561726e-06
5,Prevalence,197,Swaziland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.03377004115,4.168531862,1.85185613704
5,Prevalence,197,Swaziland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,197,Swaziland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.5262363700500001,2.09711509152,0.931636264487
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,66.0112852772,85.0681451739,50.8889198024
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,66.0112852772,85.0681451739,50.8889198024
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.10460878558e-05,1.4250153997e-05,8.52662361439e-06
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.49453795634e-06,7.08408882057e-06,4.23919531737e-06
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.09624634967,1.41272273716,0.8451099283660001
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.546676178044,0.704496636926,0.42143945638299996
5,Prevalence,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1381.8440051,1885.57692276,1106.22330766
5,Prevalence,125,Colombia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1381.8440051,1885.57692276,1106.22330766
5,Prevalence,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000109530665894,0.000149494231884,8.76575409371e-05
5,Prevalence,125,Colombia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.36564296958e-05,7.32503006296e-05,4.29771426803e-05
5,Prevalence,125,Colombia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.5848580155,14.4434277176,8.47361684954
5,Prevalence,125,Colombia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,125,Colombia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.25193333877,7.16645603044,4.20438996603
5,Prevalence,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,15.4429741282,21.5036649233,11.1097348217
5,Prevalence,83,Iceland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,15.4429741282,21.5036649233,11.1097348217
5,Prevalence,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000205306944814,0.000286482133436,0.000147228520925
5,Prevalence,83,Iceland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000101865074785,0.000141983294542,7.31703564749e-05
5,Prevalence,83,Iceland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.4037390843,27.0188566052,13.9591243232
5,Prevalence,83,Iceland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,83,Iceland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.82729196096,13.6840735261,7.06979153077
5,Prevalence,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,33.5472584579,41.0849365496,27.1323184839
5,Prevalence,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,33.5472584579,41.0849365496,27.1323184839
5,Prevalence,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000445982999905,0.000545427125765,0.000361735889237
5,Prevalence,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000221280042867,0.000270455954159,0.000179521602382
5,Prevalence,83,Iceland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,42.151352758,51.6222705863,34.0911293539
5,Prevalence,83,Iceland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.3481354446,26.144812736200002,17.265923850300002
5,Prevalence,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,162204.367666,190662.014642,138026.245004
5,Prevalence,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,106763.147341,130545.521406,88350.521798
5,Prevalence,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,268967.515007,316755.804841,229304.428952
5,Prevalence,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0160886201415,0.0188822175258,0.0136860812101
5,Prevalence,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106311005722,0.0130014780432,0.00880815878891
5,Prevalence,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133652018331,0.0157492692788,0.0114056428063
5,Prevalence,522,Sudan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1597.80339811,1878.12707678,1359.63541839
5,Prevalence,522,Sudan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1059.7888231,1295.8655485299998,877.0151297400001
5,Prevalence,522,Sudan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1329.82964757,1566.10459187,1133.72734968
5,Prevalence,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,79.3272566482,99.9182110556,63.3673465797
5,Prevalence,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,79.3272566482,99.9182110556,63.3673465797
5,Prevalence,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.65605263856e-05,9.63636829549e-05,6.11766165767e-05
5,Prevalence,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.79045027286e-05,4.7708248782e-05,3.02757624535e-05
5,Prevalence,61,Moldova,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.331227684879999,9.23419245875,5.85625250628
5,Prevalence,61,Moldova,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.68412393947,4.64041098725,2.94291228991
5,Prevalence,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1704.57813658,2104.44019192,1382.07319726
5,Prevalence,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1704.57813658,2104.44019192,1382.07319726
5,Prevalence,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000135112782839,0.000166783342331,0.00010966831823
5,Prevalence,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.61887223921e-05,8.17151791074e-05,5.36786613057e-05
5,Prevalence,125,Colombia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,13.0569857997,16.1199097376,10.586613616400001
5,Prevalence,125,Colombia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.478539336590001,7.99828313662,5.25280442261
5,Prevalence,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,18391.2338666,23315.9398318,14533.7505419
5,Prevalence,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,18391.2338666,23315.9398318,14533.7505419
5,Prevalence,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00108854000028,0.00137279046221,0.000861363470173
5,Prevalence,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000541432674195,0.000684415229766,0.000428425914657
5,Prevalence,81,Germany,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,101.969807446,129.274735579,80.5820726861
5,Prevalence,81,Germany,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,51.911886067,65.8125724934,41.0235880706
5,Prevalence,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,637.132908404,822.247857397,356.294419568
5,Prevalence,123,Peru,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,637.132908404,822.247857397,356.294419568
5,Prevalence,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.64329262429e-05,9.8251830013e-05,4.2852593674e-05
5,Prevalence,123,Peru,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.82430274073e-05,4.9236046147e-05,2.14207680335e-05
5,Prevalence,123,Peru,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.460892433000001,9.628607683550001,4.17224460361
5,Prevalence,123,Peru,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,123,Peru,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.76447051167,4.85821368137,2.10514920552
5,Prevalence,164,Nepal,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,220046.98558,247779.806285,196209.962426
5,Prevalence,164,Nepal,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,356779.920555,401057.957636,316705.240865
5,Prevalence,164,Nepal,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,576826.906135,647388.560429,514646.809459
5,Prevalence,164,Nepal,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0318051731801,0.0358799512008,0.0283707873308
5,Prevalence,164,Nepal,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0447758016001,0.0503834007432,0.0397146742105
5,Prevalence,164,Nepal,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0387476340854,0.0434739333289,0.0345684859076
5,Prevalence,164,Nepal,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3116.89891248,3509.72591925,2779.25469823
5,Prevalence,164,Nepal,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4444.61119456,4996.20798559,3945.3780266999997
5,Prevalence,164,Nepal,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3823.3241605000003,4291.02092499,3411.18203711
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,47.4115468747,57.7291439704,34.9487122005
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,47.4115468747,57.7291439704,34.9487122005
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000470575711105,0.000572511275095,0.000346481256306
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000230702136995,0.000280795012275,0.000170018731331
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,45.0860147428,54.8975346243,33.2344809943
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,22.4420620456,27.3258544854,16.542830161
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.99960130862,4.79630615389,3.31432430876
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.99960130862,4.79630615389,3.31432430876
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.96966897302e-05,4.76394191204e-05,3.29796096118e-05
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.94616382707e-05,2.33536357895e-05,1.61378426071e-05
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.80342122232,4.56104776621,3.15175699798
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.8931949418,2.27031192591,1.5688218731399999
5,Prevalence,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,88.7656554321,135.275264944,65.0202878749
5,Prevalence,85,Israel,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,88.7656554321,135.275264944,65.0202878749
5,Prevalence,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.89428655628e-05,7.47594596778e-05,3.59119560605e-05
5,Prevalence,85,Israel,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.4088248346e-05,3.67449430248e-05,1.76529708309e-05
5,Prevalence,85,Israel,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.5851497017,6.9875825023500004,3.35859350221
5,Prevalence,85,Israel,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,85,Israel,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.31038544391,3.5209338738900002,1.69234289922
5,Prevalence,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,42343.2011836,49334.210468,36602.1684531
5,Prevalence,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21916.5887635,26319.8253358,18372.1180872
5,Prevalence,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,64259.7899471,74506.9862186,55950.6827472
5,Prevalence,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0205456503267,0.0239269680415,0.017842485046
5,Prevalence,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0111137534963,0.0133400100658,0.00931694330909
5,Prevalence,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0159336601613,0.0184828684676,0.0138792015589
5,Prevalence,144,Jordan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1999.45888286,2329.5764749,1728.36556519
5,Prevalence,144,Jordan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1102.3531642,1323.82566709,924.0745777100001
5,Prevalence,144,Jordan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1565.0609228,1814.63357883,1362.69084048
5,Prevalence,144,Jordan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,78628.3682339,88295.0095363,69850.1755489
5,Prevalence,144,Jordan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,104288.579456,117823.625653,92476.4796767
5,Prevalence,144,Jordan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,182916.94769,204491.673372,164165.024725
5,Prevalence,144,Jordan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0381519175067,0.0429486701338,0.0339031196538
5,Prevalence,144,Jordan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0528838734669,0.0597028668682,0.0469188272598
5,Prevalence,144,Jordan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0453554326216,0.050653784924,0.0407046414243
5,Prevalence,144,Jordan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3712.85554506,4169.31729758,3298.3466074
5,Prevalence,144,Jordan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5245.4716741600005,5926.25284698,4651.350677140001
5,Prevalence,144,Jordan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4454.98136834,4980.4384249899995,3998.2742754
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.815387013792,1.0124838491,0.661034890624
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.815387013792,1.0124838491,0.661034890624
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.671909315e-05,5.78216396154e-05,3.77892193719e-05
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.29175613132e-05,2.84217174871e-05,1.8560129035e-05
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.43374996489,5.50548408848,3.59444456867
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.21499728022,2.75041046042,1.7957000296699999
5,Prevalence,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,803.266848477,947.770336962,690.552421375
5,Prevalence,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,397.20420123,463.42304015,341.025015187
5,Prevalence,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1200.47104971,1397.02708241,1036.77116409
5,Prevalence,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0171660099835,0.0202453638901,0.0147791115845
5,Prevalence,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00922885138598,0.0107645480552,0.00792651127104
5,Prevalence,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133632849086,0.0155495041932,0.0115492531788
5,Prevalence,27,Samoa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1669.99379517,1970.41691061,1435.66021817
5,Prevalence,27,Samoa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,915.2381419610001,1067.8196275300002,785.7900301560001
5,Prevalence,27,Samoa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1312.0047005,1526.822408,1133.09574684
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2.70633344189,4.16718409207,1.46663729791
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2.70633344189,4.16718409207,1.46663729791
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.10823775536e-05,1.70937326761e-05,5.9979555376e-06
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.97212663453e-06,9.20412358895e-06,3.23650741295e-06
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.07691198236,1.6582178721899998,0.5836085293300001
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.585598864843,0.901699042746,0.317352297946
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2507.47707154,2964.25552765,2142.65699041
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1342.55704998,1571.07103,1147.03002125
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3850.03412152,4474.05175659,3331.48704301
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0169315285024,0.0200243215808,0.0144463444267
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00911116263968,0.0106630080613,0.00778236281507
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0130311694454,0.0151432992384,0.0112786882422
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1678.5443794700002,1984.3190239799999,1434.3281098
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,908.748011656,1063.4242133,776.399968356
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1295.77978748,1505.80115691,1121.2559256200002
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,4753.8297535,5371.74918031,4213.19605155
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,5747.9468698,6484.72015875,5090.88465125
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,10501.7766233,11762.6468938,9334.53955854
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.032099868134,0.0362355211954,0.0284340386955
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0390080969463,0.0439866797335,0.0345536178535
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0355452880003,0.0398209603942,0.0316040776118
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3182.28800744,3595.9329386900004,2820.37934951
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3890.6616959800003,4389.367699869999,3445.91040244
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3534.5115008300004,3958.8740284200003,3141.66246418
5,Prevalence,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,90541.2336218,102849.81751,79420.9670057
5,Prevalence,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,68316.3342441,77774.1154303,59614.3720536
5,Prevalence,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,158857.567866,179419.008151,140310.874315
5,Prevalence,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00789587508016,0.0089611262706,0.00693665198453
5,Prevalence,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00596439637585,0.00678592489609,0.00520995834479
5,Prevalence,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0069306785702,0.00782324434567,0.00612382073814
5,Prevalence,180,Kenya,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,777.906331712,883.6584289389999,682.3639421849999
5,Prevalence,180,Kenya,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,593.241462099,675.370399507,517.675862303
5,Prevalence,180,Kenya,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,686.065648225,774.865307236,605.9671706749999
5,Prevalence,180,Kenya,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,399664.001315,447750.778852,358216.288753
5,Prevalence,180,Kenya,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,501584.889385,561880.858065,444624.247389
5,Prevalence,180,Kenya,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,901248.890699,1011153.09153,803125.313555
5,Prevalence,180,Kenya,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0348538664551,0.0390016284089,0.0312376528477
5,Prevalence,180,Kenya,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0437912391048,0.0490423625635,0.0388150821931
5,Prevalence,180,Kenya,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0393200336854,0.0440802501258,0.0350380296213
5,Prevalence,180,Kenya,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3433.8073907700004,3846.95626473,3077.69960709
5,Prevalence,180,Kenya,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4355.63407255,4879.22874452,3861.0025190099996
5,Prevalence,180,Kenya,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3892.26596326,4366.91440335,3468.4950566200005
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,591.989260106,689.883736975,510.58695105
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,283.897298238,325.032458512,243.032017745
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,875.886558344,1006.32553392,762.820489307
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0209833100195,0.0244042453432,0.0180906767525
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00963446971127,0.0110406173377,0.00825264294324
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0151854799193,0.0174458830946,0.0132173062487
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2054.37836959,2394.1012486,1771.8882059500002
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,957.430198622,1096.15657931,819.61397472
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1498.0616887,1721.15636937,1304.68054282
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,952.237284733,1075.86650511,848.564237548
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1110.38298916,1245.02097317,984.755297965
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2062.6202739,2298.10115527,1852.21840583
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0337527125246,0.0381533150232,0.0300525291052
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.037682438718,0.0422210356625,0.033416419234
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0357602932433,0.039857764795,0.0321080570787
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3304.54589687,3733.57597108,2944.76966443
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3744.7140654600003,4198.77429279,3321.04062411
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3527.77694923,3930.5287479099998,3167.9187292599995
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,36.5178556093,113.002068125,20.6579326376
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,36.5178556093,113.002068125,20.6579326376
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.40070971772e-06,1.36236515921e-05,2.49125126484e-06
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.28785777125e-06,7.07898622235e-06,1.29428237823e-06
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.436759089799,1.35152186776,0.24707200643
5,Prevalence,160,Afghanistan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.22764250709800002,0.704424552485,0.128776005563
5,Prevalence,163,India,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4541839.2241,5119444.88585,4040152.6928
5,Prevalence,163,India,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2099740.16456,2395612.33897,1849887.90523
5,Prevalence,163,India,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,6641579.38866,7470478.59069,5894124.05243
5,Prevalence,163,India,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0124374408622,0.0140179358401,0.01107118994
5,Prevalence,163,India,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00617978805557,0.00704861885994,0.00544473668635
5,Prevalence,163,India,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00942134428102,0.0105981171179,0.00835769628975
5,Prevalence,163,India,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1225.9074542,1381.8114947000001,1090.49507432
5,Prevalence,163,India,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,615.03423725,701.6980636540001,541.850089831
5,Prevalence,163,India,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,932.9501050079999,1049.3865054999999,827.9542156850001
5,Prevalence,163,India,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,12208098.1385,13590449.8198,10991233.0018
5,Prevalence,163,India,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,15713187.9715,17482000.8773,14199229.9489
5,Prevalence,163,India,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,27921286.11,31056210.6749,25259215.9627
5,Prevalence,163,India,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0334309379145,0.037258684059,0.0300658287387
5,Prevalence,163,India,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.046245817145,0.0514670240053,0.0417929755496
5,Prevalence,163,India,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396075199909,0.0440465180034,0.0358437174911
5,Prevalence,163,India,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3295.14053034,3668.25704697,2966.69120217
5,Prevalence,163,India,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4602.54499197,5120.64742897,4159.092019369999
5,Prevalence,163,India,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3922.13437255,4362.5007418899995,3548.19039355
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,20852.5057588,23635.2023063,18541.8707072
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,27475.4407994,30960.7052072,24184.8299329
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,48327.9465581,54315.9736462,42921.2772303
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0232595965897,0.0263322850473,0.0206577344158
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0314367374401,0.0353948362773,0.0276760770835
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0272961904307,0.0306655947862,0.0242639844279
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2219.91274745,2516.15261471,1973.92752797
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3087.83949302,3479.53246569,2718.02274417
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2642.12176992,2969.49129118,2346.53547356
5,Prevalence,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,719.743100163,899.388152741,578.466629655
5,Prevalence,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,719.743100163,899.388152741,578.466629655
5,Prevalence,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.63448349839e-05,0.000108151169679,6.92306909905e-05
5,Prevalence,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.32020362683e-05,5.40465524262e-05,3.46291376041e-05
5,Prevalence,123,Peru,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.42826634581,10.5319285421,6.773904224709999
5,Prevalence,123,Peru,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.25256903356,5.31399357164,3.4178434995299996
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,207729.529492,230672.233329,186742.457607
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,102275.986847,115130.414032,90507.8596489
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,310005.516339,343741.828274,279543.029896
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0201187312664,0.0223075419583,0.0181303862845
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00960357638173,0.0108137095151,0.0085070050816
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0147797749361,0.0163686250347,0.0133510767656
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1914.6772313699998,2126.1439052200003,1721.23593878
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,945.9982010099999,1064.89478042,837.1493157360001
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1431.18490006,1586.93341962,1290.55046513
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,23112.7816552,25655.0790528,20739.5278118
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12527.8316298,14032.2753275,11085.8824374
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,35640.613285,39449.6406399,32048.7738728
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143506934968,0.0159847312846,0.0128594056293
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00812108554904,0.00910139523108,0.00719899606445
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113029916057,0.0125184976251,0.0101770142625
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1367.1359185000001,1517.5144466899999,1226.75642539
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,799.290634688,895.2759411300001,707.292552402
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1093.95241543,1210.86664028,983.704553829
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,40957.5619826,46028.6115471,36487.1869706
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,51323.2363059,58023.7772198,45514.5913065
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,92280.7982885,103257.020726,82626.9760316
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0254304274035,0.0286189519322,0.0226879362313
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0332699654355,0.0376421421765,0.0295129292719
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0292657417667,0.0327616258359,0.0261626573855
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2422.6661661000003,2722.62201336,2158.24060542
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3274.48383196,3701.9863525899996,2903.88533691
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2832.46535008,3169.3693464300004,2536.15108378
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2726.92658668,3134.48523587,2341.81420865
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,885.679146238,1046.14365649,745.01429825
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3612.60573292,4115.70841135,3139.854697
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0187412041932,0.0215133335934,0.0160801984083
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00609531286892,0.00719711760758,0.00512747143525
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0124225756313,0.0141359825304,0.0108012452406
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1809.0145260299998,2079.38466367,1553.53500949
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,604.192009905,713.6575825990001,508.23335762100004
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1215.01546764,1384.2222898799998,1056.01671066
5,Prevalence,27,Samoa,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1437.32367428,1606.02295766,1276.49241291
5,Prevalence,27,Samoa,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1609.00951347,1807.32829159,1435.21664775
5,Prevalence,27,Samoa,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3046.33318775,3391.98619685,2724.40901582
5,Prevalence,27,Samoa,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0307161707929,0.0343731418065,0.0273109016725
5,Prevalence,27,Samoa,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0373845683606,0.0420013011603,0.0333238911649
5,Prevalence,27,Samoa,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0339109840059,0.0376959925893,0.0303547700827
5,Prevalence,27,Samoa,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2988.19952828,3338.9257620699996,2653.83093201
5,Prevalence,27,Samoa,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3707.48061815,4164.446857270001,3307.02700005
5,Prevalence,27,Samoa,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3329.3626386,3707.12965996,2977.52905887
5,Prevalence,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,31524.9509028,36287.2819677,27309.8564555
5,Prevalence,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,18655.7562957,21521.7186897,16183.075735
5,Prevalence,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,50180.7071985,57264.8991637,44055.2518156
5,Prevalence,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0141201583405,0.016333260901,0.0122756170373
5,Prevalence,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00831137704286,0.00958660737266,0.00720963844991
5,Prevalence,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112079765373,0.0128569612254,0.00983896906016
5,Prevalence,48,Hungary,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1328.53559938,1529.23143473,1150.90160257
5,Prevalence,48,Hungary,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,812.8202341369999,937.6885153889999,705.08700904
5,Prevalence,48,Hungary,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1074.97110656,1226.72866641,943.751601723
5,Prevalence,48,Hungary,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,64013.3369361,71990.3661028,56658.0429049
5,Prevalence,48,Hungary,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,78911.1363748,89889.8240857,69684.9706057
5,Prevalence,48,Hungary,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,142924.473311,160398.144312,128341.262206
5,Prevalence,48,Hungary,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0286717505384,0.032232456268,0.0253102512008
5,Prevalence,48,Hungary,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0351558959393,0.0400114079693,0.0310482708841
5,Prevalence,48,Hungary,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0319225195536,0.0358104066387,0.0287015268978
5,Prevalence,48,Hungary,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2697.67262182,3033.8433983600003,2387.70322665
5,Prevalence,48,Hungary,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3438.11139722,3916.4463076,3036.13282815
5,Prevalence,48,Hungary,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3061.7280585999997,3436.04903773,2749.32651118
5,Prevalence,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,29448.0529612,34183.5632957,25039.7541315
5,Prevalence,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,18327.0622729,21863.2217162,15351.5863176
5,Prevalence,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,47775.1152341,55259.0839343,40985.583126
5,Prevalence,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00915320055443,0.0106158905154,0.00778307112948
5,Prevalence,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00572332427111,0.00682713895966,0.00479325251385
5,Prevalence,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00744228785393,0.00860791709247,0.00639152860539
5,Prevalence,204,Chad,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,910.729409851,1057.1828456,774.3955273729999
5,Prevalence,204,Chad,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,571.478626523,681.743955015,478.69665814900003
5,Prevalence,204,Chad,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,741.802045652,858.0052879510001,636.381288797
5,Prevalence,204,Chad,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,111836.540713,126785.467296,98295.2296013
5,Prevalence,204,Chad,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,169352.826468,191291.198331,150414.922597
5,Prevalence,204,Chad,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,281189.36718,316524.72426,250465.280952
5,Prevalence,204,Chad,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0347615971262,0.0394079346998,0.0305634467667
5,Prevalence,204,Chad,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0528868720644,0.0597323728048,0.0469637385325
5,Prevalence,204,Chad,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0438029431481,0.0493048446,0.0390133068976
5,Prevalence,204,Chad,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3458.72872672,3921.0488367699995,3039.9414373500003
5,Prevalence,204,Chad,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5280.79837491,5964.88567889,4690.27234666
5,Prevalence,204,Chad,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4366.01454058,4914.665026029999,3888.96304834
5,Prevalence,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,324.415342015,420.805834113,247.565418271
5,Prevalence,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,324.415342015,420.805834113,247.565418271
5,Prevalence,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000178876911105,0.000232591985002,0.000136282628159
5,Prevalence,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.80369093957e-05,0.000114309155711,6.71727539113e-05
5,Prevalence,85,Israel,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,16.7575274629,21.736534646899997,12.787879481200001
5,Prevalence,85,Israel,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.44385680842,10.9527008967,6.44361308442
5,Prevalence,522,Sudan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,432967.519698,490622.096976,389052.714826
5,Prevalence,522,Sudan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,542432.006643,616680.173259,482084.070681
5,Prevalence,522,Sudan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,975399.526341,1097607.72165,877512.225464
5,Prevalence,522,Sudan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0429446534008,0.0486026786592,0.0386422483812
5,Prevalence,522,Sudan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0540134417586,0.0613540156424,0.0479893645813
5,Prevalence,522,Sudan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0484681989609,0.0545208079385,0.0436256958881
5,Prevalence,522,Sudan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4264.97130873,4832.90101874,3832.3860124
5,Prevalence,522,Sudan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5384.47387745,6121.50139187,4785.42758084
5,Prevalence,522,Sudan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4822.57200584,5426.79397404,4338.59744548
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.69195357632,2.05567770927,1.41482435845
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.69195357632,2.05567770927,1.41482435845
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.49366138855e-05,9.09509488891e-05,6.24985004522e-05
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.52250466747e-05,4.27609392214e-05,2.94012549074e-05
5,Prevalence,105,Antigua and Barbuda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.216695662159999,8.768089511980001,6.03465541445
5,Prevalence,105,Antigua and Barbuda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.43753266218,4.1765089582999995,2.87449077296
5,Prevalence,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9939.97498058,11298.00249,8671.92884707
5,Prevalence,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5740.34647402,6628.56219895,4992.13561044
5,Prevalence,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,15680.3214546,17773.6816379,13801.1666998
5,Prevalence,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148573919215,0.016933888676,0.0129194724462
5,Prevalence,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00806523426523,0.00932210590116,0.0070331995307
5,Prevalence,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113562216179,0.0128679321018,0.0100066124262
5,Prevalence,43,Albania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1392.60195589,1582.8631758099998,1214.94723049
5,Prevalence,43,Albania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,788.33042477,910.3104276989999,685.57750026
5,Prevalence,43,Albania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1087.44992863,1232.62707876,957.1281932009999
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,59882.9526408,70598.77951,50092.2819106
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,45429.0555551,53856.3214179,37927.9571773
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,105312.008196,123643.728986,89569.2494835
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0095698084252,0.0112787124013,0.00800791210813
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00686285437009,0.00813160052117,0.0057326366446
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00817827302497,0.00959613429091,0.00695355211619
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,949.036840489,1118.8633775399999,793.872360344
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,684.551189508,811.538088097,571.520316329
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,813.45927932,955.0585958459999,691.857826874
5,Prevalence,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,111018.013664,126880.588562,97368.4663623
5,Prevalence,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,64960.5824176,74133.2976097,56637.5630275
5,Prevalence,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,175978.596081,200120.557434,155123.162148
5,Prevalence,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016875048283,0.0192220798174,0.0147889194349
5,Prevalence,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00986969025998,0.0112639079899,0.0086086857251
5,Prevalence,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133715462793,0.0152117626942,0.0118132843519
5,Prevalence,7,North Korea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1621.8191583199998,1853.54937056,1422.4182090000002
5,Prevalence,7,North Korea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,973.4562079049999,1110.91243466,848.732958939
5,Prevalence,7,North Korea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1301.76443883,1480.34949106,1147.49077797
5,Prevalence,7,North Korea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,169734.801364,191373.289214,149931.821258
5,Prevalence,7,North Korea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,261280.203481,293678.610179,232122.612003
5,Prevalence,7,North Korea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,431015.004846,482234.890905,382913.91686
5,Prevalence,7,North Korea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0258003470222,0.0289781739131,0.0227710785866
5,Prevalence,7,North Korea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396971450493,0.0446177864584,0.0352786460379
5,Prevalence,7,North Korea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0327502034325,0.0365389508001,0.0290980877755
5,Prevalence,7,North Korea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2479.58996564,2795.69825288,2190.29590004
5,Prevalence,7,North Korea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3915.37185499,4400.87289196,3478.4355256699996
5,Prevalence,7,North Korea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3188.34232347,3567.23059579,2832.52470018
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,267.520246262,387.785189078,177.87929106
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,267.520246262,387.785189078,177.87929106
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.22383504771e-05,4.67054215615e-05,2.14295907034e-05
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.67601981209e-05,2.42917736736e-05,1.1142095206e-05
5,Prevalence,160,Afghanistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.1995827057899997,4.63796965602,2.12746329052
5,Prevalence,160,Afghanistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.6676493880199998,2.4173487513,1.10885174121
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,241611.926157,274269.46173,216527.202655
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,313148.710757,355848.497804,277562.758373
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,554760.636914,624771.937623,495831.279196
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0386115801343,0.0438285380681,0.0346448047763
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0473065783233,0.0537537411697,0.0419252351635
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0430813042941,0.0485259663963,0.0385265838749
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3829.11344402,4346.67650682,3431.56580004
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4718.7052388,5362.13023758,4182.47560037
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4285.1256531,4825.912437,3829.93888303
5,Prevalence,163,India,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10338.5416069,11119.0788793,9403.35199157
5,Prevalence,163,India,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10338.5416069,11119.0788793,9403.35199157
5,Prevalence,163,India,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.83112457793e-05,3.04465870872e-05,2.5757882814e-05
5,Prevalence,163,India,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.46656523635e-05,1.57702032692e-05,1.3343276389e-05
5,Prevalence,163,India,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.79052044693,3.0011986355,2.53809937608
5,Prevalence,163,India,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.4522665338099998,1.5619094798100002,1.32089939976
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,60969.3300122,71093.1527161,52177.0054604
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,33482.4840915,39689.6851293,28038.1084892
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,94451.8141037,109209.482598,81268.8463034
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106742937653,0.0124491692364,0.00912168479054
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00584253019926,0.006923076217,0.00489156288189
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00825439713826,0.00954148785672,0.00710103885972
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1054.60882287,1229.72429064,902.524766116
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,582.659848326,690.677127013,487.917204562
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,819.34542891,947.364444079,704.986541162
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,201041.68867,226377.940605,178601.197194
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,286276.531942,324291.364171,253693.400093
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,487318.220612,546868.956707,436392.655647
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0351977338951,0.0397120399428,0.031253315774
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0499540057061,0.0565721041227,0.0442794836094
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0425880874322,0.0477494602566,0.038132012055
5,Prevalence,202,Cameroon,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3477.49169285,3915.7421185,3089.33029604
5,Prevalence,202,Cameroon,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4981.764203180001,5643.29565708,4414.75481974
5,Prevalence,202,Cameroon,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4227.3614357999995,4743.94890286,3785.5951313100004
5,Prevalence,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7997.22318035,10447.1738855,6285.69267313
5,Prevalence,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7997.22318035,10447.1738855,6285.69267313
5,Prevalence,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000633741842554,0.000830079622959,0.000498298109835
5,Prevalence,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000311094216941,0.000407105133777,0.000244523421882
5,Prevalence,86,Italy,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,59.512013872299995,77.7435296198,46.775514591
5,Prevalence,86,Italy,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,29.913974069600002,39.078125202,23.511916998300002
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.00074673429,4.92683450637,2.22585269851
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.00074673429,4.92683450637,2.22585269851
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.02623089104e-05,3.32385285506e-05,1.50117915761e-05
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.01566066059e-05,1.66649704896e-05,7.52811250597e-06
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.0087468085899998,3.29810009556,1.49002061834
5,Prevalence,28,Solomon Islands,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.0099409103700001,1.65819116614,0.749140097362
5,Prevalence,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,204.510011455,279.806486052,152.840577045
5,Prevalence,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,204.510011455,279.806486052,152.840577045
5,Prevalence,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.02846548314e-05,2.77602960142e-05,1.51300056247e-05
5,Prevalence,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.01622146785e-05,1.38974235659e-05,7.58391241411e-06
5,Prevalence,522,Sudan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.01453756118,2.75624978945,1.5055648432
5,Prevalence,522,Sudan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.0111387483,1.38341970674,0.755674642346
5,Prevalence,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,39.8524254885,60.4895311202,27.6498197775
5,Prevalence,164,Nepal,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,39.8524254885,60.4895311202,27.6498197775
5,Prevalence,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.76027752557e-06,8.76029646412e-06,3.99774517238e-06
5,Prevalence,164,Nepal,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.67705723452e-06,4.07176779966e-06,1.8574101836e-06
5,Prevalence,164,Nepal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.564497538275,0.85681588988,0.391651323774
5,Prevalence,164,Nepal,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,164,Nepal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.264149850855,0.400936716595,0.183268538386
5,Prevalence,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,75.1390028949,95.3002991426,58.3250959326
5,Prevalence,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,75.1390028949,95.3002991426,58.3250959326
5,Prevalence,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.08605349141e-05,1.38279179015e-05,8.44573885782e-06
5,Prevalence,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.04741417649e-06,6.42141994475e-06,3.92784881573e-06
5,Prevalence,164,Nepal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.06432122117,1.34989987695,0.8261573209170001
5,Prevalence,164,Nepal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.498036346968,0.631669452898,0.386590407054
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,686.633704382,984.300127809,390.443771657
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,686.633704382,984.300127809,390.443771657
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.39615861959e-05,2.01294147031e-05,7.95082917211e-06
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.06586091071e-06,1.01680841364e-05,4.02084162116e-06
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.34741506761,1.93154052124,0.7661870042610001
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.689311535009,0.988138839791,0.39196647915500005
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3744.89058541,4773.12009057,2936.99161813
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3744.89058541,4773.12009057,2936.99161813
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.61473294134e-05,9.6802227754e-05,5.99097200335e-05
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.8537504112e-05,4.90805994837e-05,3.01792200178e-05
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.34878286506,9.36652816269,5.7634030116199995
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.75949543606,4.791734975170001,2.94844571084
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,60.4947490702,82.2822061819,45.7139984257
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,60.4947490702,82.2822061819,45.7139984257
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.10090232873e-05,5.56613658146e-05,3.09402504316e-05
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.34016783293e-05,3.18206758602e-05,1.76763911517e-05
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.9655478869899996,5.39375786951,2.99664107462
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.28416021151,3.1068108284599996,1.7260687566800001
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,108.109091563,132.240407193,88.951048457
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,108.109091563,132.240407193,88.951048457
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.32891537056e-05,8.98000325601e-05,6.03087026889e-05
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.18216800401e-05,5.11805534268e-05,3.44906781148e-05
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.08676019328,8.66861463809,5.83091338795
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.081982143029999,4.99313214959,3.35861291733
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,13109.1762498,15660.5491018,10968.6812682
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10892.4753321,12993.9230035,9194.92404061
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,24001.6515819,28510.4617872,20550.5382652
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00906981947174,0.0108169316391,0.00760442176856
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00629205989858,0.00749324334288,0.00531881689158
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00755595710941,0.00898119613672,0.006466732609
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,864.900535885,1033.2317647,723.677683935
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,620.622741995,740.357345583,523.901023095
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,733.821767628,871.6732427,628.3081088810001
5,Prevalence,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,948.510686882,1087.37440379,829.243328335
5,Prevalence,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,587.969156356,681.9889519,513.670911113
5,Prevalence,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1536.47984324,1749.35478541,1359.4419646
5,Prevalence,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0154191699824,0.0176267197957,0.0134728876766
5,Prevalence,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00881397824836,0.0102336404833,0.00770238670316
5,Prevalence,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119827757376,0.0136461743691,0.0105928639839
5,Prevalence,107,Barbados,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1476.46552438,1692.62280488,1290.81222019
5,Prevalence,107,Barbados,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,870.691857768,1009.9207094300001,760.667587821
5,Prevalence,107,Barbados,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1166.02328498,1327.57251744,1031.6705372200001
5,Prevalence,107,Barbados,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1834.29947448,2056.57737794,1633.15756069
5,Prevalence,107,Barbados,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2993.15511877,3376.32585268,2649.32196259
5,Prevalence,107,Barbados,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,4827.45459325,5379.15031505,4316.04113119
5,Prevalence,107,Barbados,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0298186053001,0.0333534965504,0.0266246336429
5,Prevalence,107,Barbados,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0448689785996,0.0505905295922,0.0396777664634
5,Prevalence,107,Barbados,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.037648535355,0.0419498707802,0.0336876032299
5,Prevalence,107,Barbados,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2855.29722852,3201.2982444500003,2542.19680136
5,Prevalence,107,Barbados,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4432.40221494,4999.8191185999995,3923.23821156
5,Prevalence,107,Barbados,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3663.5198878100005,4082.19772512,3275.41196199
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,11113.5370378,12392.2760653,9964.85124694
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,14856.8278727,16615.1296865,13173.3589402
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,25970.3649106,28820.9322125,23192.0470423
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.034360573086,0.0382622397559,0.0307939581243
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0454278170917,0.050809295322,0.0403322714085
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0399247594245,0.0442594111208,0.0356967101997
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3326.1914421899996,3708.90765536,2982.39910727
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4492.25388598,5023.91099499,3983.2239693200004
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3906.24019805,4334.9981543,3488.34938375
5,Prevalence,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.69499249207,2.19826237782,1.19989210184
5,Prevalence,29,Tonga,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.69499249207,2.19826237782,1.19989210184
5,Prevalence,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.68601740684e-05,8.65901489436e-05,4.72514270445e-05
5,Prevalence,29,Tonga,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.35330445252e-05,4.34467899616e-05,2.37017507043e-05
5,Prevalence,29,Tonga,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.50120854771,8.43151944778,4.60223206019
5,Prevalence,29,Tonga,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,29,Tonga,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.2924641708899998,4.27004848164,2.3307488220200003
5,Prevalence,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.710630840947,0.932779069547,0.45674959112
5,Prevalence,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.710630840947,0.932779069547,0.45674959112
5,Prevalence,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.80313429008e-05,3.67319075109e-05,1.79581237605e-05
5,Prevalence,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.40588213992e-05,1.84340588873e-05,9.01281789109e-06
5,Prevalence,29,Tonga,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.72565177665,3.57770980604,1.7518805303499998
5,Prevalence,29,Tonga,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.38037577953,1.8118910143799998,0.887220250745
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,13394.7129059,15390.7927447,11653.177572
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8669.12867958,10146.8438334,7391.81525824
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,22063.8415855,25438.4333975,19206.6005873
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106886982714,0.0122829690052,0.00932217097053
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00682548889825,0.00797567116977,0.00583035066279
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00874407409141,0.0100862067991,0.00764389198121
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1025.27558696,1178.06213362,891.972717821
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,674.75692646,789.774083573,575.337929445
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,851.482054654,981.7134270390001,741.216150762
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,38403.2465556,43031.8456041,34499.1997221
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,50640.1212514,57067.9184061,44857.5614192
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,89043.367807,99247.7644787,80059.1323424
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0306451152724,0.0344110247295,0.0275616954577
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0398707757428,0.0449571547694,0.0353090435188
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0352887231204,0.0393311383852,0.0317831240788
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2939.5113900700003,3293.79965587,2640.682745
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3941.54635766,4441.85046115,3491.4639510399998
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3436.3385668799997,3830.1439978500002,3089.62128089
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,140.57921326,207.519049734,49.8993782719
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,140.57921326,207.519049734,49.8993782719
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.35242749224e-05,3.47605067923e-05,8.36234393077e-06
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.17013949443e-05,1.72812417176e-05,4.15718946391e-06
5,Prevalence,181,Madagascar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.33459246747,3.4462592237300003,0.828676658114
5,Prevalence,181,Madagascar,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,181,Madagascar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.16421467473,1.7185807018200001,0.413244512449
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,171.885476212,234.50240402,114.945592018
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,171.885476212,234.50240402,114.945592018
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000110871950054,0.000151311377049,7.41904404371e-05
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.3691790062e-05,7.32279522383e-05,3.59324538871e-05
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.6046113531,14.4678125855,7.091659847950001
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.2166338881900005,7.117024745959999,3.48853832116
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,42.3435887954,75.4097097529,20.6007279149
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,42.3435887954,75.4097097529,20.6007279149
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.30520684137e-05,0.000148083510445,4.04232537478e-05
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.16130090523e-05,7.41120029534e-05,2.02849029397e-05
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.85008389096,13.980216712699999,3.8191718498
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.00161676521,7.12648047535,1.94684060905
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,222.430988907,284.521333621,171.214417922
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,222.430988907,284.521333621,171.214417922
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000436283245851,0.000558401162347,0.000335246644052
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000218596594014,0.000279590821548,0.000167939657291
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,41.2365123633,52.7474501155,31.7414650544
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.0205039212,26.8882579646,16.1803594048
5,Prevalence,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,499.744976032,550.225199562,452.83251405
5,Prevalence,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,306.08707504,343.72058525,272.33649095
5,Prevalence,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,805.832051072,885.327273563,732.640309913
5,Prevalence,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0417087563096,0.0460400348388,0.0378111080841
5,Prevalence,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0270124007908,0.0304102008652,0.0240656256467
5,Prevalence,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0345655394517,0.0379754596793,0.0314439442624
5,Prevalence,349,Greenland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3784.20376093,4166.45363017,3428.96994453
5,Prevalence,349,Greenland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2640.76469836,2965.4476181600003,2349.5817041
5,Prevalence,349,Greenland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3249.72507109,3570.31000839,2954.56054404
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,42581.2638308,47871.0611168,37972.9820383
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,76990.2781493,86552.3186068,68783.9790617
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,119571.54198,133314.106134,107736.255171
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.029461073767,0.0331446791378,0.0263168872315
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0444737624846,0.0499709350779,0.0397346745203
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.03764270201,0.0420005468081,0.0339263254382
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2809.37239717,3158.3759058699998,2505.3330497700003
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4386.69045145,4931.50873994,3919.1185097099997
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3655.75677134,4075.9192207700003,3293.90704373
5,Prevalence,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,11.5288986657,17.8735378004,7.45521266424
5,Prevalence,66,Brunei,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,11.5288986657,17.8735378004,7.45521266424
5,Prevalence,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.91643624409e-05,0.000153399012081,6.40046532769e-05
5,Prevalence,66,Brunei,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.93416353375e-05,7.63946163187e-05,3.19429868378e-05
5,Prevalence,66,Brunei,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.881707516659999,13.769531646999999,5.74339494851
5,Prevalence,66,Brunei,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,66,Brunei,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.6035867905200005,7.137054883039999,2.9769295001100002
5,Prevalence,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,130.454819409,156.935695923,98.6970165159
5,Prevalence,180,Kenya,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,130.454819409,156.935695923,98.6970165159
5,Prevalence,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.13766576091e-05,1.36750462008e-05,8.59486510235e-06
5,Prevalence,180,Kenya,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.6915256485e-06,6.84451835617e-06,4.30141155181e-06
5,Prevalence,180,Kenya,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.12083330392,1.3483499909,0.847978661187
5,Prevalence,180,Kenya,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,180,Kenya,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.563401362898,0.677765569496,0.426247446209
5,Prevalence,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,290.192890886,320.193589823,253.063796052
5,Prevalence,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,290.192890886,320.193589823,253.063796052
5,Prevalence,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.53070227472e-05,2.79383652522e-05,2.20526151824e-05
5,Prevalence,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.26606183886e-05,1.3979734748e-05,1.10355893792e-05
5,Prevalence,180,Kenya,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.49326056436,2.75101863464,2.17425720196
5,Prevalence,180,Kenya,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.2532696834700001,1.38283511268,1.0929185157099999
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,127.516462272,215.769853322,57.3355723696
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,127.516462272,215.769853322,57.3355723696
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.91771224433e-05,0.000134060501807,3.56029430962e-05
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.04414102987e-05,6.85437980981e-05,1.8185513744e-05
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.54268085827,12.7629257701,3.39143602719
5,Prevalence,45,Bulgaria,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.91398825812,6.62283643469,1.75985714337
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1006.01574173,1250.65068164,807.389999623
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1006.01574173,1250.65068164,807.389999623
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000624638783791,0.000777024145391,0.000500978460222
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000319047670861,0.0003968713469,0.000256001470535
5,Prevalence,45,Bulgaria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,59.506478952200005,73.9767931817,47.7576384006
5,Prevalence,45,Bulgaria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,30.878631123,38.3874520648,24.7820157644
5,Prevalence,43,Albania,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,13955.985084,15726.7981813,12413.1371625
5,Prevalence,43,Albania,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,22180.4260154,24890.48793,19637.854981
5,Prevalence,43,Albania,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,36136.4110994,40223.0245184,32391.2904738
5,Prevalence,43,Albania,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0208601306873,0.0234837381198,0.0185761062935
5,Prevalence,43,Albania,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0311635314642,0.0349198098998,0.027632774777
5,Prevalence,43,Albania,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0261711694372,0.0291453081076,0.0234620930728
5,Prevalence,43,Albania,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,1955.2496019700002,2203.3425587,1739.09482922
5,Prevalence,43,Albania,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3046.0713027399997,3418.24818613,2696.89619412
5,Prevalence,43,Albania,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2506.10536172,2789.51711981,2246.37655649
5,Prevalence,6,China,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,6123873.61022,6849583.40035,5449234.37231
5,Prevalence,6,China,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3429498.5651,3860392.90652,3067134.25605
5,Prevalence,6,China,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,9553372.17533,10633063.0609,8592124.47576
5,Prevalence,6,China,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0167114499844,0.0186821340711,0.014859694168
5,Prevalence,6,China,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00971121556068,0.0109322202052,0.00868564680861
5,Prevalence,6,China,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0132760173479,0.0147764239855,0.0119490071185
5,Prevalence,6,China,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1587.8232787700001,1775.9883147799999,1412.90002677
5,Prevalence,6,China,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,952.5060965629999,1072.18233476,851.863332907
5,Prevalence,6,China,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1281.08116192,1425.86476595,1152.1804662
5,Prevalence,6,China,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,10230082.6279,11427760.4557,9153940.28976
5,Prevalence,6,China,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,15255283.0065,17065475.4678,13619237.1271
5,Prevalence,6,China,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,25485365.6345,28461285.1044,22755417.6688
5,Prevalence,6,China,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0279168132774,0.0311573557316,0.0249623068909
5,Prevalence,6,China,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0431980110112,0.0482852787166,0.0385660920351
5,Prevalence,6,China,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0354161591792,0.0395271544006,0.0317011045709
5,Prevalence,6,China,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2652.49813668,2963.03699761,2373.47150018
5,Prevalence,6,China,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4236.98969184,4739.75104967,3782.59566168
5,Prevalence,6,China,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3417.51804701,3816.5807342299995,3051.43946788
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,70.9337731499,103.745208805,48.7704203907
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,70.9337731499,103.745208805,48.7704203907
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.2785051904e-05,1.86999878391e-05,8.78617269211e-06
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.44754853551e-06,9.42376142717e-06,4.43138260608e-06
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.26953074481,1.85677042621,0.872864157281
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.641744169045,0.9385921523730001,0.44123034089100005
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,525.719430706,750.027676892,397.080093656
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,525.719430706,750.027676892,397.080093656
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000339112181159,0.000483062328001,0.000256324583066
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000164220690026,0.00023382773106,0.000124062702248
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,32.4346789867,46.273554885399996,24.498172632600003
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,15.955308489899998,22.762945902,12.0511722022
5,Prevalence,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,75.1786265763,93.5388250825,59.5446250281
5,Prevalence,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,75.1786265763,93.5388250825,59.5446250281
5,Prevalence,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000646677031858,0.000802180189408,0.000511539761345
5,Prevalence,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000321760698454,0.000399485731442,0.000254851001784
5,Prevalence,66,Brunei,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,57.916596556,72.061045025,45.8723733312
5,Prevalence,66,Brunei,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,30.019461725899998,37.3508443467,23.7766726185
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1532.87542297,1737.49968749,1355.02645746
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,867.443661087,1004.13260665,751.884261139
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2400.31908406,2706.95220796,2130.72295469
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0152137848252,0.0172476615959,0.0134473073566
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00828043557699,0.00960322223715,0.00717924680004
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0116795771637,0.0131511416144,0.0103746616402
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1457.68802064,1652.27548329,1288.56253097
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,817.5409608370001,946.3664015019999,708.629515512
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1136.18123358,1281.3247702400001,1008.56900699
5,Prevalence,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1636.77288008,1889.8919178,1435.22583789
5,Prevalence,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,976.016945217,1132.15796561,843.845303088
5,Prevalence,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2612.7898253,2991.07743656,2305.55175862
5,Prevalence,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0171701321903,0.0198132253409,0.0150555491531
5,Prevalence,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00970012883885,0.0112556099573,0.00838262739701
5,Prevalence,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133342318363,0.0152611585538,0.0117240886507
5,Prevalence,108,Belize,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1656.38413698,1912.53596107,1452.4222265600001
5,Prevalence,108,Belize,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,959.475397469,1112.97013784,829.5438020319999
5,Prevalence,108,Belize,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1302.87688448,1491.51133936,1149.67153623
5,Prevalence,108,Belize,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2966.95419463,3313.32215536,2658.40575776
5,Prevalence,108,Belize,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,4433.10481931,5013.85525564,3939.24216719
5,Prevalence,108,Belize,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,7400.05901394,8281.91110725,6681.10004348
5,Prevalence,108,Belize,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0311241418345,0.034774855548,0.0279578144072
5,Prevalence,108,Belize,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0440583039259,0.0497686133283,0.0391467292012
5,Prevalence,108,Belize,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0377658458735,0.0422201517007,0.0340837773767
5,Prevalence,108,Belize,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3002.5032324,3353.02125643,2690.25787293
5,Prevalence,108,Belize,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4357.97250178,4928.88037224,3872.47984024
5,Prevalence,108,Belize,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3690.06559186,4129.8042561699995,3331.5541592
5,Prevalence,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,29318.5756004,33262.8817749,26058.7153198
5,Prevalence,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,17595.5971842,20008.3552943,15462.0981497
5,Prevalence,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,46914.1727846,52550.2565814,41869.4802189
5,Prevalence,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0161650614646,0.0182595429443,0.0143683355033
5,Prevalence,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0094024538491,0.0106772325059,0.00826133475071
5,Prevalence,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0127307928922,0.0142301810332,0.0113564920369
5,Prevalence,85,Israel,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1514.43773511,1718.1790829499998,1346.05112972
5,Prevalence,85,Israel,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,923.125207964,1049.70675043,811.194551716
5,Prevalence,85,Israel,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1221.07837076,1367.7739131,1089.77551251
5,Prevalence,85,Israel,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,69866.1232905,77654.7474028,63092.1861331
5,Prevalence,85,Israel,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,113372.820204,126589.374534,101155.375442
5,Prevalence,85,Israel,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,183238.943495,202919.259891,165352.620113
5,Prevalence,85,Israel,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0385215651009,0.0428151183163,0.0347259060671
5,Prevalence,85,Israel,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0605825315334,0.067642921113,0.0540285243775
5,Prevalence,85,Israel,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0497246540696,0.0550818033497,0.044867011362
5,Prevalence,85,Israel,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3608.9029344200003,4011.2207830400002,3258.99828058
5,Prevalence,85,Israel,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5947.92590062,6641.31154345,5306.956962820001
5,Prevalence,85,Israel,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4769.3286975500005,5281.56641281,4303.78489026
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.58757176373,4.58641447727,2.5954851587
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.58757176373,4.58641447727,2.5954851587
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.92940414616e-06,1.01426263395e-05,5.73827733472e-06
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.83816596707e-06,4.90972531078e-06,2.77794587334e-06
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.787203960724,1.00637530893,0.569515073563
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.382082963002,0.488461541243,0.276423922691
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2944.00915289,3307.01726721,2632.74496501
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1467.82716921,1671.99218259,1289.3013291
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4411.8363221,4932.75172457,3970.34872635
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0210516771288,0.0236431295475,0.0188079066636
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.010425787377,0.0118742361623,0.00914262161273
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0157208532735,0.0176108320386,0.0141137358907
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1982.3399597999999,2226.77041276,1772.7511285
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1025.25122955,1167.85686827,900.554098359
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1512.56366566,1691.1554476600002,1361.2030875599999
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.01841089066,2.52504417296,1.65535499919
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.01841089066,2.52504417296,1.65535499919
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.76376265359e-05,9.7031344411e-05,6.3619165625e-05
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.00117146389e-05,5.00334068585e-05,3.28096486833e-05
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.61548961502,9.52702334574,6.24567518131
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.94822287047,4.93925057516,3.23804756345
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.56380596906,8.79602821484,4.05964723153
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.56380596906,8.79602821484,4.05964723153
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.51123932573e-05,6.02759952795e-05,2.80200623656e-05
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.25712943682e-05,3.02128552648e-05,1.39910719245e-05
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.35436010711,5.83519295668,2.69312743814
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.20758266153,2.95833841966,1.36536742288
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.76465249983,2.27743896608,1.26395901431
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.76465249983,2.27743896608,1.26395901431
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.21278345331e-05,1.5734389186e-05,8.6917589886e-06
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.06805574922e-06,7.85507546975e-06,4.35200001264e-06
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.17065197911,1.51082914806,0.8384971668710001
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.593499606879,0.765963344731,0.42510306033399997
5,Prevalence,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,37.3036036632,47.3954071901,28.6464048343
5,Prevalence,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,37.3036036632,47.3954071901,28.6464048343
5,Prevalence,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.0974526882e-06,1.1563953979e-05,6.97087901623e-06
5,Prevalence,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.55555022164e-06,5.78987947986e-06,3.49315026363e-06
5,Prevalence,182,Malawi,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.897990296471,1.14092504677,0.689590040742
5,Prevalence,182,Malawi,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.45138489923499997,0.57349877754,0.346630172149
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,284.645105898,332.175116875,159.808152376
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,284.645105898,332.175116875,159.808152376
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.02998313443e-05,8.19201140959e-05,3.95845539189e-05
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.38729063816e-05,3.95471559775e-05,1.90385171999e-05
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.8711074099500005,8.0184442299,3.85764222609
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.33732872596,3.89459553888,1.8736747146400001
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,214.335341072,254.560247733,180.400634634
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,214.335341072,254.560247733,180.400634634
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.29327692144e-05,6.29353224259e-05,4.45348308865e-05
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.55053440966e-05,3.03232395712e-05,2.14885392018e-05
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.17388537424,6.14488276185,4.3547284379999995
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.51298011428,2.98459804734,2.11511179244
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,4885.09053239,5444.5216229,4373.44307276
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,8245.44469549,9284.79373508,7338.97580884
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,13130.5352279,14702.0457173,11819.2660705
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0349320652902,0.0390880067985,0.0312921073188
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0585667701147,0.0659705622492,0.0521144449271
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467889346221,0.0523386610874,0.0421609738463
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3289.36143425,3666.05272422,2944.84511251
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5759.29679565,6485.26365545,5126.14436457
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4501.70156968,5040.48168138,4052.1431684599997
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,133.164124472,170.72947718,101.231926788
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,133.164124472,170.72947718,101.231926788
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000148538201085,0.000190015096614,0.000113272434078
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.52129822975e-05,9.630410256e-05,5.73487771629e-05
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,14.176365221400001,18.175491576000002,10.77693239
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.280173425470001,9.33389685575,5.53441841886
5,Prevalence,102,United States,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,3450931.52107,3754457.94925,3201249.35295
5,Prevalence,102,United States,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,6053955.24937,6601418.37072,5607992.79595
5,Prevalence,102,United States,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,9504886.77044,10361449.2173,8829173.92315
5,Prevalence,102,United States,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0508606954323,0.0553205416113,0.0471513913771
5,Prevalence,102,United States,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0833377682251,0.0909477390868,0.0772025208071
5,Prevalence,102,United States,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0676531022671,0.073575235116,0.0628237304661
5,Prevalence,102,United States,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4580.39176537,4983.25978629,4248.99076832
5,Prevalence,102,United States,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,8171.62673044,8910.59226489,7569.66676294
5,Prevalence,102,United States,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6360.912187839999,6934.14558234,5908.70794915
5,Prevalence,148,Morocco,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,510255.35996,576604.666034,460295.21814
5,Prevalence,148,Morocco,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,743602.068995,834276.038025,665456.386933
5,Prevalence,148,Morocco,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1253857.42895,1408406.00063,1126247.49299
5,Prevalence,148,Morocco,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0581222740887,0.0656357436107,0.0524355317489
5,Prevalence,148,Morocco,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0796046859278,0.0895195246249,0.0712470695046
5,Prevalence,148,Morocco,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0691965487699,0.0777009967107,0.0622015263196
5,Prevalence,148,Morocco,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,5688.192866910001,6427.83752162,5131.25031494
5,Prevalence,148,Morocco,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,7903.91676235,8867.71115401,7073.2884033
5,Prevalence,148,Morocco,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6822.43295248,7663.355727130001,6128.08747742
5,Prevalence,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,334.944092736,381.953691425,295.507724072
5,Prevalence,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,183.790509058,210.543067537,158.678083532
5,Prevalence,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,518.734601794,589.214409563,460.129238031
5,Prevalence,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0181447069854,0.0207362138012,0.0159721767279
5,Prevalence,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00967452135715,0.0110837933469,0.00835858642869
5,Prevalence,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0138488123457,0.0157234186449,0.0122849314556
5,Prevalence,110,Dominica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1741.78257644,1986.2427765099999,1536.70482971
5,Prevalence,110,Dominica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,954.131368859,1093.01479311,823.7625426070001
5,Prevalence,110,Dominica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1347.62302584,1530.72284504,1195.37187974
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1121.64135923,1332.10974371,957.930838513
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,623.734227867,723.709299192,529.489841937
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1745.3755871,2032.89317083,1510.21281148
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0166154028845,0.0197244786586,0.0142060307229
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00919455153609,0.0106685794414,0.00780047136685
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0128958845032,0.0150025829653,0.0111595419366
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1645.0215941200001,1953.6987256300001,1404.9204784199999
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,917.1750204870001,1064.18416957,778.592603916
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1281.57387396,1492.68890635,1108.90131477
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2170.80270943,2451.56298985,1932.8859881
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2607.81206788,2931.16965075,2330.22949067
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,4778.61477731,5354.43492301,4291.23398586
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0321572564445,0.036233847033,0.0286526266257
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0384420351208,0.0432225206039,0.0343498286072
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0353073192459,0.0395654393151,0.0316941285751
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3183.74256101,3595.51118943,2834.8091510900003
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3834.6782650699997,4310.16202794,3426.5047280699996
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3508.78509907,3931.59154846,3150.91685937
5,Prevalence,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11103.8524922,12815.9870405,9586.32610793
5,Prevalence,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6997.94792545,8278.35033939,5901.17092182
5,Prevalence,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18101.8004176,20765.8642068,15742.8493249
5,Prevalence,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100369438924,0.0115689476133,0.00866447003894
5,Prevalence,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00635996730148,0.00752225883715,0.00536525393048
5,Prevalence,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00820344026991,0.00941935024212,0.00713033640128
5,Prevalence,170,Congo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,998.179852049,1152.09203806,861.7619499940001
5,Prevalence,170,Congo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,635.06743081,751.264618912,535.5343446410001
5,Prevalence,170,Congo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,817.483564903,937.793606625,710.952518033
5,Prevalence,170,Congo,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,49524.9714004,56037.4928888,43745.3343346
5,Prevalence,170,Congo,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,63243.7157861,71170.2099897,56244.0252812
5,Prevalence,170,Congo,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,112768.687186,126525.788109,100657.210577
5,Prevalence,170,Congo,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0447664609353,0.0506018950246,0.0395526548607
5,Prevalence,170,Congo,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0574779788883,0.0646676910587,0.0511023725028
5,Prevalence,170,Congo,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0511049923514,0.0573225196135,0.0456149447288
5,Prevalence,170,Congo,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4452.042987790001,5037.485539400001,3932.4830174599997
5,Prevalence,170,Congo,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5739.40025376,6458.7337445,5104.17468296
5,Prevalence,170,Congo,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5092.672899040001,5713.9483327299995,4545.714428259999
5,Prevalence,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2079.18441154,3142.43229793,1451.05693306
5,Prevalence,86,Italy,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2079.18441154,3142.43229793,1451.05693306
5,Prevalence,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00016476042017,0.000249797709927,0.000114924315076
5,Prevalence,86,Italy,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.08790857102e-05,0.000122458305472,5.64999882846e-05
5,Prevalence,86,Italy,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.4724269602,23.3846761919,10.7981631101
5,Prevalence,86,Italy,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,86,Italy,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.777283085630001,11.754409768999999,5.42774391687
5,Prevalence,349,Greenland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,834.135310671,929.0598936,759.263470897
5,Prevalence,349,Greenland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1253.5500756,1395.4759514,1144.18050732
5,Prevalence,349,Greenland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2087.68538627,2308.33419361,1914.06090098
5,Prevalence,349,Greenland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.069616843535,0.0777976386793,0.0634730331564
5,Prevalence,349,Greenland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.110626588729,0.123195741596,0.101024812945
5,Prevalence,349,Greenland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0895495339425,0.0989006664799,0.0822173045924
5,Prevalence,349,Greenland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,6316.29757408,7035.092121199999,5749.3478072
5,Prevalence,349,Greenland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,10814.996964,12039.4617427,9871.41156448
5,Prevalence,349,Greenland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,8419.12844159,9308.9515259,7718.9430344
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.77575069552,6.55766446507,3.26167103884
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.77575069552,6.55766446507,3.26167103884
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000248016647815,0.000340933076244,0.00016914475632
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000121377701055,0.000166653957017,8.29119944085e-05
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,23.9327937258,32.8625259088,16.3452627976
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.8651012052,16.292172164900002,8.10345000009
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.88865385573,1.09038306003,0.712993773112
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.88865385573,1.09038306003,0.712993773112
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.61499687311e-05,5.6894542453e-05,3.70245381404e-05
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.25855090079e-05,2.77829183961e-05,1.81138013726e-05
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.45332488624,5.464253584720001,3.57303678262
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.2078137254,2.70899931436,1.7713954969699999
5,Prevalence,163,India,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4460.54994328,6280.27944172,3848.99981468
5,Prevalence,163,India,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,163,India,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4460.54994328,6280.27944172,3848.99981468
5,Prevalence,163,India,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.22147361932e-05,1.72103393829e-05,1.05242628634e-05
5,Prevalence,163,India,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,163,India,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.32744066027e-06,8.91232197374e-06,5.45760363059e-06
5,Prevalence,163,India,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.2039663131,1.6951373666499998,1.03890017485
5,Prevalence,163,India,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,163,India,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.626578452873,0.882197896278,0.540673320477
5,Prevalence,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.433955691436,0.521781598116,0.361732796028
5,Prevalence,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.433955691436,0.521781598116,0.361732796028
5,Prevalence,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.35084333927e-05,2.82347636177e-05,1.96238528295e-05
5,Prevalence,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.1585431046e-05,1.392763843e-05,9.6575740709e-06
5,Prevalence,110,Dominica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.25666455591,2.71337848917,1.8810896956
5,Prevalence,110,Dominica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.12737550175,1.3555388317,0.939747307085
5,Prevalence,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,386.071350116,528.181320356,281.631718085
5,Prevalence,91,Portugal,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,386.071350116,528.181320356,281.631718085
5,Prevalence,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000178604391873,0.000244625038645,0.000130987448769
5,Prevalence,91,Portugal,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.53442115077e-05,0.000116941209799,6.24188715029e-05
5,Prevalence,91,Portugal,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,16.8296065862,23.0244586269,12.2768783961
5,Prevalence,91,Portugal,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,91,Portugal,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.223646141249999,11.2507086468,5.99899368598
5,Prevalence,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,344.3531361,424.684441072,280.154089556
5,Prevalence,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,344.3531361,424.684441072,280.154089556
5,Prevalence,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000125666645828,0.000154903033437,0.000102395593701
5,Prevalence,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.35308500673e-05,7.84253951069e-05,5.17773252643e-05
5,Prevalence,109,Cuba,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,12.1570483619,14.993065976199999,9.89056424488
5,Prevalence,109,Cuba,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.2174709450800005,7.66789349763,5.05832452025
5,Prevalence,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,44.4663186035,66.7449483232,28.7836128777
5,Prevalence,69,Singapore,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,44.4663186035,66.7449483232,28.7836128777
5,Prevalence,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.01118549742e-05,7.52310807126e-05,3.24327267035e-05
5,Prevalence,69,Singapore,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.35098445657e-05,3.53188687565e-05,1.52352811564e-05
5,Prevalence,69,Singapore,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.43692271984,6.659921193170001,2.87207643779
5,Prevalence,69,Singapore,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,69,Singapore,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.18390644301,3.27809288602,1.41367038223
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,367.074825738,509.902913542,237.885096824
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,367.074825738,509.902913542,237.885096824
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.26777299616e-05,8.70429400918e-05,4.06891275827e-05
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.10645753279e-05,4.31114686267e-05,2.01738668107e-05
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.9225445064799995,8.22699484599,3.8381413667799995
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.98964147551,4.1529050534700005,1.93745553223
5,Prevalence,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.49623263811,8.8274419524,5.54585775372
5,Prevalence,108,Belize,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.49623263811,8.8274419524,5.54585775372
5,Prevalence,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.86399931038e-05,9.24000522346e-05,5.82399352063e-05
5,Prevalence,108,Belize,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.82574444589e-05,4.49746643132e-05,2.83111388067e-05
5,Prevalence,108,Belize,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.58604995234,8.93320936463,5.61230633831
5,Prevalence,108,Belize,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,108,Belize,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.7380229096,4.40183514095,2.76546157751
5,Prevalence,125,Colombia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,301769.24291,339833.230158,270572.377289
5,Prevalence,125,Colombia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,377714.031971,426051.848253,335224.620702
5,Prevalence,125,Colombia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,679483.274881,760727.579066,612874.011676
5,Prevalence,125,Colombia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0239196308379,0.0270155865657,0.0215057568515
5,Prevalence,125,Colombia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0287512527973,0.0324885879903,0.0255187836549
5,Prevalence,125,Colombia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0263842784207,0.0295944046662,0.0237898344888
5,Prevalence,125,Colombia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2311.53775525,2603.10605025,2072.57127864
5,Prevalence,125,Colombia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,2849.33093029,3213.9730229300003,2528.80697965
5,Prevalence,125,Colombia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2582.49183796,2891.2746442400003,2329.3319958800002
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2162.17312223,2725.46960762,1732.74338429
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2162.17312223,2725.46960762,1732.74338429
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000902160971113,0.00113891175702,0.000723305382482
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000453660987735,0.000572497079513,0.000363260247249
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,84.8635756604,106.972514772,68.00879993410001
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,43.4977753198,54.8299594582,34.858671418
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,20.4495053996,29.51856515,11.1928897407
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,20.4495053996,29.51856515,11.1928897407
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.42622797297e-06,1.06974461454e-05,4.06761456909e-06
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.52332395232e-06,5.07967013928e-06,1.92932747335e-06
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.731396084687,1.0557596653,0.40032438793499997
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.348649720024,0.5032708260650001,0.19083091733000002
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,76601.5760087,85566.3643653,68551.7082282
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,119445.746337,134264.852118,105892.519379
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,196047.322345,218208.539204,176063.468907
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0294865438239,0.0328911978727,0.0263589016702
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0438244282071,0.0492058654725,0.0388455660352
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0368273808763,0.0410246263869,0.0331062057187
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2804.46700258,3132.6776536,2509.7525888299997
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4318.4269257099995,4854.19506634,3828.42521346
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3566.20335384,3969.3274819300004,3202.6866054300003
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,55.6482404459,70.2089546831,43.7224477234
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,55.6482404459,70.2089546831,43.7224477234
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.00300573488e-05,1.26512510232e-05,7.87882387506e-06
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.05818592398e-06,6.38104868536e-06,3.97223822694e-06
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.995959315336,1.25655837231,0.7825185262009999
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.50345459205,0.6351866717619999,0.39556088217
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,78088.8113022,92295.6366426,66416.205022
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,40102.0808951,46457.6165422,33603.8794476
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,118190.892197,137913.839229,101547.033728
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0190085105012,0.0224502427983,0.0161542199364
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00934730392156,0.0108307710647,0.00783111978905
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0140731408055,0.0164231625854,0.0120678821074
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1852.98681633,2190.1037428,1576.0049390499998
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,927.0356989740001,1073.9559659400002,776.817441304
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1383.95970697,1614.9061317500002,1189.06795972
5,Prevalence,114,Haiti,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,82599.9692395,93246.8805663,73294.578682
5,Prevalence,114,Haiti,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,142971.198772,161783.762055,125900.71405
5,Prevalence,114,Haiti,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,225571.168011,253857.458766,200505.063903
5,Prevalence,114,Haiti,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0299321906955,0.0337609986772,0.0265724198613
5,Prevalence,114,Haiti,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0496066390737,0.056138249718,0.0436484918883
5,Prevalence,114,Haiti,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0399830365277,0.0449978075444,0.0355798949095
5,Prevalence,114,Haiti,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2930.66486569,3308.4195941899998,2600.50758574
5,Prevalence,114,Haiti,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4932.52122152,5581.55661064,4343.58772391
5,Prevalence,114,Haiti,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3945.61160103,4440.3854586,3507.1641166599998
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,56.878464358,76.5823522414,40.6878347065
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,56.878464358,76.5823522414,40.6878347065
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000400319356984,0.000539066699931,0.000286646778362
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000198783843212,0.000267276159711,0.00014239563366
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,37.719312828199996,50.7860705086,26.9823945304
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,19.0791762437,25.6886013373,13.6482301008
5,Prevalence,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.69863246162,12.2516795938,7.60228775599
5,Prevalence,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.69863246162,12.2516795938,7.60228775599
5,Prevalence,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00023249805925,0.000294228214212,0.000182317397758
5,Prevalence,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000117033780917,0.000147665943474,9.18265128586e-05
5,Prevalence,351,Guam,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,22.135405761799998,27.9622823266,17.350871358699997
5,Prevalence,351,Guam,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,11.3318977513,14.3148821227,8.88252522899
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12047.815399,14051.5917059,10234.1896585
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7864.48968993,9409.42051834,6602.51982
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,19912.305089,23156.610349,17147.5191801
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00974822461375,0.0113633695355,0.008282066593
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00626329459765,0.0074937432215,0.00525860510173
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00799194812548,0.00929718559031,0.0068831958826
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,971.886446868,1133.52928175,825.582887385
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,625.846683852,748.790431491,525.420630878
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,797.6893693829999,927.6566336139999,686.931708816
5,Prevalence,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.43126294558,13.151230618,6.30488664644
5,Prevalence,351,Guam,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.43126294558,13.151230618,6.30488664644
5,Prevalence,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000226089055026,0.000315024591563,0.000150789187931
5,Prevalence,351,Guam,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000113807172521,0.000158160801477,7.59676363631e-05
5,Prevalence,351,Guam,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.525182336,30.015347746099998,14.389783792
5,Prevalence,351,Guam,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,351,Guam,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.0195027792,15.365918984699999,7.36663968801
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,113.73174521,153.599895664,59.5424715464
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,113.73174521,153.599895664,59.5424715464
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000155756227604,0.000210144699406,8.13669948404e-05
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.67750049844e-05,0.000103660192729,4.01421090114e-05
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.1991093817,20.527088641,7.9572553486999995
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.5563793696,10.205234085,3.95602391202
5,Prevalence,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,33.5458519963,46.7657284982,17.2788750617
5,Prevalence,211,Mali,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,33.5458519963,46.7657284982,17.2788750617
5,Prevalence,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.29063987118e-06,1.15631174486e-05,4.27264124169e-06
5,Prevalence,211,Mali,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.19366590193e-06,5.85188120949e-06,2.16035997517e-06
5,Prevalence,211,Mali,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8171352153629999,1.13915495818,0.420891897344
5,Prevalence,211,Mali,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,211,Mali,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.415468073117,0.5791973061,0.214000256375
5,Prevalence,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,86809.2868721,101953.908462,72716.9384057
5,Prevalence,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,62692.6888403,74622.5578811,52098.1471872
5,Prevalence,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,149501.975712,174898.50584,125959.895483
5,Prevalence,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00963276076944,0.0113242786658,0.00806742748265
5,Prevalence,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00695308089014,0.00827757862744,0.00577309260704
5,Prevalence,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00829257720354,0.00969558668863,0.00698663396509
5,Prevalence,190,Uganda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,953.903552121,1120.32017471,799.0498291590001
5,Prevalence,190,Uganda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,692.98276891,824.8513142459999,575.874459377
5,Prevalence,190,Uganda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,823.828757166,963.776017073,694.100420107
5,Prevalence,190,Uganda,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,441362.676755,503419.476605,392623.848079
5,Prevalence,190,Uganda,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,538052.572042,614437.0898,478645.25376
5,Prevalence,190,Uganda,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,979415.248797,1106706.54183,875345.445437
5,Prevalence,190,Uganda,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0489757189874,0.0558729994094,0.0435525498048
5,Prevalence,190,Uganda,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0596739122591,0.0681018359025,0.0530765915732
5,Prevalence,190,Uganda,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0543262149621,0.061394780312,0.0485379491422
5,Prevalence,190,Uganda,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4849.91226515,5531.8231982199995,4314.34581281
5,Prevalence,190,Uganda,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5947.44248635,6791.769880780001,5290.77503951
5,Prevalence,190,Uganda,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5397.05541228,6098.49248186,4823.58006955
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,60904.5100182,69169.5164918,53881.4973726
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,73814.7663788,83436.813677,65615.5775536
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,134719.276397,152700.652234,120885.882118
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0492796008871,0.0560051146352,0.0435949860166
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0587862412906,0.0664627601539,0.0522578848561
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0540705972543,0.0612797805241,0.0485343511996
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4913.11211861,5579.84276719,4346.57199657
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5874.09082838,6639.80184472,5221.60918764
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5396.87063615,6117.2067443099995,4842.70317491
5,Prevalence,150,Oman,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,87841.4944945,100693.244967,77761.9705893
5,Prevalence,150,Oman,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,48573.6624642,55387.478673,42426.0076589
5,Prevalence,150,Oman,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,136415.156959,155057.221903,121631.836171
5,Prevalence,150,Oman,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396476731094,0.0454016950025,0.0351902000968
5,Prevalence,150,Oman,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.053441461788,0.060939850118,0.0466665354557
5,Prevalence,150,Oman,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0436602168382,0.0495281334715,0.0389263552468
5,Prevalence,150,Oman,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3875.54070272,4442.55612458,3430.83509538
5,Prevalence,150,Oman,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5300.3364018600005,6043.8569900699995,4629.5070491199995
5,Prevalence,150,Oman,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4285.75910754,4871.437425120001,3821.31107172
5,Prevalence,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40946.9421052,49788.7692226,34317.6595826
5,Prevalence,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,11039.4621023,13330.872826,9134.31147755
5,Prevalence,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,51986.4042075,62930.1962816,43584.1588943
5,Prevalence,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0184820230064,0.0224223307878,0.0154939769698
5,Prevalence,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012145866047,0.0146441711246,0.0100485020962
5,Prevalence,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0166387574503,0.0200977202295,0.0140062122466
5,Prevalence,150,Oman,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1806.5669498700001,2196.66574175,1514.08496975
5,Prevalence,150,Oman,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1204.621185,1454.65890204,996.731997841
5,Prevalence,150,Oman,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1633.2584316000002,1977.07987782,1369.28483675
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,148.98321786,183.377264173,124.608953812
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,148.98321786,183.377264173,124.608953812
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000118887038439,0.000146471957077,9.90660002915e-05
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.90438432762e-05,7.28011599148e-05,4.91815458655e-05
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.4036677913,14.036301747000001,9.53798107939
5,Prevalence,126,Costa Rica,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.74952172137,7.076847840409999,4.80887644198
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,336.336026618,411.715048187,271.943451462
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,336.336026618,411.715048187,271.943451462
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000268390471736,0.000329179480013,0.000216527692788
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000133293540862,0.000163390277866,0.000107452335723
5,Prevalence,126,Costa Rica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,25.7442708575,31.5140302489,20.8154503779
5,Prevalence,126,Costa Rica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,12.9797927478,15.888800407,10.4947711804
5,Prevalence,168,Angola,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,262166.075128,295954.744256,233789.210115
5,Prevalence,168,Angola,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,335512.340552,376837.909639,300017.452833
5,Prevalence,168,Angola,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,597678.41568,668005.077852,536608.531606
5,Prevalence,168,Angola,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.046856541839,0.052923248596,0.0417637566165
5,Prevalence,168,Angola,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0584085201189,0.065582625707,0.052222635036
5,Prevalence,168,Angola,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0527085247142,0.0588715644674,0.0472559584279
5,Prevalence,168,Angola,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4628.23629489,5224.73584098,4127.27583872
5,Prevalence,168,Angola,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5821.23985541,6538.250888200001,5205.39289516
5,Prevalence,168,Angola,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5229.91055659,5845.29525721,4695.5261401
5,Prevalence,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,80.713522071,111.168661458,58.5545551157
5,Prevalence,148,Morocco,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,80.713522071,111.168661458,58.5545551157
5,Prevalence,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.19399738595e-06,1.2723694765e-05,6.67450791372e-06
5,Prevalence,148,Morocco,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.45436721373e-06,6.15689064811e-06,3.23082573505e-06
5,Prevalence,148,Morocco,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.899773165623,1.2392790683900001,0.6527508162979999
5,Prevalence,148,Morocco,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,148,Morocco,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.439174805661,0.604885947718,0.318604425921
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,61292.3262614,69409.0112245,53889.3596978
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,88898.1779887,101304.344081,78386.1633267
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,150190.50425,169622.897553,133100.765287
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0242899866516,0.0274891809392,0.0213737189334
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0338990654659,0.0385992011443,0.0299190680472
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0291870713527,0.0329043458031,0.0259062981367
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2316.85225829,2623.66325787,2037.0198413
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3339.74163577,3805.8185608199997,2944.82450882
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2829.8704081,3196.01309497,2507.86771683
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,303.285981188,352.24590285,263.6081093
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,159.653412107,182.98806975,138.677016034
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,462.939393295,533.714869512,405.427695362
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.015750321322,0.0182429331002,0.0136725440513
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00794676001492,0.0091095030683,0.00691585310299
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117657799615,0.0135436229434,0.0103049648828
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1519.86175378,1765.2153705599999,1321.02341738
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,786.64206411,901.616263606,683.287458114
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1150.14855329,1325.9864983,1007.26376722
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,557.191141838,627.729522413,497.072409345
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,771.129424076,878.04697995,679.2672651
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1328.32056591,1499.55145844,1181.13855841
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0289364806252,0.0325630984138,0.0258405735229
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0383830862084,0.0436738970967,0.0337995714355
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0337599057211,0.0380866124901,0.0300438970367
5,Prevalence,298,American Samoa,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2792.2606337,3145.7507171800003,2490.98669468
5,Prevalence,298,American Samoa,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3799.4981369099996,4326.30082614,3346.87618918
5,Prevalence,298,American Samoa,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3300.14252259,3725.5566613899996,2934.47657268
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,23935.7180474,26893.3839705,21283.6638739
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,14018.0227351,16084.5160077,12166.6459064
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,37953.7407825,42490.5847633,33834.4520732
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0157434461356,0.0176956447405,0.0140455733335
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00908997353701,0.0104296838756,0.00788832191192
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0123930128327,0.01386754599,0.0110624803274
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1531.78693052,1721.0653134400002,1362.06643524
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,900.47065061,1033.2152307000001,781.544427633
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1216.7214842399999,1362.16368383,1084.6652766299999
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,47837.8316398,53596.9249252,42615.1346932
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,58908.8459408,66333.8373032,52485.8023399
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,106746.677581,119224.403844,95861.7985621
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0314644787382,0.035322528682,0.0281363559823
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0381994777482,0.04299066672,0.0340765040508
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0348558901886,0.0389323882663,0.0313244701193
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3061.42331495,3429.98145926,2727.1923172
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3784.10620623,4261.06268785,3371.51148018
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3422.08628993,3822.0973904599996,3073.13870579
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,83138.3556618,96306.4656054,72246.5083132
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,51077.2501292,59756.7582079,43340.1350529
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,134215.605791,155309.477602,116944.050284
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.010267836993,0.011913608366,0.00891869964896
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00619669997942,0.00724710861757,0.00525585471218
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00821407151654,0.00946890063639,0.00715242343038
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,999.91443625,1158.28878857,868.9169524220001
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,614.9600101469999,719.45957429,521.806671747
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,807.538705888,934.4547812879999,703.620465527
5,Prevalence,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,39802.6322705,46690.987646,33678.7120592
5,Prevalence,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,28858.2978478,34478.971889,24288.4668339
5,Prevalence,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,68660.9301183,80318.450859,58557.5947224
5,Prevalence,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00970692180888,0.0113689892646,0.00823220238043
5,Prevalence,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00705899218214,0.00843543710469,0.00594258158235
5,Prevalence,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00838493503277,0.00979827726678,0.00715231093989
5,Prevalence,182,Malawi,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,958.1481155420001,1123.96792056,810.7301616169999
5,Prevalence,182,Malawi,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,702.125305325,838.876873215,590.940854571
5,Prevalence,182,Malawi,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,830.818043816,971.877574482,708.564626404
5,Prevalence,182,Malawi,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,133476.337956,150727.471433,119080.719059
5,Prevalence,182,Malawi,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,174093.578271,197401.185766,153790.01721
5,Prevalence,182,Malawi,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,307569.916227,345679.957112,274695.948456
5,Prevalence,182,Malawi,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0325517679131,0.0367240016585,0.029020539336
5,Prevalence,182,Malawi,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0425849261407,0.0482810049139,0.0376219319889
5,Prevalence,182,Malawi,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0375608233692,0.0421843345691,0.033525083389
5,Prevalence,182,Malawi,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3213.10663107,3628.38421672,2866.56836634
5,Prevalence,182,Malawi,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4235.71436691,4802.7908145599995,3741.72667283
5,Prevalence,182,Malawi,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3721.68911339,4182.83214719,3323.9041496699997
5,Prevalence,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,43089.1377536,48024.5833998,38451.306761
5,Prevalence,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,17496.6398273,19682.3240587,15451.7635858
5,Prevalence,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,60585.7775809,67424.8199697,54836.2142967
5,Prevalence,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0205018390396,0.0228372262652,0.0182725081291
5,Prevalence,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00824425410897,0.00926286628426,0.0072861320913
5,Prevalence,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143431722258,0.0159371910842,0.0129819967425
5,Prevalence,93,Sweden,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1898.76503876,2116.25028289,1694.3944757
5,Prevalence,93,Sweden,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,807.553841014,908.4336507209999,713.172995347
5,Prevalence,93,Sweden,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1365.79145541,1519.96469591,1236.17845515
5,Prevalence,93,Sweden,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,92845.4952811,102666.386319,84174.8389916
5,Prevalence,93,Sweden,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,170954.430334,187168.477258,156386.988817
5,Prevalence,93,Sweden,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,263799.925615,288905.013709,241679.001275
5,Prevalence,93,Sweden,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0441756865034,0.048941957765,0.0400195217872
5,Prevalence,93,Sweden,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0805523194098,0.0882647823606,0.0736991254061
5,Prevalence,93,Sweden,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0624522781291,0.0684655448328,0.0571084619782
5,Prevalence,93,Sweden,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4091.32764397,4524.09482206,3709.2466861199996
5,Prevalence,93,Sweden,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,7890.36684857,8638.72287584,7218.009557879999
5,Prevalence,93,Sweden,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5946.86902984,6512.81562944,5448.194742629999
5,Prevalence,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1879.84638328,2354.96550531,1495.7986204
5,Prevalence,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1879.84638328,2354.96550531,1495.7986204
5,Prevalence,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00084198917325,0.00105374923373,0.000669793624061
5,Prevalence,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000419868398174,0.000525326816196,0.000334171361714
5,Prevalence,48,Hungary,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,79.2211492811,99.24378689,63.03647300960001
5,Prevalence,48,Hungary,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,40.2700691085,50.448070911900004,32.0429979556
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.4167728967,19.552682365,8.80775702754
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.4167728967,19.552682365,8.80775702754
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.54293423268e-05,2.43880182909e-05,1.10026441067e-05
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.63516273097e-06,1.20522479318e-05,5.43640030863e-06
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.47912580776,2.32917822831,1.04920826339
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.7420561160019999,1.1685151732899999,0.526372675486
5,Prevalence,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,28.4929728283,34.611517699,21.6132914057
5,Prevalence,107,Barbados,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,28.4929728283,34.611517699,21.6132914057
5,Prevalence,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000463202545298,0.000561495811313,0.00035206478678
5,Prevalence,107,Barbados,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000222217700792,0.000269580881314,0.000168802437399
5,Prevalence,107,Barbados,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,44.352575727499996,53.8767916229,33.6435636101
5,Prevalence,107,Barbados,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,107,Barbados,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.6231081211,26.266426951999996,16.4021683428
5,Prevalence,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.11464304687,3.75829568324,2.57373637284
5,Prevalence,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.11464304687,3.75829568324,2.57373637284
5,Prevalence,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.06332216061e-05,6.10774941216e-05,4.1805981111e-05
5,Prevalence,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.42909433334e-05,2.92819354204e-05,2.00467979217e-05
5,Prevalence,107,Barbados,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.84829864657,5.850217697590001,4.00631545422
5,Prevalence,107,Barbados,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.36367976647,2.85214303187,1.9531896583900001
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,142.261396893,180.62003626,85.4659908394
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,142.261396893,180.62003626,85.4659908394
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.842762072e-05,0.000124822450145,5.91088738895e-05
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.47857268086e-05,5.68335954557e-05,2.69200525419e-05
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.38594127224,11.916718730100001,5.6387663014100005
5,Prevalence,127,El Salvador,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.3494719260000005,5.5222414101299995,2.61302036886
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,55065.0521645,59840.2319988,50741.6332147
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,27347.9229146,29927.8981851,24982.1058705
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,82412.9750791,88897.4055351,76010.0069696
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0229758399889,0.0249853962987,0.0211478877219
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115421819686,0.0126202295164,0.0105375624116
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0172916831461,0.0186683406678,0.0159787107602
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2161.25950904,2348.68152026,1991.5687533
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1128.7059733600001,1235.18694846,1031.06375615
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1657.95284225,1788.4041443,1529.14036866
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,73786.5604574,82310.8873885,65977.6643411
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,81492.9350647,92421.1781793,71751.158006
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,155279.495522,173085.572495,140128.729934
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0307873509733,0.0343010883837,0.0275252023244
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.034394036081,0.0390225375175,0.0302991934442
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0325803806974,0.0362940010416,0.0293939972538
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2896.06382196,3230.6368753599995,2589.57085913
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3363.3838621499995,3814.41531051,2961.32034926
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3123.85374629,3482.06962065,2819.05641498
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,56469.7946927,65875.1537666,48910.1038858
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,31101.6168392,37269.6465436,26093.3138444
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,87571.4115318,100243.82506,76493.8179743
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101781120925,0.0118628350735,0.00881299035139
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0057030843208,0.0068352684513,0.00478430518865
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00795986045432,0.00911049213963,0.00695422303775
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1010.6630076499999,1178.9945651,875.364129914
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,569.014108126,681.860200318,477.38559001699997
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,792.266366641,906.9148215060001,692.0463902189999
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,172293.15822,194835.77309,152881.739308
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,244453.194753,275430.001788,217325.642438
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,416746.352973,466718.940012,373505.100821
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0310542315269,0.0351008636161,0.027538929785
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0448252286677,0.0505268994805,0.0398423520238
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.037880476305,0.0424202323528,0.0339680462445
5,Prevalence,205,Cote d'Ivoire,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3083.60110802,3487.05550462,2736.18700589
5,Prevalence,205,Cote d'Ivoire,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4472.35001672,5039.08068925,3976.04270043
5,Prevalence,205,Cote d'Ivoire,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3770.3414060000005,4222.44785572,3379.1339430599996
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,438730.581123,491996.45815,392277.033623
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,555546.921892,624786.030656,496225.320789
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,994277.503016,1108310.77863,896621.703369
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0424914673973,0.0476662625953,0.0379530646958
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0521651240792,0.0586516930837,0.0465582334677
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0474030454297,0.0528513133148,0.042702689993
5,Prevalence,63,Ukraine,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4043.85190894,4534.81225628,3615.6819230300002
5,Prevalence,63,Ukraine,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5138.51202896,5778.93676941,4589.81893242
5,Prevalence,63,Ukraine,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4590.22460499,5116.67556653,4139.38260866
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11302.1928477,12617.2275285,10051.6978765
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7285.78498036,8383.09389181,6352.97614321
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,18587.9778281,20730.6317193,16557.0427843
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0140445980286,0.0156655848977,0.0125045044703
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00886879731568,0.010208099596,0.00772109743019
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114299953247,0.0127626107054,0.0101738316157
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1346.35345789,1503.0046063500001,1197.39048662
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,873.7776307940001,1005.3769002600001,761.906707083
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1110.86211741,1238.9122507,989.4885702749999
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,32759.4262792,36604.9668785,29233.6960686
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,36728.2030692,41317.3434352,32699.879255
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,69487.6293483,77340.0908815,62715.303976
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0407078610569,0.0454558273075,0.0364180088185
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0447082580902,0.0503678691641,0.0398518619731
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0427286494045,0.0475781934743,0.038591413162
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3902.4079171000003,4360.50104585,3482.41162748
5,Prevalence,38,Mongolia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4404.78031503,4955.15178595,3921.6670680899997
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4152.74731795,4622.02924448,3748.01691787
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40728.7698187,45778.4725542,36305.5343941
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,24145.0316496,27572.9004519,20983.3099973
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,64873.8014683,73114.1364957,58057.6950051
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0161408892125,0.0181545511688,0.0144050785691
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00920709162154,0.0105244128162,0.00800516967132
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0126072005811,0.0142145819252,0.0113016819688
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1539.54904452,1730.4279995200002,1372.35057763
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,907.084591853,1035.86334098,788.3045034200001
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1222.34392882,1377.6072749500001,1093.91571643
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,293.973783865,332.466013287,259.462798744
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,157.81310105,181.268583512,136.448742758
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,451.786884915,508.503600438,399.534733244
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016843468838,0.0190231023362,0.0148473675043
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00870624570057,0.0100052484295,0.00751545467359
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0126978702468,0.0142807693593,0.0112154593979
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1598.5124018899999,1807.81782124,1410.8554040699998
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,856.672375806,983.998077872,740.698128709
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1227.2782180699999,1381.34906848,1085.33534692
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,513.669213931,576.97470795,461.788767834
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,808.708973571,907.710605725,713.963206227
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1322.3781875,1478.91219435,1183.9430464
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0294316417387,0.03308149114,0.0264387947285
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0446149982149,0.0501721172716,0.0393772162073
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0371668471881,0.0414902883473,0.0332488710909
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2793.128687,3137.35876074,2511.0234754
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4389.99444985,4927.41474551,3875.67668365
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3592.2378443499997,4017.46217779,3216.17904546
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.85009930468,7.97251880501,4.07909082304
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.85009930468,7.97251880501,4.07909082304
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000148231169148,0.000202031915657,0.000103747798742
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.05445312063e-05,9.61410592705e-05,4.93035039878e-05
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,14.233184519200002,19.396992311600002,9.92435330262
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.87273151393,9.36616258682,4.79214019928
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.67189800987,1.08784719407,0.485059196333
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.67189800987,1.08784719407,0.485059196333
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.51202746922e-05,5.67683477116e-05,2.5374770139e-05
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.78940137895e-05,2.89532490819e-05,1.29244611801e-05
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.46062865202,5.60298603882,2.49831035082
5,Prevalence,24,Marshall Islands,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.7713742278899998,2.86797170873,1.27879729775
5,Prevalence,66,Brunei,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,3140.50128113,3528.60062495,2781.20565
5,Prevalence,66,Brunei,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,5051.46634982,5698.53184851,4454.66218479
5,Prevalence,66,Brunei,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,8191.96763095,9192.33644065,7279.47275561
5,Prevalence,66,Brunei,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0270131919268,0.0303667552143,0.0239285793422
5,Prevalence,66,Brunei,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0430298091282,0.0486097888271,0.0379921733285
5,Prevalence,66,Brunei,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0350604269378,0.0394114655171,0.0311795822718
5,Prevalence,66,Brunei,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2419.399688,2718.38617051,2142.60319596
5,Prevalence,66,Brunei,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4187.640669949999,4724.05477445,3692.89296297
5,Prevalence,66,Brunei,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3271.12199247,3670.57772294,2906.75506755
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,316.351252249,568.727910067,157.275493783
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,316.351252249,568.727910067,157.275493783
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0001320013081,0.000236718832339,6.56138206141e-05
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.6377293622e-05,0.000119149776866,3.30444133331e-05
5,Prevalence,47,Czech Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.4165350843,22.3221182106,6.172938063570001
5,Prevalence,47,Czech Republic,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,47,Czech Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.3642339972599995,11.441451471199999,3.16400847905
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,63.8915078359,79.5300128631,50.9646968533
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,63.8915078359,79.5300128631,50.9646968533
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.42058413945e-05,5.49469896476e-05,3.52158984876e-05
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.01140476292e-05,2.49810309004e-05,1.60650602223e-05
5,Prevalence,127,El Salvador,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.21535253723,5.2471299060500005,3.3624838646999997
5,Prevalence,127,El Salvador,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.95340637525,2.43153494748,1.55818460258
5,Prevalence,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.3419397318,11.6222154776,7.00554976947
5,Prevalence,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.3419397318,11.6222154776,7.00554976947
5,Prevalence,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.74612700276e-05,5.90798499586e-05,3.55647673082e-05
5,Prevalence,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.39507031889e-05,2.97771065417e-05,1.79521200228e-05
5,Prevalence,113,Guyana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.61982813743,5.747482816650001,3.4644235428899997
5,Prevalence,113,Guyana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.35333497876,2.9277609361000003,1.7647732474500002
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,35657.3739231,41193.7461935,30550.9920423
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,26711.0560177,31240.1787439,22996.7263486
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62368.4299407,71836.2541131,53875.8006393
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129492802864,0.0149366264747,0.0111140958342
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00875686005143,0.010248259869,0.0075322785175
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0107458998807,0.0123720192304,0.00929286289664
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1275.3200220699998,1473.33366215,1092.68539881
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,870.240171731,1017.79796714,749.228150081
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1063.33797382,1224.75773349,918.5446025189999
5,Prevalence,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3710.92479869,4340.05952083,3199.03920286
5,Prevalence,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1998.99759877,2321.8074502,1725.23961091
5,Prevalence,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,5709.92239746,6597.94249801,4942.34101057
5,Prevalence,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.015982783902,0.0186941190532,0.0137824691013
5,Prevalence,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0089542656125,0.0104213424636,0.00773945529945
5,Prevalence,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012537470085,0.014520821195,0.010873865916
5,Prevalence,22,Fiji,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1569.32713902,1835.3843207500001,1352.85388742
5,Prevalence,22,Fiji,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,890.9338739839999,1034.80709908,768.922589525
5,Prevalence,22,Fiji,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1239.03292263,1431.73013705,1072.4704821999999
5,Prevalence,22,Fiji,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,7247.69235654,8130.44428833,6459.96015008
5,Prevalence,22,Fiji,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,8851.65788042,10013.587919,7875.86751499
5,Prevalence,22,Fiji,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,16099.350237,18004.8876727,14427.6567313
5,Prevalence,22,Fiji,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0312154814761,0.0350014051229,0.0278067072149
5,Prevalence,22,Fiji,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396500249563,0.0448478946988,0.0352525350604
5,Prevalence,22,Fiji,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.035349899593,0.0395356863466,0.031702450143
5,Prevalence,22,Fiji,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3065.00425834,3438.3145889800003,2731.8771816900003
5,Prevalence,22,Fiji,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3945.0982089399995,4462.95917644,3510.1978914
5,Prevalence,22,Fiji,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3493.5019406499996,3906.99681044,3130.7503749
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.0451791806,28.3268187878,13.8891088797
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.0451791806,28.3268187878,13.8891088797
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.50676510229e-05,8.75636221898e-05,4.27634046814e-05
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.23534666994e-05,4.3522338339e-05,2.13102212947e-05
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.2986513340900006,8.4779869735,4.156897568980001
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.16543587946,4.2606778384899995,2.08908098165
5,Prevalence,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.584431549836,0.991521822552,0.337794574056
5,Prevalence,349,Greenland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.584431549836,0.991521822552,0.337794574056
5,Prevalence,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.87764397278e-05,8.29382962271e-05,2.82242989826e-05
5,Prevalence,349,Greenland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.5068694135e-05,4.26141390503e-05,1.44960634884e-05
5,Prevalence,349,Greenland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.42547334134,7.50807069586,2.55787163228
5,Prevalence,349,Greenland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,349,Greenland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.35687058775,3.99856684901,1.36224352795
5,Prevalence,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.92019749533,3.62126114624,2.34996466335
5,Prevalence,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.92019749533,3.62126114624,2.34996466335
5,Prevalence,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000243725028111,0.000302445593131,0.000196211859738
5,Prevalence,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000125261733033,0.000155330812666,0.000100776432631
5,Prevalence,349,Greenland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,22.1125231358,27.421166207099997,17.7945663161
5,Prevalence,349,Greenland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,11.776447710800001,14.6036672533,9.47683710586
5,Prevalence,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,22556.4912799,26424.3626656,19420.5012028
5,Prevalence,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,14238.0876049,17092.4601402,12023.769155
5,Prevalence,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,36794.5788848,43164.7587895,31812.1235367
5,Prevalence,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103293580202,0.0121160131281,0.00891686421261
5,Prevalence,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00634802607451,0.00762042673847,0.0053648268961
5,Prevalence,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00831205115475,0.00973570556063,0.00718382187594
5,Prevalence,129,Honduras,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1007.0990714,1179.79125266,867.083824552
5,Prevalence,129,Honduras,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,630.086958588,756.403284158,532.095345096
5,Prevalence,129,Honduras,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,817.7570767330001,959.3339028559999,707.022336889
5,Prevalence,129,Honduras,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,53275.6555459,60325.5351716,47494.9340651
5,Prevalence,129,Honduras,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,82650.5911012,93945.3067491,72810.271082
5,Prevalence,129,Honduras,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,135926.246647,153360.015934,121131.150796
5,Prevalence,129,Honduras,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0243971794675,0.0276285013146,0.0217439161961
5,Prevalence,129,Honduras,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0368499772572,0.0418680977098,0.0325097290879
5,Prevalence,129,Honduras,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0307067399881,0.0346093311512,0.0273194086694
5,Prevalence,129,Honduras,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2378.6440259,2693.40606652,2120.54718083
5,Prevalence,129,Honduras,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3657.5880846800005,4157.42017085,3222.1182740900003
5,Prevalence,129,Honduras,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3020.95182166,3408.41618844,2692.13179708
5,Prevalence,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,22648.3456428,26860.6602499,19083.0763478
5,Prevalence,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,16789.0465628,19838.2452678,14138.4251916
5,Prevalence,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,39437.3922055,46113.6289011,33826.1525989
5,Prevalence,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00934273271512,0.0110804189978,0.00787404926897
5,Prevalence,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00681635703041,0.00805870276792,0.00573805551217
5,Prevalence,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00806949057944,0.00943641746892,0.0069175355006
5,Prevalence,187,Somalia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,926.604523119,1098.94160369,780.739800504
5,Prevalence,187,Somalia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,679.663453596,803.102799293,572.359535618
5,Prevalence,187,Somalia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,802.4815159850001,938.3311816180001,688.302666567
5,Prevalence,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,84.9795163526,115.891389528,58.6253346765
5,Prevalence,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,84.9795163526,115.891389528,58.6253346765
5,Prevalence,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.51883284973e-05,2.07040767167e-05,1.04795301843e-05
5,Prevalence,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.49425499528e-06,1.02199205517e-05,5.16959143757e-06
5,Prevalence,168,Angola,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.5002142505,2.04592731923,1.03496190961
5,Prevalence,168,Angola,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.743602676634,1.0140931738699999,0.512993691364
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,18690.7642141,22071.0850907,15875.4604054
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12423.4421089,14766.4327701,10437.9393692
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,31114.206323,36460.0856235,26559.8979608
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0104989533326,0.0123797940094,0.00889691426832
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00709753411056,0.00843683016348,0.0059644234437
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00881262178217,0.0103194763674,0.0075082465206
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1021.73569431,1206.52185169,867.836348151
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,705.0193519530001,837.981999753,592.343827523
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,866.339382865,1015.18925954,739.529890927
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,47273.2337811,53061.2566646,42019.5304629
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,86090.7533357,96774.2330444,76927.6622173
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,133363.987117,148347.590454,119770.935074
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0265543825182,0.0298175225177,0.0235944500816
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0491838083594,0.0552534591652,0.0440072409721
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0377733329058,0.0420065372501,0.033939280318
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2584.20414415,2900.60798467,2297.00902756
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4885.57411013,5491.85213476,4365.57679332
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3713.36723475,4130.56848147,3334.88429368
5,Prevalence,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9800.4471035,11582.2696384,8792.88811038
5,Prevalence,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9800.4471035,11582.2696384,8792.88811038
5,Prevalence,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000409316997541,0.000484254660747,0.000366698350337
5,Prevalence,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000200756974929,0.000237177137275,0.000179900003911
5,Prevalence,67,Japan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,37.1465964435,43.9002314499,33.3276495205
5,Prevalence,67,Japan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,18.9202821585,22.3601849262,16.9751361626
5,Prevalence,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,147656.589823,174819.681256,126093.191992
5,Prevalence,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,103709.935312,125602.611183,86557.8147042
5,Prevalence,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,251366.525136,295816.270241,215847.040953
5,Prevalence,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0168195228356,0.0199183942709,0.0143277296364
5,Prevalence,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0111024805669,0.0134415199346,0.00925673603287
5,Prevalence,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0138722599822,0.0163238037239,0.0118886595399
5,Prevalence,148,Morocco,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1646.0369197300001,1948.8439357,1405.65381873
5,Prevalence,148,Morocco,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1102.35666402,1335.05893181,920.042844256
5,Prevalence,148,Morocco,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1367.7242919599998,1609.58225662,1174.4572635499999
5,Prevalence,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,24361.825194,29037.0100647,20426.4457751
5,Prevalence,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4969.23082667,6105.42828866,4075.85490754
5,Prevalence,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29331.0560207,34929.8941354,24671.0145197
5,Prevalence,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0191841615878,0.0229253988536,0.0160731255761
5,Prevalence,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120949752974,0.014840084989,0.00992757264479
5,Prevalence,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0174511456296,0.0208040103755,0.0146682235653
5,Prevalence,151,Qatar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1848.0035944200001,2202.64690939,1549.47935604
5,Prevalence,151,Qatar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1197.25782789,1471.00669423,982.0129842199999
5,Prevalence,151,Qatar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1692.18050029,2015.19119159,1423.33128623
5,Prevalence,151,Qatar,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,54930.8077952,62857.3597107,48821.2127868
5,Prevalence,151,Qatar,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,23616.4821935,26817.3359009,20797.2122146
5,Prevalence,151,Qatar,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,78547.2899886,88824.2329198,69887.1856605
5,Prevalence,151,Qatar,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0432548319406,0.0496462663505,0.0383555311539
5,Prevalence,151,Qatar,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0574816089676,0.0651258864434,0.0506727176694
5,Prevalence,151,Qatar,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467320723229,0.0529852053187,0.0417087658116
5,Prevalence,151,Qatar,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4166.86062892,4768.14137512,3703.40793415
5,Prevalence,151,Qatar,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5690.019071260001,6461.21431069,5010.76041558
5,Prevalence,151,Qatar,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4531.58564681,5124.48766911,4031.9630057399995
5,Prevalence,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,428219.710305,471476.036483,387153.081656
5,Prevalence,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,315741.257453,350699.519818,284004.340958
5,Prevalence,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,743960.967758,818316.823431,673734.141948
5,Prevalence,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0178841547953,0.019667090905,0.0162195205934
5,Prevalence,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0126935479415,0.0141016579255,0.0114162404548
5,Prevalence,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0152393625306,0.016729882109,0.0137996318405
5,Prevalence,67,Japan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1623.0794983,1787.03378275,1467.42481585
5,Prevalence,67,Japan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1242.3192849,1379.86647734,1117.446838
5,Prevalence,67,Japan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1436.2560479400001,1579.80396515,1300.6794415499999
5,Prevalence,67,Japan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,935337.797099,1034820.47579,854802.429273
5,Prevalence,67,Japan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1349132.94433,1484591.4811,1234976.02413
5,Prevalence,67,Japan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2284470.74143,2508092.7787,2092110.02537
5,Prevalence,67,Japan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0390633840341,0.0432549512975,0.0356728869164
5,Prevalence,67,Japan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.05423838919,0.0596840843674,0.0496256633598
5,Prevalence,67,Japan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467953669986,0.0513982507703,0.042822206862
5,Prevalence,67,Japan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3545.20720537,3922.27601454,3239.9543147100003
5,Prevalence,67,Japan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5308.314434909999,5841.29119532,4859.15126687
5,Prevalence,67,Japan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4410.2917504,4842.00593621,4038.9292007500003
5,Prevalence,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2132.09441575,2636.78713972,1738.44115592
5,Prevalence,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2132.09441575,2636.78713972,1738.44115592
5,Prevalence,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0004840714902,0.000598357914007,0.000393698678333
5,Prevalence,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000242177189651,0.000299229536652,0.000197136134727
5,Prevalence,52,Romania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,46.1076431791,57.0218840587,37.5946880742
5,Prevalence,52,Romania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,23.4234853188,28.968109667,19.0987559427
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,53009.6920882,61567.3930623,45900.6100636
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,31055.0729746,36578.1686867,26421.2322159
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,84064.7650628,96399.4251818,73384.6913353
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.013091322334,0.0152019440381,0.0113253593595
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00713197493886,0.00841125110655,0.00607754641709
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0100034596681,0.0114540041608,0.00873116450948
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1279.6119819399999,1486.18810552,1108.00437244
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,707.970579519,833.882029647,602.331705961
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,985.61945901,1130.23749279,860.400665124
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,117609.291055,132651.838407,104266.906107
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,192539.712434,219827.538911,170328.35572
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,310149.00349,349805.087028,278227.086527
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0290452014421,0.0327976657424,0.0257616548737
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0442178867635,0.0504447366353,0.0390956058085
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0369069314787,0.0415480155305,0.0331641018436
5,Prevalence,128,Guatemala,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2838.99513641,3202.1103153800004,2516.9205312900003
5,Prevalence,128,Guatemala,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4389.377925610001,5011.46560642,3883.01984692
5,Prevalence,128,Guatemala,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3636.3498167599996,4101.29856876,3262.0804959
5,Prevalence,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,57.3731812992,75.3943293176,43.6311466932
5,Prevalence,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,57.3731812992,75.3943293176,43.6311466932
5,Prevalence,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000613906392827,0.0008096986874,0.000466010068885
5,Prevalence,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000307663097316,0.00040510889291,0.000233512987581
5,Prevalence,88,Malta,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,57.3129854706,75.3152257361,43.5853689801
5,Prevalence,88,Malta,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,29.433460289400003,38.6786290697,22.3835526372
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,976849.820982,1126442.50449,795023.09676
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,428300.961959,484615.922318,348774.684649
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1405150.78294,1588379.4806,1160498.53478
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0198632831814,0.022995595222,0.0161708904818
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00892380845971,0.0101002881074,0.00726970016808
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144601413698,0.0163458869849,0.0119263207965
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1916.92041795,2210.47349359,1560.11289984
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,880.332338862,996.0824425719999,716.87355655
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1410.63078746,1594.57406614,1165.02441007
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1319124.1399,1494365.37444,1167770.3159
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2241437.128,2541510.69087,1971126.05983
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3560561.2679,3997365.38644,3144377.49047
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0268231069596,0.0303858745688,0.0237780453718
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467010284887,0.0529803905805,0.0410150438846
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0366410254111,0.0411086598429,0.0323092542908
5,Prevalence,165,Pakistan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2588.58213746,2932.46662549,2291.57308927
5,Prevalence,165,Pakistan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4607.06317419,5223.83615601,4051.4642005600003
5,Prevalence,165,Pakistan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3574.4472451700003,4012.9548738000003,3156.64037575
5,Prevalence,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,226.13148435,274.724270708,182.714659047
5,Prevalence,132,Panama,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,226.13148435,274.724270708,182.714659047
5,Prevalence,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000226449916599,0.0002753436007,0.000183435814815
5,Prevalence,132,Panama,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000111975224257,0.000136166608573,9.07429762325e-05
5,Prevalence,132,Panama,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.495469978,26.114573696799997,17.368379637100002
5,Prevalence,132,Panama,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,132,Panama,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.831898802300001,13.1595363972,8.75219433595
5,Prevalence,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,179.122359775,221.890932609,143.00209712
5,Prevalence,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,179.122359775,221.890932609,143.00209712
5,Prevalence,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000179371701687,0.000222359489932,0.000142565540523
5,Prevalence,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.86963615434e-05,0.000109971495669,7.06313998977e-05
5,Prevalence,132,Panama,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,17.0269050239,21.0923741734,13.5934069255
5,Prevalence,132,Panama,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.58012001248,10.6287726103,6.84992737294
5,Prevalence,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,688.045962279,1029.49656432,435.204281143
5,Prevalence,68,South Korea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,688.045962279,1029.49656432,435.204281143
5,Prevalence,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.65807965731e-05,8.47542250834e-05,3.58894407532e-05
5,Prevalence,68,South Korea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.81441701385e-05,4.2206333031e-05,1.78378135243e-05
5,Prevalence,68,South Korea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.18962132879,7.765029694239999,3.28255021267
5,Prevalence,68,South Korea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,68,South Korea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.66715836328,3.99076591103,1.6870366252
5,Prevalence,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1323.68703709,1625.24220773,1076.43867983
5,Prevalence,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1323.68703709,1625.24220773,1076.43867983
5,Prevalence,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000108848067835,0.000134106704455,8.85146632992e-05
5,Prevalence,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.41431857047e-05,6.65889609773e-05,4.40393789712e-05
5,Prevalence,68,South Korea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.983976154090001,12.2584712186,8.1190929651
5,Prevalence,68,South Korea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.13117312633,6.30012903837,4.17273348711
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7.1210500924,10.2495216884,5.33665549768
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7.1210500924,10.2495216884,5.33665549768
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.40835229967e-05,4.90427879352e-05,2.55650829738e-05
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.74611420415e-05,2.51307624913e-05,1.30899990575e-05
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.38559185368,4.87297472734,2.53722936146
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.73863524866,2.50246515024,1.3029675733
5,Prevalence,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2411.11821936,2712.3702756,2144.42674992
5,Prevalence,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1685.09623087,1917.97388207,1475.0758048
5,Prevalence,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4096.21445023,4582.72069466,3650.2540517
5,Prevalence,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0207393705791,0.0234038844507,0.0184359106182
5,Prevalence,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143541204429,0.0163433080348,0.0125756772154
5,Prevalence,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0175311600009,0.0196102860221,0.0156153008816
5,Prevalence,66,Brunei,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1857.49284762,2089.57335504,1652.03734859
5,Prevalence,66,Brunei,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1396.93645775,1589.99088112,1222.8305612
5,Prevalence,66,Brunei,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1635.65309064,1829.91915068,1457.57732996
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,790.151450571,901.62875945,696.52403815
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,473.281672383,545.343936438,406.547630425
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1263.43312295,1446.59611322,1116.64096714
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165660441949,0.018942857468,0.0146088732301
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00947038817065,0.0109172800154,0.00812988056267
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129354659888,0.0148190651506,0.0114196996213
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1621.32235677,1850.06414168,1429.20701375
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,940.880426988,1084.13966927,808.213650402
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1275.71829009,1460.6622910899998,1127.49878039
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,402451.38112,471234.12462,345457.465117
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,244834.354891,288257.728231,207151.447298
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,647285.736011,749759.420436,559580.634158
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00915382398582,0.0107298634167,0.0078455108465
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0057768857985,0.00679990567321,0.0048886082491
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00749632424454,0.00868686116659,0.00647914198765
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,907.387395116,1062.4684741800002,778.8860073579999
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,576.4618968330001,678.70212441,487.737581983
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,745.5090164090001,863.5327135699999,644.494981062
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1518251.6195,1702793.19312,1352510.7956
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2264136.12015,2558641.96836,2006683.18992
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3782387.73964,4239588.16082,3362599.45974
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0345331215504,0.0387853200802,0.0307914137306
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0534225077928,0.0603771816818,0.0473901887341
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0438045989096,0.0490987737016,0.0389769944088
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3423.1274801699997,3839.20431737,3049.43977151
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5330.90302253,6024.31633033,4724.73072057
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4356.351463630001,4882.93040293,3872.86182336
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,7734.33564313,8765.63313883,6824.48850484
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,9097.76269415,10341.6570455,8019.24016042
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,16832.0983373,18903.6134242,14920.161472
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0316717009604,0.0356624626952,0.0279621031328
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0435387769618,0.049444148675,0.0383203591742
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0371436536602,0.0417701992029,0.0328507725325
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3077.66907092,3488.0459347900005,2715.62008235
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4314.946112109999,4904.90842218,3803.41742422
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3642.1445808,4090.3808788999995,3228.43796188
5,Prevalence,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,551.290245317,685.675646402,426.808340832
5,Prevalence,109,Cuba,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,551.290245317,685.675646402,426.808340832
5,Prevalence,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000201184861059,0.000250699532728,0.000156158077793
5,Prevalence,109,Cuba,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000101709361811,0.000126662399423,7.89037605408e-05
5,Prevalence,109,Cuba,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.4627592177,24.2071034645,15.0680481657
5,Prevalence,109,Cuba,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,109,Cuba,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.95382566101,12.380222400600001,7.70624158762
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,43131.5869241,47975.5867922,38519.0789409
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,22754.7708712,25643.3623411,20247.4509558
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,65886.3577953,72997.7909656,59297.100755
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0231871214608,0.0257341530622,0.0207456352663
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119179640541,0.01346321579,0.010611798325
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0174790164189,0.01942788307,0.0157303244699
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2164.63445972,2407.73910263,1933.14764372
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1172.08874928,1320.87889014,1042.93774705
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1674.81692603,1855.5880149299999,1507.3194411099998
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,64044.5332843,71731.735056,57097.6510236
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,116953.582745,130895.697286,105149.279757
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,180998.116029,201497.961714,163456.433158
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0344303768687,0.0385021069178,0.0307133221305
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0612553615516,0.068577733707,0.0550757355354
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0480175793238,0.0533993219641,0.0434400955367
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3214.18741091,3599.98313604,2865.5459209600003
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6024.23022844,6742.38272872,5416.19550889
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4600.93285544,5122.03448684,4155.0270812
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,9.1729954109,13.3432242039,5.14521234582
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,9.1729954109,13.3432242039,5.14521234582
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000352828376374,0.000512339262128,0.000197364237627
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00018183829299,0.000264106433529,0.000101892709913
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,34.609826776800006,50.3441523356,19.4129507366
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,17.943338712400003,26.100742525300003,10.0645736461
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,54.3590806227,83.0995203333,18.4292973727
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,54.3590806227,83.0995203333,18.4292973727
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.97416610573e-05,3.02682888005e-05,6.68451541356e-06
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.36609413022e-06,1.43227501844e-05,3.17699346438e-06
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.94420441755,2.9721336836,0.6591414158209999
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.926784187174,1.41678852042,0.31420659051100003
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.18052091263,5.57147524286,2.74945462865
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.18052091263,5.57147524286,2.74945462865
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.8228705402e-05,3.7593700518e-05,1.86209655483e-05
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.41497868196e-05,1.88482768911e-05,9.31993642635e-06
5,Prevalence,28,Solomon Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.79850610034,3.72963268953,1.8405279417800002
5,Prevalence,28,Solomon Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.40700947803,1.8751535124799998,0.925365236244
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34332.1442752,39248.8164102,30304.6456601
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20866.2391723,24317.4410205,17958.8238593
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,55198.3834475,62748.4048177,48569.8027679
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0132154990475,0.0150864125797,0.0116778013305
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00765576694538,0.0089211631273,0.00659762770101
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103689444903,0.0117737377705,0.00913029710802
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1256.93713843,1436.94185222,1109.48603419
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,754.3954627400001,879.169792879,649.281124583
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1004.08747144,1141.42630989,883.510121198
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,42511.2605343,48512.2032593,37574.4221667
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20350.8484569,22896.5434661,18020.6132813
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62862.1089912,70584.6058618,55994.3342506
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0461225072268,0.0525371236628,0.040801159978
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0195087031481,0.0219872225983,0.0173003382369
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0319929462232,0.0359538179015,0.0286028265827
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4145.688104559999,4730.89862428,3664.24879089
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1904.1207531700002,2142.30790829,1686.09302981
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3001.7063785,3370.4606008200003,2673.76569093
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,48215.4879323,53926.4941249,43506.4217357
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,74011.6861046,82502.9819703,67197.3117242
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,122227.174037,135659.512297,111059.191163
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0523113627535,0.058256596064,0.0472471640181
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0709494181677,0.0790738417519,0.0643897954101
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0622064274693,0.0690832978211,0.0563844245704
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4701.96301554,5258.89899298,4242.735990290001
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6924.880197869999,7719.36563239,6287.2953961700005
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5836.42664589,6477.82948903,5303.14823756
5,Prevalence,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10730.4768007,12325.828075,9245.94200219
5,Prevalence,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6397.1461071,7544.92212632,5428.65540091
5,Prevalence,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,17127.6229078,19616.1832485,14902.954759
5,Prevalence,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00967060423029,0.0111061657187,0.00833585615703
5,Prevalence,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00587069089519,0.00692578047429,0.00498245655633
5,Prevalence,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00778785598989,0.00892026775703,0.00677681861967
5,Prevalence,210,Liberia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,963.998259335,1107.3204881699999,830.6314958400001
5,Prevalence,210,Liberia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,586.559422706,691.7999202589999,497.757738328
5,Prevalence,210,Liberia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,777.205647755,890.1298499070001,676.256166388
5,Prevalence,210,Liberia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,30126.2815715,33918.6804378,26656.1631354
5,Prevalence,210,Liberia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,67954.5136928,75269.3082413,60737.8570326
5,Prevalence,210,Liberia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,98080.7952643,108026.777573,88837.9985755
5,Prevalence,210,Liberia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0271507028911,0.030547380415,0.0240350438617
5,Prevalence,210,Liberia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0623621601197,0.0690612702188,0.0557219023614
5,Prevalence,210,Liberia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0445969561577,0.0491007375834,0.0404093648728
5,Prevalence,210,Liberia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2706.46715282,3047.16645014,2394.72069512
5,Prevalence,210,Liberia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6230.8034949600005,6901.502834280001,5569.10249679
5,Prevalence,210,Liberia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4450.64375986,4901.9657947,4031.23040482
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,623.49909643,750.88709095,514.72915966
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,623.49909643,750.88709095,514.72915966
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000676471049768,0.000813089599494,0.000557928901466
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00031732513172,0.000381734665938,0.000261840006204
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,60.803484883399996,73.2263320751,50.1962662939
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,29.7724852821,35.855344445300005,24.5786504231
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3375.24350362,4164.4164656,2677.28904641
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3375.24350362,4164.4164656,2677.28904641
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000947273704669,0.00117349100974,0.000757041269808
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00046293252953,0.000572743092227,0.00036860499104
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,87.7289267355,108.24101627499999,69.5877776968
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,44.1201150208,54.4359342547,34.9966752161
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,11787.1246872,13254.9226986,10518.4776485
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,15812.2120045,17882.1334929,13959.2993857
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,27599.3366918,30887.5901573,24696.4777213
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0231189919059,0.0260368814674,0.02057914701
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0311438641387,0.0351925846079,0.0274919091953
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0271230158034,0.0303866804329,0.0242419349793
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2185.21670601,2457.33198607,1950.0220528099999
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3048.0843127000003,3447.0983921499997,2690.90254176
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2608.2335379799997,2918.98495443,2333.90324492
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,31.3078863788,45.156619449,21.3678049279
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,31.3078863788,45.156619449,21.3678049279
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.42668769664e-05,2.06090472851e-05,9.78314756753e-06
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.09425623808e-06,1.02472025125e-05,4.85757778427e-06
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.37213044548,1.9790787411000001,0.936486588073
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.691145138751,0.996866337032,0.47171036470000005
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,65.7380641245,89.1872175294,49.0916614574
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,65.7380641245,89.1872175294,49.0916614574
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.99571778746e-05,4.07439030473e-05,2.23469239547e-05
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.48961655855e-05,2.02463924458e-05,1.11258645406e-05
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.88110152569,3.90880735413,2.1515397906400002
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.4512172077299998,1.9688749054599999,1.08373534895
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,20.6998149122,32.5462828797,14.5974694819
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,20.6998149122,32.5462828797,14.5974694819
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.30801471269e-06,5.19517902167e-06,2.331644817e-06
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.60749613035e-06,2.52526252843e-06,1.13323815365e-06
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.32805474808199997,0.515799908183,0.23134357451100002
5,Prevalence,184,Mozambique,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.15989113500899998,0.251396552677,0.112754919482
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,20.3315421459,25.5566033873,15.8485887526
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,20.3315421459,25.5566033873,15.8485887526
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.2491693261e-06,4.08219340594e-06,2.53008096457e-06
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.57889998693e-06,1.98394805711e-06,1.23021970539e-06
5,Prevalence,184,Mozambique,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.32221828867,0.405026089442,0.251171559395
5,Prevalence,184,Mozambique,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.157046493603,0.197406321743,0.12241891315
5,Prevalence,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,214.095027504,287.056275724,147.409282573
5,Prevalence,84,Ireland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,214.095027504,287.056275724,147.409282573
5,Prevalence,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000210457054265,0.000281351229607,0.00014549244095
5,Prevalence,84,Ireland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000101468815041,0.000135765267186,7.00636945831e-05
5,Prevalence,84,Ireland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.7438097273,26.4722845505,13.5940608294
5,Prevalence,84,Ireland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,84,Ireland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.7470047878,13.068677616999999,6.7110338794799995
5,Prevalence,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,695.806623226,875.798190955,544.059655482
5,Prevalence,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,695.806623226,875.798190955,544.059655482
5,Prevalence,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000683967291155,0.000861327506656,0.000535373015644
5,Prevalence,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000329765953344,0.000415345550449,0.000258631791186
5,Prevalence,84,Ireland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,64.16717723960001,80.7659712761,50.1730957667
5,Prevalence,84,Ireland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,31.6776646662,39.872057094999995,24.7691510105
5,Prevalence,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.37325394403,8.81551272931,5.44003960636
5,Prevalence,112,Grenada,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.37325394403,8.81551272931,5.44003960636
5,Prevalence,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000255944164493,0.000305314469633,0.000188207047383
5,Prevalence,112,Grenada,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000129897851534,0.00015500817632,9.56177703573e-05
5,Prevalence,112,Grenada,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,24.891990254299998,29.7610334067,18.3654888184
5,Prevalence,112,Grenada,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,112,Grenada,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.7549477893,15.2499026144,9.41069189768
5,Prevalence,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.12909620476,1.37456338726,0.897914380632
5,Prevalence,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.12909620476,1.37456338726,0.897914380632
5,Prevalence,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.91933936331e-05,4.77367090614e-05,3.11804956779e-05
5,Prevalence,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.98917582589e-05,2.42401740065e-05,1.5821822546e-05
5,Prevalence,112,Grenada,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.81181116754,4.64050454511,3.03134493692
5,Prevalence,112,Grenada,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.9532167547800001,2.37784896202,1.5532967033400003
5,Prevalence,130,Mexico,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,928218.777275,1028977.65613,837678.31015
5,Prevalence,130,Mexico,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1368320.01807,1527177.39512,1216842.69313
5,Prevalence,130,Mexico,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2296538.79534,2551067.13735,2063501.71681
5,Prevalence,130,Mexico,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0278532103001,0.030936212578,0.0251877657724
5,Prevalence,130,Mexico,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0397102256742,0.044309782444,0.0353034616049
5,Prevalence,130,Mexico,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0338806967369,0.0376131607293,0.0304346699553
5,Prevalence,130,Mexico,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2664.46350231,2953.69311264,2404.56596949
5,Prevalence,130,Mexico,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3916.8522458800003,4371.58568971,3483.24439645
5,Prevalence,130,Mexico,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3291.5301428599996,3656.33465287,2957.52813517
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.20078432006,5.4792501363,3.1280866995
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.20078432006,5.4792501363,3.1280866995
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000240688321746,0.000314855336492,0.000179576269916
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000118067023758,0.000154389359369,8.80254588798e-05
5,Prevalence,305,Bermuda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,22.8421927459,29.7939808808,17.0092901401
5,Prevalence,305,Bermuda,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,305,Bermuda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.4114226574,14.884372628300001,8.49744160071
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,185.883453006,251.685475989,102.298734873
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,185.883453006,251.685475989,102.298734873
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.04570497857e-05,1.41552384839e-05,5.7555789435e-06
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.21024148353e-06,7.05347593289e-06,2.86731734556e-06
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.04267993957,1.41178460294,0.5738264324810001
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.5200400492070001,0.704132214036,0.286197820498
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,321.433099301,420.646251638,215.018809329
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,321.433099301,420.646251638,215.018809329
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.80824507975e-05,2.36478764702e-05,1.20991260075e-05
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.00961567738e-06,1.17858865029e-05,6.02800636496e-06
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.8030214047300002,2.35953981458,1.20610950298
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.899262855695,1.17682824298,0.601551081473
5,Prevalence,88,Malta,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2928.67613167,3300.13646037,2620.06086839
5,Prevalence,88,Malta,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,5191.74563205,5848.40190831,4564.65690251
5,Prevalence,88,Malta,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,8120.42176372,9075.48986198,7252.59835379
5,Prevalence,88,Malta,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0313360430913,0.035260838586,0.0280484048003
5,Prevalence,88,Malta,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0558100181774,0.0629262390016,0.0490574093219
5,Prevalence,88,Malta,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0435444154989,0.0486459462313,0.0388637723028
5,Prevalence,88,Malta,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2925.60337045,3296.67396371,2617.31190569
5,Prevalence,88,Malta,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5475.36978702,6167.89908069,4814.02330997
5,Prevalence,88,Malta,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4165.9204893900005,4655.887374739999,3720.71167761
5,Prevalence,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,38975.9199198,43635.5810357,34728.1910702
5,Prevalence,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,28277.900027,31798.4625089,25071.9155416
5,Prevalence,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,67253.8199468,74395.5898209,60606.2028638
5,Prevalence,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00884901806112,0.00988829547708,0.00787845914563
5,Prevalence,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00642771149605,0.00723366302265,0.00570473153992
5,Prevalence,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00763907061499,0.00845146697953,0.00689006222196
5,Prevalence,52,Romania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,842.874403197,943.6419820049999,751.01507245
5,Prevalence,52,Romania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,631.45513822,710.070497441,559.864412798
5,Prevalence,52,Romania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,738.859804949,817.320280508,665.828160573
5,Prevalence,68,South Korea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,438474.302261,488513.037785,392764.052519
5,Prevalence,68,South Korea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,718783.299434,796427.269302,651590.209889
5,Prevalence,68,South Korea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1157257.60169,1274393.93022,1058203.07133
5,Prevalence,68,South Korea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0360562758445,0.0402269121902,0.0323454838676
5,Prevalence,68,South Korea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0584995718961,0.06472567039,0.0530184234782
5,Prevalence,68,South Korea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0473358155847,0.0520773577205,0.0432548381044
5,Prevalence,68,South Korea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3307.2145116700003,3684.6341949099997,2962.44265046
5,Prevalence,68,South Korea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5732.44902213,6351.6761236699995,5196.56990424
5,Prevalence,68,South Korea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4486.02195208,4940.0921093199995,4102.0445239
5,Prevalence,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,15961.1201302,17788.3627902,14356.1920424
5,Prevalence,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8064.43672239,9107.11207136,7113.20973609
5,Prevalence,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,24025.5568526,26666.3924909,21684.9857616
5,Prevalence,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0177074805606,0.0197458299805,0.0159096722553
5,Prevalence,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00892777804486,0.0100662380302,0.00786487465896
5,Prevalence,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133129456281,0.0147532018476,0.0120090576167
5,Prevalence,46,Croatia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1675.98792137,1867.85644955,1507.46340254
5,Prevalence,46,Croatia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,871.409846991,984.077054583,768.6241731590001
5,Prevalence,46,Croatia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1279.4605255200001,1420.0959736099999,1154.81540963
5,Prevalence,46,Croatia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,27044.2745139,30406.2130066,24209.8326013
5,Prevalence,46,Croatia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,30644.3604045,34711.3923325,27235.3748421
5,Prevalence,46,Croatia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,57688.6349184,64419.3788078,51991.5043628
5,Prevalence,46,Croatia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0300031750407,0.0337421412738,0.0267670634284
5,Prevalence,46,Croatia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0339250032601,0.0384466789513,0.0301276307038
5,Prevalence,46,Croatia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0319661676403,0.0357522843115,0.0288224712277
5,Prevalence,46,Croatia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2839.76795222,3192.7863030800004,2542.1390658699997
5,Prevalence,46,Croatia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3311.3034834900004,3750.77021776,2942.94253162
5,Prevalence,46,Croatia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3072.15901807,3430.5990395300005,2768.76319256
5,Prevalence,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,300330.610939,323938.258639,278337.542174
5,Prevalence,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,163711.712833,178440.431569,150673.879413
5,Prevalence,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,464042.323772,498349.4474,432626.153445
5,Prevalence,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0237989988101,0.0256830604092,0.0220852372469
5,Prevalence,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0125087446936,0.0136293405135,0.0115238520986
5,Prevalence,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0180509909922,0.0193709901968,0.0168055058283
5,Prevalence,86,Italy,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2234.93568722,2410.61399777,2071.27240262
5,Prevalence,86,Italy,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1231.27864179,1342.05359178,1133.22086971
5,Prevalence,86,Italy,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1735.77124552,1864.09858909,1618.2576431999998
5,Prevalence,86,Italy,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,432561.859598,486146.406348,384316.722493
5,Prevalence,86,Italy,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,774716.41569,874475.517114,685906.138683
5,Prevalence,86,Italy,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1207278.27529,1344708.11222,1077673.23179
5,Prevalence,86,Italy,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0342772968747,0.0384744368663,0.030398946451
5,Prevalence,86,Italy,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0591936702596,0.0667839480505,0.0523608774971
5,Prevalence,86,Italy,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.046962386277,0.0523004115997,0.0420095898584
5,Prevalence,86,Italy,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3218.9457275900004,3617.6996722599997,2859.92545219
5,Prevalence,86,Italy,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5826.65564716,6576.945585379999,5158.71200795
5,Prevalence,86,Italy,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4515.87885035,5029.94135502,4031.0853385399996
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.1995997636,51.8467307587,21.8306727303
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.1995997636,51.8467307587,21.8306727303
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000230247345693,0.000366962706592,0.000156119368367
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000114738051429,0.000183538357293,7.76896774427e-05
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.6815064037,34.9108446443,14.699619687
5,Prevalence,87,Luxembourg,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,11.0393815852,17.7752471768,7.48447584135
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,137.988415698,170.113709397,110.016605922
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,137.988415698,170.113709397,110.016605922
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000986744058485,0.00121587810352,0.000784702715142
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000491709998382,0.000606052295584,0.00039118669785
5,Prevalence,87,Luxembourg,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,92.9140964656,114.545569098,74.0793600957
5,Prevalence,87,Luxembourg,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,47.308251854299996,58.3221581852,37.7183350851
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,430745.788847,486354.645103,382151.275996
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,591546.603027,669021.936261,527324.802609
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1022292.39187,1150270.58357,916250.529058
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0349793525495,0.0394683785327,0.0310370717927
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0466925007979,0.052758138868,0.0416344960826
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0409190543854,0.0460293864499,0.0366589740974
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3466.31720328,3913.81533347,3075.26521799
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4655.07437208,5264.75319766,4149.6919462099995
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4067.3398276300004,4576.519784630001,3645.43676403
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,45.6599047594,60.8150532465,24.5294317111
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,45.6599047594,60.8150532465,24.5294317111
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.69447065811e-05,4.92036158798e-05,1.98516175373e-05
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.83259236606e-05,2.44072666273e-05,9.84670529979e-06
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.68334350512,4.905895721189999,1.9787672237499998
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.82914135108,2.43625844705,0.982652024741
5,Prevalence,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7527.90695926,9399.10872508,6852.87281744
5,Prevalence,135,Brazil,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7527.90695926,9399.10872508,6852.87281744
5,Prevalence,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000136127440902,0.000169504876913,0.00012381483444
5,Prevalence,135,Brazil,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.72488105404e-05,8.37815757177e-05,6.12305159906e-05
5,Prevalence,135,Brazil,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,13.2664843688,16.5641166471,12.0768668643
5,Prevalence,135,Brazil,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,135,Brazil,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.616182169259999,8.26075772328,6.02290320382
5,Prevalence,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,7965.69033482,8603.46801148,7330.55276127
5,Prevalence,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,7965.69033482,8603.46801148,7330.55276127
5,Prevalence,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000144043011414,0.000155858776605,0.000132500017569
5,Prevalence,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.11593918643e-05,7.69348394791e-05,6.54785424699e-05
5,Prevalence,135,Brazil,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,14.037993148099998,15.1619533171,12.9186856517
5,Prevalence,135,Brazil,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.0009444383899995,7.56147916804,6.44273006195
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,35.0964295239,58.7018917423,18.9626704923
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,35.0964295239,58.7018917423,18.9626704923
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.91470216705e-05,6.5411500862e-05,2.11947656736e-05
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.98225580277e-05,3.30997564119e-05,1.07179600501e-05
5,Prevalence,44,Bosnia and Herzegovina,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.7362901222200002,6.2492766713800005,2.01872496468
5,Prevalence,44,Bosnia and Herzegovina,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,44,Bosnia and Herzegovina,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.91874571745,3.2092724221399997,1.0367021173400002
5,Prevalence,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1316.46932284,1599.2925714,1069.05507333
5,Prevalence,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1316.46932284,1599.2925714,1069.05507333
5,Prevalence,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.0011040301157,0.00134027911172,0.00089313684177
5,Prevalence,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000552882486677,0.000670943378918,0.000447661224503
5,Prevalence,90,Norway,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,101.95941146700001,123.863827675,82.7973916377
5,Prevalence,90,Norway,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,52.5274934704,63.8122200375,42.6555958499
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,62598.7214444,70267.2447859,55536.306886
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,35786.5114073,41496.9510754,30874.3012964
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,98385.2328517,110623.101039,87673.5433948
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148094894122,0.0166446697847,0.0131694483778
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00840122989909,0.00974887724865,0.00725478255308
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115929672626,0.0130468984981,0.0103469896898
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1451.83219061,1629.68580782,1288.03586118
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,835.219002229,968.494572671,720.57325817
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1144.49462532,1286.85516012,1019.8878052099999
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,122668.857661,138494.447911,110307.557065
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,182518.844482,204976.2391,162576.135879
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,305187.702143,339205.141577,274472.944137
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0290206731582,0.0327383615266,0.026044300972
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0428482024891,0.0481406966892,0.0381641444616
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0359609731825,0.0399868521922,0.0323231664192
5,Prevalence,122,Ecuador,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2845.0197101,3212.05757975,2558.32800606
5,Prevalence,122,Ecuador,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4259.79513458,4783.92676932,3794.35358897
5,Prevalence,122,Ecuador,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3550.1840539600003,3945.90173913,3192.8857639899998
5,Prevalence,208,Guinea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,97138.7872708,109568.594725,85951.2979545
5,Prevalence,208,Guinea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,147842.063282,167144.406258,131032.790355
5,Prevalence,208,Guinea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,244980.850553,276285.205727,218796.849472
5,Prevalence,208,Guinea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0318781347607,0.0359234418755,0.0282427758908
5,Prevalence,208,Guinea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0490459360984,0.0554666150527,0.0434291054998
5,Prevalence,208,Guinea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0404155409566,0.0456006049394,0.0361048863492
5,Prevalence,208,Guinea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3167.69275901,3573.0283842100002,2802.86908873
5,Prevalence,208,Guinea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4895.83134231,5535.03383735,4339.18756035
5,Prevalence,208,Guinea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4025.11887188,4539.46009691,3594.90680978
5,Prevalence,187,Somalia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,86616.6974549,97959.5524357,77418.5078819
5,Prevalence,187,Somalia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,120413.906729,136173.410226,107005.079626
5,Prevalence,187,Somalia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,207030.604184,233322.867874,185380.862207
5,Prevalence,187,Somalia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0357304877595,0.0403100707406,0.0319428433275
5,Prevalence,187,Somalia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0488881219363,0.0553220550326,0.0434779297146
5,Prevalence,187,Somalia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0423616323772,0.0476811771171,0.0379170412152
5,Prevalence,187,Somalia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3543.7212459300004,4007.7878447,3167.39865719
5,Prevalence,187,Somalia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4874.66226283,5512.64718553,4331.8387199
5,Prevalence,187,Somalia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4212.70839195,4747.70967994,3772.1742493399997
5,Prevalence,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,281078.006853,318185.944389,249495.590611
5,Prevalence,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,177466.418227,201506.776427,155803.443083
5,Prevalence,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,458544.425081,516475.250048,409122.356543
5,Prevalence,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0271867942837,0.0307600770157,0.0241752763281
5,Prevalence,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165325028026,0.0187111635942,0.0145074527189
5,Prevalence,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0217595975087,0.0245105629836,0.0194517304223
5,Prevalence,97,Argentina,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2554.4079446,2891.64105476,2267.39020222
5,Prevalence,97,Argentina,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1626.6263809400002,1846.97613073,1428.0673115
5,Prevalence,97,Argentina,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2092.4976233700004,2356.8561172,1866.9675431899998
5,Prevalence,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1563.27381269,1892.85328432,1274.96560533
5,Prevalence,67,Japan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1563.27381269,1892.85328432,1274.96560533
5,Prevalence,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.52905336421e-05,7.90348578392e-05,5.31918894476e-05
5,Prevalence,67,Japan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.20228445402e-05,3.87749485264e-05,2.61375438138e-05
5,Prevalence,67,Japan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.92527063687,7.17447442312,4.83249716266
5,Prevalence,67,Japan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,67,Japan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.01798288534,3.65425350963,2.46138862242
5,Prevalence,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,305.564144555,387.281607431,226.929306933
5,Prevalence,190,Uganda,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,305.564144555,387.281607431,226.929306933
5,Prevalence,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.39069420349e-05,4.29904642673e-05,2.52092800468e-05
5,Prevalence,190,Uganda,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.69490715371e-05,2.14837799898e-05,1.2596942036e-05
5,Prevalence,190,Uganda,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.35769055817,4.255642619710001,2.49361191369
5,Prevalence,190,Uganda,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,190,Uganda,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.6838073760799999,2.13411042766,1.2504910922
5,Prevalence,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,90.9096517106,110.265762839,74.5048914836
5,Prevalence,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,90.9096517106,110.265762839,74.5048914836
5,Prevalence,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.00877615445e-05,1.22337368708e-05,8.26149759097e-06
5,Prevalence,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.04257495227e-06,6.11702702581e-06,4.13091770867e-06
5,Prevalence,190,Uganda,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.9989603971359999,1.21165495812,0.8186967454449999
5,Prevalence,190,Uganda,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.500956492557,0.607618099524,0.410558267617
5,Prevalence,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40951.8864015,45542.4584017,36749.9319699
5,Prevalence,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,14790.8447155,16604.4154168,13251.0853379
5,Prevalence,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,55742.731117,61146.4948788,50641.9798557
5,Prevalence,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0176110705158,0.0195533742312,0.0157594239266
5,Prevalence,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00625353390074,0.00702413411497,0.00560002387747
5,Prevalence,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0118840331117,0.0130168189393,0.0107833962224
5,Prevalence,82,Greece,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1661.11511608,1847.32066632,1490.67290604
5,Prevalence,82,Greece,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,615.890264544,691.407286087,551.774737093
5,Prevalence,82,Greece,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1145.35214763,1256.38388766,1040.54643943
5,Prevalence,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,29.6423149658,37.4497237108,23.3096893731
5,Prevalence,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,29.6423149658,37.4497237108,23.3096893731
5,Prevalence,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.16308264792e-05,1.46920090114e-05,9.13823586704e-06
5,Prevalence,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.66479097802e-06,7.15341599527e-06,4.4506236399e-06
5,Prevalence,175,Burundi,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.1450798367900001,1.44667930167,0.900451106255
5,Prevalence,175,Burundi,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.560540871487,0.708180207585,0.440789918411
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,348.423218627,456.525295633,212.47696247
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,348.423218627,456.525295633,212.47696247
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000134120291427,0.000175332243793,8.20383611851e-05
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.54515451645e-05,8.56312325798e-05,3.99522319716e-05
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.7561529473,16.7138875485,7.77901266664
5,Prevalence,111,Dominican Republic,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.33800062127,8.304433954619999,3.86506710273
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,14739.4965967,16567.322442,12992.6687175
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8188.35965651,9405.44049779,7160.62692246
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,22927.8562532,25838.1464842,20364.5669863
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.020185790814,0.0226804458404,0.0177998234695
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0109007101152,0.0125299945032,0.0095340991691
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0154774911546,0.017454457566,0.013773391542
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1969.78618933,2214.05681846,1736.3401276700001
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1081.92855369,1242.74153328,946.134153203
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1523.3352804,1716.69604367,1353.02939001
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,19110.8653488,21418.292311,17031.3220456
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,32028.4407482,36347.5007551,28222.0851396
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,51139.306097,57389.6701049,45721.3738537
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.026172515479,0.0293013477586,0.0232350565934
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.042637623594,0.0484784968217,0.0376115163879
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0345216851983,0.0387654362698,0.0308795925233
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2553.97586909,2862.34038704,2276.06572121
5,Prevalence,115,Jamaica,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4231.92019272,4802.59790384,3728.9861508400004
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3397.71448026,3812.9909851200005,3037.74505086
5,Prevalence,102,United States,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4737988.1631,5055001.65626,4436177.53395
5,Prevalence,102,United States,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2999518.67669,3197946.74749,2810122.91655
5,Prevalence,102,United States,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7737506.83979,8241748.14158,7260372.25948
5,Prevalence,102,United States,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0698294972177,0.0745870321726,0.0654701708476
5,Prevalence,102,United States,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0412909290739,0.0440465464766,0.0386809963663
5,Prevalence,102,United States,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0550733660665,0.058640176916,0.0517034675704
5,Prevalence,102,United States,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,6288.69099087,6709.46027729,5888.10033528
5,Prevalence,102,United States,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,4048.74928658,4316.58742886,3793.10295415
5,Prevalence,102,United States,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,5178.13654695,5515.58766233,4858.82593964
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,242104.390971,271309.183193,216527.008199
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,313430.161954,353283.822407,277420.738158
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,555534.552925,623980.137469,498519.665448
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0299007101278,0.0335575123236,0.0268221460535
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0380255743017,0.0428466764461,0.0336238140233
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0339991462058,0.0382362935036,0.0304412569309
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2911.81697887,3263.0663284400002,2604.19489432
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3773.6372864299997,4253.46749214,3340.0909313099996
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3342.4999373299997,3754.31835771,2999.4569046
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3471.56962167,4026.50304136,2930.79725437
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1369.48050392,1642.21489384,1140.77107782
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4841.05012559,5610.42443956,4129.12759476
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0142160588792,0.016563213264,0.0120793097546
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00655380457144,0.00785388091281,0.00545713101648
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106828405078,0.0123890416689,0.00912810772404
5,Prevalence,162,Bhutan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1381.41696264,1602.23766412,1166.23126783
5,Prevalence,162,Bhutan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,649.526127979,778.880369783,541.052332592
5,Prevalence,162,Bhutan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1047.5107813099999,1213.98868751,893.4643436230001
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,832.219758434,1031.23517052,699.586060177
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,832.219758434,1031.23517052,699.586060177
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.83979811872e-05,9.70477053788e-05,6.58822616718e-05
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.52758698028e-05,5.60537309998e-05,3.80628288762e-05
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.651242529099999,9.48094576491,6.43183793962
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.45055177106,5.51484805309,3.7412521723700003
5,Prevalence,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1571.20465725,1759.75884206,1404.04897697
5,Prevalence,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1094.33248446,1187.73507711,1011.7382249
5,Prevalence,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2665.5371417,2922.29448879,2443.58928074
5,Prevalence,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0168114203523,0.0188231924023,0.0150464315895
5,Prevalence,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117637733498,0.0127600995623,0.0108849345155
5,Prevalence,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0142934158926,0.0156423569476,0.0131280276807
5,Prevalence,88,Malta,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1569.55615242,1757.9125065599999,1402.57585156
5,Prevalence,88,Malta,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1154.1156764999998,1252.62083644,1067.0093069999998
5,Prevalence,88,Malta,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1367.46786275,1499.18893884,1253.60467085
5,Prevalence,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,106.557588181,131.257186098,87.7378489583
5,Prevalence,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,106.557588181,131.257186098,87.7378489583
5,Prevalence,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000120083511398,0.000147554663944,9.88513248585e-05
5,Prevalence,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.63375170025e-05,6.92749516592e-05,4.64810161009e-05
5,Prevalence,69,Singapore,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.6324921608,13.0970588398,8.75462749467
5,Prevalence,69,Singapore,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.23343984139,6.446529045209999,4.30913238724
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,38.4190966639,50.7703985111,25.4820151473
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,38.4190966639,50.7703985111,25.4820151473
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.9474338989e-06,1.18176813849e-05,5.93553470072e-06
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.46737180169e-06,5.90100679035e-06,2.96345474995e-06
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8893548221169999,1.17527226451,0.589877301042
5,Prevalence,201,Burkina Faso,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.445021178547,0.588090417075,0.29516665922199997
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,49.3109234264,99.8331708841,32.8919041706
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,49.3109234264,99.8331708841,32.8919041706
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.1484202792e-05,2.32501264311e-05,7.65811082795e-06
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.73391866338e-06,1.16092246772e-05,3.82384629078e-06
5,Prevalence,201,Burkina Faso,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.14148721184,2.31101508476,0.761407115808
5,Prevalence,201,Burkina Faso,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.5711848316070001,1.1564008324700001,0.380997869022
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.90332718355,2.48120744831,1.36481372159
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.90332718355,2.48120744831,1.36481372159
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.20681681363e-06,5.48711927048e-06,3.01108619802e-06
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.0362774079e-06,2.65519733193e-06,1.45843003095e-06
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.417638111827,0.544439654263,0.29947464135699997
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.20270783074100002,0.264253137249,0.145355160826
5,Prevalence,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0149547556,39.1309479486,23.8322668176
5,Prevalence,113,Guyana,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.0149547556,39.1309479486,23.8322668176
5,Prevalence,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000162648009407,0.00019915224468,0.000120891829148
5,Prevalence,113,Guyana,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.20786712918e-05,0.000100381434592,6.10301329158e-05
5,Prevalence,113,Guyana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.8322139774,19.3512546181,11.7856655024
5,Prevalence,113,Guyana,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,113,Guyana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.06491103912,9.85750617147,6.00360404104
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5821.11829583,6596.8044249,5127.36384432
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3451.85406091,3915.33613414,3035.33507093
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,9272.97235675,10409.1132622,8271.39466597
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0114174138329,0.0128957938431,0.0100277418592
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00679882805038,0.00771637950475,0.00597923747804
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00911295444125,0.0102255075257,0.00812353269771
5,Prevalence,49,Macedonia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1079.17794078,1222.98250151,950.5627053
5,Prevalence,49,Macedonia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,665.4060930750001,754.750483107,585.114670283
5,Prevalence,49,Macedonia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,876.3282164240001,983.6974929590001,781.675632808
5,Prevalence,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,37751.7613817,44049.5169001,32190.0365263
5,Prevalence,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,26734.7112794,31872.2843313,22723.7620868
5,Prevalence,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,64486.472661,75008.9387509,55568.6236092
5,Prevalence,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00974241319784,0.0113703306772,0.00830018913713
5,Prevalence,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00692190469873,0.00825106827441,0.00588256031735
5,Prevalence,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0083344634318,0.00969740145124,0.00717813401405
5,Prevalence,191,Zambia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,967.8050280780001,1129.25443423,825.2245210290001
5,Prevalence,191,Zambia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,690.589396669,823.2990203960001,586.981807493
5,Prevalence,191,Zambia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,829.722820814,965.111374191,714.980262173
5,Prevalence,191,Zambia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,147654.367967,166535.337594,131232.164221
5,Prevalence,191,Zambia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,164335.2811,185682.092377,145159.367639
5,Prevalence,191,Zambia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,311989.649067,349786.479485,278629.831632
5,Prevalence,191,Zambia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0381046379751,0.043055197685,0.0339036965334
5,Prevalence,191,Zambia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.042548171448,0.0480525823532,0.0375894202313
5,Prevalence,191,Zambia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0403227419041,0.0452278262195,0.0360136848167
5,Prevalence,191,Zambia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3785.2707928299997,4269.30376695,3364.27079771
5,Prevalence,191,Zambia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4244.97580843,4796.38933846,3749.63915156
5,Prevalence,191,Zambia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4014.25168731,4500.56907231,3585.02365418
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,28.1327293251,37.0167785124,22.1867764249
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,28.1327293251,37.0167785124,22.1867764249
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.85283325302e-05,5.07940275889e-05,3.03669416442e-05
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.8991174312e-05,2.50115078707e-05,1.4971241129e-05
5,Prevalence,115,Jamaica,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.7596576877300003,4.94692193924,2.96504059695
5,Prevalence,115,Jamaica,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.8691489793800002,2.45940850519,1.47409766152
5,Prevalence,58,Estonia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,10161.8243135,11456.5252355,9007.16606013
5,Prevalence,58,Estonia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,13920.0585965,15688.2400529,12286.6476797
5,Prevalence,58,Estonia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,24081.8829101,27061.4575226,21570.6299127
5,Prevalence,58,Estonia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0360847114977,0.0407209240376,0.0319502344206
5,Prevalence,58,Estonia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0495315328857,0.055861378716,0.0436525603643
5,Prevalence,58,Estonia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0428011338602,0.0481658426028,0.0383315552475
5,Prevalence,58,Estonia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3379.58778611,3810.1753742799997,2995.57515117
5,Prevalence,58,Estonia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4848.52603044,5464.40517766,4279.58910438
5,Prevalence,58,Estonia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4097.08336674,4604.00243244,3669.84049193
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,745.857317643,1033.37820674,510.772266483
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,745.857317643,1033.37820674,510.772266483
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00020933043299,0.000288862533353,0.000143614546099
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000102299300415,0.000141415555149,7.01345550916e-05
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.386234476000002,26.859443145999997,13.275931854
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.74961083791,13.5079929174,6.67665343922
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.772399498906,0.986209334193,0.500831533362
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.772399498906,0.986209334193,0.500831533362
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.03741713846e-05,5.15411396262e-05,2.61548346311e-05
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.0570815932e-05,2.62662717611e-05,1.33311276796e-05
5,Prevalence,24,Marshall Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.9782642565599997,5.07949752591,2.5795461941
5,Prevalence,24,Marshall Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.03633370824,2.60001633021,1.32037907194
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4254.19054436,4897.31098741,3654.71059209
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2770.65394767,3327.28082799,2307.35578092
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7024.84449202,8086.53604364,6093.07305027
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0094027216843,0.0108086474754,0.00808340251811
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00574500601022,0.00689768835678,0.00478463320805
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0075155001443,0.00865662242915,0.0065215720448
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,933.476977396,1074.59386462,801.9359173490001
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,573.37912682,688.571511229,477.500860057
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,748.158803477,861.2308980720001,648.9234385139999
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,13692.0107827,15474.1378139,12132.6830579
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,30204.1046844,34035.6400442,26899.0335664
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,43896.1154671,49095.0721125,39234.3809257
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.030262497997,0.0342215964148,0.0268461857738
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0626288722872,0.0705758271139,0.0557841559098
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0469620888966,0.0525429013102,0.0419988441272
5,Prevalence,206,The Gambia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3004.37338352,3395.41711725,2662.21745137
5,Prevalence,206,The Gambia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6250.65543999,7043.58102381,5566.68016647
5,Prevalence,206,The Gambia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4675.01668719,5228.71509113,4178.53342118
5,Prevalence,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,55513.434769,64103.3048465,47456.6970334
5,Prevalence,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,36110.2882199,42494.3671013,30546.2948343
5,Prevalence,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,91623.7229889,105245.553228,79123.7718096
5,Prevalence,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00992183303997,0.0114402811804,0.00847874980197
5,Prevalence,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00628634376096,0.00740100415215,0.00531676478405
5,Prevalence,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00808017580116,0.00928412379328,0.0069769167662
5,Prevalence,168,Angola,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,980.024946121,1131.66908407,837.792637886
5,Prevalence,168,Angola,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,626.524343724,737.290029312,529.987387743
5,Prevalence,168,Angola,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,801.7419795029999,920.938108891,692.362713137
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,573.693451876,664.079125976,496.293257438
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,429.528319619,505.926787113,363.489315563
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1003.2217715,1150.83378741,870.193607087
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0145363562572,0.0168347018016,0.0125776568933
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00988292059248,0.011643482154,0.00836455340268
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120975237238,0.0138853691992,0.0104936970215
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1395.78566666,1615.69235719,1207.47241044
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,975.7880124320001,1149.34748533,825.7628206850001
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1178.59091365,1352.00638931,1022.3086336099999
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1407.21341568,1564.85479605,1252.10673143
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1519.48288093,1724.87480403,1331.93750941
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2926.69629661,3274.92163221,2613.95648807
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0356567120394,0.039645015357,0.0318096245126
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0349613471707,0.0396768370854,0.0306418195995
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0352922047563,0.0395030946859,0.0315162536551
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3423.7244806000003,3807.26307332,3046.3527571
5,Prevalence,376,Northern Mariana Islands,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3451.91018283,3918.5126564099996,3025.8509058199998
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3438.30024447,3847.3974432100003,3070.8916543
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,99260.0115587,112645.937682,88384.4135044
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,155391.99731,175731.101762,137600.248152
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,254652.008869,286677.588137,227618.033879
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0360470048764,0.0408876895918,0.0321195108499
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0509431551523,0.0575821888585,0.0450731987842
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0438757897852,0.0494133908554,0.0392762184363
5,Prevalence,185,Rwanda,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3550.12908143,4028.8895093899996,3161.15293359
5,Prevalence,185,Rwanda,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5062.636173389999,5725.27960237,4482.98500452
5,Prevalence,185,Rwanda,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4341.63809152,4887.65174943,3880.72778455
5,Prevalence,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.82914785878,13.0336491466,7.52774036803
5,Prevalence,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.82914785878,13.0336491466,7.52774036803
5,Prevalence,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.1923956662e-06,1.08554026689e-05,6.25669281653e-06
5,Prevalence,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.12954980193e-06,5.47332799483e-06,3.15907697643e-06
5,Prevalence,149,Palestine,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.800814403432,1.06189611916,0.613310838195
5,Prevalence,149,Palestine,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.406779521618,0.539397884839,0.311535717009
5,Prevalence,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.3825556224,15.9714597623,7.55050602831
5,Prevalence,88,Malta,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.3825556224,15.9714597623,7.55050602831
5,Prevalence,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000111093281405,0.000169794598323,8.0619238069e-05
5,Prevalence,88,Malta,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.56751203748e-05,8.50793763785e-05,4.03969452245e-05
5,Prevalence,88,Malta,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.3716622656,15.9547025383,7.5425840522800005
5,Prevalence,88,Malta,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,88,Malta,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.3264353082,8.19364232615,3.87354360203
5,Prevalence,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,94.6558290892,123.399100438,49.0188954321
5,Prevalence,35,Georgia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,94.6558290892,123.399100438,49.0188954321
5,Prevalence,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000102033680144,0.000132978769651,5.2833210709e-05
5,Prevalence,35,Georgia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.00864436194e-05,6.53135569417e-05,2.59295389248e-05
5,Prevalence,35,Georgia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.75653256408,12.7192097242,5.05256204653
5,Prevalence,35,Georgia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,35,Georgia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.8603338318,6.336227028420001,2.51699444354
5,Prevalence,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,260.527409296,336.3965686,194.245457007
5,Prevalence,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,260.527409296,336.3965686,194.245457007
5,Prevalence,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000280832753034,0.000362993033131,0.000209793054236
5,Prevalence,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000137855720687,0.000178260182054,0.000102938052907
5,Prevalence,35,Georgia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,26.8535406334,34.6736604345,20.021610343
5,Prevalence,35,Georgia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,13.377413664799999,17.2731002306,9.97400556785
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.14081566012,8.09948337417,4.03626251366
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.14081566012,8.09948337417,4.03626251366
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.36295907527e-05,1.79726075284e-05,8.98155836615e-06
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.75938200805e-06,8.91544038018e-06,4.45178490332e-06
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.34536898747,1.77448637922,0.884290086487
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.670393244342,0.8842211258620001,0.440639040694
5,Prevalence,195,Namibia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,24687.6075194,27833.7539341,22008.0430992
5,Prevalence,195,Namibia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,28996.9166963,32678.7515237,25595.7052277
5,Prevalence,195,Namibia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,53684.5242158,60428.2061549,48024.7127763
5,Prevalence,195,Namibia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396007629334,0.0446722762501,0.0353553554342
5,Prevalence,195,Namibia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0436800420161,0.0492334103981,0.0385726146608
5,Prevalence,195,Namibia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0417043549369,0.0468975426301,0.037262818255
5,Prevalence,195,Namibia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3864.3462542199995,4356.811921590001,3444.9145728699996
5,Prevalence,195,Namibia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4343.32023698,4894.80603398,3833.86777496
5,Prevalence,195,Namibia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4109.10608142,4625.2791289100005,3675.8943515000005
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,526.442329693,603.168569987,457.379737775
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,248.173481276,283.983439363,215.908284213
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,774.615810969,876.262329762,680.5389351
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0202492369544,0.0232348344353,0.0175903858597
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101512561708,0.0116429843479,0.00882672202166
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0153554285445,0.0173874599339,0.0134963545431
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1986.27351508,2275.76258238,1725.69948927
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1008.0980668000001,1153.5606252300001,877.034575985
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1515.2295674,1714.0607925299998,1331.20535578
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,736.084972797,829.745385863,656.971330488
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,852.329387707,970.342410225,749.167602575
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1588.4143605,1787.40508028,1411.91964083
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.028312769159,0.0319445426894,0.0252236375993
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0348634582388,0.0397310520318,0.0306135218219
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0314873388422,0.0353901060464,0.0279931390378
5,Prevalence,186,Seychelles,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2777.25783786,3130.6397514899995,2478.7610728
5,Prevalence,186,Seychelles,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3462.22168303,3941.59884794,3043.1712848
5,Prevalence,186,Seychelles,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3107.10467077,3496.35133727,2761.86253401
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,45.0956700221,55.7547467065,34.6140180646
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,45.0956700221,55.7547467065,34.6140180646
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.73587754414e-05,2.14599372632e-05,1.33080937939e-05
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.47118161243e-06,1.04712277322e-05,6.49568821311e-06
5,Prevalence,111,Dominican Republic,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.6510015214500002,2.04124191071,1.2672568444
5,Prevalence,111,Dominican Republic,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.8203138290909999,1.01420801018,0.629647096604
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,428.615328345,489.485247588,379.023410475
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,234.399414326,272.324803875,202.8131896
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,663.01474267,752.98135695,586.536545955
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0149506233685,0.0170026954559,0.0132305098937
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00829185192344,0.00963725390906,0.00718377927668
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.011644614477,0.0132345327446,0.0103021685664
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1456.7856502700001,1663.6714497799999,1288.23172897
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,822.4540853530001,955.525627632,711.625226667
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1144.66844573,1299.9922084,1012.63189672
5,Prevalence,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,32202.852485,37440.5859676,27886.1742533
5,Prevalence,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19159.0692153,22995.7339609,16035.9360088
5,Prevalence,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,51361.9217003,59667.6007491,44702.576891
5,Prevalence,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0189196144676,0.0219830880967,0.0164487173547
5,Prevalence,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110755143541,0.0132702027759,0.00926324800462
5,Prevalence,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0149658077759,0.0173546912939,0.0130205656928
5,Prevalence,147,Libya,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1841.8027298,2141.3684850699997,1594.9156022000002
5,Prevalence,147,Libya,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1098.37837338,1318.3321475,919.3309503229999
5,Prevalence,147,Libya,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1470.53082457,1708.3287234,1279.8687253
5,Prevalence,147,Libya,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,73013.0543977,82445.4307291,65514.2045885
5,Prevalence,147,Libya,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,97987.766808,111287.176487,86517.6611295
5,Prevalence,147,Libya,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,171000.821206,191361.595653,152529.667158
5,Prevalence,147,Libya,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0428951338142,0.0482955188886,0.0384566799537
5,Prevalence,147,Libya,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0566448522898,0.0643931257898,0.0500402251381
5,Prevalence,147,Libya,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0498253550045,0.0556977477467,0.0445409321477
5,Prevalence,147,Libya,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4175.89227425,4715.36549277,3747.0047384199997
5,Prevalence,147,Libya,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5617.582081269999,6380.029557520001,4960.00754693
5,Prevalence,147,Libya,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4895.883375949999,5478.82781117,4367.04020784
5,Prevalence,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1586.20556597,2019.39011723,1255.52301543
5,Prevalence,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1586.20556597,2019.39011723,1255.52301543
5,Prevalence,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000831363560759,0.00105780359207,0.000658779111719
5,Prevalence,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000410508537656,0.000523540918291,0.000325192594739
5,Prevalence,75,Austria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,78.0572137471,99.3742358503,61.7843175455
5,Prevalence,75,Austria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,39.410866852299996,50.1737711307,31.194727501299997
5,Prevalence,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34725.8169204,40366.2139312,29789.3200756
5,Prevalence,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,22490.7684349,26794.1614552,18791.006226
5,Prevalence,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,57216.5853553,66473.4111035,49285.4016729
5,Prevalence,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00858203537283,0.00999139049788,0.0073545114963
5,Prevalence,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00568959744676,0.00678393975539,0.00475732763122
5,Prevalence,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00715270085501,0.00830589111839,0.00615718986821
5,Prevalence,211,Mali,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,845.877692749,983.270745896,725.630771822
5,Prevalence,211,Mali,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,566.6706823119999,675.097687203,473.45257901
5,Prevalence,211,Mali,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,708.63200823,823.2785391100001,610.40366088
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1919.77020861,2158.47546036,1712.05862802
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1919.77020861,2158.47546036,1712.05862802
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000134216711305,0.000151256590121,0.000119686195868
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.56430507531e-05,7.39864715913e-05,5.85375780712e-05
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.6082072016,14.1759184103,11.2440488068
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.30801914251,7.09236160741,5.62551629891
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,15.165998664,35.0605469524,7.46109830989
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,15.165998664,35.0605469524,7.46109830989
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.22711948036e-05,2.83626253264e-05,6.03554534442e-06
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.08696641398e-06,1.40692372549e-05,2.99438663785e-06
5,Prevalence,169,Central African Republic,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.2234274901,2.8283028311900003,0.6018800990850001
5,Prevalence,169,Central African Republic,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,169,Central African Republic,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.6075517553750001,1.40452978516,0.29889250788
5,Prevalence,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,629.808556728,945.17351362,436.233866656
5,Prevalence,75,Austria,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,629.808556728,945.17351362,436.233866656
5,Prevalence,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000330090043833,0.000498736488138,0.00023006955058
5,Prevalence,75,Austria,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00016299236171,0.000245318901385,0.000113251530853
5,Prevalence,75,Austria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,30.9928941035,46.5120111565,21.4670789864
5,Prevalence,75,Austria,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,75,Austria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.6482247347,23.4837831217,10.8386675751
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,17.5898490801,24.5072362792,8.17516781581
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,17.5898490801,24.5072362792,8.17516781581
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.72671605314e-05,2.40227247646e-05,8.00263499416e-06
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.69034335526e-06,1.20968282578e-05,4.03099086544e-06
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.6957716453399998,2.36265110626,0.7881373919040001
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8590790393479999,1.1969206162,0.399270925051
5,Prevalence,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,85.2708162729,110.665822631,67.3255497971
5,Prevalence,129,Honduras,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,85.2708162729,110.665822631,67.3255497971
5,Prevalence,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.90484831217e-05,5.07283833197e-05,3.08022167606e-05
5,Prevalence,129,Honduras,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.92631678533e-05,2.5042589612e-05,1.51907025959e-05
5,Prevalence,129,Honduras,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.8071594921400003,4.94099218818,3.00594174158
5,Prevalence,129,Honduras,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,129,Honduras,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8951382393599998,2.45954057232,1.4963058814699999
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2347.64594585,2637.99962805,2081.98787065
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1248.87963197,1413.01562795,1103.75922015
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3596.52557782,4016.03512598,3207.5149448
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165224688088,0.0185296735139,0.0146238583541
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00866976164158,0.0098161302061,0.00765850975919
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0125691805542,0.0139914176315,0.0112221130804
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1556.85623444,1749.40611238,1380.6834042300002
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,847.709444779,959.121009561,749.2052009930001
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1206.40995039,1347.12923132,1075.9211527100001
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,3636.54017108,4050.67571879,3234.67555185
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,4900.65293471,5514.3994245,4335.9764863
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,8537.19310579,9536.66702421,7664.10226149
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0255937030705,0.0285199856953,0.0227611607941
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0340204119892,0.038272259183,0.0301636616034
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0298359210408,0.0333277329284,0.0268110829899
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2411.59457931,2686.23118305,2145.0955192799997
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3326.44529705,3743.0416469100005,2943.15651059
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2863.69566637,3198.95681057,2570.82815873
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,407.934201897,550.386736827,297.312434961
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,407.934201897,550.386736827,297.312434961
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.84284866973e-05,5.18923146623e-05,2.80292877569e-05
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.21930398239e-05,2.99576329611e-05,1.61817109581e-05
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.7504559138299998,5.06013269402,2.73342410313
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.18155393011,2.94336278552,1.58996992148
5,Prevalence,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,11321.8825815,13061.311442,9910.73817301
5,Prevalence,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5194.75345833,6217.9955276,4405.99798084
5,Prevalence,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,16516.6360398,19034.1965356,14377.1750875
5,Prevalence,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0177202195482,0.0204834384251,0.0155069532387
5,Prevalence,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00816502332153,0.00977174666353,0.00692640422881
5,Prevalence,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129527553899,0.0149226367486,0.0112765951619
5,Prevalence,193,Botswana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1745.2998668,2013.43769077,1527.76800932
5,Prevalence,193,Botswana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,813.4609447130001,973.693276626,689.947522755
5,Prevalence,193,Botswana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1283.03883548,1478.60698138,1116.84206986
5,Prevalence,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10208.8624246,11846.3118128,8844.6403231
5,Prevalence,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5025.91839867,5945.51995757,4223.72841966
5,Prevalence,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,15234.7808232,17386.7822776,13274.166829
5,Prevalence,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0163756014627,0.0189509279566,0.0142003945138
5,Prevalence,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0075708477289,0.00894740384151,0.00636344945351
5,Prevalence,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0118349180443,0.0135027835594,0.0103084514207
5,Prevalence,195,Namibia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1597.99118805,1854.30081242,1384.4497760900001
5,Prevalence,195,Namibia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,752.8101459540001,890.5532067959999,632.6536477220001
5,Prevalence,195,Namibia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1166.0964019799999,1330.81430518,1016.02762508
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2691.22715773,3014.29489819,2404.35462096
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,4568.18615734,5153.44469609,4038.68142544
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,7259.41331507,8148.09087322,6459.14370872
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0267107052058,0.029913159045,0.0238709420025
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.043606997558,0.049206228388,0.0385339569722
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.035323331071,0.039652973411,0.0313658881689
5,Prevalence,106,The Bahamas,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2559.2227064500003,2866.44400315,2286.42124195
5,Prevalence,106,The Bahamas,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4305.38543065,4856.97494542,3806.34229194
5,Prevalence,106,The Bahamas,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3436.2136393200003,3856.86553138,3057.4092901100003
5,Prevalence,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,33786.4597829,38867.7444748,28810.6260911
5,Prevalence,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,23823.1846689,28048.3921931,19896.6570171
5,Prevalence,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,57609.6444518,66126.408228,49297.3917788
5,Prevalence,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00841180389928,0.00967952961858,0.00716901950177
5,Prevalence,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00563091115408,0.00663373938892,0.0047019684432
5,Prevalence,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00698524181063,0.00803281792083,0.00597659620518
5,Prevalence,213,Niger,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,829.2183395220001,953.927897196,707.096857182
5,Prevalence,213,Niger,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,560.792142171,660.252529671,468.362608346
5,Prevalence,213,Niger,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,692.205136449,794.537787309,592.329776161
5,Prevalence,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,444.580559435,523.0313332,382.69056675
5,Prevalence,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,230.866699841,269.592963475,196.606080275
5,Prevalence,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,675.447259276,785.918716625,586.798009743
5,Prevalence,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0175368102593,0.0206564040588,0.0151336168462
5,Prevalence,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00916295708721,0.0107061089193,0.00781048481574
5,Prevalence,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133627592697,0.0155202322531,0.0116268609702
5,Prevalence,29,Tonga,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1705.20574378,2006.1066878000001,1467.82430914
5,Prevalence,29,Tonga,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,908.601711916,1061.01325268,773.765212714
5,Prevalence,29,Tonga,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1312.03289152,1526.61986871,1139.83479671
5,Prevalence,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.01897526958,2.4224639869,1.66844836953
5,Prevalence,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.01897526958,2.4224639869,1.66844836953
5,Prevalence,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.1179460496e-05,2.54767412936e-05,1.7447506691e-05
5,Prevalence,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.03037568904e-05,1.23826495413e-05,8.47799120943e-06
5,Prevalence,108,Belize,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.0431659457499998,2.45148912787,1.6884391514000001
5,Prevalence,108,Belize,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.0067691567100001,1.2079702322299999,0.831977678638
5,Prevalence,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,31024.5607861,34481.38794,27942.415005
5,Prevalence,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20347.9638176,23037.2310195,17943.9468599
5,Prevalence,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,51372.5246037,57011.1960469,46288.5666348
5,Prevalence,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143525300633,0.0159432905655,0.0129156198183
5,Prevalence,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00861428326275,0.00976185233563,0.00759982094793
5,Prevalence,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113562081854,0.0125753571719,0.0102319916772
5,Prevalence,91,Portugal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1352.4213915,1503.11126014,1218.06461801
5,Prevalence,91,Portugal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,847.602863477,959.625403003,747.462541064
5,Prevalence,91,Portugal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1094.27820426,1214.3866729200001,985.985601561
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10572.9051501,11053.8161611,10132.7897399
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10572.9051501,11053.8161611,10132.7897399
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000739179107524,0.00077353269711,0.000707992615625
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000361520420226,0.000378347965388,0.00034661036351
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,69.438195393,72.5966076057,66.547710761
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.740662074999996,36.320849042,33.2945221045
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.404512988392,0.537805415191,0.249778901247
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.404512988392,0.537805415191,0.249778901247
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.43381982929e-05,1.9051971124e-05,8.83216292726e-06
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.01315928617e-06,9.325649677e-06,4.32222795331e-06
5,Prevalence,23,Kiribati,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.4037800845,1.86634435196,0.866806894115
5,Prevalence,23,Kiribati,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,23,Kiribati,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.69185376202,0.919828807509,0.427206239254
5,Prevalence,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,39396.1555913,44897.1921338,34648.8047005
5,Prevalence,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,23503.2180129,27268.6800488,20222.0935617
5,Prevalence,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62899.3736042,71867.2464181,55412.9669942
5,Prevalence,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0142761357455,0.0162981623826,0.0125730741441
5,Prevalence,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00815490461671,0.00946039152394,0.00701353920781
5,Prevalence,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0111490560231,0.0127464893585,0.00982203424738
5,Prevalence,114,Haiti,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1397.78416503,1592.9621374700002,1229.34712336
5,Prevalence,114,Haiti,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,810.863464941,940.772296655,697.664330257
5,Prevalence,114,Haiti,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1100.2137391,1257.07661888,969.264145536
5,Prevalence,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,20.3527017024,28.13884164,15.7704978678
5,Prevalence,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,20.3527017024,28.13884164,15.7704978678
5,Prevalence,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.18551270963e-05,4.40252367618e-05,2.46994652715e-05
5,Prevalence,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.59612386525e-05,2.20560454812e-05,1.23733844764e-05
5,Prevalence,193,Botswana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.13742589315,4.33768114206,2.4310663558
5,Prevalence,193,Botswana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.58103058203,2.18587044738,1.22507762298
5,Prevalence,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,25.7125630386,33.480788074,17.589436404
5,Prevalence,208,Guinea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,25.7125630386,33.480788074,17.589436404
5,Prevalence,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.43810919171e-06,1.09893999645e-05,5.76590180806e-06
5,Prevalence,208,Guinea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.24191194682e-06,5.52452737395e-06,2.90025017152e-06
5,Prevalence,208,Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.838485861739,1.09180743272,0.573590960908
5,Prevalence,208,Guinea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,208,Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.42246617438600004,0.550100759377,0.289000435159
5,Prevalence,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,64.1774578098,83.1508603281,46.1362451643
5,Prevalence,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,64.1774578098,83.1508603281,46.1362451643
5,Prevalence,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.10612215964e-05,2.7296438949e-05,1.51251809339e-05
5,Prevalence,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.05876393741e-05,1.37181169835e-05,7.60614985468e-06
5,Prevalence,208,Guinea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.09282485512,2.7115469069300002,1.50450148536
5,Prevalence,208,Guinea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.05445750554,1.36619697566,0.758034232754
5,Prevalence,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,19731.2153935,22008.9508983,17620.4833994
5,Prevalence,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,11265.7461495,12975.7052789,9927.37997414
5,Prevalence,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,30996.961543,34300.1909685,27894.3077285
5,Prevalence,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.010023580712,0.0111658889739,0.00896663358971
5,Prevalence,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00568609935379,0.00655448599997,0.00500723212882
5,Prevalence,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00784779465262,0.0086936055484,0.00705254283963
5,Prevalence,53,Serbia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,948.736545811,1058.2569616600001,847.246164135
5,Prevalence,53,Serbia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,556.732068518,641.2350451140001,490.592519539
5,Prevalence,53,Serbia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,755.4182001519999,835.920272067,679.8042998349999
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,19156.9837453,21785.7715739,16879.3605391
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10955.4509062,12509.9233008,9695.72656668
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,30112.4346515,33984.9490768,26810.1875994
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0146979241548,0.0167305693316,0.0129546107387
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00844841376768,0.00963778983133,0.00748704528656
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115811105284,0.0130771629382,0.0102948383626
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1380.86920152,1570.35686816,1216.69410068
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,825.0484200779999,942.114801392,730.179337561
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1109.0446093,1251.6697838300001,987.4224510739999
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,32280.8646977,36155.5131154,28789.4648856
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,41160.5510054,46011.0577227,36443.8076649
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,73441.4157031,82126.1481772,65598.3055721
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0247669444454,0.0278052034417,0.0220821436466
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0317411174549,0.0355403529251,0.0280936840254
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.028245091521,0.0314401463924,0.0251394412238
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2326.8617049599998,2606.1532018800003,2075.19544398
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3099.7763458,3465.06509001,2744.56124107
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2704.85622061,3024.71596775,2415.99352612
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.40909057543,9.7544807129,3.37914575134
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.40909057543,9.7544807129,3.37914575134
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.20052662462e-05,2.16620113125e-05,7.49856684368e-06
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.95388767736e-06,1.0742366876e-05,3.71917215091e-06
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.18505799773,2.13707373196,0.740324762968
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.590510769335,1.06489729279,0.36890156108399996
5,Prevalence,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,95.7542399025,148.951178397,65.9684996065
5,Prevalence,114,Haiti,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,95.7542399025,148.951178397,65.9684996065
5,Prevalence,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.46987152051e-05,5.39371251308e-05,2.39199514325e-05
5,Prevalence,114,Haiti,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.69725841802e-05,2.63818984178e-05,1.16964159776e-05
5,Prevalence,114,Haiti,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.3973812485300003,5.28482019122,2.34057670746
5,Prevalence,114,Haiti,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,114,Haiti,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.67489951459,2.60540166836,1.1538978125800001
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,318.678716445,485.886120956,114.355437884
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,318.678716445,485.886120956,114.355437884
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.58791258335e-05,3.94749525581e-05,9.26873710337e-06
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.27557649037e-05,1.94701118503e-05,4.5726042514e-06
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.56448593517,3.9100450045299997,0.9202463074249999
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.26790989145,1.9331690103199999,0.454979838164
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,59.2820680229,74.0778504394,46.5682921031
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,59.2820680229,74.0778504394,46.5682921031
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.81406321184e-06,6.01310599534e-06,3.77754958316e-06
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.37286363614e-06,2.96583749913e-06,1.86304395426e-06
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.477057367835,0.596122664477,0.374746489052
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.235862379736,0.294729564489,0.18527876239799998
5,Prevalence,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,399049.212868,433944.489215,367696.714704
5,Prevalence,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,239117.270128,263091.316498,218847.947633
5,Prevalence,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,638166.482996,697780.501284,588088.748885
5,Prevalence,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119742932279,0.0130438226882,0.0110497045154
5,Prevalence,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00693944919357,0.00763478450919,0.00634983391013
5,Prevalence,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00941481792053,0.0103012228874,0.00867090838206
5,Prevalence,130,Mexico,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1145.4757104100001,1245.64303357,1055.47797592
5,Prevalence,130,Mexico,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,684.479510759,753.105852645,626.4580389629999
5,Prevalence,130,Mexico,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,914.656534089,1000.09873891,842.882274648
5,Prevalence,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1518.74007411,2384.88215585,846.688798934
5,Prevalence,71,Australia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1518.74007411,2384.88215585,846.688798934
5,Prevalence,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000284647554289,0.000449425015813,0.000159419951699
5,Prevalence,71,Australia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000137965363773,0.000217216507552,7.7132005029e-05
5,Prevalence,71,Australia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,25.8800610685,40.6395385799,14.427984219299999
5,Prevalence,71,Australia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,71,Australia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,13.0220878999,20.4486242208,7.25973861597
5,Prevalence,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,45.800914877,67.4565671609,16.9179689792
5,Prevalence,187,Somalia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,45.800914877,67.4565671609,16.9179689792
5,Prevalence,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.88933114072e-05,2.78044364602e-05,6.97491932491e-06
5,Prevalence,187,Somalia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.37153884711e-06,1.37981267841e-05,3.4614216e-06
5,Prevalence,187,Somalia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8738381847999999,2.75982896196,0.692159455061
5,Prevalence,187,Somalia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,187,Somalia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.931968001648,1.3726224086099998,0.344250890705
5,Prevalence,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,5.76229167644,7.69772123195,4.39823492799
5,Prevalence,149,Palestine,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,5.76229167644,7.69772123195,4.39823492799
5,Prevalence,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.80260272069e-06,6.41765849613e-06,3.6757279444e-06
5,Prevalence,149,Palestine,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.42088327806e-06,3.23516665772e-06,1.84965214899e-06
5,Prevalence,149,Palestine,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.469473675396,0.6271597624449999,0.358339291525
5,Prevalence,149,Palestine,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,149,Palestine,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.238472580253,0.318570379169,0.182021058761
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.5040440828,15.1511639698,9.49700207455
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.5040440828,15.1511639698,9.49700207455
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000262163023261,0.000315915564733,0.000198956711684
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000128022710585,0.000154913517623,9.72119343361e-05
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,25.6572157234,31.0888765155,19.4870259045
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.625628889,15.298488413200001,9.58934749089
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,5.30708989481,6.66138979381,4.04579852248
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,5.30708989481,6.66138979381,4.04579852248
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000111267813893,0.000139690011394,8.46757246122e-05
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.43362280961e-05,6.82536842375e-05,4.13819901943e-05
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.889688919300001,13.6685950422,8.301628239420001
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.35869411918,6.72616274101,4.08513840532
5,Prevalence,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,705.177765721,819.855296987,612.104096737
5,Prevalence,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,370.192581116,430.1534725,319.97141675
5,Prevalence,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1075.37034684,1235.82359884,942.456680597
5,Prevalence,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0169047350428,0.0197081173946,0.0146753175965
5,Prevalence,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00899498152838,0.0104609393184,0.00776617553742
5,Prevalence,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129765263654,0.0149443917199,0.0113861778318
5,Prevalence,351,Guam,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1609.4429848999998,1871.1740790899999,1397.01886873
5,Prevalence,351,Guam,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,886.2220380580001,1029.76533438,765.995148304
5,Prevalence,351,Guam,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1256.46444108,1443.93827853,1101.16789989
5,Prevalence,351,Guam,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1713.62843023,1903.47515375,1543.94216852
5,Prevalence,351,Guam,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1722.66847678,1924.64057716,1534.81333567
5,Prevalence,351,Guam,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3436.29690701,3815.09023372,3087.27297824
5,Prevalence,351,Guam,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0410799602894,0.0456850008103,0.0369712805926
5,Prevalence,351,Guam,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0418575946773,0.0468506899885,0.0372756845086
5,Prevalence,351,Guam,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0414660676002,0.0460100757535,0.0372694268
5,Prevalence,351,Guam,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3911.05248891,4344.34391163,3523.77373906
5,Prevalence,351,Guam,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4123.9799128,4607.490754359999,3674.26434717
5,Prevalence,351,Guam,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4014.97482738,4457.55755894,3607.17470822
5,Prevalence,52,Romania,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,117457.442637,131468.758895,104148.780796
5,Prevalence,52,Romania,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,136192.546126,153678.848089,119385.786785
5,Prevalence,52,Romania,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,253649.988763,281920.342417,226920.199142
5,Prevalence,52,Romania,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0266671904177,0.02989216125,0.0236709324372
5,Prevalence,52,Romania,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0309572465007,0.0349340050937,0.0271337766984
5,Prevalence,52,Romania,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0288109412378,0.032017684712,0.0257565574028
5,Prevalence,52,Romania,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2540.07787544,2843.07982777,2252.2711879
5,Prevalence,52,Romania,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3041.22593815,3431.70101631,2665.92527817
5,Prevalence,52,Romania,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2786.63399894,3097.21602987,2492.97681842
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,33979.6587877,40313.9868357,29286.8998365
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,17838.3450229,20737.244401,15273.7918173
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,51818.0038106,60419.5338992,44943.1313887
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165681461359,0.0196467564968,0.0142773016572
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00910088149874,0.0105808608871,0.00778902686813
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0129190743716,0.0150754986608,0.0111952156194
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1644.0996222400001,1950.58493499,1417.04133224
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,908.1643060399999,1055.74957466,777.6008664809999
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1285.49267224,1498.8780419099999,1114.9419471800002
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,66762.3139565,74930.0171115,59036.2473378
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,77460.6952606,86754.0802707,68845.1298499
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,144223.009217,160609.277472,128865.404079
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0325527186661,0.0365698571796,0.0287523064876
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0395194020424,0.0442553680861,0.0351181155174
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0359571665073,0.0400772908167,0.0321221916195
5,Prevalence,26,Papua New Guinea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3230.2824416599997,3625.47527616,2856.4581108
5,Prevalence,26,Papua New Guinea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3943.5854876900003,4416.71909608,3504.96021318
5,Prevalence,26,Papua New Guinea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3577.86112708,3984.36902429,3196.87213838
5,Prevalence,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1113.39955055,1662.65335739,793.046696628
5,Prevalence,92,Spain,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1113.39955055,1662.65335739,793.046696628
5,Prevalence,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000109398287439,0.000163375226976,7.79180040925e-05
5,Prevalence,92,Spain,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.41012937182e-05,8.0819049771e-05,3.85887382107e-05
5,Prevalence,92,Spain,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.2638531808,15.3271392487,7.310686317090001
5,Prevalence,92,Spain,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,92,Spain,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.1907349597,7.7513888916,3.69723089147
5,Prevalence,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,175.172032864,313.163799023,94.9638319368
5,Prevalence,48,Hungary,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,175.172032864,313.163799023,94.9638319368
5,Prevalence,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.84612911132e-05,0.000140445035166,4.24222186654e-05
5,Prevalence,48,Hungary,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.91254785318e-05,7.00399771961e-05,2.11829554758e-05
5,Prevalence,48,Hungary,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.382161589820001,13.1974592672,4.00199929797
5,Prevalence,48,Hungary,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,48,Hungary,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.7525352773900003,6.70859488369,2.03431520199
5,Prevalence,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,47.7435843769,60.0169084678,36.860352598
5,Prevalence,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,47.7435843769,60.0169084678,36.860352598
5,Prevalence,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.04910326114e-06,8.86682452315e-06,5.43923259218e-06
5,Prevalence,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.45455096991e-06,4.34835174344e-06,2.66748955724e-06
5,Prevalence,207,Ghana,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.6886325651849999,0.8656576202249999,0.531657593256
5,Prevalence,207,Ghana,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.340490230203,0.428019203983,0.26287489943
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6.54280522166,11.6609637274,4.74958547108
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6.54280522166,11.6609637274,4.74958547108
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.42279846608e-06,1.14529159646e-05,4.6658181696e-06
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.23251360798e-06,5.76468000947e-06,2.34709755972e-06
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.630767411669,1.12418995502,0.45788979384199996
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.319547188772,0.569515376236,0.23196727301199999
5,Prevalence,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,62.4470058224,76.4123800636,50.213869306
5,Prevalence,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,62.4470058224,76.4123800636,50.213869306
5,Prevalence,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.37312910455e-05,0.000114665577185,7.5095314201e-05
5,Prevalence,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.29033090878e-05,5.24577642324e-05,3.44188760055e-05
5,Prevalence,33,Armenia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.92239017539,10.917754345099999,7.17452707721
5,Prevalence,33,Armenia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.15439846172,5.0834698959899995,3.3405672322399997
5,Prevalence,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,160986.058543,180418.716761,143386.013897
5,Prevalence,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,80825.7304761,91852.4665919,71076.0396791
5,Prevalence,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,241811.789019,269776.772823,217120.691472
5,Prevalence,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0180096339678,0.0201850345764,0.0160387907577
5,Prevalence,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00898803652701,0.0102160652036,0.00791084633118
5,Prevalence,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0134852989579,0.0150626466471,0.0120991313907
5,Prevalence,51,Poland,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1700.9147193000001,1906.2324635600003,1514.9596417599998
5,Prevalence,51,Poland,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,878.5085566180001,998.360019417,772.537515725
5,Prevalence,51,Poland,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1295.53524098,1445.36094707,1163.2497674699998
5,Prevalence,51,Poland,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,246388.075596,274613.609534,219880.271796
5,Prevalence,51,Poland,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,247026.548672,280056.093181,219632.114466
5,Prevalence,51,Poland,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,493414.624268,550424.545326,442883.405579
5,Prevalence,51,Poland,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0275635881214,0.0307906641282,0.0245293421528
5,Prevalence,51,Poland,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0274698395302,0.0311477476861,0.0243742471559
5,Prevalence,51,Poland,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0275165296974,0.0307062170845,0.0247011031771
5,Prevalence,51,Poland,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2603.23849303,2901.45826789,2323.1675721799998
5,Prevalence,51,Poland,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,2684.97340441,3043.97711896,2387.21865834
5,Prevalence,51,Poland,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2643.5271694,2948.96455984,2372.80019266
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,76651.4821864,85389.1824278,68489.2744803
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,44775.9809342,50231.9516724,39784.5995296
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,121427.463121,134404.842804,109758.185966
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0215115943256,0.0239651840472,0.0192450245896
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012011035341,0.0134641521585,0.0107092786958
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0166540222357,0.0184400896229,0.0150397460288
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1992.31618628,2219.42544921,1780.1650567200002
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1177.45738609,1320.93102776,1046.20087805
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1587.26137353,1756.89757421,1434.72427518
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,139286.825428,154422.037945,124656.211507
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,244351.681521,271805.819319,221026.223706
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,383638.506949,424242.169998,348139.851068
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0390902736021,0.0434128546892,0.0350419323914
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0655468471274,0.0728478343278,0.0592511770157
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0526171408865,0.0582164136616,0.0476874081368
5,Prevalence,89,Netherlands,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3620.32656017,4013.71919943,3240.04938747
5,Prevalence,89,Netherlands,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6425.625663780001,7147.576956739999,5812.24473909
5,Prevalence,89,Netherlands,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5014.80116467,5545.559399459999,4550.77396815
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.283486359192,0.389581785418,0.154725561375
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.283486359192,0.389581785418,0.154725561375
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.07790278403e-06,8.37103113645e-06,3.31269198713e-06
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.0444961444e-06,4.18895721436e-06,1.66064475781e-06
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.601626526645,0.8267866470649999,0.328365013182
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.302475886062,0.41567818668199996,0.165089958496
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,26.5320050888,31.9065814003,21.657538026
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,26.5320050888,31.9065814003,21.657538026
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.20331133285e-05,9.8763942905e-05,6.70068992544e-05
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.0788995459e-05,4.90860139916e-05,3.3325293693e-05
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.9408137994,9.54938087143,6.4819253668300005
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.99071731066,4.79911511746,3.25754166024
5,Prevalence,211,Mali,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,109819.903808,124656.694701,97174.9791856
5,Prevalence,211,Mali,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,164929.118379,186369.020715,146573.923949
5,Prevalence,211,Mali,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,274749.022187,310097.411342,244416.022198
5,Prevalence,211,Mali,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.027140698145,0.0307830878338,0.024013325277
5,Prevalence,211,Mali,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.041722939453,0.0471390567845,0.0370791223015
5,Prevalence,211,Mali,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0343467012047,0.0387324326265,0.0305613634932
5,Prevalence,211,Mali,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2675.07621387,3036.48197942,2367.06158346
5,Prevalence,211,Mali,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4155.5047937,4695.69816773,3693.0327985
5,Prevalence,211,Mali,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3402.7887218799997,3840.58136259,3027.11207909
5,Prevalence,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,37736.9232556,42741.0112344,33391.1030164
5,Prevalence,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21585.35759,24663.5552507,18827.1505664
5,Prevalence,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,59322.2808455,67105.0384079,52697.7858263
5,Prevalence,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0137714185227,0.0155764257717,0.0121826934539
5,Prevalence,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00805413319373,0.0092050081192,0.0070302626089
5,Prevalence,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0109445165771,0.0123741200862,0.00973148560308
5,Prevalence,109,Cuba,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1332.2649134100002,1508.92931163,1178.84000949
5,Prevalence,109,Cuba,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,797.703626876,911.460808241,695.771947624
5,Prevalence,109,Cuba,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1071.09394074,1211.61558537,951.485315208
5,Prevalence,109,Cuba,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,97460.750536,109215.582636,87417.2993819
5,Prevalence,109,Cuba,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,138297.783391,155396.356294,123193.971018
5,Prevalence,109,Cuba,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,235758.533927,262970.861113,213599.519154
5,Prevalence,109,Cuba,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.035566605315,0.0399175551314,0.0319006613463
5,Prevalence,109,Cuba,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0516029721822,0.0579931907215,0.0459626434702
5,Prevalence,109,Cuba,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0434957435656,0.0484836892628,0.0394149916097
5,Prevalence,109,Cuba,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3440.7558214000005,3855.7485929100003,3086.18166888
5,Prevalence,109,Cuba,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5110.90182036,5742.7928401300005,4552.728722729999
5,Prevalence,109,Cuba,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4256.74019219,4748.07259458,3856.6479145900003
5,Prevalence,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,28.1108804465,36.5790396195,19.0129439153
5,Prevalence,204,Chad,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,28.1108804465,36.5790396195,19.0129439153
5,Prevalence,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.73758671328e-06,1.13849272312e-05,5.90729315442e-06
5,Prevalence,204,Chad,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.37904667387e-06,5.70228784745e-06,2.96077150358e-06
5,Prevalence,204,Chad,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.869375153365,1.13126688578,0.588006521666
5,Prevalence,204,Chad,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,204,Chad,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.436476364696,0.5679610877919999,0.295213117146
5,Prevalence,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,32.1762298202,49.6704586043,23.5010275401
5,Prevalence,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,32.1762298202,49.6704586043,23.5010275401
5,Prevalence,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.00012029647e-05,1.54426590166e-05,7.30894300646e-06
5,Prevalence,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.01234127095e-06,7.73776790569e-06,3.66184059894e-06
5,Prevalence,204,Chad,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.9951027605809999,1.5361405221400002,0.726807879988
5,Prevalence,204,Chad,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.499598859889,0.771230956129,0.364899387867
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,213.94550588,299.500101791,151.827997786
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,213.94550588,299.500101791,151.827997786
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.96855486696e-05,6.95828090533e-05,3.52876865597e-05
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.42595034777e-05,3.39622436561e-05,1.72193042449e-05
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.79499226799,6.71246010261,3.4028014398199997
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.3695817352899997,3.3171529731500002,1.6815910620899999
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,512.89439434,711.574911933,402.627385634
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,512.89439434,711.574911933,402.627385634
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000119113588309,0.000164863380525,9.36062193534e-05
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.81581454369e-05,8.06340781434e-05,4.56344364268e-05
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,11.495098460000001,15.9479685576,9.02377076378
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.68062967233,7.88114201173,4.45935283943
5,Prevalence,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,51.3423935189,72.7268918705,30.4392096867
5,Prevalence,193,Botswana,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,51.3423935189,72.7268918705,30.4392096867
5,Prevalence,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.03580762573e-05,0.000113767400891,4.76599224552e-05
5,Prevalence,193,Botswana,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.02642333357e-05,5.70267944919e-05,2.38822005173e-05
5,Prevalence,193,Botswana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.91457356363,11.2110537962,4.6922893105100005
5,Prevalence,193,Botswana,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,193,Botswana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.98835965342,5.64954185761,2.36456673474
5,Prevalence,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,712.562270992,1239.98392523,349.949124719
5,Prevalence,52,Romania,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,712.562270992,1239.98392523,349.949124719
5,Prevalence,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000161777320974,0.000282095634134,7.95832272353e-05
5,Prevalence,52,Romania,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.09364934143e-05,0.00014096255113,3.97809255633e-05
5,Prevalence,52,Romania,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.409527219400001,26.8152929579,7.56783060552
5,Prevalence,52,Romania,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,52,Romania,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.82830805709,13.6226355895,3.8445896788800002
5,Prevalence,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,30.1949748598,38.3783086966,23.5663545826
5,Prevalence,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,30.1949748598,38.3783086966,23.5663545826
5,Prevalence,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.38273369112e-05,1.756816473e-05,1.08187601771e-05
5,Prevalence,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.82121134677e-06,8.66572283161e-06,5.34070481996e-06
5,Prevalence,129,Honduras,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.3481410191299998,1.71350936502,1.05218730705
5,Prevalence,129,Honduras,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.671081314741,0.8529553668179999,0.523760668467
5,Prevalence,91,Portugal,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,94298.1508579,104188.573504,85500.4637621
5,Prevalence,91,Portugal,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,181055.38295,198389.742734,164034.737227
5,Prevalence,91,Portugal,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,275353.533808,300532.986896,251494.218364
5,Prevalence,91,Portugal,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0436240468685,0.048351899065,0.0395455000833
5,Prevalence,91,Portugal,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0766497752733,0.0839685329422,0.0695516125777
5,Prevalence,91,Portugal,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0608687936456,0.0666365276502,0.0556437108249
5,Prevalence,91,Portugal,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4110.6411555,4541.78405707,3727.13273757
5,Prevalence,91,Portugal,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,7541.936992419999,8264.0069313,6832.93494277
5,Prevalence,91,Portugal,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5865.2630533,6401.60669074,5357.03946374
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,0.450946296867,0.601693184207,0.300241508778
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,0.450946296867,0.601693184207,0.300241508778
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.66817208259e-06,1.29000642656e-05,6.45912137428e-06
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.84292011787e-06,6.4595417828e-06,3.22758431605e-06
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.957016962157,1.27693826804,0.637185001053
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.481153241728,0.6419980120000001,0.320353390756
5,Prevalence,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2375.57556112,3175.35001995,1797.75905552
5,Prevalence,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2375.57556112,3175.35001995,1797.75905552
5,Prevalence,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000233423557355,0.000312189057136,0.000176380652179
5,Prevalence,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000115434370741,0.000154294901699,8.72147482255e-05
5,Prevalence,92,Spain,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.8991994087,29.2719054773,16.5726086301
5,Prevalence,92,Spain,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,11.0750746292,14.8036707484,8.38125969601
5,Prevalence,97,Argentina,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,378606.660363,425192.736103,340276.199383
5,Prevalence,97,Argentina,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,624187.959112,698690.593265,563542.402385
5,Prevalence,97,Argentina,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1002794.61948,1114620.40348,907320.860891
5,Prevalence,97,Argentina,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0366202200529,0.0411772757947,0.0328893185095
5,Prevalence,97,Argentina,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0581486319768,0.0650687530022,0.0524512997505
5,Prevalence,97,Argentina,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0475864158231,0.0529837397802,0.0430262600202
5,Prevalence,97,Argentina,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3440.73829161,3864.10774449,3092.39501444
5,Prevalence,97,Argentina,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5721.1984729,6404.07668374,5165.33182813
5,Prevalence,97,Argentina,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4576.100467509999,5086.400395860001,4140.4205158899995
5,Prevalence,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,69369.9471104,80279.4938454,59263.8183681
5,Prevalence,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,40827.6313638,48696.1106505,34519.8605012
5,Prevalence,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,110197.578474,126765.03677,95552.6885555
5,Prevalence,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0102420450258,0.0119229372313,0.00876312295653
5,Prevalence,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00579320638877,0.00690505267152,0.00490129413284
5,Prevalence,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00797345211862,0.0091695006573,0.00691669992963
5,Prevalence,207,Ghana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1000.56175607,1157.91628341,854.79537823
5,Prevalence,207,Ghana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,575.936413752,686.933392776,486.955622851
5,Prevalence,207,Ghana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,785.8898604330001,904.0430691339999,681.4477242840001
5,Prevalence,207,Ghana,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,228234.614129,255355.579673,201872.608016
5,Prevalence,207,Ghana,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,320304.969064,361432.202432,281687.068205
5,Prevalence,207,Ghana,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,548539.583194,615388.447365,490146.169968
5,Prevalence,207,Ghana,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.033697664172,0.0377249316534,0.0298307747918
5,Prevalence,207,Ghana,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0454496327407,0.0513068618596,0.0399658683921
5,Prevalence,207,Ghana,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0396903169874,0.0444546651435,0.0354400091089
5,Prevalence,207,Ghana,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3291.95618308,3683.13712009,2911.72214472
5,Prevalence,207,Ghana,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4518.39327994,5098.55603986,3973.62850705
5,Prevalence,207,Ghana,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3911.98883357,4388.73111105,3495.54781912
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,6506.33178089,7373.09051857,5793.665186
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,7221.3927612,8159.91944784,6419.45778539
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,13727.7245421,15475.9445135,12360.7193399
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0447157104948,0.0505951919607,0.0398007325567
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0496982878687,0.0561241929403,0.0441748429336
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0472052637572,0.0532201890746,0.042460348206
5,Prevalence,203,Cape Verde,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4316.23233287,4891.23099792,3843.45678084
5,Prevalence,203,Cape Verde,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4926.28490265,5566.52841245,4379.22143513
5,Prevalence,203,Cape Verde,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4616.999165470001,5204.97207564,4157.23892927
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5565.13728228,6524.48119808,4776.96910491
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2854.38391348,3308.84304384,2443.97067898
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,8419.52119576,9760.40787742,7307.78534992
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0172062328426,0.0202418353824,0.0147462309835
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00872791930675,0.010104749902,0.00747018876577
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012943579498,0.0150152267682,0.0112688110499
5,Prevalence,183,Mauritius,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1665.6004240500001,1952.72427238,1429.70808504
5,Prevalence,183,Mauritius,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,863.079072954,1000.49372242,738.982565724
5,Prevalence,183,Mauritius,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1266.3923767200001,1468.07708446,1099.17457806
5,Prevalence,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,70.0807369069,93.6600698758,39.6440110066
5,Prevalence,168,Angola,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,70.0807369069,93.6600698758,39.6440110066
5,Prevalence,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.25254287455e-05,1.6757592951e-05,7.08485396972e-06
5,Prevalence,168,Angola,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.18031886263e-06,8.26595338149e-06,3.49706180332e-06
5,Prevalence,168,Angola,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.2371936756800002,1.65345929892,0.699868777935
5,Prevalence,168,Angola,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,168,Angola,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.613232762213,0.819560779381,0.346899982046
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,296.628788757,371.729046581,233.566291524
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,296.628788757,371.729046581,233.566291524
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000347129348974,0.000434588595252,0.000273548047376
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000168381028082,0.00021099491414,0.000132665341504
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,33.0616856195,41.432218784999996,26.0328585571
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,16.3171571439,20.4483229475,12.8481726211
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,6389.38232904,7228.64972509,5659.27429004
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,13640.5762542,15437.5034818,12035.1620764
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,20029.9585832,22479.5834951,17820.447815
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0294907482283,0.0333467073691,0.0259969733555
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0554426255529,0.0628034692642,0.0489978430387
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.043290290054,0.0485181709289,0.0385114569812
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2763.66439929,3126.68124576,2447.8633576400002
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5450.20127102,6168.17790759,4808.745204260001
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4160.17642491,4668.95789673,3701.26610963
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.4237702418,17.9259715269,5.65738913015
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.4237702418,17.9259715269,5.65738913015
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.33637219873e-05,0.000126338388346,3.97569784566e-05
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.64297943927e-05,6.2768034233e-05,1.97769293513e-05
5,Prevalence,50,Montenegro,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.9125890622499995,11.8877212211,3.75173332823
5,Prevalence,50,Montenegro,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,50,Montenegro,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.4965245952400004,6.0130450771,1.89770109851
5,Prevalence,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,179787.081311,211931.158096,154310.194019
5,Prevalence,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,101521.833341,121383.754894,85260.127205
5,Prevalence,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,281308.914652,330776.089922,243457.619924
5,Prevalence,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0142505495672,0.0167923439181,0.0122557028991
5,Prevalence,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00772771708677,0.00923409847171,0.00648881171977
5,Prevalence,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.010923100103,0.012832599432,0.009451017172
5,Prevalence,125,Colombia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1377.16031743,1623.3823855900002,1182.00859721
5,Prevalence,125,Colombia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,765.842079862,915.672858245,643.169956642
5,Prevalence,125,Colombia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1069.16241045,1257.17082965,925.302122342
5,Prevalence,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3040.74059665,3477.2507732,2680.6844004
5,Prevalence,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1460.73548564,1699.42740044,1263.56387439
5,Prevalence,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,4501.47608228,5134.55497946,3984.7836402
5,Prevalence,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0154479946865,0.0176823867368,0.0136147792329
5,Prevalence,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00756008264776,0.00880250391839,0.00653941578742
5,Prevalence,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115406476109,0.0131606282537,0.0102267634299
5,Prevalence,113,Guyana,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1503.7239984799999,1719.58944546,1325.66700022
5,Prevalence,113,Guyana,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,750.049067861,872.611058012,648.8066562949999
5,Prevalence,113,Guyana,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1133.9701844200001,1293.4495597799998,1003.8098074400001
5,Prevalence,113,Guyana,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,9043.6593484,10131.423472,8123.20795428
5,Prevalence,113,Guyana,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,13368.5020639,14900.5086114,12000.8062761
5,Prevalence,113,Guyana,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,22412.1614123,24785.2327212,20267.2982398
5,Prevalence,113,Guyana,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0459453641167,0.0514407858152,0.0412804959913
5,Prevalence,113,Guyana,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0691892581994,0.077075478325,0.0620553453105
5,Prevalence,113,Guyana,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0574594576375,0.0636488031512,0.0519377960381
5,Prevalence,113,Guyana,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4472.32085868,5010.2480397,4017.1341017799996
5,Prevalence,113,Guyana,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6864.37250985,7651.01738442,6162.09686796
5,Prevalence,113,Guyana,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5645.86423329,6243.66638986,5105.55015791
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,467.162068717,601.629070979,370.829691364
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,467.162068717,601.629070979,370.829691364
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000546698695362,0.0007043755137,0.000433838152576
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000265185343469,0.000341893579383,0.000210379784636
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,52.0690035313,67.0564421195,41.3319783479
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,25.697967209700003,33.0948190655,20.398850607099998
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,63.167482914,79.8296303819,48.4323384502
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,63.167482914,79.8296303819,48.4323384502
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.9720579642e-05,5.00693640322e-05,3.03635564248e-05
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.92853755497e-05,2.43463407107e-05,1.47252375217e-05
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.7827852932200003,4.78059814704,2.9003710319600002
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.86977929947,2.36298461624,1.4336139368199998
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,86.621505644,108.166642776,68.3296478129
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,86.621505644,108.166642776,68.3296478129
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.44703251589e-05,6.80214978737e-05,4.2836792815e-05
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.64464674153e-05,3.30310913548e-05,2.080346385e-05
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.1873296593500005,6.47756039395,4.0919215855
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.56402646853,3.20176996495,2.02258116244
5,Prevalence,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,49.1389039771,62.0971122721,39.5601010145
5,Prevalence,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,49.1389039771,62.0971122721,39.5601010145
5,Prevalence,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.05520945897e-05,1.33743968919e-05,8.48422275574e-06
5,Prevalence,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.31968318742e-06,6.73676924358e-06,4.28534251651e-06
5,Prevalence,153,Syria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.0324103871,1.30466287463,0.831159344158
5,Prevalence,153,Syria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.524153733451,0.662376052366,0.421978777795
5,Prevalence,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,17761.1409073,19810.9584751,15785.9991139
5,Prevalence,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13978.0430285,15990.7215556,12200.5303089
5,Prevalence,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,31739.1839358,35504.1809684,28381.6653807
5,Prevalence,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0200151375764,0.0222847280746,0.0177570618736
5,Prevalence,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0139216047772,0.0159198751384,0.0121618948922
5,Prevalence,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0167803806045,0.0187159434332,0.0150306883211
5,Prevalence,69,Singapore,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1772.23597763,1976.7701604400002,1575.1530669400001
5,Prevalence,69,Singapore,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1351.96908967,1546.63719525,1180.0464358
5,Prevalence,69,Singapore,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1558.82947971,1743.7425000699998,1393.92924431
5,Prevalence,69,Singapore,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,31819.9481774,35582.9688036,28364.2513022
5,Prevalence,69,Singapore,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,52339.2683745,57947.259785,46994.7830897
5,Prevalence,69,Singapore,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,84159.2165519,92813.4063589,75598.0885033
5,Prevalence,69,Singapore,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.035858081827,0.0399525693388,0.0318594021227
5,Prevalence,69,Singapore,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0521281792278,0.057629104561,0.0467327418022
5,Prevalence,69,Singapore,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0444948575943,0.049099185376,0.0399465783906
5,Prevalence,69,Singapore,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3175.0469894099997,3550.52740326,2830.23184708
5,Prevalence,69,Singapore,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5062.3018454,5604.71189713,4545.37834685
5,Prevalence,69,Singapore,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4133.37242746,4558.41190615,3712.90355817
5,Prevalence,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,27956.3451102,32501.5463467,23939.9561498
5,Prevalence,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,17210.3051325,20378.3352933,14448.0895805
5,Prevalence,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,45166.6502427,51916.4726259,39168.755027
5,Prevalence,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00917443395234,0.0106590121916,0.00786532127141
5,Prevalence,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00570944480753,0.0067618091406,0.00479266344498
5,Prevalence,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00745132415426,0.00856814682278,0.00646124938956
5,Prevalence,208,Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,911.655523629,1059.87439119,780.6812075529999
5,Prevalence,208,Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,569.924075787,674.834282056,478.45253396899994
5,Prevalence,208,Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,742.103457724,853.005340035,643.555995055
5,Prevalence,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,7.96906561545,9.74604768169,6.12523183438
5,Prevalence,110,Dominica,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,7.96906561545,9.74604768169,6.12523183438
5,Prevalence,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000431715234037,0.000529046556431,0.000332350044819
5,Prevalence,110,Dominica,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000212756377504,0.000260343975786,0.000163684608451
5,Prevalence,110,Dominica,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,41.440885032800004,50.68158062570001,31.852545893899997
5,Prevalence,110,Dominica,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,110,Dominica,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,20.702872491300003,25.3193024358,15.912768167100001
5,Prevalence,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,47.372718912,69.5892577015,17.2814651197
5,Prevalence,175,Burundi,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,47.372718912,69.5892577015,17.2814651197
5,Prevalence,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.85878591289e-05,2.72617771313e-05,6.79000550714e-06
5,Prevalence,175,Burundi,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.05320612856e-06,1.32708311403e-05,3.31051986075e-06
5,Prevalence,175,Burundi,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8300036722000002,2.68822647431,0.667581370806
5,Prevalence,175,Burundi,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,175,Burundi,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.895825618689,1.3159438864,0.32679524288
5,Prevalence,110,Dominica,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,531.133001023,593.977027425,474.094692865
5,Prevalence,110,Dominica,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,816.572628152,915.5634687,721.846284362
5,Prevalence,110,Dominica,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1347.70562918,1505.02519972,1204.09365201
5,Prevalence,110,Dominica,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.028773008108,0.0321875862321,0.0256744476963
5,Prevalence,110,Dominica,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.042983524611,0.0482189108156,0.0379765619128
5,Prevalence,110,Dominica,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0359802477616,0.0402485321394,0.0322172508467
5,Prevalence,110,Dominica,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2762.00783061,3088.8105197600003,2465.39614677
5,Prevalence,110,Dominica,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4239.16100709,4753.06276775,3747.39798554
5,Prevalence,110,Dominica,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3501.2106993499997,3909.91194071,3128.1204783599997
5,Prevalence,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,92091.097262,106970.925613,78779.2453732
5,Prevalence,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,49694.7132689,59846.3583456,41634.4385001
5,Prevalence,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,141785.810531,163989.030412,122352.095603
5,Prevalence,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0133106814667,0.0155324533242,0.0113673367734
5,Prevalence,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00623671477687,0.00749826686551,0.00522674906672
5,Prevalence,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0095243064174,0.0110153295486,0.00821000928673
5,Prevalence,164,Nepal,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1304.44250417,1515.2107666,1115.8841534800001
5,Prevalence,164,Nepal,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,619.075419273,745.5402586629999,518.663973996
5,Prevalence,164,Nepal,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,939.784724418,1086.95210879,810.9741730700001
5,Prevalence,6,China,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,13828.4975296,16261.5046141,9832.0305016
5,Prevalence,6,China,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,6,China,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,13828.4975296,16261.5046141,9832.0305016
5,Prevalence,6,China,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.77372416976e-05,4.43525325716e-05,2.68776069329e-05
5,Prevalence,6,China,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,6,China,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.92172439243e-05,2.2600068697e-05,1.3685664576e-05
5,Prevalence,6,China,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.5855100358700005,4.21635017598,2.5492895349699998
5,Prevalence,6,China,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,6,China,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8543638160099998,2.18062343257,1.3184484837300001
5,Prevalence,6,China,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,17520.4960447,19120.594645,15904.9627235
5,Prevalence,6,China,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,17520.4960447,19120.594645,15904.9627235
5,Prevalence,6,China,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.78120901675e-05,5.21518592487e-05,4.33988620936e-05
5,Prevalence,6,China,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.4347794229e-05,2.65619759437e-05,2.21131669327e-05
5,Prevalence,6,China,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.54278668144,4.95766686474,4.12390451989
5,Prevalence,6,China,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.34945075083,2.56401961055,2.13281213714
5,Prevalence,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4377.65810158,5957.80790204,4034.12305294
5,Prevalence,130,Mexico,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4377.65810158,5957.80790204,4034.12305294
5,Prevalence,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000131360414999,0.000178112770397,0.000120741518559
5,Prevalence,130,Mexico,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.45833435754e-05,8.76861005595e-05,5.93435012947e-05
5,Prevalence,130,Mexico,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.566121826899998,17.1019614097,11.5800002128
5,Prevalence,130,Mexico,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,130,Mexico,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.27430881017,8.53906946172,5.78193482109
5,Prevalence,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,18339.8162216,19590.4852634,17117.4716838
5,Prevalence,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,18339.8162216,19590.4852634,17117.4716838
5,Prevalence,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00055032538652,0.000587893840184,0.000513097727161
5,Prevalence,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000270566388022,0.000288941215274,0.000252192436061
5,Prevalence,130,Mexico,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,52.644669724299995,56.2347307066,49.1359145817
5,Prevalence,130,Mexico,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,26.285668689999998,28.0781987609,24.5337349106
5,Prevalence,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3778.40550759,4615.3176806,3034.09203574
5,Prevalence,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3778.40550759,4615.3176806,3034.09203574
5,Prevalence,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000708221701279,0.000865082592437,0.000571013206412
5,Prevalence,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000343255889858,0.000419692385928,0.0002760251815
5,Prevalence,71,Australia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,64.3858464954,78.64723230839999,51.7023870714
5,Prevalence,71,Australia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,32.397070098,39.5729812808,26.0151252077
5,Prevalence,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,235909.662519,265196.798468,208995.894414
5,Prevalence,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,166670.652307,190220.741007,145671.067826
5,Prevalence,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,402580.314826,451811.541867,358805.460624
5,Prevalence,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0193991323312,0.0217746152389,0.0171849632792
5,Prevalence,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0135647640799,0.0154859848467,0.0118851931117
5,Prevalence,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0164668285266,0.0184803864915,0.0146594548289
5,Prevalence,68,South Korea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1779.36051281,2000.26021096,1576.36206118
5,Prevalence,68,South Korea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1329.23374623,1517.05069057,1161.7576131399999
5,Prevalence,68,South Korea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1560.57227634,1751.4134208799999,1390.8823502500002
5,Prevalence,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,31721.292553,34565.5783375,29213.3645422
5,Prevalence,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12302.4810177,13627.5972073,11055.402253
5,Prevalence,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,44023.7735707,47827.0442188,40737.3208006
5,Prevalence,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0266024453068,0.028968237878,0.0244725735616
5,Prevalence,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103497580741,0.01145648313,0.00929483559436
5,Prevalence,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0184888413464,0.0200660385589,0.0171200563356
5,Prevalence,90,Norway,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2456.78669724,2677.07417344,2262.54983995
5,Prevalence,90,Norway,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1012.48476231,1121.5408094900001,909.8511354149999
5,Prevalence,90,Norway,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1756.5608545999999,1908.31241513,1625.4304716699999
5,Prevalence,90,Norway,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,47721.8454322,53530.8280383,42609.5242201
5,Prevalence,90,Norway,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,72303.8272984,80587.5493437,65129.699041
5,Prevalence,90,Norway,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,120025.672731,133568.037087,108749.047093
5,Prevalence,90,Norway,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0400210237937,0.044792121318,0.0357955334087
5,Prevalence,90,Norway,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0608275137189,0.0677710647883,0.0547957393039
5,Prevalence,90,Norway,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0504079246179,0.0562262547372,0.0456675489095
5,Prevalence,90,Norway,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3696.01569134,4145.91637452,3300.0708311099997
5,Prevalence,90,Norway,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5950.54959169,6632.29356951,5360.1243325
5,Prevalence,90,Norway,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4789.05784682,5329.401964979999,4339.11733606
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,15415.6518744,18201.5778515,13160.4138932
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,10525.5942109,12592.3945644,8870.13348016
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,25941.2460854,30622.3134863,22223.1334889
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00969360631293,0.0114257525289,0.00826441559465
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00624620551162,0.00746579529097,0.00526216229615
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00791997010349,0.00933079551822,0.00679196493551
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,923.166453781,1090.0016564500002,788.1115066049999
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,616.082339807,737.0559563200001,519.185186066
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,767.869838964,906.43104992,657.812422628
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,45983.4679348,51880.6829385,41236.527667
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,69048.5566655,78049.2965725,61285.7329897
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,115032.0246,129085.295593,103267.775975
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0289150521691,0.0325623764348,0.0259124173104
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0409756372643,0.0463486274804,0.0363700702266
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0351198497604,0.0393732442465,0.031474005497
5,Prevalence,131,Nicaragua,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2753.7203987,3106.87517324,2469.44983726
5,Prevalence,131,Nicaragua,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4041.53870065,4568.36852049,3587.16638894
5,Prevalence,131,Nicaragua,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3404.98763686,3820.96930939,3056.76181658
5,Prevalence,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,431.744615269,684.311386395,262.606413432
5,Prevalence,51,Poland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,431.744615269,684.311386395,262.606413432
5,Prevalence,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.83036432943e-05,7.67010008871e-05,2.95529751683e-05
5,Prevalence,51,Poland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.40788773694e-05,3.82079639159e-05,1.4684205277e-05
5,Prevalence,51,Poland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.56164203121,7.2301621658099995,2.7745950054999997
5,Prevalence,51,Poland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,51,Poland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.31312280701,3.66627913583,1.40694489912
5,Prevalence,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6397.56777025,7904.75180261,5101.80426438
5,Prevalence,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6397.56777025,7904.75180261,5101.80426438
5,Prevalence,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000715719952375,0.000883609166616,0.000572549409729
5,Prevalence,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000356783827257,0.000440487412507,0.000285068413689
5,Prevalence,51,Poland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,67.5941586905,83.518466227,53.903636419099996
5,Prevalence,51,Poland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.275725499299995,42.3506420966,27.333519361799997
5,Prevalence,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,138.390701927,196.669870379,96.4591063937
5,Prevalence,78,Denmark,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,138.390701927,196.669870379,96.4591063937
5,Prevalence,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00011207445394,0.000159139348037,7.82169203826e-05
5,Prevalence,78,Denmark,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.56520950067e-05,7.8953977195e-05,3.89499580455e-05
5,Prevalence,78,Denmark,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.5893502427,15.0487432366,7.38083735019
5,Prevalence,78,Denmark,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,78,Denmark,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.36431455067,7.62333764234,3.73895775342
5,Prevalence,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1030.50340834,1292.2418647,814.532341958
5,Prevalence,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1030.50340834,1292.2418647,814.532341958
5,Prevalence,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000834515366712,0.00104533542334,0.000659626580757
5,Prevalence,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000414396542974,0.000518993152904,0.000327602011005
5,Prevalence,78,Denmark,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,78.8518402271,98.8794876611,62.326212186999996
5,Prevalence,78,Denmark,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,39.9444785734,50.09001140429999,31.5729859962
5,Prevalence,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,469.873828031,645.161684967,274.697667101
5,Prevalence,141,Egypt,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,469.873828031,645.161684967,274.697667101
5,Prevalence,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.01109797571e-05,2.76606293285e-05,1.1747141485e-05
5,Prevalence,141,Egypt,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.00953487887e-05,1.38818173321e-05,5.89857336589e-06
5,Prevalence,141,Egypt,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.9548564352,2.6841215585200002,1.1428482929500001
5,Prevalence,141,Egypt,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,141,Egypt,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.991033772725,1.360741928,0.579378226972
5,Prevalence,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,376.230470153,474.119522728,294.212616844
5,Prevalence,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,376.230470153,474.119522728,294.212616844
5,Prevalence,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.61029577423e-05,2.02619454345e-05,1.26303404594e-05
5,Prevalence,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.08339296286e-06,1.0175727255e-05,6.34008694819e-06
5,Prevalence,141,Egypt,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.5652639321900002,1.97252016342,1.22403801413
5,Prevalence,141,Egypt,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.793526006357,0.999988574167,0.620538157821
5,Prevalence,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,33.3182441117,52.7087333723,24.8861513274
5,Prevalence,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,33.3182441117,52.7087333723,24.8861513274
5,Prevalence,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.37443899425e-05,2.17541760966e-05,1.02788869317e-05
5,Prevalence,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.81747650974e-06,1.07918096958e-05,5.09551332735e-06
5,Prevalence,187,Somalia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.3631386673099999,2.15645555402,1.0181591515200001
5,Prevalence,187,Somalia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.6779676228429999,1.07252994929,0.506389376361
5,Prevalence,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.1186408079,31.6103953786,10.1738851633
5,Prevalence,195,Namibia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.1186408079,31.6103953786,10.1738851633
5,Prevalence,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.38774819721e-05,5.06058491193e-05,1.63232045732e-05
5,Prevalence,195,Namibia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.6406274177e-05,2.45288162098e-05,7.90469522705e-06
5,Prevalence,195,Namibia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.3056966105799996,4.94796884954,1.5925162043599999
5,Prevalence,195,Namibia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,195,Namibia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.6164571939999999,2.41951418559,0.778726718859
5,Prevalence,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,213.775643527,320.008548846,152.688911873
5,Prevalence,90,Norway,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,213.775643527,320.008548846,152.688911873
5,Prevalence,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000179283449955,0.000269232979439,0.000128067828507
5,Prevalence,90,Norway,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.97817742213e-05,0.000134676057017,6.40869322231e-05
5,Prevalence,90,Norway,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,16.5567388634,24.784385582400002,11.825624283
5,Prevalence,90,Norway,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,90,Norway,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.52970785166,12.7684304286,6.092330206460001
5,Prevalence,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,133.819160394,176.523342586,98.1884666007
5,Prevalence,207,Ghana,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,133.819160394,176.523342586,98.1884666007
5,Prevalence,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.97573817461e-05,2.60652585563e-05,1.44753780218e-05
5,Prevalence,207,Ghana,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.68258718625e-06,1.2769767429e-05,7.10129097743e-06
5,Prevalence,207,Ghana,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.93014900108,2.5460954347499998,1.41622746824
5,Prevalence,207,Ghana,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,207,Ghana,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.954350565062,1.25890157469,0.700245154035
5,Prevalence,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,23.1774860563,32.1155782959,12.9144400741
5,Prevalence,170,Congo,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,23.1774860563,32.1155782959,12.9144400741
5,Prevalence,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.09503854202e-05,2.90283088085e-05,1.16730650239e-05
5,Prevalence,170,Congo,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.05036505903e-05,1.45565434965e-05,5.85269763218e-06
5,Prevalence,170,Congo,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.08353808904,2.88702711194,1.16094246493
5,Prevalence,170,Congo,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,170,Congo,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.04670328308,1.4503506186400001,0.5832205784469999
5,Prevalence,92,Spain,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,326798.208103,366642.771931,290262.991628
5,Prevalence,92,Spain,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,635863.706986,708493.937962,572140.820636
5,Prevalence,92,Spain,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,962661.915089,1063362.776,870045.628079
5,Prevalence,92,Spain,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0321105835364,0.0361033428399,0.028540644928
5,Prevalence,92,Spain,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.061127066176,0.0681141312128,0.05500506349
5,Prevalence,92,Spain,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0467774466804,0.0515797155231,0.0423224837464
5,Prevalence,92,Spain,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3012.58324205,3379.8896173599996,2675.7840241599997
5,Prevalence,92,Spain,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5997.59724357,6682.660517859999,5396.54987552
5,Prevalence,92,Spain,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4487.98713322,4957.4605392,4056.2044918700003
5,Prevalence,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,22.5115008272,28.8029841569,17.2009421072
5,Prevalence,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,22.5115008272,28.8029841569,17.2009421072
5,Prevalence,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.03485221884e-05,2.6036405871e-05,1.55453104611e-05
5,Prevalence,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.02018498102e-05,1.30511991057e-05,7.79408917584e-06
5,Prevalence,170,Congo,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.0236694049099997,2.58924175051,1.5462771916100002
5,Prevalence,170,Congo,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.01662715989,1.30075272211,0.776800492164
5,Prevalence,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,49.7096722978,77.6230839584,31.9812950095
5,Prevalence,7,North Korea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,49.7096722978,77.6230839584,31.9812950095
5,Prevalence,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.55606001433e-06,1.18034911027e-05,4.86086809486e-06
5,Prevalence,7,North Korea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.77715779462e-06,5.90429902246e-06,2.4304875232e-06
5,Prevalence,7,North Korea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.726189347347,1.13396556592,0.46720235070399996
5,Prevalence,7,North Korea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,7,North Korea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.367716785474,0.574200343563,0.23657486466099997
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,27588.7547586,31044.8320241,24649.4417708
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,40813.4724371,46235.7985498,36077.3772542
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,68402.2271957,76388.8031516,61298.0117492
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0322852162612,0.0362269295369,0.0288200071531
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0449914591893,0.0509245452944,0.0397300811416
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0388280245904,0.0433356643966,0.0348015364333
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3074.9905978,3460.1984547600005,2747.38031308
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4432.88856093,5021.82564379,3918.4853282199997
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3762.71600213,4202.04697692,3371.92251135
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9551.08397596,11111.0507147,8274.18952919
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,4453.18824898,5316.08103907,3748.23670186
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,14004.2722249,16176.9967151,12163.5033398
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016282888703,0.0189043698396,0.0140966249753
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00792570587725,0.0094587771213,0.0066745093646
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0121941845166,0.0140772279929,0.0105925681904
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1615.4134655900002,1879.2569499499998,1399.44714295
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,791.060504027,944.344031983,665.8335216950001
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1213.34617987,1401.59351738,1053.85985606
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,32121.2819789,36643.0753836,28654.7726995
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,39710.9739937,44934.115973,35521.4652188
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,71832.2559725,81351.4132565,64409.4454034
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0547609161092,0.0624528234733,0.0487887458141
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0706766775017,0.0800006418316,0.0632358923984
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0625475721375,0.0708288406531,0.0561160943299
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,5432.80234696,6197.59155549,4846.4976110200005
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,7054.22302999,7982.05744789,6310.00231941
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6223.62890237,7048.37958849,5580.50809586
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,51406.293714,59898.9646301,44411.0675159
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,34312.8902225,41528.0313134,28561.5246946
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,85719.1839365,99335.3528676,73850.5252617
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0176846833103,0.0206145886085,0.0152415958081
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0112631340213,0.013620815665,0.00936587643371
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0143985525878,0.0167271642834,0.0124159854132
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1717.77454647,2001.56263694,1484.02453958
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1115.9759575,1350.63774015,928.921308056
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1412.8042208,1637.22284045,1217.18767032
5,Prevalence,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1864.94959952,2402.14158767,1414.64322734
5,Prevalence,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1864.94959952,2402.14158767,1414.64322734
5,Prevalence,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000947440203031,0.00121724593005,0.000716890225061
5,Prevalence,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000472177865947,0.000606197665934,0.000357384875678
5,Prevalence,53,Serbia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,89.6724203692,115.502236785,68.0203272982
5,Prevalence,53,Serbia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,45.4501602646,58.541914572799996,34.4758707775
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,120782.831228,137625.955295,108251.009142
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,166299.418746,188886.508556,146182.077798
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,287082.249974,323079.951773,256096.477603
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0415508734362,0.0473233714057,0.037196124931
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0545872750421,0.0619387133922,0.0479961492048
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0482217581437,0.0543478921316,0.0429725475496
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4036.03641003,4598.86029236,3617.27747129
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5408.6424041499995,6143.25406218,4754.35567164
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4731.62477584,5324.93076296,4220.92427708
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,171864.290362,197251.341151,147501.040383
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,110575.249414,130552.671507,93092.3030451
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,282439.539776,323922.643883,243882.910231
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00966835957075,0.0110959908409,0.00829774926706
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00617715495136,0.00729418176542,0.00520156406751
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00791665292633,0.00907891152922,0.00683627596126
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,964.041957424,1106.44607223,827.380669911
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,617.166651443,728.668988202,519.587025576
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,790.171851164,906.2277730469999,682.303231331
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,804677.186098,908904.02932,717666.799492
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1003134.7605,1127558.39723,895712.617991
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1807811.9466,2018904.54191,1624196.06895
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0452677004681,0.0511278710789,0.0403665807271
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0560389267574,0.0630025598206,0.0500292866774
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0506721371221,0.0565773146471,0.0455295024755
5,Prevalence,171,Democratic Republic of the Congo,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4513.69256492,5098.33437588,4025.62338404
5,Prevalence,171,Democratic Republic of the Congo,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5598.91408215,6293.37436732,4999.34623733
5,Prevalence,171,Democratic Republic of the Congo,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5057.65628117,5648.22312228,4543.96015329
5,Prevalence,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,147.920267564,254.101225282,82.6655852413
5,Prevalence,53,Serbia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,147.920267564,254.101225282,82.6655852413
5,Prevalence,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.514111761e-05,0.000129340789561,4.18973704634e-05
5,Prevalence,53,Serbia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.74492795949e-05,6.43745799681e-05,2.09148077276e-05
5,Prevalence,53,Serbia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.112454093939999,12.217955861,3.97481149717
5,Prevalence,53,Serbia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,53,Serbia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.60492308686,6.19262923538,2.01461964363
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,59.0317834173,111.066451274,28.3926992072
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,59.0317834173,111.066451274,28.3926992072
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000130609488747,0.000245476664583,6.27143847998e-05
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.65405048497e-05,0.00012496854818,3.19810050441e-05
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.3182543057,23.1764095955,5.924748821970001
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,6.38651648762,12.0160307079,3.07174256168
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,441.238046343,580.57373876,334.8444025
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,441.238046343,580.57373876,334.8444025
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000976238120477,0.00128780779982,0.000742506285742
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000497349349733,0.000654825471334,0.00037845510215
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,92.0738312411,121.149227472,69.8725036596
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,47.7365563906,62.810973008599994,36.2260662572
5,Prevalence,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,12.3189584222,15.3667666054,9.94969073743
5,Prevalence,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,12.3189584222,15.3667666054,9.94969073743
5,Prevalence,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.9760497673e-05,2.46525431903e-05,1.59346293833e-05
5,Prevalence,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.56990132673e-06,1.19397597033e-05,7.72350376818e-06
5,Prevalence,195,Namibia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.92828409141,2.40535689512,1.55742309584
5,Prevalence,195,Namibia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.942914326033,1.1761988214,0.7615664908040001
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,516.862609843,611.128189925,441.291033987
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,255.710062697,301.425476237,216.876459833
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,772.57267254,900.256026487,662.452832019
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0187516298818,0.0221610386161,0.0160155986598
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00984755820952,0.0116119732388,0.00835970151269
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144323362135,0.0168280391078,0.0123914465195
5,Prevalence,25,Federated States of Micronesia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1843.30460001,2179.48712527,1573.79113405
5,Prevalence,25,Federated States of Micronesia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,979.5064917880001,1154.62100964,830.7529945509999
5,Prevalence,25,Federated States of Micronesia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1426.83213877,1662.64518196,1223.45641354
5,Prevalence,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,187429.88085,220327.326591,161137.389406
5,Prevalence,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,121276.919157,146896.024651,101212.626714
5,Prevalence,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,308706.800007,362900.265465,265712.301909
5,Prevalence,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0178546417083,0.0209856740771,0.0153183691701
5,Prevalence,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113978047453,0.0138077712749,0.00950776321371
5,Prevalence,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0146043939895,0.0171457387061,0.0125570568986
5,Prevalence,139,Algeria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1719.9774442599999,2021.8656191500002,1478.70058899
5,Prevalence,139,Algeria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1125.77148502,1363.58473619,939.521632558
5,Prevalence,139,Algeria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1424.58066016,1674.6657337600002,1226.17514891
5,Prevalence,139,Algeria,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,399174.74515,453677.415298,355137.571291
5,Prevalence,139,Algeria,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,585135.274706,664877.466055,513923.702422
5,Prevalence,139,Algeria,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,984310.019857,1111219.35068,879359.543036
5,Prevalence,139,Algeria,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.038025387571,0.043262919159,0.0338946758122
5,Prevalence,139,Algeria,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.054991920749,0.0625394308755,0.0483393880925
5,Prevalence,139,Algeria,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0465658598297,0.0525862772716,0.0415700974126
5,Prevalence,139,Algeria,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3663.08485534,4163.23650074,3258.97135218
5,Prevalence,139,Algeria,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5431.60736373,6171.82640785,4770.57509115
5,Prevalence,139,Algeria,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4542.26799624,5127.91294568,4057.95595792
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,103094.1398,116995.806817,90275.2394479
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,58319.929458,67103.1779156,50510.9023657
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,161414.069258,181279.830372,142366.309107
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0176033872854,0.0199544028972,0.015454706828
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00978535365203,0.0112419018242,0.00847808098044
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0136601416009,0.0153294552775,0.0120478172702
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1663.36558246,1887.66110984,1456.5398822700001
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,959.162359243,1103.61660311,830.7307078519999
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1314.63713212,1476.43385368,1159.50262066
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,326.811947202,367.381535137,290.613527635
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,186.662055037,214.3438756,162.213517088
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,513.474002239,575.960222987,459.128282775
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0165759480271,0.0186204077158,0.0147198058639
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00833272704398,0.00955858417275,0.00724261964111
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0121915641804,0.0136540399623,0.0108725831865
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1579.03357402,1775.05070859,1404.1362965199999
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,820.8533642790001,942.585204925,713.340004782
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1182.11311804,1325.9680764700001,1056.99911498
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,634.922498441,714.237118088,570.171733988
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1031.1915715,1163.87897632,915.454173875
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1666.11406995,1862.94543752,1490.21482776
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0322038784566,0.0361248417229,0.0289012672035
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0460330311556,0.0519846216155,0.0408905734618
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0395592705226,0.0442845702572,0.0354088326971
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3067.70897002,3450.9276632300002,2754.85739929
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4534.70348067,5118.2013031,4025.7439484399997
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3835.70597469,4288.84856934,3430.75304479
5,Prevalence,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,524.198414988,665.398380385,410.560698566
5,Prevalence,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,524.198414988,665.398380385,410.560698566
5,Prevalence,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000242509637253,0.000307888805946,0.000189735664504
5,Prevalence,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000115878902195,0.000147199170055,9.07168456762e-05
5,Prevalence,91,Portugal,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,22.8508359782,29.006019124799998,17.897145267499997
5,Prevalence,91,Portugal,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,11.1658693953,14.1735480284,8.74528996646
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,4.33215306142,5.42790274139,3.4080359251
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,4.33215306142,5.42790274139,3.4080359251
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000109770041832,0.000137682074013,8.63170113734e-05
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.22402756186e-05,6.5461051854e-05,4.10755915806e-05
5,Prevalence,376,Northern Mariana Islands,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.5400490962,13.205988009299999,8.29168901992
5,Prevalence,376,Northern Mariana Islands,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.08943922449,6.37673247622,4.0037809075
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,19.2948855055,25.1643970206,14.0710779271
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,19.2948855055,25.1643970206,14.0710779271
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000978650971657,0.00127903051565,0.000709888048909
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000458126380032,0.000598857001392,0.000333037774
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,93.22569839009999,121.58499132499999,67.986206318
5,Prevalence,422,"Virgin Islands, U.S.",2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,44.42043252,57.933145000399996,32.3942511795
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.92240612235,2.37731500436,1.53471496159
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.92240612235,2.37731500436,1.53471496159
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.7506657866e-05,0.000120565263246,7.7870779423e-05
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.56447047273e-05,5.64567336084e-05,3.64522175077e-05
5,Prevalence,422,"Virgin Islands, U.S.",1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.2883501845,11.4863004246,7.4151709313500005
5,Prevalence,422,"Virgin Islands, U.S.",3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.4257381786100005,5.47302344446,3.53320066964
5,Prevalence,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,10745.3319928,12349.4231576,9359.65645194
5,Prevalence,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,6809.79975831,7970.4452519,5765.62232161
5,Prevalence,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,17555.1317511,20205.284836,15295.2964017
5,Prevalence,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0107601374934,0.0123853240672,0.0093647845293
5,Prevalence,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00667043723212,0.00780765942348,0.00564849148506
5,Prevalence,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00869272030572,0.00999578868738,0.00756599025505
5,Prevalence,132,Panama,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1021.4232746900001,1173.9040032100002,889.7045665510001
5,Prevalence,132,Panama,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,657.539996608,769.609493656,556.716411105
5,Prevalence,132,Panama,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,840.9063918569999,967.851076755,732.658272914
5,Prevalence,132,Panama,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,27608.9278141,31199.8764961,24565.1938935
5,Prevalence,132,Panama,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,38108.1184187,43183.8796871,33808.1888874
5,Prevalence,132,Panama,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,65717.0462327,73495.3086387,58755.7075285
5,Prevalence,132,Panama,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0276469777898,0.0312941391748,0.0246230455619
5,Prevalence,132,Panama,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0373282771005,0.042264868609,0.0330699066057
5,Prevalence,132,Panama,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0325409934829,0.0364097262083,0.0291139662468
5,Prevalence,132,Panama,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2624.43277485,2965.77900449,2335.10335529
5,Prevalence,132,Panama,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3679.64006947,4169.74494269,3264.44788324
5,Prevalence,132,Panama,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3147.90484142,3520.4905142200005,2814.45053898
5,Prevalence,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,12.3922915604,16.4734025855,8.1269135459
5,Prevalence,210,Liberia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,12.3922915604,16.4734025855,8.1269135459
5,Prevalence,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.11682933569e-05,1.48363926684e-05,7.32862447766e-06
5,Prevalence,210,Liberia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.63472599834e-06,7.48861848956e-06,3.69636154227e-06
5,Prevalence,210,Liberia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.11329139565,1.47992784596,0.7301008759950001
5,Prevalence,210,Liberia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,210,Liberia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.5623289957550001,0.7475188819899999,0.368777567132
5,Prevalence,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,9.07523034953,11.5713532041,6.96065537943
5,Prevalence,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,9.07523034953,11.5713532041,6.96065537943
5,Prevalence,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.17890346406e-06,1.04218594254e-05,6.27630813654e-06
5,Prevalence,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.12648281737e-06,5.25955846564e-06,3.16622325494e-06
5,Prevalence,210,Liberia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.815295202862,1.03954041876,0.625327261244
5,Prevalence,210,Liberia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.41180964342299997,0.525077012192,0.315855895596
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,115787.774054,135444.385155,98914.1943789
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,89540.5959672,106580.041171,75756.5238537
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,205328.370021,239781.416508,176076.905199
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0094026823435,0.0109884022302,0.00803335418822
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00706769809214,0.00841415355981,0.00597604838829
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00821861275944,0.00959406216211,0.00704519210506
5,Prevalence,189,Tanzania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,931.772668529,1089.95424797,795.986826804
5,Prevalence,189,Tanzania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,704.6243379890001,838.713324853,596.152950427
5,Prevalence,189,Tanzania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,816.928956692,954.005442121,700.5477248320001
5,Prevalence,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1460.55046639,2163.47075456,1151.7177752
5,Prevalence,196,South Africa,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1460.55046639,2163.47075456,1151.7177752
5,Prevalence,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.90319250664e-05,0.000146593712092,7.8076586733e-05
5,Prevalence,196,South Africa,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.93596311762e-05,7.30377926549e-05,3.89236663144e-05
5,Prevalence,196,South Africa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.793954018159999,14.507498082000001,7.723027168030001
5,Prevalence,196,South Africa,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,196,South Africa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.90342084447,7.263294106200001,3.8665948735199995
5,Prevalence,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,472.741075471,537.47243433,416.96810805
5,Prevalence,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,257.293950043,296.973379525,223.208109089
5,Prevalence,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,730.035025514,826.1117339,645.079127163
5,Prevalence,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0164095792516,0.018663109256,0.0144640875093
5,Prevalence,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00920417103506,0.0106104466632,0.00798544618567
5,Prevalence,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012861112906,0.0145535080733,0.0113734755071
5,Prevalence,112,Grenada,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1595.9664935899998,1814.49855096,1407.67782593
5,Prevalence,112,Grenada,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,912.8424305489999,1053.6194167400001,791.910702854
5,Prevalence,112,Grenada,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1262.8832135,1429.0857352799999,1115.91851432
5,Prevalence,112,Grenada,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,870.995822967,975.353948775,781.483459725
5,Prevalence,112,Grenada,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1200.24022039,1366.48651059,1056.84222205
5,Prevalence,112,Grenada,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,2071.23604336,2330.84757642,1857.59332929
5,Prevalence,112,Grenada,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0302336297843,0.0338507484499,0.0271053073731
5,Prevalence,112,Grenada,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0429363473789,0.0488855745384,0.0377952925213
5,Prevalence,112,Grenada,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0364893159387,0.0410804162096,0.0326879732213
5,Prevalence,112,Grenada,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2940.46830632,3292.77971052,2638.27596486
5,Prevalence,112,Grenada,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4258.28201496,4848.10026597,3749.52626178
5,Prevalence,112,Grenada,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3583.0188127,4032.1192471699997,3213.43956259
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,228.113265707,337.425335802,160.021632547
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,228.113265707,337.425335802,160.021632547
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.49980319678e-05,6.66854411411e-05,3.16005273566e-05
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.38744587992e-05,5.01713237917e-05,2.37894561025e-05
5,Prevalence,156,United Arab Emirates,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.35075177624,6.43563571167,3.0520557402999997
5,Prevalence,156,United Arab Emirates,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,156,United Arab Emirates,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.29374236473,4.87210649507,2.31056281956
5,Prevalence,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,354808.061916,410570.916515,308596.538625
5,Prevalence,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,108473.522049,128094.450848,91144.111212
5,Prevalence,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,463281.583965,531604.122397,405514.309992
5,Prevalence,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0385219831921,0.0444230289193,0.0335166967078
5,Prevalence,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0119975305864,0.0141547477235,0.0100792236786
5,Prevalence,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0253826959524,0.0290887812479,0.0222501388393
5,Prevalence,143,Iraq,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3766.12173598,4358.01837337,3275.6080160300003
5,Prevalence,143,Iraq,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1191.5444251,1407.0735965,1001.1867923499999
5,Prevalence,143,Iraq,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2500.8920961400004,2869.7116267799997,2189.05211826
5,Prevalence,143,Iraq,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,349024.376905,391899.292128,313247.394683
5,Prevalence,143,Iraq,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,529019.594221,594185.590786,473079.420191
5,Prevalence,143,Iraq,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,878043.971126,984674.264773,793642.605456
5,Prevalence,143,Iraq,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0378941113286,0.0426009635454,0.0339115397758
5,Prevalence,143,Iraq,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0585112957996,0.0657318465655,0.0523244290042
5,Prevalence,143,Iraq,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0481070029489,0.0539067851468,0.0434866206064
5,Prevalence,143,Iraq,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3704.7306229499995,4159.82780782,3324.97467922
5,Prevalence,143,Iraq,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5811.09874885,6526.9248642600005,5196.61512884
5,Prevalence,143,Iraq,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4739.86729336,5315.480198820001,4284.25084839
5,Prevalence,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,447.219304618,598.080589778,333.40482321
5,Prevalence,93,Sweden,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,447.219304618,598.080589778,333.40482321
5,Prevalence,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000212791380817,0.000285056989637,0.000157725402954
5,Prevalence,93,Sweden,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000105877025663,0.000141767258434,7.8673956193e-05
5,Prevalence,93,Sweden,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,19.7071564793,26.3550067009,14.6918099333
5,Prevalence,93,Sweden,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,93,Sweden,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.081711077000001,13.4825926444,7.515979441319999
5,Prevalence,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1446.19788436,1718.3150796,1206.90996251
5,Prevalence,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1446.19788436,1718.3150796,1206.90996251
5,Prevalence,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00068810230048,0.000817734431982,0.000575410920821
5,Prevalence,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000342376346295,0.000406354712955,0.000286315368032
5,Prevalence,93,Sweden,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,63.7281255815,75.7192361881,53.18366904530001
5,Prevalence,93,Sweden,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,32.601788607399996,38.7361547071,27.2074962155
5,Prevalence,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9634.59461501,10829.4418925,8553.0580325
5,Prevalence,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,7206.15258911,8249.22969641,6217.95669317
5,Prevalence,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,16840.7472041,18759.4234059,14963.5187596
5,Prevalence,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144610629972,0.0162348163754,0.0128170840103
5,Prevalence,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00912982313253,0.0104595712534,0.00788831612357
5,Prevalence,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0115700726168,0.0128894333722,0.0102631461306
5,Prevalence,33,Armenia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1376.58501324,1547.30406485,1222.0557247499999
5,Prevalence,33,Armenia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,897.110008619,1026.96500421,774.087297435
5,Prevalence,33,Armenia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1120.36075001,1248.00410706,995.4747789460001
5,Prevalence,33,Armenia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,18732.7447853,21158.4265187,16729.4277395
5,Prevalence,33,Armenia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,27022.7391727,30639.9127024,23749.8927929
5,Prevalence,33,Armenia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,45755.4839581,51250.1219811,40676.2810227
5,Prevalence,33,Armenia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0281169831584,0.0317465611897,0.0250886448133
5,Prevalence,33,Armenia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0342364263124,0.0387869112393,0.0301152591301
5,Prevalence,33,Armenia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0314353651015,0.035168377879,0.0279681359655
5,Prevalence,33,Armenia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2676.5231708,3023.10310016,2390.2904508700003
5,Prevalence,33,Armenia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3364.12107187,3814.43107242,2956.6771262
5,Prevalence,33,Armenia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3043.96519364,3409.50579003,2706.06215757
5,Prevalence,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1046.54134837,1433.79700767,762.186188625
5,Prevalence,155,Turkey,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1046.54134837,1433.79700767,762.186188625
5,Prevalence,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.1281150735e-05,7.00654038296e-05,3.7389204843e-05
5,Prevalence,155,Turkey,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.52579429833e-05,3.45586880669e-05,1.84060734391e-05
5,Prevalence,155,Turkey,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.94202335286,6.77073897386,3.59922897388
5,Prevalence,155,Turkey,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,155,Turkey,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.46714657558,3.3800741681699997,1.7967995704600002
5,Prevalence,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,6950.05061386,8595.93864817,5203.58817597
5,Prevalence,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,6950.05061386,8595.93864817,5203.58817597
5,Prevalence,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000340550306003,0.00042064850382,0.000255367931017
5,Prevalence,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000167735058413,0.000207239087644,0.000125779337777
5,Prevalence,155,Turkey,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,32.8198331493,40.5921176504,24.5726117983
5,Prevalence,155,Turkey,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,16.3842485524,20.2643121868,12.267087936000001
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,155935.719959,174768.265343,137485.964117
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,222416.030511,252178.253833,195415.584521
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,378351.75047,425780.395683,334852.288689
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0266263431918,0.0298354323439,0.0235019105284
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0373187026266,0.0423066035289,0.0328136648785
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0320192643625,0.0360453284651,0.0283519761582
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2515.93456388,2819.78702226,2218.25819808
5,Prevalence,8,Taiwan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3657.9791255,4147.46538866,3213.9146055799997
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3081.48640611,3467.76907905,2727.20497359
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,23.5642374611,32.1930973757,15.5996206266
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,23.5642374611,32.1930973757,15.5996206266
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.00009801423e-05,5.43502960706e-05,2.64389685022e-05
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.62293890971e-05,3.56934909338e-05,1.73474498208e-05
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.90931188926,5.34084154136,2.58798030211
5,Prevalence,140,Bahrain,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.5787903353,3.52310353827,1.70716964521
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,19.3519386256,24.042220838,15.4431756455
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,19.3519386256,24.042220838,15.4431756455
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.28507944091e-05,4.0856899808e-05,2.6188083281e-05
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.15408442801e-05,2.67953201465e-05,1.71797362337e-05
5,Prevalence,140,Bahrain,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.2104906375099995,3.98860943077,2.56202604724
5,Prevalence,140,Bahrain,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.11781061786,2.63109921713,1.6900488363600001
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1803.19753153,2161.05214291,1463.47920266
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1803.19753153,2161.05214291,1463.47920266
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000222705560001,0.000267739569163,0.000180613520171
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000110358154725,0.000132488087649,8.96665884775e-05
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,21.6872612988,25.9912193113,17.6014304137
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,10.8493479018,13.0024615287,8.80535534186
5,Prevalence,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,47131.4586952,51828.7451828,42733.0386388
5,Prevalence,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,22595.8801201,25604.4581242,19953.9493324
5,Prevalence,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,69727.3388153,77068.8135066,63241.4701313
5,Prevalence,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0218777261586,0.0240157385759,0.0197769492592
5,Prevalence,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101333842275,0.011474062378,0.00894497888967
5,Prevalence,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0159043718037,0.0175386962234,0.0144399480066
5,Prevalence,57,Belarus,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2083.0656448600002,2290.67127339,1888.6689942
5,Prevalence,57,Belarus,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,998.0986561489999,1130.99269023,881.400056458
5,Prevalence,57,Belarus,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1540.42734383,1702.61635822,1397.14051202
5,Prevalence,57,Belarus,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,87702.2291655,98042.7291592,78454.4623953
5,Prevalence,57,Belarus,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,117010.988846,130994.650799,103964.392542
5,Prevalence,57,Belarus,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,204713.218012,227913.865449,183967.887759
5,Prevalence,57,Belarus,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0407099072778,0.0455383807164,0.0364563770467
5,Prevalence,57,Belarus,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0524750316218,0.0587278092213,0.046641286262
5,Prevalence,57,Belarus,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0466937668018,0.0519546524919,0.0419172645683
5,Prevalence,57,Belarus,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3876.1690304,4333.18735497,3467.44615647
5,Prevalence,57,Belarus,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5168.5754262,5786.257681919999,4592.28496221
5,Prevalence,57,Belarus,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4522.55663312,5035.1089879599995,4064.24753196
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,10.1577611984,15.7378380134,4.96949214937
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,10.1577611984,15.7378380134,4.96949214937
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.86170244259e-05,7.5282921285e-05,2.37977148253e-05
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.49069753609e-05,3.85904428879e-05,1.21890789149e-05
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.82934863799,7.48230885633,2.3626672919700002
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.48006142883,3.84246137196,1.21332305021
5,Prevalence,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,4.73792392601,7.06287399001,3.06438822265
5,Prevalence,74,Andorra,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,4.73792392601,7.06287399001,3.06438822265
5,Prevalence,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000272664985499,0.000405740741634,0.000176737383538
5,Prevalence,74,Andorra,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000134645075858,0.000200020923868,8.72019748022e-05
5,Prevalence,74,Andorra,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,25.578557752200002,38.1302302594,16.5436660344
5,Prevalence,74,Andorra,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,74,Andorra,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.927934817999999,19.2718110287,8.36151272541
5,Prevalence,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,12.58670996,16.0762216332,9.41508273643
5,Prevalence,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,12.58670996,16.0762216332,9.41508273643
5,Prevalence,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000724354616408,0.000929955265039,0.000541546599094
5,Prevalence,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000357693027723,0.000458297879485,0.000267105988564
5,Prevalence,74,Andorra,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,67.9516793956,86.790452929,50.8290638002
5,Prevalence,74,Andorra,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.344191353899994,43.8656991202,25.690065484999998
5,Prevalence,53,Serbia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,51891.285511,58306.5531984,46529.0504783
5,Prevalence,53,Serbia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,65926.8220133,74295.6612798,58661.9734741
5,Prevalence,53,Serbia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,117818.107524,131411.369734,106512.339023
5,Prevalence,53,Serbia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0263609861818,0.0296346058611,0.0235911185903
5,Prevalence,53,Serbia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0332744881955,0.0375010484781,0.0295520380095
5,Prevalence,53,Serbia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0298289044591,0.0331911915413,0.0269266960944
5,Prevalence,53,Serbia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2495.09003838,2803.55552237,2237.25755105
5,Prevalence,53,Serbia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3257.98003108,3671.55238875,2898.96482684
5,Prevalence,53,Serbia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2871.31184158,3202.58939788,2595.78214876
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,2149.34571656,2478.42080464,1857.10571057
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1268.23991903,1507.1179007,1061.50342287
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,3417.58563559,3933.77482741,2946.83708856
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0102873839745,0.011872128463,0.00887514902596
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00637646473878,0.00757691949938,0.00533728185354
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00838004638794,0.00964491303606,0.00723106995483
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1021.87279324,1178.32639531,882.931854647
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,636.52915873,756.421931719,532.768185744
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,834.41834761,960.4481763900001,719.483049234
5,Prevalence,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,40998.6174949,44240.0810296,37967.0622128
5,Prevalence,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,21163.7843709,23010.7749248,19438.845401
5,Prevalence,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,62162.4018658,66822.9047895,57843.2546664
5,Prevalence,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0214875122121,0.0232460360353,0.0198763172417
5,Prevalence,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108196434159,0.0117745486552,0.00994354224522
5,Prevalence,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0160872079267,0.0172794230666,0.0149528206349
5,Prevalence,75,Austria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2017.54294513,2177.0554430099996,1868.36003736
5,Prevalence,75,Austria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1062.073183,1154.76166925,975.509674787
5,Prevalence,75,Austria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1544.4871684500001,1660.2820339600003,1437.17362798
5,Prevalence,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,46.7051906917,69.1198615082,25.6586949276
5,Prevalence,58,Estonia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,46.7051906917,69.1198615082,25.6586949276
5,Prevalence,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000165851900384,0.000244745181303,9.11102724659e-05
5,Prevalence,58,Estonia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.30098789768e-05,0.000123024758483,4.56323334462e-05
5,Prevalence,58,Estonia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.533066419899999,22.9876676198,8.53348860491
5,Prevalence,58,Estonia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,58,Estonia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.94601737074,11.7594556852,4.36534853162
5,Prevalence,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,86.6278727428,113.42634996,66.7800951422
5,Prevalence,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,86.6278727428,113.42634996,66.7800951422
5,Prevalence,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00030762997476,0.000402263762598,0.000238284563124
5,Prevalence,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000153970737332,0.000201692199943,0.000119008250945
5,Prevalence,58,Estonia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,28.8104273037,37.7229811421,22.209515430899998
5,Prevalence,58,Estonia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,14.738117357200002,19.297378593999998,11.3613880633
5,Prevalence,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.40811792931,1.88050286737,0.948999326095
5,Prevalence,27,Samoa,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.40811792931,1.88050286737,0.948999326095
5,Prevalence,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.00920405585e-05,4.01998193102e-05,2.02057124246e-05
5,Prevalence,27,Samoa,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.56748490476e-05,2.09405543128e-05,1.05379241775e-05
5,Prevalence,27,Samoa,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.92748071114,3.9095701836299996,1.9729719821
5,Prevalence,27,Samoa,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,27,Samoa,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.5389436859499999,2.05521707657,1.03716918197
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2046.78233423,2432.97271655,1623.10120946
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2046.78233423,2432.97271655,1623.10120946
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000252794046856,0.000300064141636,0.000200964612564
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000125267548887,0.000148648662859,9.9277398795e-05
5,Prevalence,133,Venezuela,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,24.6168833575,29.261638902,19.5212223999
5,Prevalence,133,Venezuela,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,133,Venezuela,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,12.314931245699999,14.6385334806,9.76575743551
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,9908.49337765,11124.5300284,8863.36683731
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,11751.6704025,13258.352386,10493.5380878
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,21660.1637802,24288.8833522,19410.5083484
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0474249129846,0.0532515452047,0.0424923212604
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0590851407782,0.0666625251817,0.0527534303455
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0531115578741,0.0595508989914,0.0475785757755
5,Prevalence,172,Equatorial Guinea,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4710.83815256,5288.98375258,4213.94909054
5,Prevalence,172,Equatorial Guinea,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5898.15914381,6654.36228885,5266.70298801
5,Prevalence,172,Equatorial Guinea,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5288.42288024,5930.23615883,4739.1597546699995
5,Prevalence,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,281589.950262,297379.04567,266489.122698
5,Prevalence,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,132053.744071,142052.112648,122529.691558
5,Prevalence,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,413643.694333,436829.115103,392948.053366
5,Prevalence,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0276687717512,0.0292568903642,0.0261926379334
5,Prevalence,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0126946906543,0.0136584080698,0.0117977341336
5,Prevalence,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0200998020743,0.0212131722421,0.0190755504868
5,Prevalence,92,Spain,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2595.83175261,2741.38323684,2456.62505278
5,Prevalence,92,Spain,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1245.55806966,1339.86473815,1155.7252478300002
5,Prevalence,92,Spain,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1928.43151765,2036.52332898,1831.94720793
5,Prevalence,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,43.1357745537,57.5250980565,30.6297971253
5,Prevalence,144,Jordan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,43.1357745537,57.5250980565,30.6297971253
5,Prevalence,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.09299756164e-05,2.80137052674e-05,1.48711083906e-05
5,Prevalence,144,Jordan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.06956940609e-05,1.42993214002e-05,7.60031710553e-06
5,Prevalence,144,Jordan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.03688443929,2.71635268665,1.44634836834
5,Prevalence,144,Jordan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,144,Jordan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.05058101162,1.40103606194,0.745995257588
5,Prevalence,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,2.61209592168,3.32346224925,2.06451326191
5,Prevalence,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,2.61209592168,3.32346224925,2.06451326191
5,Prevalence,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.58225388116e-05,7.11163533036e-05,4.41169055181e-05
5,Prevalence,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.90775812458e-05,3.70197117755e-05,2.29806698807e-05
5,Prevalence,27,Samoa,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,5.43055398074,6.90948636216,4.29212825598
5,Prevalence,27,Samoa,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.8547811529700002,3.6322392730799997,2.25632355277
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,109.410450679,193.380966536,52.3395657521
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,109.410450679,193.380966536,52.3395657521
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.39409902401e-05,0.000148445057248,4.03334408447e-05
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.20776080396e-05,7.42436442598e-05,2.0212764622e-05
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.886498400520001,13.9392413962,3.7727282817
5,Prevalence,54,Slovakia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.02960012799,7.12224438044,1.92767253536
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,21495.7600294,24012.3408934,19118.9542478
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8320.431651,9477.41581441,7259.86235125
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,29816.1916804,33161.4129321,26806.9805601
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0251547466207,0.0281245265498,0.0224459802527
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00917216208295,0.0104309496394,0.0080120807559
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016924846575,0.0188373765015,0.0152006832388
5,Prevalence,385,Puerto Rico,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2395.8768912,2676.37025028,2130.9625993
5,Prevalence,385,Puerto Rico,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,903.7100762389999,1029.37401897,788.5180762399999
5,Prevalence,385,Puerto Rico,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1640.14924891,1824.16544327,1474.61652723
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1077447.53587,1231193.08301,939080.186757
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,596954.313988,675317.349562,525098.219355
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1674401.84985,1896689.23873,1465856.45772
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0155506319203,0.0177896125791,0.0135625880875
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00860413466456,0.00972954392278,0.00757329633151
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0120750372071,0.0136914113058,0.0105670060242
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1514.7986813500002,1730.9517137000003,1320.26607443
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,853.25835359,965.266782291,750.5506395069999
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1186.76294837,1344.31320253,1038.95258585
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,223.621231397,306.409673256,130.38300495
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,223.621231397,306.409673256,130.38300495
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.86186259678e-05,0.000121733483411,5.15811069061e-05
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.34564630663e-05,5.96431338747e-05,2.53122969348e-05
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.45289103164,11.5822972752,4.92848253424
5,Prevalence,34,Azerbaijan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.2134428439,5.77333215195,2.45666002169
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,684.174662936,924.239712438,471.675437162
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,684.174662936,924.239712438,471.675437162
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00027114397182,0.000367440222939,0.000186798218387
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000132960114011,0.000179797969383,9.16525029243e-05
5,Prevalence,34,Azerbaijan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,25.8618282186,34.9362961985,17.8293494215
5,Prevalence,34,Azerbaijan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,12.891132114400001,17.4144072908,8.88724868806
5,Prevalence,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,46.5968140598,61.7827971464,35.9023014891
5,Prevalence,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,46.5968140598,61.7827971464,35.9023014891
5,Prevalence,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.6885690068e-05,2.2328888404e-05,1.30091244574e-05
5,Prevalence,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.25946061482e-06,1.09359375221e-05,6.36220048669e-06
5,Prevalence,114,Haiti,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.6532650929,2.19206707421,1.2738214619300001
5,Prevalence,114,Haiti,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.8150550965650001,1.08068297608,0.627990440925
5,Prevalence,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,109.80930596,169.882272075,38.6632202608
5,Prevalence,191,Zambia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,109.80930596,169.882272075,38.6632202608
5,Prevalence,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.83380100157e-05,4.38093899996e-05,9.97393009723e-06
5,Prevalence,191,Zambia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.41921739316e-05,2.19489047112e-05,4.99439468037e-06
5,Prevalence,191,Zambia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.81507390777,4.35510585674,0.9911712089899999
5,Prevalence,191,Zambia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,191,Zambia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.41287441122,2.18581032852,0.49746489229199997
5,Prevalence,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,58.0053536072,78.2872834851,44.0797020206
5,Prevalence,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,58.0053536072,78.2872834851,44.0797020206
5,Prevalence,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.49693416086e-05,2.01831974086e-05,1.13838183578e-05
5,Prevalence,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.49686694848e-06,1.01112650871e-05,5.70096212503e-06
5,Prevalence,191,Zambia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.4870265868900001,2.00697461042,1.13002826068
5,Prevalence,191,Zambia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.746332736639,1.00729258411,0.567156694915
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,14787.3997564,16751.5398355,13077.33166
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,23257.2661254,26088.8083166,20553.8236877
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,38044.6658818,42635.229948,33902.2788729
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.032821030611,0.03710540803,0.0290037910972
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0507874605392,0.0569938284146,0.0449128889189
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0418772594254,0.0468890755902,0.0373590316702
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3239.7176757600005,3670.03398807,2865.06507085
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5060.7569209,5676.89755684,4472.49065808
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4153.33864458,4654.49082175,3701.11398585
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1440.82131653,1841.80832661,1100.61581581
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1440.82131653,1841.80832661,1100.61581581
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00110549821158,0.0014120900716,0.000843590856125
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000554147855701,0.000708267985644,0.000422953989195
5,Prevalence,54,Slovakia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,103.85694362599999,132.760795077,79.3343306524
5,Prevalence,54,Slovakia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,53.0656233065,67.8340233735,40.5358135786
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,4559.64304148,5286.22037889,3915.92377956
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2639.08128699,3162.29855055,2241.12447519
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7198.72432847,8242.2790228,6241.37514722
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0101201878753,0.0117363812756,0.00870106515195
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00576301825409,0.006902876576,0.00489348412612
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00792389515691,0.00907775779279,0.00687025992657
5,Prevalence,209,Guinea-Bissau,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,998.955624381,1158.13881288,857.92551054
5,Prevalence,209,Guinea-Bissau,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,574.261343356,688.11287575,487.66635499000006
5,Prevalence,209,Guinea-Bissau,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,785.8852023569999,899.810136096,681.371330079
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1701137.84744,1927325.00409,1488068.7414
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2361015.19283,2670071.1951,2084470.63839
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,4062153.04028,4575066.09539,3580381.94061
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0245523110207,0.0278326530173,0.0214528537978
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.034030267914,0.0385048723277,0.030059787156
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0292944729762,0.0329927631833,0.0258100979975
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2391.65368366,2709.65339614,2092.09682347
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3374.7238089,3816.47388839,2979.44406019
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2879.12529434,3242.6618071499997,2537.66121227
5,Prevalence,75,Austria,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,57032.2644507,63958.5232591,50443.834864
5,Prevalence,75,Austria,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,107669.894889,121488.716053,96068.0176794
5,Prevalence,75,Austria,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,164702.15934,185118.305569,148179.397125
5,Prevalence,75,Austria,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0298905192573,0.033419269696,0.0264590145066
5,Prevalence,75,Austria,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.055044482037,0.0620260039633,0.0491201448156
5,Prevalence,75,Austria,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0426237798053,0.0477783723569,0.038383970285
5,Prevalence,75,Austria,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2806.5590943800003,3147.40045559,2482.34231722
5,Prevalence,75,Austria,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5403.25425617,6096.7313357699995,4821.03122643
5,Prevalence,75,Austria,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4092.19019988,4599.44981235,3681.66561487
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,7281.29837631,7995.70309765,6616.79156065
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3837.42172532,4383.03794394,3414.77966333
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,11118.7201016,12241.7365641,10091.7000799
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0161095805179,0.0176914931542,0.0146444399089
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00881783205884,0.0100613982534,0.00785001958811
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0125327055872,0.013765918384,0.011374214548
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1519.39988737,1668.4758346899998,1380.73621385
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,862.154069281,984.737740512,767.1990188130001
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1202.90943522,1324.40607208,1091.7984383599999
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,13643.6810185,15249.0450393,12175.4613387
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,16185.6080528,18101.8536619,14532.2585943
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,29829.2890713,33201.2584977,26974.4713475
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0301862653908,0.0337834190623,0.0269609867513
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0371919046198,0.041601373594,0.0333757783033
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0336227607497,0.0374128017271,0.0304135526713
5,Prevalence,55,Slovenia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2847.04819545,3182.04200924,2540.67250519
5,Prevalence,55,Slovenia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3636.4227977499995,4066.94596353,3264.96454645
5,Prevalence,55,Slovenia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3227.1640028499996,3591.96982592,2918.30766467
5,Prevalence,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,44422.992116,49131.8981096,40239.8525051
5,Prevalence,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,25315.7347186,28516.6007329,22477.6505325
5,Prevalence,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,69738.7268346,76961.018332,63618.3203959
5,Prevalence,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0187708260665,0.0207387065948,0.0169917374514
5,Prevalence,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0103177332481,0.0116085100327,0.00916229213231
5,Prevalence,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144679293818,0.0159434965133,0.0131931064934
5,Prevalence,76,Belgium,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1726.0616509200001,1909.02686029,1563.52516883
5,Prevalence,76,Belgium,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1007.2926795999999,1134.65255837,894.3675973759999
5,Prevalence,76,Belgium,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1370.9455454,1512.92359412,1250.6286953000001
5,Prevalence,76,Belgium,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,101204.443593,112147.984044,91308.9696804
5,Prevalence,76,Belgium,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,167090.283589,187045.730393,150172.457191
5,Prevalence,76,Belgium,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,268294.727182,297628.510501,243409.296734
5,Prevalence,76,Belgium,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0427642477881,0.0474852424721,0.0385600074715
5,Prevalence,76,Belgium,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0681001004298,0.0761155221688,0.0612669568914
5,Prevalence,76,Belgium,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0556609308306,0.06163050054,0.050445153992
5,Prevalence,76,Belgium,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3932.3129908100004,4357.52580514,3547.82295031
5,Prevalence,76,Belgium,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6648.38770682,7442.39885075,5975.24103045
5,Prevalence,76,Belgium,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5274.2210502,5850.87367058,4785.01553173
5,Prevalence,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1161673.25648,1273841.3784,1060170.12222
5,Prevalence,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,660224.411726,721542.808591,603735.658297
5,Prevalence,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1821897.6682,1988871.90697,1667848.68181
5,Prevalence,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0210064162529,0.0230113470244,0.0191827925102
5,Prevalence,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0116563574733,0.0127403357528,0.0106579060089
5,Prevalence,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016275426687,0.0177692817795,0.014899238945
5,Prevalence,135,Brazil,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2047.22510282,2244.89978772,1868.3454021
5,Prevalence,135,Brazil,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1157.54866628,1265.0560944400002,1058.50888522
5,Prevalence,135,Brazil,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1601.24280651,1747.9943520900001,1465.85110168
5,Prevalence,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,478.41716485,818.603022681,331.877202418
5,Prevalence,76,Belgium,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,478.41716485,818.603022681,331.877202418
5,Prevalence,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000202160307062,0.000347638636461,0.00014016567123
5,Prevalence,76,Belgium,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.9255147751e-05,0.000170228877732,6.88418553288e-05
5,Prevalence,76,Belgium,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,18.588966705199997,31.8069363966,12.895135708399998
5,Prevalence,76,Belgium,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,76,Belgium,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.40487317113,16.092352389200002,6.524145090209999
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,325.800181681,577.882186344,223.076601837
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,325.800181681,577.882186344,223.076601837
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00017514344016,0.000309588378636,0.000120313231078
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.64305417827e-05,0.000152840068768,5.93596130882e-05
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,16.350854455900002,29.002032696399997,11.1954911453
5,Prevalence,94,Switzerland,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.2817699603,14.6896398485,5.67055883887
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1026.11250419,1299.86596926,801.749811013
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1026.11250419,1299.86596926,801.749811013
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000551647279015,0.000696561605964,0.000429228993622
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000272223747232,0.000344111239686,0.000212453628408
5,Prevalence,94,Switzerland,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,51.4972586107,65.2360571623,40.2372227121
5,Prevalence,94,Switzerland,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,26.083557318100002,33.0423110298,20.3803063162
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9728.89552547,11338.9638457,8202.46304924
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,5744.40925598,6901.0733658,4855.52006361
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,15473.3047814,18009.8177823,13276.6365538
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00955018107695,0.011155409614,0.00808176892814
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00571362615645,0.00686518190356,0.00482470408701
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00764451699048,0.00889724820758,0.00656910986384
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,937.926476656,1093.1471492199998,790.7688234020001
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,568.614357026,683.10756073,480.62704030400005
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,755.70812158,879.590091355,648.423992981
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,31069.7121519,35053.6981132,27500.1937723
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,40506.0007912,45967.1963728,35765.7546227
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,71575.712943,80557.8424488,63490.6505587
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0304990579483,0.0344873715002,0.0269967109023
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0402889926277,0.0457227065549,0.0355746071614
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0353617572376,0.0398044902586,0.0314177092274
5,Prevalence,212,Mauritania,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2995.31489191,3379.39609681,2651.19095839
5,Prevalence,212,Mauritania,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4009.51474194,4550.0949958599995,3540.29816855
5,Prevalence,212,Mauritania,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3495.72042579,3934.4029381799996,3100.85020294
5,Prevalence,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,24742.3225817,29305.6379647,20786.4029227
5,Prevalence,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19031.568444,22903.5672497,15933.3146374
5,Prevalence,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,43773.8910257,51574.2718507,37318.8750559
5,Prevalence,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00970818481428,0.011495126505,0.00815731192645
5,Prevalence,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00709044435411,0.0085337602533,0.00593622524129
5,Prevalence,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00836541468751,0.00985392473937,0.00712811145729
5,Prevalence,175,Burundi,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,955.793592245,1132.07403593,802.9767882020001
5,Prevalence,175,Burundi,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,705.0047595,848.4389485879999,590.233153251
5,Prevalence,175,Burundi,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,827.7712132869999,975.2776503059999,705.705838794
5,Prevalence,175,Burundi,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,92999.8920636,105069.664939,82843.7486361
5,Prevalence,175,Burundi,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,126340.99323,143595.204644,111845.763431
5,Prevalence,175,Burundi,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,219340.885294,246850.987941,195181.715291
5,Prevalence,175,Burundi,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0364905296268,0.0411951079418,0.0324499123057
5,Prevalence,175,Burundi,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0470698104655,0.0534992069465,0.0416576688266
5,Prevalence,175,Burundi,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0419171735847,0.0472075399476,0.0373993569238
5,Prevalence,175,Burundi,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3592.5770759800002,4058.831266,3200.24621142
5,Prevalence,175,Burundi,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4680.171358940001,5319.33576644,4143.210570429999
5,Prevalence,175,Burundi,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4147.770885540001,4667.99128432,3690.91715385
5,Prevalence,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,829900.57931,940038.548086,739203.523512
5,Prevalence,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,213274.943587,255194.826025,179817.367401
5,Prevalence,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,1043175.5229,1173409.20337,929655.075357
5,Prevalence,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0365127862398,0.0412802224616,0.0324742302052
5,Prevalence,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00916959379325,0.010951636885,0.00772890916106
5,Prevalence,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0226836415215,0.0255150279332,0.0202053984249
5,Prevalence,142,Iran,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3520.3077372700004,3987.49567919,3135.58509068
5,Prevalence,142,Iran,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,905.2639437839999,1083.19651036,763.250367984
5,Prevalence,142,Iran,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2213.20857738,2489.51327623,1972.3627919000003
5,Prevalence,142,Iran,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1344981.23671,1477810.72624,1210461.23573
5,Prevalence,142,Iran,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1938377.60611,2166700.20527,1728001.76319
5,Prevalence,142,Iran,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3283358.84282,3618282.88695,2963171.19263
5,Prevalence,142,Iran,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0591747240422,0.0650786159144,0.0533920927167
5,Prevalence,142,Iran,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0833389712115,0.093263162588,0.0743626391193
5,Prevalence,142,Iran,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0713960476045,0.0786710301231,0.0645538398389
5,Prevalence,142,Iran,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,5705.19887817,6268.64068237,5134.58619024
5,Prevalence,142,Iran,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,8227.61139561,9196.746414879999,7334.65293534
5,Prevalence,142,Iran,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6965.997374410001,7676.57459844,6286.68498811
5,Prevalence,29,Tonga,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,688.065909748,764.543226325,611.426866663
5,Prevalence,29,Tonga,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,916.718959353,1028.9952725,810.6424547
5,Prevalence,29,Tonga,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1604.7848691,1780.00925169,1431.77529205
5,Prevalence,29,Tonga,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0271411842022,0.0301895815728,0.0240881957372
5,Prevalence,29,Tonga,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0363840367254,0.0408381907935,0.0321777149675
5,Prevalence,29,Tonga,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0317483092436,0.0352087403873,0.0283658961481
5,Prevalence,29,Tonga,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2639.1031197800003,2932.4347932600003,2345.15113809
5,Prevalence,29,Tonga,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3607.84996878,4049.72595351,3190.3740236199997
5,Prevalence,29,Tonga,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3117.23898967,3457.60627993,2781.17388241
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,28168.4537131,32981.9738652,24151.3241084
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,19336.1817748,23362.1962434,16148.0674938
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,47504.635488,55400.4673678,40559.1567307
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.018169511289,0.0212613877593,0.0156206103035
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117115994726,0.0141114168357,0.00977826672471
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148389724184,0.0172398990282,0.0126908269084
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1737.8751865999998,2034.8491461100002,1490.0351761900001
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1155.02366595,1395.51281965,964.5854767000001
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1441.7407264,1681.3750751999999,1230.94909553
5,Prevalence,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,40.7440639842,52.0400899335,32.0722953941
5,Prevalence,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,40.7440639842,52.0400899335,32.0722953941
5,Prevalence,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.00695389956e-05,1.2886715632e-05,7.9229492898e-06
5,Prevalence,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,5.09351288071e-06,6.51171458728e-06,4.01051250017e-06
5,Prevalence,211,Mali,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.992474703048,1.26763184015,0.7812412099989999
5,Prevalence,211,Mali,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.504618507122,0.644520696387,0.39721795616600003
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,842.842604009,1139.17872821,651.792768583
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,842.842604009,1139.17872821,651.792768583
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.96003427082e-05,0.000134185664478,7.696224718e-05
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.92485627257e-05,6.64494528454e-05,3.80802718094e-05
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.708259043750001,13.121598431299999,7.50765683907
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.84082905686,6.54282242289,3.74354281357
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,77489.3778856,86723.6116356,69343.7289006
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,44128.6226184,49832.3459985,38976.5337484
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,121618.000504,134978.657333,109947.619412
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0179961898894,0.0201136361017,0.0161122914784
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00977804505361,0.0110645619992,0.00864101031134
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0137905305002,0.0153177167664,0.0124629582211
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1736.7084495899999,1943.66806414,1554.1464287600002
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,966.2545445620001,1091.14511014,853.4427460239999
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1346.99624323,1494.97396431,1217.73939456
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,167523.470756,187529.523387,150066.61947
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,198013.757776,220883.36685,177872.855648
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,365537.228531,406430.336275,330728.312719
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0389057004325,0.0434742258383,0.0347944309477
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0438762141934,0.0488901751713,0.0394060782786
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0414492070821,0.0460828291276,0.0375408254927
5,Prevalence,36,Kazakhstan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3754.5717246,4202.95163932,3363.32505367
5,Prevalence,36,Kazakhstan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4335.7730648199995,4836.53339654,3894.7613799600003
5,Prevalence,36,Kazakhstan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4048.5559008900004,4501.47292202,3663.0251518500004
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,36.8386143359,51.0403324177,25.3434558673
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,36.8386143359,51.0403324177,25.3434558673
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00017002474181,0.000236321574943,0.000117860726291
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.9616530908e-05,0.000110412718262,5.51332542901e-05
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,15.9341798184,22.0769931062,10.9620622352
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.65129564548,10.600959895199999,5.2637776152699995
5,Prevalence,193,Botswana,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,27301.7805356,30819.5799278,24446.4469134
5,Prevalence,193,Botswana,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,32772.6100738,37209.6670726,29147.3725103
5,Prevalence,193,Botswana,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,60074.3906094,67432.4922969,54072.5924501
5,Prevalence,193,Botswana,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0427310883377,0.0482510916514,0.0382759747218
5,Prevalence,193,Botswana,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0515115854597,0.0584789726971,0.0458205042593
5,Prevalence,193,Botswana,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0471119790071,0.0528816106236,0.0423990111248
5,Prevalence,193,Botswana,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4208.6458316,4750.92444705,3768.4881674599997
5,Prevalence,193,Botswana,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5131.95449316,5826.76563424,4564.26842357
5,Prevalence,193,Botswana,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4666.675222729999,5238.26438881,4200.44589476
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,57920.0381598,64790.440355,52294.3725555
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,94801.3455971,106972.385968,84120.3233167
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,152721.383757,170401.736965,137311.953651
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0373605390891,0.0418503853955,0.0337490871656
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0574195363407,0.0648369528627,0.0508995719433
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0477055017791,0.0532022813298,0.0429402082833
5,Prevalence,146,Lebanon,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3573.42288469,3997.2978200499997,3226.34296467
5,Prevalence,146,Lebanon,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5662.84486794,6389.8673913600005,5024.82679104
5,Prevalence,146,Lebanon,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4635.01375168,5171.60318166,4167.34564463
5,Prevalence,135,Brazil,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1557408.60772,1724085.71112,1407271.2345
5,Prevalence,135,Brazil,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2984602.73177,3253076.31867,2744647.2702
5,Prevalence,135,Brazil,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,4542011.33949,4981759.12409,4149432.4939
5,Prevalence,135,Brazil,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0281626331597,0.0311598232125,0.025461620705
5,Prevalence,135,Brazil,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0526936176845,0.0573464935146,0.048458187732
5,Prevalence,135,Brazil,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0405749170994,0.0445430755287,0.0371222483054
5,Prevalence,135,Brazil,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2744.6323476000002,3038.3686011,2480.0441791000003
5,Prevalence,135,Brazil,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5232.80092373,5703.50639437,4812.09529762
5,Prevalence,135,Brazil,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3991.91629221,4378.40505558,3646.88371247
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,167.742024962,218.681812172,125.408170909
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,167.742024962,218.681812172,125.408170909
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000774237342257,0.00101256194114,0.000575873389528
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.00036254017309,0.000474333156355,0.000270148104815
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,72.5551608559,94.5886641228,54.2440692188
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,34.8396335826,45.419710469099996,26.0469892606
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1548.78214968,1730.66797031,1390.29240999
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2205.65516374,2484.67047044,1943.80306554
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3754.43731342,4164.48638209,3360.78321307
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0324716652046,0.0362723741427,0.0291480868106
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0441353016485,0.0497468650723,0.0389148946394
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0384394664506,0.0426121936763,0.0344115007026
5,Prevalence,116,Saint Lucia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3177.96686094,3551.18081525,2852.7596388399998
5,Prevalence,116,Saint Lucia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4384.82597856,4939.50632269,3864.26596466
5,Prevalence,116,Saint Lucia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3790.9441051500003,4204.98034279,3393.46225458
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,467374.644926,506441.673523,430439.195264
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,233498.51967,254638.676288,214991.03928
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,700873.164596,759844.438063,647384.604947
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0326750040998,0.0354430294459,0.0301254121263
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0156268821998,0.017057381427,0.0143940467606
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0239648509955,0.0259876966287,0.0221320365449
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3069.51130795,3326.08638609,2826.93550365
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1535.4218279400002,1674.4336639100002,1413.72174431
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2302.94298709,2496.7119706000003,2127.1892137199998
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,630218.672347,706909.833467,557171.06343
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,940693.118225,1054941.47821,834505.468318
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1570911.79057,1761981.70586,1397930.19513
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0440597127764,0.0492965588012,0.0389663733107
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0629558022504,0.0706095340358,0.0557959618128
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0537139342585,0.0602452482002,0.047754837818
5,Prevalence,95,United Kingdom,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4138.9993279499995,4642.67317683,3659.2547289999998
5,Prevalence,95,United Kingdom,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6185.73834709,6937.00403381,5487.47766538
5,Prevalence,95,United Kingdom,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5161.73321249,5789.55454119,4593.34684496
5,Prevalence,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,247.868102691,359.673071945,140.44683959
5,Prevalence,57,Belarus,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,247.868102691,359.673071945,140.44683959
5,Prevalence,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00011506186149,0.000166730009833,6.4944907977e-05
5,Prevalence,57,Belarus,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.65386547208e-05,8.20369627437e-05,3.19341785891e-05
5,Prevalence,57,Belarus,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.955008469200001,15.8964445466,6.207318733129999
5,Prevalence,57,Belarus,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,57,Belarus,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.4759411377900005,7.945954116079999,3.1027736858300003
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.55881850533,2.51632138652,1.16691375503
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.55881850533,2.51632138652,1.16691375503
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.30913013035e-05,3.73269177408e-05,1.72695926029e-05
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.15173903378e-05,1.860092907e-05,8.61207783613e-06
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.28619431825,3.69048714592,1.7114189929799999
5,Prevalence,30,Vanuatu,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.14459093243,1.84765489519,0.856827718148
5,Prevalence,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,62.5184350444,80.602183618,41.5059035152
5,Prevalence,143,Iraq,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,62.5184350444,80.602183618,41.5059035152
5,Prevalence,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.78785246624e-06,8.7395549382e-06,4.47258387718e-06
5,Prevalence,143,Iraq,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.42535559447e-06,4.41318710025e-06,2.26197476745e-06
5,Prevalence,143,Iraq,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.66360396618,0.855554504742,0.44056576549000004
5,Prevalence,143,Iraq,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,143,Iraq,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.337487751461,0.43510765573,0.224057656589
5,Prevalence,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,35.6107936492,47.1370244478,23.0729496404
5,Prevalence,213,Niger,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,35.6107936492,47.1370244478,23.0729496404
5,Prevalence,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.86611153862e-06,1.17037201398e-05,5.74696772542e-06
5,Prevalence,213,Niger,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.31787925566e-06,5.70642755539e-06,2.7982650176e-06
5,Prevalence,213,Niger,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.8739928174960001,1.15688016424,0.566277529863
5,Prevalence,213,Niger,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,213,Niger,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.42787929888500004,0.566372015488,0.277231606029
5,Prevalence,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,33.804689985,42.8244757213,25.1946474252
5,Prevalence,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,33.804689985,42.8244757213,25.1946474252
5,Prevalence,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.41626458915e-06,1.06239515226e-05,6.27454877584e-06
5,Prevalence,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.0988405445e-06,5.18182770613e-06,3.05461271822e-06
5,Prevalence,213,Niger,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.829665761892,1.05103763095,0.618350186347
5,Prevalence,213,Niger,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.406178171491,0.514554851746,0.30272473515000003
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,22.357974684,30.7836639342,16.7201828119
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,22.357974684,30.7836639342,16.7201828119
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.47056172368e-05,2.02421941142e-05,1.09920808405e-05
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.30052689211e-06,1.00500240882e-05,5.45826420024e-06
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.43081788255,1.97002713663,1.07002252686
5,Prevalence,37,Kyrgyzstan,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.716752224713,0.9868630733120001,0.536015824217
5,Prevalence,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,575.838077949,701.141323966,468.686584477
5,Prevalence,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,575.838077949,701.141323966,468.686584477
5,Prevalence,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000267299715781,0.00032639437163,0.000216838540308
5,Prevalence,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000131346603391,0.000160373351216,0.000106705918437
5,Prevalence,57,Belarus,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,25.4502735621,30.988291993900003,20.7145068147
5,Prevalence,57,Belarus,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,12.721505452,15.4897244851,10.3542977931
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.72976031087,2.30502196109,1.07812143747
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.72976031087,2.30502196109,1.07812143747
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.56234425699e-05,3.41474678429e-05,1.59644280621e-05
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.27803990064e-05,1.70365852428e-05,7.96299671205e-06
5,Prevalence,30,Vanuatu,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.53690098052,3.38059119317,1.58119440865
5,Prevalence,30,Vanuatu,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.27010807244,1.69250443633,0.791630338726
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,16.0961997291,30.3174905153,8.89273455634
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,16.0961997291,30.3174905153,8.89273455634
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.74407170088e-05,5.15982318179e-05,1.52038315729e-05
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.40155932533e-05,2.63738283618e-05,7.7528633833e-06
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.72241536695,5.1277198006599995,1.50406416532
5,Prevalence,194,Lesotho,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.394593174,2.6267420905,0.7704767037670001
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,16.7225943913,21.1157490372,12.6509867423
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,16.7225943913,21.1157490372,12.6509867423
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.8509180787e-05,3.60944539565e-05,2.15794041144e-05
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.45611830904e-05,1.84249968351e-05,1.10188939221e-05
5,Prevalence,194,Lesotho,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.82836002984,3.57139204477,2.1397125591
5,Prevalence,194,Lesotho,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.44886472473,1.82949267323,1.0960959762
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,6.2913838208,7.65246954034,4.8437865329
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,6.2913838208,7.65246954034,4.8437865329
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00021945509941,0.000266578820571,0.000168576935239
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000110497405525,0.000134363579938,8.48857435742e-05
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,21.383270882799998,26.0093540251,16.4631506329
5,Prevalence,117,Saint Vincent and the Grenadines,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.861822635600001,13.211682713800002,8.362603793309999
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,0.584164347728,0.7107917232,0.484628766145
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,0.584164347728,0.7107917232,0.484628766145
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.03764730686e-05,2.48104385814e-05,1.6886378773e-05
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.02597810252e-05,1.2485011551e-05,8.50616916305e-06
5,Prevalence,117,Saint Vincent and the Grenadines,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.9854685142900002,2.41585196379,1.6471651514599999
5,Prevalence,117,Saint Vincent and the Grenadines,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.00853639132,1.22715349248,0.8366921891760001
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,149.301638223,198.99900246,84.5467161386
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,149.301638223,198.99900246,84.5467161386
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,8.38659194573e-05,0.000111585210179,4.74938669639e-05
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.22875374969e-05,5.63280085624e-05,2.39536979794e-05
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,8.1616145409,10.8783344338,4.621769165
5,Prevalence,136,Paraguay,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.157132847160001,5.540898944739999,2.35410632437
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,10.7378693293,13.6246623444,8.16071242024
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,10.7378693293,13.6246623444,8.16071242024
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.33435319291e-05,1.69120556263e-05,1.01666933348e-05
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.60293635652e-06,8.37368281569e-06,5.03315910184e-06
5,Prevalence,38,Mongolia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.2791294305999998,1.62301347244,0.972130234715
5,Prevalence,38,Mongolia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.641720813844,0.8142424851600001,0.48770373854300003
5,Prevalence,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,165.586794932,204.981756856,129.12281679
5,Prevalence,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,165.586794932,204.981756856,129.12281679
5,Prevalence,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.03468328098e-05,9.93324499888e-05,6.27545956953e-05
5,Prevalence,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.10587258804e-05,5.0827998447e-05,3.20656374202e-05
5,Prevalence,144,Jordan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.8190589931100005,9.67930111834,6.0972188166
5,Prevalence,144,Jordan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.03290179277,4.99237451301,3.1448138091899995
5,Prevalence,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,998.530575664,1277.83041195,745.34923972
5,Prevalence,97,Argentina,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,998.530575664,1277.83041195,745.34923972
5,Prevalence,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.65827510449e-05,0.00012370873525,7.22063943205e-05
5,Prevalence,97,Argentina,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.73842344585e-05,6.06483286988e-05,3.54142865411e-05
5,Prevalence,97,Argentina,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.0745429141,11.6127910279,6.7736570383300005
5,Prevalence,97,Argentina,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,97,Argentina,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.55664215321,5.83118440402,3.4012876995
5,Prevalence,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,8331.6108609,10109.5595413,6796.45025921
5,Prevalence,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,8331.6108609,10109.5595413,6796.45025921
5,Prevalence,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000805889574716,0.000981035172434,0.000658072081296
5,Prevalence,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000395375195035,0.000480848625265,0.000323213961007
5,Prevalence,97,Argentina,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,75.7168204395,91.8746347243,61.7654391803
5,Prevalence,97,Argentina,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,38.0200368203,46.133434748,31.0145653004
5,Prevalence,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,329.516534206,420.672566367,249.64568347
5,Prevalence,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,329.516534206,420.672566367,249.64568347
5,Prevalence,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.75346573743e-05,4.80112478447e-05,2.84346117124e-05
5,Prevalence,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.8185055164e-05,2.32551790353e-05,1.37801438143e-05
5,Prevalence,148,Morocco,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.67336386148,4.68954738957,2.78298457478
5,Prevalence,148,Morocco,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.7929506253599998,2.2889447497799997,1.35836092527
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,312846.288418,354614.697562,274710.35882
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,404651.735731,463924.482242,353262.957999
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,717498.02415,812407.287558,631163.50626
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.022065513157,0.0250583091264,0.019352445147
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0273344634349,0.0313540036292,0.0238653051504
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0247567896447,0.0279950365251,0.021808608324
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2153.75885555,2441.30927378,1891.21587797
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,2710.8097603200004,3107.88488832,2366.5502701299997
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2436.08344252,2758.3238910600003,2142.9563781
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,286.118023537,351.689237922,222.871762489
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,286.118023537,351.689237922,222.871762489
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000160719651841,0.000197836201149,0.000124809272562
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,8.10392463438e-05,9.97561052791e-05,6.30280462969e-05
5,Prevalence,136,Paraguay,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,15.640719345800001,19.2251875617,12.1833453346
5,Prevalence,136,Paraguay,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,7.96662814935,9.79238339486,6.20560856248
5,Prevalence,213,Niger,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,124748.304512,140571.99174,109974.257407
5,Prevalence,213,Niger,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,201483.418291,227540.946861,177912.632889
5,Prevalence,213,Niger,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,326231.722803,365223.089912,290738.315965
5,Prevalence,213,Niger,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0310585656964,0.0350471088146,0.0273741442512
5,Prevalence,213,Niger,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0476231878123,0.0537869605159,0.0420423246695
5,Prevalence,213,Niger,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.039556007193,0.0443102842427,0.0352413727206
5,Prevalence,213,Niger,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3061.68751004,3450.0469810400004,2699.08927137
5,Prevalence,213,Niger,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4742.87209395,5356.260164,4188.02137093
5,Prevalence,213,Niger,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3919.8171824399997,4388.31555363,3493.34833756
5,Prevalence,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,30586.2703908,33270.1546309,28103.8759001
5,Prevalence,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13541.1376001,15063.3416272,12090.1271408
5,Prevalence,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,44127.4079909,47812.7574205,40445.8185237
5,Prevalence,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0247693333352,0.0269439025888,0.0228471215218
5,Prevalence,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0108164605793,0.0120274220523,0.00967092673759
5,Prevalence,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0177449840042,0.019230067995,0.0162764604118
5,Prevalence,78,Denmark,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2340.39372065,2545.75860307,2150.44638794
5,Prevalence,78,Denmark,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1063.7572339199999,1183.33769999,949.7695529590001
5,Prevalence,78,Denmark,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1710.47110443,1853.32299617,1567.7649567400001
5,Prevalence,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1053.34175583,1340.44719519,712.460527351
5,Prevalence,16,Philippines,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1053.34175583,1340.44719519,712.460527351
5,Prevalence,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.91512750221e-05,4.98541730183e-05,2.65334898914e-05
5,Prevalence,16,Philippines,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.97791035763e-05,2.51666497846e-05,1.33897553334e-05
5,Prevalence,16,Philippines,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.85414583045,4.90465600523,2.60687165932
5,Prevalence,16,Philippines,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,16,Philippines,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.9570322315900002,2.49045321827,1.32369974707
5,Prevalence,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,683.615246718,845.45458492,559.264752167
5,Prevalence,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,683.615246718,845.45458492,559.264752167
5,Prevalence,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.54091030602e-05,3.14406362955e-05,2.07673121456e-05
5,Prevalence,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.28365902631e-05,1.58861206949e-05,1.05030679408e-05
5,Prevalence,16,Philippines,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.50132764432,3.09349291935,2.0463329216400004
5,Prevalence,16,Philippines,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.27010731743,1.57079301555,1.03907315924
5,Prevalence,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,66.0519719229,89.0040367992,29.0218317862
5,Prevalence,33,Armenia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,66.0519719229,89.0040367992,29.0218317862
5,Prevalence,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,9.91470426414e-05,0.000133471186573,4.35570686238e-05
5,Prevalence,33,Armenia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,4.53814737784e-05,6.11233214526e-05,1.99437432183e-05
5,Prevalence,33,Armenia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,9.437465537189999,12.716842593900001,4.14662165769
5,Prevalence,33,Armenia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,33,Armenia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,4.39422526246,5.92115232261,1.9307291317
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1220.23823251,1662.37706565,880.157098683
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1220.23823251,1662.37706565,880.157098683
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000208357537875,0.000283958299345,0.000149901374591
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000103266494905,0.000140745046076,7.44124485911e-05
5,Prevalence,8,Taiwan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,19.687853085500002,26.821512856600002,14.2008365166
5,Prevalence,8,Taiwan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,9.93823213718,13.539232535,7.1684408264599995
5,Prevalence,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,9182.9038601,10123.7266723,8358.90645914
5,Prevalence,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,3099.16588456,3485.44546201,2727.55910144
5,Prevalence,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,12282.0697447,13546.0084349,11207.4123549
5,Prevalence,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0326087339238,0.0360037539442,0.0297011716198
5,Prevalence,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110277341183,0.0124056764421,0.00970982822376
5,Prevalence,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0218292261151,0.0240987285061,0.0199191190201
5,Prevalence,58,Estonia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,3054.02147971,3366.9173916,2779.9789981500003
5,Prevalence,58,Estonia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1079.47724212,1214.0231259099999,950.042071388
5,Prevalence,58,Estonia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,2089.56516598,2304.6007678,1906.73224826
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,34172.8693592,38470.54358,30199.7058114
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,20291.1051455,23410.1051045,17536.3798412
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,54463.9745047,61123.257666,48350.8864794
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0155723301147,0.017537154335,0.0137831142657
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00914552705446,0.0105643033822,0.00791262329957
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0123412596209,0.0138577413958,0.0109588311023
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1497.69402795,1686.0481561,1323.5622260500002
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,902.5657918740001,1041.3015900300002,780.033243356
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1202.3332000300002,1349.34188432,1067.38218416
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,389.688876425,454.611444425,332.136994915
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,266.987930936,317.7128803,223.003134829
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,656.676807361,761.385336237,564.655965896
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00835484985589,0.00975125521369,0.00712610410355
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00574511255141,0.00683657747107,0.00479633686741
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00705234796284,0.00817203049361,0.00605763165904
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,827.013920048,964.7952905440001,704.874926576
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,572.911131535,681.758329367,478.52716736400004
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,700.664750604,812.38725161,602.4798303919999
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,1363.62619098,1543.40420973,1208.4245519
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,2122.1070202,2400.08605475,1860.45225744
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,3485.73321118,3926.95156438,3087.47118611
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0292358754516,0.0331098438395,0.025918614103
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0456639539783,0.0516733397002,0.0400496589625
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0374348716072,0.0421441498702,0.0331498793084
5,Prevalence,215,Sao Tome and Principe,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2893.94414341,3275.4765222300002,2564.5687783500002
5,Prevalence,215,Sao Tome and Principe,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4553.684243029999,5150.1804317099995,3992.21719214
5,Prevalence,215,Sao Tome and Principe,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3719.22742467,4190.00108979,3294.2875465700004
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1063.09720106,1482.38052508,701.885377447
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1063.09720106,1482.38052508,701.885377447
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.41806130737e-05,3.3730592732e-05,1.59516387611e-05
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.23119819825e-05,1.71794647004e-05,8.12414275811e-06
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.3969131310700003,3.34225068251,1.5825065441200001
5,Prevalence,214,Nigeria,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.22441837448,1.70732643362,0.8083939568899999
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,277.675591548,392.229214562,214.507619808
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,277.675591548,392.229214562,214.507619808
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.31584534019e-06,8.9155860191e-06,4.87958632626e-06
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.21582863178e-06,4.54126089102e-06,2.4848181319e-06
5,Prevalence,214,Nigeria,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.626061540654,0.884339977413,0.48363981216499996
5,Prevalence,214,Nigeria,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.319811863014,0.45174858595899997,0.247058378949
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26193.9576701,31596.0665099,22016.2226714
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,13384.4740136,16197.0967537,10892.9755263
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,39578.4316837,47217.3154388,33521.6221418
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0177571172633,0.0214822209402,0.0149720978458
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.012059262664,0.0146119576559,0.00979548205066
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0153106748857,0.01828655301,0.012999839703
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1717.06462275,2071.18331279,1443.20600773
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1191.91567242,1442.38566633,970.042471292
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1494.4020807699999,1782.8309874400002,1265.70911854
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,59750.6604733,67703.72527,53205.6997965
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,62797.2372569,71474.3162837,54897.4127529
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,122547.89773,137632.632968,109836.243734
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0405054365791,0.0458735376008,0.0361335303882
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0565792942542,0.0642577787481,0.0494767900916
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0474066438376,0.0533206340171,0.0425514979907
5,Prevalence,145,Kuwait,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3916.7714393100005,4438.11022961,3487.7365994
5,Prevalence,145,Kuwait,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5592.2265750100005,6364.93878413,4888.73052234
5,Prevalence,145,Kuwait,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4627.16246125,5196.73176372,4147.19593974
5,Prevalence,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,290466.756845,314843.92497,266623.788571
5,Prevalence,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,159197.867081,175296.827625,144678.104298
5,Prevalence,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,449664.623926,486918.878673,414737.673771
5,Prevalence,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0544431076573,0.0589970200376,0.0500028029695
5,Prevalence,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0280648564321,0.030905354703,0.0254850920323
5,Prevalence,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0408497746164,0.0442047031948,0.0376963335369
5,Prevalence,71,Australia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,4949.693192199999,5365.09185751,4543.39754918
5,Prevalence,71,Australia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,2747.43354438,3025.26907724,2496.8517742900003
5,Prevalence,71,Australia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,3855.54602667,4174.9740764200005,3556.07291553
5,Prevalence,71,Australia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,281823.154187,312012.133822,254649.92631
5,Prevalence,71,Australia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,423710.038042,472352.092342,381389.938781
5,Prevalence,71,Australia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,705533.192228,781594.79132,640841.094067
5,Prevalence,71,Australia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0528224910322,0.058357825814,0.0477737773844
5,Prevalence,71,Australia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0746952385922,0.0832297556406,0.0671939137591
5,Prevalence,71,Australia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0640938212611,0.0710006118375,0.0584064299243
5,Prevalence,71,Australia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,4802.40204708,5316.8367748400005,4339.35717926
5,Prevalence,71,Australia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,7312.37919799,8151.8427794,6582.019787770001
5,Prevalence,71,Australia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,6049.43229073,6701.60500025,5494.7447552799995
5,Prevalence,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,26622.2443239,31168.1290316,23113.5008312
5,Prevalence,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,12897.0646701,15714.4635072,10702.1053295
5,Prevalence,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,39519.3089939,45978.4535067,34396.6414847
5,Prevalence,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0221890602493,0.0260454564682,0.0192115794028
5,Prevalence,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0109260066769,0.0133124317621,0.00905557267026
5,Prevalence,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0166033993972,0.0193212149378,0.0144507226361
5,Prevalence,149,Palestine,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2169.00559566,2539.37442138,1883.13622354
5,Prevalence,149,Palestine,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1084.75409194,1321.72157217,900.139128205
5,Prevalence,149,Palestine,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1635.5075575399999,1902.81940926,1423.5058389
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,227.216208961,382.189338238,128.196912435
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,227.216208961,382.189338238,128.196912435
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.00024651539351,0.000413697128707,0.000138769457793
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.000115639438953,0.000194249827956,6.51645978378e-05
5,Prevalence,72,New Zealand,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,22.1580711278,37.271014157399996,12.501732676100001
5,Prevalence,72,New Zealand,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,72,New Zealand,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,10.8497209954,18.249788191900002,6.12148551704
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,120288.235176,135372.249342,107067.044391
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,159201.345308,177342.0709,141956.562388
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,279489.580485,311279.504391,250362.641334
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0292808552034,0.0329777049534,0.0261173012885
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0371078748031,0.0413403857125,0.0330729198283
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0332792048637,0.0370873215071,0.0297806810729
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2854.34635545,3212.27829114,2540.61777112
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3680.24120273,4099.59849926,3281.5953212400004
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3272.69141233,3644.9364555499997,2931.62866694
5,Prevalence,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,21.1629293664,28.2128465092,12.2368658323
5,Prevalence,12,Laos,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,21.1629293664,28.2128465092,12.2368658323
5,Prevalence,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.18035792203e-05,1.57336140939e-05,6.88002270573e-06
5,Prevalence,12,Laos,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.84028938663e-06,7.78099979842e-06,3.39073093279e-06
5,Prevalence,12,Laos,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.15441548439,1.53898103165,0.667508129553
5,Prevalence,12,Laos,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,12,Laos,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.575152748335,0.7667509505510001,0.332565822652
5,Prevalence,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,35.7463325183,46.670596689,27.8680186324
5,Prevalence,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,35.7463325183,46.670596689,27.8680186324
5,Prevalence,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.99375403835e-05,2.60117280774e-05,1.55685051315e-05
5,Prevalence,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.86493449419e-06,1.28740470056e-05,7.70331252544e-06
5,Prevalence,12,Laos,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.94992475073,2.54583184355,1.5201710345300001
5,Prevalence,12,Laos,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.9714912824640001,1.26838404492,0.757379435977
5,Prevalence,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,353105.220003,418330.634603,301199.225155
5,Prevalence,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,143679.390773,165096.423299,124492.176142
5,Prevalence,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,496784.610776,573326.624132,429748.698173
5,Prevalence,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0208224193415,0.0246456229584,0.0177858794611
5,Prevalence,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00826204464432,0.00950548843178,0.00716035489672
5,Prevalence,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144631505927,0.016670095637,0.0125305962491
5,Prevalence,18,Thailand,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2013.5625765200002,2385.50681986,1717.57157213
5,Prevalence,18,Thailand,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,816.069636435,937.714013217,707.090170529
5,Prevalence,18,Thailand,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1413.62476831,1631.4287895100001,1222.87081908
5,Prevalence,18,Thailand,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,509143.347751,576592.659574,449484.890762
5,Prevalence,18,Thailand,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,690837.358181,780318.724939,611104.084972
5,Prevalence,18,Thailand,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1199980.70593,1348434.51972,1069100.80041
5,Prevalence,18,Thailand,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0300238654629,0.0340239301244,0.0265822383601
5,Prevalence,18,Thailand,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0397253717209,0.044850356614,0.0351314652448
5,Prevalence,18,Thailand,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.034935553682,0.0391889262485,0.0311355339009
5,Prevalence,18,Thailand,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2903.3611882200003,3287.98707989,2563.1622062700003
5,Prevalence,18,Thailand,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3923.81529942,4432.05121305,3470.9465690600005
5,Prevalence,18,Thailand,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3414.60345309,3837.03599944,3042.1783173100002
5,Prevalence,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,12528.1177128,14090.9387276,11108.568356
5,Prevalence,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,8381.51997376,9643.25190191,7350.83758036
5,Prevalence,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,20909.6376866,23391.8881481,18636.0559445
5,Prevalence,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0135042653642,0.0152066263262,0.0119935453541
5,Prevalence,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00871106775525,0.0100401664066,0.00764026014322
5,Prevalence,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0110639670532,0.0123739164768,0.00988250370511
5,Prevalence,35,Georgia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1291.32024523,1452.4060892700002,1145.00195021
5,Prevalence,35,Georgia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,857.5865903839999,986.685415612,752.128463184
5,Prevalence,35,Georgia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1073.65621787,1201.11340685,956.913631945
5,Prevalence,35,Georgia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,25957.0916377,29334.6738504,23173.1766124
5,Prevalence,35,Georgia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,33702.2685233,38177.2718799,29746.878356
5,Prevalence,35,Georgia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,59659.3601609,66677.8547027,53187.7943287
5,Prevalence,35,Georgia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0279797273967,0.0315904951419,0.0249724515765
5,Prevalence,35,Georgia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0350275208671,0.0397169239037,0.0309052339791
5,Prevalence,35,Georgia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.031567791222,0.0352276936985,0.028157912391
5,Prevalence,35,Georgia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2675.4951308199998,3023.63524182,2388.54653124
5,Prevalence,35,Georgia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3448.37376056,3906.25048012,3043.66320951
5,Prevalence,35,Georgia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3063.35499212,3423.7366695900005,2731.0566998599998
5,Prevalence,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,91.8055866342,126.026670136,65.8804446997
5,Prevalence,147,Libya,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,91.8055866342,126.026670136,65.8804446997
5,Prevalence,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.39379583811e-05,7.42226281564e-05,3.86273677616e-05
5,Prevalence,147,Libya,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.67505643477e-05,3.67831454283e-05,1.91814232058e-05
5,Prevalence,147,Libya,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,5.2507081524100006,7.2079411348,3.76795139328
5,Prevalence,147,Libya,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,147,Libya,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.62846366615,3.60823927566,1.8862071639799998
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,2600.97134017,3266.83033736,1535.03086514
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,2600.97134017,3266.83033736,1535.03086514
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.75395912765e-05,4.70867549187e-05,2.22147895742e-05
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.87570893114e-05,2.35041970884e-05,1.10864517636e-05
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.65674227762,4.59288282956,2.1581215353300003
5,Prevalence,11,Indonesia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.8434860284899999,2.31542577627,1.08798121282
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3193.80017882,4598.330138,2866.69218917
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3193.80017882,4598.330138,2866.69218917
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.60961065173e-05,6.64501030554e-05,4.13702883695e-05
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.30323991381e-05,3.31678685263e-05,2.06732414734e-05
5,Prevalence,11,Indonesia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.49020870003,6.464857171779999,4.03032296557
5,Prevalence,11,Indonesia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.26366431514,3.2591506230300005,2.03182054223
5,Prevalence,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,156.080837668,198.50298964,121.491358938
5,Prevalence,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,156.080837668,198.50298964,121.491358938
5,Prevalence,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,9.16963529278e-05,0.000116432002666,7.12149149961e-05
5,Prevalence,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.54776992735e-05,5.78431210613e-05,3.53830318147e-05
5,Prevalence,147,Libya,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,8.92685245883,11.3531355138,6.948549562289999
5,Prevalence,147,Libya,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.46871291644,5.68329134447,3.47838987177
5,Prevalence,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,32.9265503346,44.834277674,23.5290143806
5,Prevalence,151,Qatar,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,32.9265503346,44.834277674,23.5290143806
5,Prevalence,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.59294030699e-05,3.50292235891e-05,1.83895351608e-05
5,Prevalence,151,Qatar,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.95908891163e-05,2.65090498648e-05,1.39185365704e-05
5,Prevalence,151,Qatar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.49769394885,3.40097285958,1.7848294535399998
5,Prevalence,151,Qatar,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,151,Qatar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.89961337834,2.58659934954,1.35744649963
5,Prevalence,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,58.0471122982,71.5339566743,46.2206682954
5,Prevalence,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,58.0471122982,71.5339566743,46.2206682954
5,Prevalence,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.57099290171e-05,5.62980118974e-05,3.64196500288e-05
5,Prevalence,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.45362243278e-05,4.25501413475e-05,2.75101066922e-05
5,Prevalence,151,Qatar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.40325268399,5.42631793818,3.5061396453700002
5,Prevalence,151,Qatar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.3488801582699996,4.12696926109,2.66658362196
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,3.38825292855,4.77592370288,1.75159704999
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,3.38825292855,4.77592370288,1.75159704999
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.25027424091e-05,1.76491032139e-05,6.44180047328e-06
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.332915359e-06,8.93614221828e-06,3.26642458281e-06
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.22702765164,1.7295610950900002,0.634326321022
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.6247078337240001,0.88055910033,0.322950034052
5,Prevalence,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,364.250912807,406.773872513,326.37185435
5,Prevalence,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,182.561137419,204.236677825,162.787132187
5,Prevalence,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,546.812050226,604.328773475,495.803441102
5,Prevalence,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0209618136245,0.0233666794331,0.0187758300744
5,Prevalence,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0102493647191,0.0114698578838,0.00915192952724
5,Prevalence,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0155393096246,0.017188157849,0.0140568952823
5,Prevalence,74,Andorra,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1966.4758563100002,2196.04391135,1761.97876022
5,Prevalence,74,Andorra,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1007.19496306,1126.7795330699998,898.101216436
5,Prevalence,74,Andorra,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1492.03546815,1648.9760313,1352.85299409
5,Prevalence,74,Andorra,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,656.550502075,735.078107512,583.498450737
5,Prevalence,74,Andorra,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1088.12261078,1233.42446184,965.026244475
5,Prevalence,74,Andorra,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1744.67311286,1957.43591293,1550.77659567
5,Prevalence,74,Andorra,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0377830750371,0.0420918914562,0.0334460437331
5,Prevalence,74,Andorra,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0610893593417,0.0691737761076,0.0541979355477
5,Prevalence,74,Andorra,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0495801968673,0.0554862265194,0.0440202055954
5,Prevalence,74,Andorra,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3544.50919787,3968.45498556,3150.1242007200003
5,Prevalence,74,Andorra,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6003.20324614,6804.83767158,5324.07710861
5,Prevalence,74,Andorra,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4760.5281625299995,5341.07433716,4231.46066909
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,68.5988351808,90.1313153503,53.3119476116
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,68.5988351808,90.1313153503,53.3119476116
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.5120779779e-05,5.93137313544e-05,3.5055702929e-05
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.23998319014e-05,2.94219180663e-05,1.73787602956e-05
5,Prevalence,37,Kyrgyzstan,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.39004165118,5.76803129996,3.41174409017
5,Prevalence,37,Kyrgyzstan,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.19914229368,2.8894308052,1.70907506581
5,Prevalence,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,1912.04498204,2227.17281429,1626.53340342
5,Prevalence,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,996.876068183,1151.15642642,844.93149743
5,Prevalence,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,2908.92105023,3347.2832211,2487.142106
5,Prevalence,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0187691024168,0.0219574169203,0.0160071287572
5,Prevalence,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00934912334107,0.0107942600712,0.00791854031562
5,Prevalence,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0139516675543,0.0160619712392,0.0119416649972
5,Prevalence,14,Maldives,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1810.37470092,2108.7460574499996,1540.0447957
5,Prevalence,14,Maldives,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,923.888849104,1066.87342579,783.06904303
5,Prevalence,14,Maldives,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1362.3903232999999,1567.69681646,1164.85056809
5,Prevalence,14,Maldives,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,2915.0618535,3274.64497787,2600.4061207
5,Prevalence,14,Maldives,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,4194.94929993,4705.46071806,3708.24218444
5,Prevalence,14,Maldives,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,7110.01115343,7932.19214581,6336.22210474
5,Prevalence,14,Maldives,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0286148119535,0.0321344792123,0.0255380090387
5,Prevalence,14,Maldives,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0393419782023,0.0441846126791,0.0347659030726
5,Prevalence,14,Maldives,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0341006797885,0.0380392072364,0.0303985826692
5,Prevalence,14,Maldives,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2760.05757225,3100.52037379,2462.13321194
5,Prevalence,14,Maldives,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3887.8121408,4360.94598523,3436.7397446200002
5,Prevalence,14,Maldives,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3329.96675632,3715.03441841,2967.56341363
5,Prevalence,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1169.91112542,1533.45098227,887.157402951
5,Prevalence,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1169.91112542,1533.45098227,887.157402951
5,Prevalence,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000494345444957,0.000648092478615,0.000373981472957
5,Prevalence,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,0.000242710531216,0.000317877872799,0.000183874364001
5,Prevalence,76,Belgium,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,45.4570624893,59.582455120300004,34.4706265523
5,Prevalence,76,Belgium,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,22.9984761511,30.145055533,17.4400156821
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,166729.27508,193607.538248,144225.915892
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,79891.0496141,93799.5828865,68388.0744661
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,246620.324694,284864.976249,213750.049223
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0197031512216,0.0228922579254,0.0170504802648
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00923403801513,0.0108497147885,0.00789693271855
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0144104819991,0.0166348117952,0.0124771705367
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1920.46650817,2230.06303335,1661.2621925400001
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,915.1937302339999,1074.52324849,783.421137617
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1416.45287995,1636.10933732,1227.6639128900001
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,286817.409675,321051.951121,255096.158636
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,349588.72209,391546.591685,310532.7699
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,636406.131765,705315.022614,568134.312913
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0338940732918,0.0378952436728,0.0301563204585
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0404062335419,0.0452915990732,0.0359388574258
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.03718605906,0.0412112534981,0.0332359682304
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3303.69833957,3698.0279510799996,2938.31799357
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4004.72153216,4485.37085863,3557.31518633
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3655.1703484799996,4050.94550212,3263.0541895600004
5,Prevalence,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,81351.2039722,95759.5044428,69036.926665
5,Prevalence,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,48811.8006614,59123.755469,40287.3797109
5,Prevalence,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,130163.004634,152528.264161,111648.645482
5,Prevalence,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0174695567241,0.020562341022,0.0148248681148
5,Prevalence,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0106566693746,0.0129146802251,0.00880809354834
5,Prevalence,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0140912269241,0.0165405171013,0.0120692110767
5,Prevalence,153,Syria,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1709.1921306099998,2011.91111419,1450.46865953
5,Prevalence,153,Syria,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1057.6143618199999,1281.04540422,872.914147912
5,Prevalence,153,Syria,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1388.41975124,1626.9849883900001,1190.93120985
5,Prevalence,153,Syria,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,170862.68862,193907.139409,153260.418696
5,Prevalence,153,Syria,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,240497.067219,271470.386144,211413.803158
5,Prevalence,153,Syria,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,411359.755839,463386.730304,366425.017076
5,Prevalence,153,Syria,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0366906158469,0.041586044212,0.0328637670734
5,Prevalence,153,Syria,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0525054511726,0.0592964479387,0.0461912914683
5,Prevalence,153,Syria,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0445324640247,0.0500313790939,0.0396426604154
5,Prevalence,153,Syria,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3589.8320927600003,4073.9969485799998,3220.0076799999997
5,Prevalence,153,Syria,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5210.89467752,5881.99933838,4580.74218688
5,Prevalence,153,Syria,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4387.88280494,4942.8429424,3908.57396453
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,320.717240391,437.388659816,183.374639446
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,320.717240391,437.388659816,183.374639446
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.26214021137e-05,3.08468821079e-05,1.29399203744e-05
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.10663595745e-05,1.51020613076e-05,6.3281143167e-06
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.20794563398,3.0111583044800003,1.26242429017
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.0889144398300001,1.4850427963,0.622602303974
5,Prevalence,149,Palestine,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,63513.5761378,71461.8561568,56937.2192063
5,Prevalence,149,Palestine,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,73812.5394954,83340.8686338,65032.1044154
5,Prevalence,149,Palestine,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,137326.115633,153350.958723,123626.296171
5,Prevalence,149,Palestine,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0529370022349,0.0594243144073,0.0475111191856
5,Prevalence,149,Palestine,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0625313263392,0.0706239410782,0.0551389938772
5,Prevalence,149,Palestine,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0576949147149,0.0645296544411,0.0520207686449
5,Prevalence,149,Palestine,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,5174.6689860999995,5822.24263268,4638.87062103
5,Prevalence,149,Palestine,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,6208.26957932,7009.6840318899995,5469.75945119
5,Prevalence,149,Palestine,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,5683.24461342,6346.43313189,5116.277254
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,418.747951949,559.152193728,319.312721197
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,418.747951949,559.152193728,319.312721197
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.95351059729e-05,3.94697711254e-05,2.24897827386e-05
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.44486833947e-05,1.92925380957e-05,1.10054933151e-05
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.8828282231299998,3.84942712579,2.1982763626399997
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.42175297771,1.89846014225,1.08414574941
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,3594.61215232,3987.29212158,3243.12199129
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,1868.5746962,2099.02295484,1641.48617316
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,5463.18684853,6016.62815976,4940.016335
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.016591035818,0.0184001379232,0.0149620773175
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00759488532904,0.00853018977424,0.00668953497742
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0118073849488,0.0129636724281,0.0106585063571
5,Prevalence,77,Cyprus,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1554.8140842199998,1724.66393753,1402.78047678
5,Prevalence,77,Cyprus,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,746.603955322,838.6813990239999,655.86892083
5,Prevalence,77,Cyprus,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1134.69136932,1249.6398594,1026.0300544400002
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,52793.2618933,59365.1837126,46813.9795449
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,74295.9802927,84021.5840408,65111.2032064
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,127089.242186,143079.786914,112899.039249
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0240572577496,0.0270247206334,0.0213197219456
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0334864606817,0.0378642598855,0.0293197950907
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0287977009433,0.0323874228918,0.0255853436662
5,Prevalence,39,Tajikistan,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2313.76979856,2601.7973550799998,2051.71584662
5,Prevalence,39,Tajikistan,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3304.74904176,3737.3522531300005,2896.202265
5,Prevalence,39,Tajikistan,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2805.5906062100003,3158.59390771,2492.33120379
5,Prevalence,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,45.3790957676,70.4652218855,30.569877816
5,Prevalence,150,Oman,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,45.3790957676,70.4652218855,30.569877816
5,Prevalence,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.04828335024e-05,3.18185365514e-05,1.37674930501e-05
5,Prevalence,150,Oman,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.45241661523e-05,2.25541523969e-05,9.76537483837e-06
5,Prevalence,150,Oman,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.00211225585,3.10890470517,1.34873394897
5,Prevalence,150,Oman,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,150,Oman,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.42567642272,2.2138080048699997,0.960414774921
5,Prevalence,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1.21816535415,1.7751366984,0.850152926475
5,Prevalence,14,Maldives,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1.21816535415,1.7751366984,0.850152926475
5,Prevalence,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.19576174412e-05,1.74156060067e-05,8.33484618804e-06
5,Prevalence,14,Maldives,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,5.84246069156e-06,8.51451592654e-06,4.07444577091e-06
5,Prevalence,14,Maldives,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.15339113849,1.68074632116,0.80494724991
5,Prevalence,14,Maldives,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,14,Maldives,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.570526549888,0.831383533168,0.398168290015
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,60.493848124,86.193741661,41.5313509473
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,60.493848124,86.193741661,41.5313509473
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,2.08108285531e-05,2.97606951826e-05,1.43375624436e-05
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.01613292301e-05,1.4525129635e-05,6.99293109049e-06
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.02144105357,2.88021961501,1.38779694826
5,Prevalence,154,Tunisia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.9970459357739999,1.42062577398,0.684510342016
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,203.456072186,262.734779033,156.144614333
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,203.456072186,262.734779033,156.144614333
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.99918854629e-05,9.08130064392e-05,5.37597471372e-05
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.41751219973e-05,4.42523096215e-05,2.62428056782e-05
5,Prevalence,154,Tunisia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.798616217519999,8.77945253952,5.21767325926
5,Prevalence,154,Tunisia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.35331700946,4.33033526126,2.57354025147
5,Prevalence,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,76.9075828298,102.157396495,59.6716944539
5,Prevalence,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,76.9075828298,102.157396495,59.6716944539
5,Prevalence,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.47142117267e-05,4.64347153245e-05,2.69516241055e-05
5,Prevalence,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.46154865865e-05,3.28876150601e-05,1.91127673917e-05
5,Prevalence,150,Oman,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.39313976065,4.50715405606,2.63269747387
5,Prevalence,150,Oman,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.41620785329,3.2094820120699996,1.8747074274599997
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,81550.4627548,95223.2347451,70466.8448324
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,45727.3085296,53076.0655883,38967.6074564
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,127277.771284,147132.276488,109744.42363
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0171739394267,0.0200507422934,0.0148718196756
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00870667589127,0.0101209196624,0.00741786490083
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0127271694513,0.0146791183997,0.0110050082657
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1636.79927211,1911.22546769,1414.33998574
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,856.635878769,994.3043566059999,730.002524318
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1233.27314369,1425.65573966,1063.38168061
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,172567.996523,191832.539002,154607.88962
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,221312.147762,247326.32726,196951.105919
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,393880.144284,436607.913359,356294.670597
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0363418321425,0.0404805934946,0.0326468676918
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0421388497673,0.0471210837961,0.037542176002
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0393862078769,0.0436480837409,0.0356212077746
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3463.6121188899997,3850.27073544,3103.13482775
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,4145.96730655,4633.3058408199995,3689.5979474499995
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3816.5486312099997,4230.56444527,3452.35970156
5,Prevalence,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,1244.87503083,1884.23872121,428.909277695
5,Prevalence,18,Thailand,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,1244.87503083,1884.23872121,428.909277695
5,Prevalence,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,7.34107464349e-05,0.000110999639507,2.52877271907e-05
5,Prevalence,18,Thailand,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.62432068335e-05,5.4812233414e-05,1.24885590914e-05
5,Prevalence,18,Thailand,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,7.098829562740001,10.744764901,2.4458309347
5,Prevalence,18,Thailand,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,18,Thailand,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.5423524377699995,5.3616929106199995,1.22048220729
5,Prevalence,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,80.0332996748,116.312529919,47.6115329815
5,Prevalence,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,80.0332996748,116.312529919,47.6115329815
5,Prevalence,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.2165438033e-05,1.76415153554e-05,7.24635346688e-06
5,Prevalence,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.08130372501e-06,8.83555691289e-06,3.61826432138e-06
5,Prevalence,7,North Korea,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.16917547371,1.69916469544,0.695538442798
5,Prevalence,7,North Korea,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.592029404479,0.8603973358760001,0.352196243712
5,Prevalence,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,494324.005837,580801.434478,421903.080906
5,Prevalence,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,241555.068223,282106.33566,205924.885693
5,Prevalence,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,735879.07406,855211.980355,631378.616532
5,Prevalence,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0183733609732,0.0215879059611,0.0157137458053
5,Prevalence,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00916689724462,0.0107074745504,0.00781492055912
5,Prevalence,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0138179613081,0.0160457197118,0.0118474506714
5,Prevalence,16,Philippines,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1808.7166823599998,2125.1349950100002,1543.73069437
5,Prevalence,16,Philippines,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,911.7581162859999,1064.82030406,777.2707368829999
5,Prevalence,16,Philippines,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1367.20970048,1588.9215453,1173.0554647200001
5,Prevalence,16,Philippines,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,676656.413907,761928.992763,599483.30463
5,Prevalence,16,Philippines,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,883957.205153,1002894.47572,781225.957899
5,Prevalence,16,Philippines,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1560613.61906,1749827.00178,1387041.06724
5,Prevalence,16,Philippines,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0251505546333,0.0283157648538,0.0222565246934
5,Prevalence,16,Philippines,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0335456273644,0.0380510439232,0.029666772192
5,Prevalence,16,Philippines,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0293044834206,0.0328333759372,0.0260431539209
5,Prevalence,16,Philippines,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2475.8654841899997,2787.87528768,2193.4913964800003
5,Prevalence,16,Philippines,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3336.5276173899997,3785.46053593,2948.76490486
5,Prevalence,16,Philippines,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,2899.5063916,3251.05106985,2577.02123752
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,173009.004985,194711.8353,153931.595423
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,81587.4753729,94092.7205441,71116.3460361
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,254596.480358,287011.555228,226460.946242
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0162979053765,0.0183109202569,0.0145062419576
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0105060233175,0.0121160391409,0.00916070147924
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0138509225504,0.0156347442152,0.0123241263671
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1590.60613911,1790.1371123,1415.21269777
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1043.00786191,1202.87393166,909.1457688450001
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1361.5331828800001,1534.88279086,1211.06973868
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,431922.356286,482973.45855,389991.904074
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,394179.770475,441808.171643,349001.103814
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,826102.126761,920912.870854,740485.251966
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0406883014369,0.0454473207695,0.0366900558828
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0507585793989,0.05688188785,0.0449600311244
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0449428514197,0.0500458040582,0.0403036797467
5,Prevalence,152,Saudi Arabia,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3970.99764599,4440.35007465,3585.49843622
5,Prevalence,152,Saudi Arabia,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5039.16315259,5648.04088341,4461.60263484
5,Prevalence,152,Saudi Arabia,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4417.83584933,4924.86553802,3959.97321162
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,3.46978125002,6.64270088022,2.33163141188
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,3.46978125002,6.64270088022,2.33163141188
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.28037553196e-05,2.451968733e-05,8.59489615988e-06
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.48530038344e-06,1.24163009363e-05,4.35725520892e-06
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.2565524559999999,2.40559894242,0.8443809467969999
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.639739586715,1.2247454261700002,0.429893646983
5,Prevalence,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,141.05345661,204.409682419,62.8049666983
5,Prevalence,153,Syria,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,141.05345661,204.409682419,62.8049666983
5,Prevalence,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.02906593447e-05,4.38536778024e-05,1.34463219152e-05
5,Prevalence,153,Syria,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.52703817073e-05,2.20739897161e-05,6.78353129258e-06
5,Prevalence,153,Syria,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,2.96353890614,4.29465580779,1.31953492514
5,Prevalence,153,Syria,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,153,Syria,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.5045857745,2.18039251024,0.669926577718
5,Prevalence,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,754.438951006,937.184141434,612.703571371
5,Prevalence,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,754.438951006,937.184141434,612.703571371
5,Prevalence,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,4.44892508506e-05,5.5357730684e-05,3.60518149617e-05
5,Prevalence,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.1964527572e-05,2.73272211708e-05,1.77761243834e-05
5,Prevalence,18,Thailand,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,4.30214551345,5.34423964188,3.4939075151499996
5,Prevalence,18,Thailand,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.14679272301,2.6668030491700003,1.74347780775
5,Prevalence,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,313229.192387,375255.699739,262981.090277
5,Prevalence,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,246561.452074,297087.159569,205130.911897
5,Prevalence,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,559790.644462,664978.005405,473795.722745
5,Prevalence,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0153481704313,0.0183420173377,0.0128786869248
5,Prevalence,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0117263134826,0.0141299869085,0.0097654902306
5,Prevalence,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0135102191226,0.016040118508,0.0114277269521
5,Prevalence,155,Turkey,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1479.14459948,1772.0488868300001,1241.8608127900002
5,Prevalence,155,Turkey,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,1160.68655069,1398.53601442,965.6525323239999
5,Prevalence,155,Turkey,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1319.66651263,1567.63821269,1116.93961898
5,Prevalence,155,Turkey,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,695025.403607,776282.044941,621020.486475
5,Prevalence,155,Turkey,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,1196491.58326,1332816.207,1068761.78106
5,Prevalence,155,Turkey,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,1891516.98687,2090271.77156,1709730.82166
5,Prevalence,155,Turkey,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0340562506241,0.0381043562742,0.0304954742639
5,Prevalence,155,Turkey,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0569044483668,0.0634042615344,0.050828095282
5,Prevalence,155,Turkey,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0456507018607,0.0504213999482,0.0412237884305
5,Prevalence,155,Turkey,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,3282.07937585,3665.7930434200002,2932.6101176499997
5,Prevalence,155,Turkey,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,5632.47692217,6274.22426738,5031.18964756
5,Prevalence,155,Turkey,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,4459.116368479999,4927.66659555,4030.5684513999995
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,51.6155066891,72.8686204754,29.2956802115
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,51.6155066891,72.8686204754,29.2956802115
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.25643288579e-05,1.77187797277e-05,7.11339062779e-06
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,6.14590683298e-06,8.67383213474e-06,3.48282473442e-06
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.2247958679100002,1.72911574416,0.6951637283509999
5,Prevalence,10,Cambodia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.604393284327,0.853257241448,0.34303862376600003
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,101.110357847,142.373975104,75.8641959219
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,101.110357847,142.373975104,75.8641959219
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,2.46125406728e-05,3.4800526864e-05,1.84189365231e-05
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.20393282974e-05,1.69921587406e-05,9.02245026225e-06
5,Prevalence,10,Cambodia,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,2.3992702278499998,3.3784238030700005,1.80019842191
5,Prevalence,10,Cambodia,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.18395469072,1.66713222315,0.888334019702
5,Prevalence,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,39894.3706569,47531.3277661,33546.3240329
5,Prevalence,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,16876.1540184,19778.8593061,14291.1237286
5,Prevalence,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,56770.5246753,66564.5299996,48170.5639103
5,Prevalence,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0222511112376,0.0264961907607,0.0186804028238
5,Prevalence,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00921850374542,0.0108018637992,0.00781171533646
5,Prevalence,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.015666889675,0.0183901926419,0.013301010365
5,Prevalence,12,Laos,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,2176.19585782,2592.78381631,1829.91660737
5,Prevalence,12,Laos,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,914.0447306840001,1071.26079248,774.0345534559999
5,Prevalence,12,Laos,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1542.87351841,1809.04881872,1309.14920814
5,Prevalence,12,Laos,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,48181.0767213,54035.8969744,42481.6552424
5,Prevalence,12,Laos,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,62622.7238884,70849.7442399,55335.4229814
5,Prevalence,12,Laos,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,110803.80061,124477.224699,98307.0545577
5,Prevalence,12,Laos,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0268731712133,0.0301871069723,0.0236721056505
5,Prevalence,12,Laos,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0342075436455,0.0386997704065,0.0302308763496
5,Prevalence,12,Laos,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0305785222473,0.0343322951056,0.0271489815853
5,Prevalence,12,Laos,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2628.22693677,2947.60120872,2317.3295041300003
5,Prevalence,12,Laos,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3391.76631885,3837.35745255,2997.0721848900002
5,Prevalence,12,Laos,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3011.3558167399997,3382.96351376,2671.72713337
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,288.056114606,411.494974999,204.742438328
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,288.056114606,411.494974999,204.742438328
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.40393756564e-05,4.87008270789e-05,2.41446701001e-05
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.68312830169e-05,2.40900655413e-05,1.19517067968e-05
5,Prevalence,13,Malaysia,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.31796632779,4.73979340092,2.35832006959
5,Prevalence,13,Malaysia,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,13,Malaysia,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.65443749872,2.3634031102099997,1.17592909983
5,Prevalence,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,1.57567496312,1.96442513707,1.25607522364
5,Prevalence,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,1.57567496312,1.96442513707,1.25607522364
5,Prevalence,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,1.54671611638e-05,1.93594843668e-05,1.23165611759e-05
5,Prevalence,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,7.55718347407e-06,9.45415921685e-06,6.01346911417e-06
5,Prevalence,14,Maldives,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,1.4918906808599999,1.8599696154599998,1.18928520441
5,Prevalence,14,Maldives,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,0.737965824909,0.920036587925,0.58828160011
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,211196.867211,246319.485902,182317.041741
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,119044.482956,137307.761681,101807.3219
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,330241.350166,378641.893702,287774.554541
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0148961510046,0.0173792640195,0.0128708541568
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00804153527131,0.0092697427414,0.00686370847192
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0113948167527,0.0130761754233,0.00992410960542
5,Prevalence,15,Myanmar,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1453.96362322,1695.76176447,1255.14336498
5,Prevalence,15,Myanmar,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,797.4930485,919.84090927,682.019271161
5,Prevalence,15,Myanmar,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1121.25115066,1285.58297981,977.065864853
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,1,Number,2016,154.336673802,225.7379222,87.1677695309
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,438,Prostate cancer,1,Number,2016,0.0,0.0,0.0
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,1,Number,2016,154.336673802,225.7379222,87.1677695309
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,2,Percent,2016,3.25024435457e-05,4.7408384284e-05,1.83757787332e-05
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,438,Prostate cancer,2,Percent,2016,0.0,0.0,0.0
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,2,Percent,2016,1.54329534342e-05,2.25686827432e-05,8.7208493228e-06
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,438,Prostate cancer,3,Rate,2016,3.09769125529,4.53078565424,1.7495442318799999
5,Prevalence,17,Sri Lanka,2,Female,24,15-49 years,438,Prostate cancer,3,Rate,2016,0.0,0.0,0.0
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,438,Prostate cancer,3,Rate,2016,1.49546360662,2.1873145181,0.84462249828
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,1,Number,2016,317.174197427,391.322135389,256.845991513
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,1,Number,2016,317.174197427,391.322135389,256.845991513
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,2,Percent,2016,6.67950965603e-05,8.25344415019e-05,5.39030068371e-05
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,2,Percent,2016,3.1716024376e-05,3.91704962359e-05,2.56429129237e-05
5,Prevalence,17,Sri Lanka,1,Male,24,15-49 years,468,Testicular cancer,3,Rate,2016,6.36600306049,7.854226263479999,5.1551556883
5,Prevalence,17,Sri Lanka,3,Both,24,15-49 years,468,Testicular cancer,3,Rate,2016,3.07329721137,3.79176249896,2.48873986558
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,1,Number,2016,5291.78160872,6274.40785732,4437.8793303
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,1,Number,2016,2555.65151606,2994.59254589,2145.43634099
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,1,Number,2016,7847.43312478,9228.78861359,6671.97432998
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0195269127172,0.0232097052642,0.0164214916559
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.00967968547274,0.0113477987236,0.00812903941547
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,2,Percent,2016,0.0146674909671,0.0172698595639,0.0124745889033
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,561,Drug use disorders,3,Rate,2016,1916.37475042,2272.22468362,1607.1411337200002
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,561,Drug use disorders,3,Rate,2016,959.908772217,1124.77606432,805.830979305
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,561,Drug use disorders,3,Rate,2016,1446.86747154,1701.5543598000002,1230.14270724
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,567,Depressive disorders,1,Number,2016,7997.82612816,9084.67631437,7064.58453337
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,567,Depressive disorders,1,Number,2016,10365.6260261,11676.1085556,9190.13374668
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,567,Depressive disorders,1,Number,2016,18363.4521542,20571.8930538,16372.7952788
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0295122527972,0.0335429746152,0.02605440359
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0392602875993,0.0441819342112,0.0347573315394
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,567,Depressive disorders,2,Percent,2016,0.0343226530907,0.0385311275338,0.0305783352737
5,Prevalence,19,Timor-Leste,1,Male,24,15-49 years,567,Depressive disorders,3,Rate,2016,2896.3462938499997,3289.9400602499995,2558.3806028
5,Prevalence,19,Timor-Leste,2,Female,24,15-49 years,567,Depressive disorders,3,Rate,2016,3893.3537258099996,4385.574072779999,3451.8360370499995
5,Prevalence,19,Timor-Leste,3,Both,24,15-49 years,567,Depressive disorders,3,Rate,2016,3385.7544453899995,3792.93488894,3018.72784775
